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I. SUMMARY 
 
To protect genome integrity, the cell needs to respond to DNA damage instantly. However, 
investigations of these events are not straightforward, as damage has to be induced in a locus- 
and time-resolved manner to study subsequent changes around the damage site.  
In addition to this, DNA damage factors often play major roles in cell cycle regulation. Hence, 
the possibilities to study function of DNA damage factors in mutant backgrounds is often 
limited to the viability of the mutant organism. 
To dissect damage-associated processes in the context of chromatin, I applied an in vitro 
system, where chromatin was reconstituted by Drosophila embryo extract and DNA double 
strand breaks were simulated by free DNA ends of recombinant DNA fragments. This system 
allows the purification of chromatin for detailed analysis by mass spectrometry and Western 
blot analysis after distinct time points by immobilization to paramagnetic beads. Furthermore, 
reconstitution of chromatin with defined properties, including nucleosomes with histone 
variant or mutant histones could be used to better understand the DNA damage response. In 
addition to this, the biochemical analysis allowed to modify reaction conditions, for example 
by omitting ATP. 
I demonstrated that Drosophila embryo extract is able to mount a DNA damage response with 
endogenous factors. This DNA damage response is characterized by the recruitment of DNA 
damage-associated factors like the Ku and RPA complexes and phosphorylation of the histone 
variant H2A.V (gH2A.V) at its H2A.X-like C-terminal motif. This phosphorylation mark has been 
shown to spread along DNA including free DNA ends. 
I was able to dissect this spreading event and showed that phosphorylation of H2A.V initiated 
very rapidly and spread over long distances in cis. However, H2A.V phosphorylation did not 
spread in trans to circular DNA molecules, unless DNA-DNA bridging proteins were added. In 
these cases, spreading of H2A.V to circular DNA fragments was observed. Furthermore, 
phosphorylation of H2A.V was not initiated by nucleosomes including the phospho-mimic form 
of H2A.V in the absence of DNA damage. 
I furthermore showed that the recruitment of Ku is independent from the phosphorylation of 
H2A.V, or even the presence of H2A.V in general.  
In addition to this, I applied the in vitro system to investigate the role of the chromatin 
remodeling complex ACF in the incorporation and turnover processes of H2A.V and to address 
the role of ACF in the DNA damage response. 
To summarize, this study established a cell-free system that can be used to study the DNA 
damage response of Drosophila at a mechanistic level and demonstrated its potential by 
monitoring the spreading of the damage-associated gH2A.V mark along extended chromatin 
regions. 
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II. ZUSAMMENFASSUNG 
 
Um ihre Genomintegrität zu schützen, muss die Zelle umgehend auf Zellschäden reagieren. Die 
Analyse dieser Prozesse ist jedoch nicht trivial, da dazu ein zeitlich und räumlich definierter 
DNA-Bruch induziert werden muss, um die darauffolgenden Prozesse am Bruch zu erfassen. 
Außerdem haben DNA-Reparaturfaktoren häufig wichtige Funktionen in der Regulation des 
Zellzyklus. Darum sind die Möglichkeiten zur Analyse derer Funktionen durch die 
Überlebensfähigkeit der Mutanten limitiert. 
Zur Erforschung der Vorgänge nach Induzieren des DNA-Bruchs habe ich ein in vitro-System 
verwendet, in welchem Chromatin mithilfe eines Drosophila Embryonen-Extrakts assembliert 
und DNA-Brüche durch freie DNA-Enden simuliert werden. Durch Immobilisieren der DNA an 
paramagnetische Partikeln wird eine Aufreinigung des Chromatins für differenzierte Analysen 
bestimmter Zeitpunkte mithilfe von Massenspektrometrie oder Western Blots ermöglicht. 
Außerdem ermöglicht das System die Herstellung von Chromatin mit definierten 
Eigenschaften, zum Beispiel aus Nukleosomen mit Histon-Varianten oder -Mutanten, um 
Vorgänge nach Erkennen eines DNA-Schadens besser zu verstehen. Schließlich ermöglicht 
diese biochemische Analyse die Modifikation von Reaktionsbedingungen, etwa durch den 
Verzicht von ATP. 
Ich konnte zeigen, dass Drosophila Embryonen-Extrakt mithilfe endogener Faktoren eine 
Antwort auf DNA-Schäden initiieren kann. Diese Reaktion zeichnet sich durch die Rekrutierung 
von DNA-Schaden-assoziierten Faktoren aus, wie den Ku- und den RPA-Komplex, und durch die 
Phosphorylierung der Histon-Variante H2A.V (gH2A.V) an ihrem H2A-X-ähnlichen C-terminalen 
Motiv. Diese Phosphorylierung wandert entlang der DNA, welche freie DNA-Enden beinhaltet. 
Zudem konnte ich den Ausbreitungsprozess der Phosphorylierung aufgliedern und zeigen, dass 
die Phosphorylierung rapide initiiert wird und sich in cis über lange Distanzen ausbreitet. Diese 
Ausbreitung erfolgte jedoch nicht in trans, solange keine DNA-DNA-verknüpfenden Proteine 
zugegeben wurden. Diese konnten dann eine Ausbreitung der Phosphorylierung auf zirkuläre 
DNA-Fragmente ermöglichen. Des Weiteren wurde in Abwesenheit von DNA-Brüchen keine 
Phosphorylierung durch Nukleosome initiiert, welche eine Phospho-Mimik-Mutante besaßen. 
Schließlich konnte ich demonstrieren, dass die Rekrutierung von Ku unabhängig von der H2A.V-
Phosphorylierung, und von H2A.V selbst stattfindet. 
So konnte ich schließlich das in vitro-System zur Untersuchung der Rolle des Chromatin-
Remodeling-Komplexes ACF im Einbau und Umbau von H2A.V und in der Antwort auf DNA-
Schäden verwenden. 
Zusammenfassend wurde mit dieser Studie ein zellfreies System etabliert, welches zur Analyse 
der Antwort auf DNA-Schäden in Drosophila auf mechanistischer Ebene verwendet werden 
kann und welches sein Potential zur Veranschaulichung der DNA-Bruch-abhängigen 
Phosphorylierungs-Ausbreitung entlang der DNA beweisen konnte. 
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III. INTRODUCTION 
A. CHROMATIN 
1. THE COMPOSITION OF CHROMATIN 
 
The human genome consists of 3.2*109 base pairs resulting in about 2 m double-stranded DNA, 
which needs to be packed and organized in the nucleosome of about 6 µm diameter in size 
(Alberts 2017). The first level of organization is achieved by nucleosomes, which are repetitive 
building blocks composed of histone octamers with 147 bp of DNA wrapped around in a left-
handed helical turn (Kornberg 1974), forming a so-called beads-on-a-string-structure (P. Zhu & 
G. Li 2016; Cutter & Hayes 2015; Khorasanizadeh 2004; Luger et al. 2012). The octamer, in turn, 
is comprised of a tetramer with two histones H3 and H4 and two associated dimers of histones 
H2A and H2B (Luger et al. 1997). On top of this, the beads-on-a-string-structure is organized 
into chromatin loops and tertiary structures (Dixon et al. 2016; Hansen et al. 2018). According 
to the current state of knowledge, DNA loops are often formed to regulate the expression of 
chromatin and are mediated by cohesin, which brings together different regions on the 
genome (reviewed in Hansen et al. 2018). Chromatin structure is not only regulated by the 
histones forming the nucleosome, but also by high-mobility group proteins, which can bind and 
modify specific DNA structures and thereby affect transcription (Reeves 2015). Finally, 
chromatin structure is also regulated by long non-coding RNA, which has been shown to be 
able to act on nucleosome positioning and loop formation (reviewed in Böhmdorfer & 
Wierzbicki 2015). Chromatin fibers are organized into chromosomes (reviewed in Gilbert et al. 
2005). A simplified illustration of chromatin composition is shown in Figure 1. 
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FIGURE 1: CHROMATIN IS COMPOSED OF DNA WRAPPED AROUND HISTONES AND OTHER ASSOCIATED 
NON-HISTONE PROTEINS LIKE CHROMATIN REMODELERS AND OTHER COMPONENTS LIKE NON-CODING 
RNA (FIGURE ADAPTED FROM AMERICAN ASSOCIATION FOR CANCER RESEARCH HUMAN EPIGENOME 
TASK FORCEEUROPEAN UNION, NETWORK OF EXCELLENCE, SCIENTIFIC ADVISORY BOARD 2008). 
 
2. CHROMATIN ORGANIZATION 
 
Binding of chromatin components is highly regulated and results in the formation of chromatin 
domains, which are characterized by the abundance of histone modifications, structural 
proteins, enzymes, and non-coding RNA, which determine the functional state of this 
chromatin domain. According to this observation, five chromatin states have been described: 
Blue and black chromatin states have been described as transcriptionally inactive, with black 
as repressed “void” chromatin, and blue as Polycomb Group Protein (PcG)-regulated 
chromatin. PcG proteins in turn are essential during the development of Drosophila to keep 
developmental genes in a repressed state in tissues where they should not be expressed 
(reviewed in Schuettengruber et al. 2017; Dorafshan et al. 2017; Kassis et al. 2017). 
Red and yellow were described as highly transcribed, but differently regulated chromatin, and 
green as HP1-bound chromatin (Filion, van Bemmel, Braunschweig, Talhout, Kind, L. D. Ward, 
Brugman, de Castro, Kerkhoven, Bussemaker & van Steensel 2010). The chromosome is 
organized in topologically associated domains (TADs), resulting in the formation of regulatory 
units of chromatin domains composed of similar chromatin components (Figure 2). 
 - Introduction - 
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FIGURE 2: ORGANIZATION OF CHROMATIN INTO TOPOLOGICALLY ASSOCIATED DOMAINS (TADS) (FIGURE 
ADAPTED FROM SCHWARTZ & CAVALLI 2017). CHROMATIN REGIONS ARE CHARACTERIZED ACCORDING 
TO THEIR EPIGENETIC MODIFICATIONS, WHICH DEFINE THEIR CHROMATIN STATE. THESE CHROMATIN 
STATES WERE DESCRIBED AS TRANSCRIPTIONALLY INACTIVE, WITH “BLACK” AS REPRESSED “VOID” 
CHROMATIN, AND “BLUE” AS POLYCOMB GROUP PROTEIN (PCG)-REGULATED CHROMATIN, OR AS HIGHLY 
TRANSCRIBED WITH “RED” AND “YELLOW”, AND “GREEN” AS HP1-BOUND CHROMATIN (FILION, VAN 
BEMMEL, BRAUNSCHWEIG, TALHOUT, KIND, L. D. WARD, BRUGMAN, DE CASTRO, KERKHOVEN, 
BUSSEMAKER & VAN STEENSEL 2010). THESE CHROMATIN STATES ARE ORGANIZED WITHIN 
TOPOLOGICALLY ORGANIZED DOMAINS (TADS) BY BINDING OF INSULATORS. TADS CAN BE MEASURED BY 
HI-C, A METHOD, WHICH DETERMINES THE CONTACT FREQUENCIES OF DNA REGIONS WITH OTHER DNA 
REGIONS. 
 
Processes like transcription require transient access to DNA regions and therefore, 
nucleosomes need to be remodeled in an ATP-dependent process. This task is mediated by 
chromatin remodeling complexes, which are, according to their ATPase subunits, divided into 
different subclasses with specific functions: The Swi/Snf family, the Iswi family, the Chd family, 
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and the Ino80 family (reviewed in Clapier & Cairns 2009). Depending on situation and 
requirements, they can modify chromatin by sliding or evicting nucleosomes or by exchange of 
histones (reviewed in Becker & Workman 2013). To avoid an unintended DNA damage 
response at the ends of the chromosomes, the telomeres, these DNA ends form specific 
structures consisting of typical repeat sequences and a telomeric loop (T-loop), which are 
bound by telomere-specific proteins (reviewed in O'Sullivan & Karlseder 2010). 
 
3. TECHNIQUES TO INVESTIGATE CHROMATIN COMPOSITION AND ORGANIZATION 
 
In the last decades, many techniques have been developed to investigate protein-DNA contacts 
or DNA-DNA contacts, to better understand the 3-dimensional organization of chromatin by 
DNA-binding proteins. 
The most common method to map protein-DNA contacts is by chromatin immunoprecipitation 
(ChIP). Here, protein binding to DNA is captured by cross-linking reagents (e.g. formaldehyde), 
and after fragmentation of chromatin by either sonication or micrococcal nuclease (MNase) 
treatment, the cross-linked protein-DNA complex is purified by immunoprecipitation with 
antibodies against the target of interest. After de-crosslinking, the isolated DNA fragments are 
purified and analyzed by qPCR or sequencing to identify the sequences to which the protein of 
interest had been bound.  
Other indirect ways to investigate binding of chromatin-associated factors test for the 
accessibility of chromatin. Examples are MNase-Seq and DNase-Seq, in which DNA not 
protected by protein binding are digested and the remaining DNA is purified and sequenced to 
identify regions, which are occupied by nucleosomes and other DNA binding proteins. ATAC-
Seq, another approach to investigate DNA accessibility, utilizes transposases, which integrate 
adapters into accessible chromatin regions, that can be identified by sequencing. Finally, FAIRE-
Seq identifies accessible chromatin regions by isolation of free DNA from protein-associated 
DNA by phenol-chloroform extraction after fragmentation. The listed techniques are reviewed 
in P. J. Park 2009; Furey 2012; Tsompana & Buck 2014. 
To capture the three-dimensional chromatin organization, different techniques called 
chromosome conformation capture (3C) and variants thereof called 4C, 5C, Capture C, Hi-C, or 
Capture Hi-C have been developed. The common principle of these techniques is the cross-
linking of DNA regions, which are in close proximity to each other in the nucleus through DNA-
interacting proteins. After cross-linking, DNA is fragmented by DNA restriction enzymes and 
the cross-linked DNA fragments are ligated in a highly diluted reaction, resulting in ligation 
products of the proximal DNA regions. Depending on the variations of these techniques, these 
ligation products are processed and analyzed in different ways to identify the chromosome 
conformation. A similar approach, but with an additional chromatin immunoprecipitation step 
to isolate the DNA-interacting protein, is ChIA-PET. An overview of the methods described can 
be found in de Wit & de Laat 2012; Denker & de Laat 2016; Sati & Cavalli 2016. 
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B. HISTONE VARIANTS 
 
1. PROPERTIES OF HISTONE VARIANTS  
 
Besides canonical histones H2A, H2B, H3 and H4, several histone variants have been described, 
predominantly of histone H2A and H3. Histone variants differ from their canonical part in their 
amino acid sequence and often include additional protein domains. In addition to this, 
transcription of canonical histones differs from transcription of variant in many ways: genes of 
canonical histones do not contain intron sequences, are only expressed in S-phase and their 
mRNA is not polyadenylated. Instead, its mRNA contains a stabilizing loop structure at its 3’end. 
In contrast to this, histone variant genes may contain introns and their mRNA is generally 
polyadenylated. In addition to this, expression of histone variant genes is not limited to S-phase 
(reviewed in Bönisch & Hake 2012; Buschbeck & Hake 2017). Histone variants can influence 
the chromatin structure and recruit factors involved in the regulation of transcription, DNA 
repair or cell cycle control (reviewed in Bönisch et al. 2008; Zink & Hake 2016). 
 
2. H2A VARIANTS 
 
H2A contributes the largest number of histone variants. Among those, two variants are 
common in most organisms (reviewed in Bönisch & Hake 2012). These are H2A.X, a variant 
mainly involved in the DNA damage response, and H2A.Z, which has important roles in the 
regulation of transcription (reviewed in Talbert & Henikoff 2010). 
H2A.X contains a characteristic C-terminal SQ motif, which is conserved from fly and frog to 
mouse and human and is phosphorylated in response to DNA double-strand breaks (DSBs) by 
DNA damage-associated kinases (reviewed in Kinner et al. 2008, also see III.B.5). 
Similarly, H2A.Z can be found in nearly all species, from yeast to human, and is essential in 
many organisms like fly, frog and mouse (reviewed in Zlatanova & Thakar 2008). 
In yeast and mammals, the incorporation of H2A.Z has been shown to depend on the 
remodeling complexes SWR1 (Kobor et al. 2004; G. Mizuguchi 2004), or p400/SRCAP (Ruhl et 
al. 2006), respectively. These SWR1-llike remodeling complexes are large multi-subunit 
complexes, which are not only required to regulate transcription, but also to maintain the 
genome integrity (reviewed in Morrison & Shen 2009). Another complex in turn, Ino80, 
regulates the incorporation of H2A.Z and replaces H2A.Z for its canonical counterpart (Brahma 
et al. 2017; Lademann et al. 2017; Papamichos-Chronakis et al. 2011). In contrast to this, 
incorporation of H2A.X is not well understood and seems to be performed in a more random 
manner and similar to the incorporation of H2A.  
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3. H2A.V AND ITS FUNCTION IN DROSOPHILA 
 
H2A.V is an essential histone variant in Drosophila melanogaster (van Daal & Elgin 1992; 
Clarkson et al. 1999) and particularly highly expressed in early stages during development, but 
the protein is present in all stages (van Daal & Elgin 1992). In contrast to mammals, H2A.V is 
the only H2A variant in flies. This means, that H2A.V needs to combine functions of H2A.X and 
H2A.Z (reviewed in Baldi & Becker 2013). Like other histones, H2A.V bears the typical histone 
fold, a motif composed of three alpha-helices (Clarkson et al. 1999; Chakravarthy et al. 2004). 
In addition to this, two additional alpha-helices are flanking the three alpha-helices, an N-
terminal and a C-terminal helix. Clarkson et al performed rescue experiments with H2A.V 
constructs, in which different H2A.V regions were replaced for its counterparts in H2A in a 
H2A.V mutant background. Strikingly, the construct lacking the C-terminal alpha-helix was not 
able to rescue the H2A.V mutant lethality (Clarkson et al. 1999). This C-terminal helix is located 
in the inside of the nucleosome and might be important for the stability of the core particle 
rather than for interactions with DNA or other proteins.  
Interestingly, H2A.V shows a very high sequence similarity with H2A.Z in many organisms 
ranging from Homo sapiens with 98% identity to Saccharomyces cerevisiae with 76% identity 
(protein-protein BLAST on https://blast.ncbi.nlm.nih.gov). However, besides its high sequence 
similarity to H2A.Z, H2A.V exhibits the typical C-terminal motif found in H2A.X (Talbert & 
Henikoff 2010), which consists of the four amino acids SQAY and whose serine residue is 
phosphorylated by DNA damage activated kinases like ATM and ATR to convey the DNA damage 
response (Joyce et al. 2011; Ravi et al. 2009). Truncations of the H2A.X-like C-terminus of H2A.V 
were not lethal, suggesting that the H2A.X-function including the SQAY motif is not essential 
(Clarkson et al. 1999). 
Another modification of H2A.V, which is implicated in the DNA damage response, is acetylation 
at lysine 5. Kusch et al showed, that this acetylation mark is important to remove 
phosphorylated H2A.V from sites of damage (Kusch 2004, see also chapter III.B.5). 
 
 
FIGURE 3: COMPARISON OF H2A AND H2A.V. H2A.V CONTAINS, LIKE H2A, A HISTONE FOLD AND IN 
ADDITION TO THIS THE H2A.X-LIKE PHOSPHORYLATION MOTIF SQAY. THE SERINE (S) RESIDUE OF THIS 
MOTIF IS PHOSPHORYLATED BY ATM AND ATR KINASES DURING THE DNA DAMAGE RESPONSE. IN 
ADDITION TO THE C-TERMINAL PHOSPHORYLATION, H2A.V CAN BECOME ACETYLATED ON ITS N-
TERMINAL LYSINE (K) 5 BY TIP60 (FIGURE ADAPTED FROM BALDI & BECKER 2013). 
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H2A.V is distributed along the entire genome and can be found in eu- and heterochromatin 
(Leach et al. 2000), supporting its role as a damage sensor, which is spread over the entire 
genome to sense DNA damage. Furthermore, H2A.V is enriched at boundaries of transposons 
and of genes in heterochromatic regions (Zhang & Pugh 2011). 
In addition to that, H2A.V is enriched at promotors, pointing to its H2A.Z-like role as a 
transcriptional regulator (Weber et al. 2010), which will be addressed in the next chapter. 
 
4. THE ROLE OF H2A.V IN TRANSCRIPTIONAL REGULATION 
 
In most cases, histone variants are incorporated into chromatin in a cell cycle-independent 
manner to influence chromatin structure and function, either by site-specific replacement of 
canonical histones or to replenish nucleosomes that are evicted, for example by transcription 
(reviewed in Weber et al. 2014). 
Interestingly, H2A.V has opposing effects on transcription depending on context as roles of 
H2A.V as an activator and as a repressor of transcription have been described (reviewed in 
Baldi & Becker 2013). On one hand, H2A.V has been shown to facilitate transcription of heat 
shock genes (Kusch et al. 2014). On the other hand, the H2A.V gene has been classified as a 
polycomb group gene and thus somehow contributes to developmental silencing 
(Swaminathan 2005). In addition to that, H2A.V has also been reported to be involved in the 
establishment of heterochromatin (Swaminathan 2005; Hanai et al. 2008). 
H2A.V is incorporated into promotor regions similarly to H2A.Z, with particularly high 
abundance in the first nucleosomes after the nucleosome-free region (NFR), but absent in the 
-1 nucleosome upstream of the NFR, where it might facilitate nucleosome disruption to 
facilitate gene transcription (Mavrich et al. 2008; Weber et al. 2010). 
 
FIGURE 4: DISTRIBUTION OF H2A.V NUCLEOSOMES IN DROSOPHILA (BLACK) AND H2A.Z NUCLEOSOMES 
IN SACCHAROMYCES (GREEN) AROUND TRANSCRIPTION START SITES (TSS) (FIGURE ADAPTED FROM 
MAVRICH ET AL. 2008). 
However, to date, it is controversially discussed whether homotypic nucleosomes consisting of 
two H2A.V molecules are more or less stable than nucleosomes consisting of H2A. Tremethick 
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et al suggest that H2A.V nucleosomes are more stable and less prone to disassembly than 
canonical nucleosomes (Y.-J. Park et al. 2004). In contrast to that, Henikoff’s lab showed, that 
incorporation of H2A.V into nucleosomes downstream of the transcription start site reduces 
the barrier created by nucleosomes and facilitates transcription (Weber et al. 2014). 
 
5. THE ROLE OF H2A.V IN THE DNA DAMAGE RESPONSE 
 
It has been shown that C-terminal phosphorylation of H2A.V is essential for the DNA damage 
response in Drosophila, equivalent to C-terminal H2A.X phosphorylation in mammals. This 
phosphorylation is mediated by ATM and ATR, or their Drosophila homologues Tefu and Mei-
41, respectively (Madigan et al. 2002; Zou & Elledge 2003). Tefu (from telomere fusion) is 
required to prevent the fusion of Drosophila telomeres during mitosis and meiosis. Mei-41, in 
turn, is required for the crossover process during meiosis (Sibon et al. 1999). In absence of the 
checkpoint proteins Tefu, Mei-41, or the MRN complex, telomeres can fuse, maybe due to the 
impaired recruitment of capping proteins to the telomeres. Strikingly, this phenotype can be 
rescued in H2A.V mutants (Rong 2008). However, the role of H2A.V in this observation is still 
elusive. 
H2A.V has been shown to be important for the recruitment of Parp1, an enzyme that transfers 
poly(ADP-ribose) residues to chromatin components to decondense chromatin structure and 
facilitate DNA repair. Phosphorylation of H2A.V in turn then leads to the activation of Parp1 
(Kotova et al. 2011). Interestingly, this phosphorylation mark was reported to be mediated by 
Jil1 (Thomas et al. 2014), a kinase that was reported to phosphorylate serine 10 of H3 to 
regulate chromatin structure (Jin et al. 1999; Y. Wang et al. 2001). Unlike ATM and ATR, Jil1 
was not implicated in the DNA damage response so far, but in transcriptional regulation and 
dosage compensation (Jin et al. 1999). Phosphorylated H2A.V is a target of the Domino 
(Dom)/Tip60 complex, which acetylates H2A.V on its N-terminal lysine 5 by the histone acetyl 
transferase subunit Tip60 (Kusch 2004). 
 
6. H2A.V INCORPORATION AND THE ROLE OF REMODELERS 
 
How H2A.V is incorporated, is still barely understood. However, Kusch et al showed that the 
Dom/Tip60 complex, a SWR1-like complex in Drosophila, is involved in the incorporation of 
H2A.V at heat shock promotors (Kusch et al. 2014) and at the promotor of the E2f gene (Lu et 
al. 2007). Furthermore, a former PhD student in our lab, Kenneth Börner, discovered that the 
two splice variants of the Domino (Dom) remodeling ATPase, DomA and DomB, have distinct 
functions in the incorporation of H2A.V during oogenesis in Drosophila. For example, H2A.V 
incorporation into the germline chromatin of the germarium is DomB-dependent, whereas 
DomA mediates the eviction of H2A.V from germline cells (Börner & Becker 2016). 
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In addition to that, the Iswi-containing chromatin remodeling factors, ACF and RSF, have also 
been implicated in H2A.V incorporation. For instance, Chioda et al. showed that 
heterochromatic localization of H2A.V is diminished in acf1 mutants (Chioda et al. 2010). Other 
unpublished data from our lab suggested a role of Acf1 in the removal of phosphorylated H2A.V 
after DNA damage (preliminary observation from Natascha Steffen and Alessandro Scacchetti). 
Finally, Rsf1, a component of the Iswi remodeling component RSF, was shown to be required 
for the incorporation of H2A.V during the establishment of heterochromatin (Hanai et al. 2008). 
 
C. POST-TRANSLATIONAL HISTONE MODIFICATIONS 
 
Besides incorporation of histone variants, another mode to alter chromatin structure and to 
regulate chromatin-associated processes is the deposition of post-translational histone 
modifications by “writers” like histone acetyltransferases, kinases and methyltransferases. 
These combinations of histone modifications build a histone code, which can be recognized by 
“readers”, to influence and regulate the structure of chromatin (Prakash & Fournier 2018). The 
most common post-translational histone modifications addressed in this thesis, which are 
deposited by so-called writers: phosphorylation is mediated by kinases, acetylation by histone 
acetyl transferases, and methylation by histone methyl transferases. These modifications can 
be recognized by readers to regulate processes like transcription or DNA repair and modify 
chromatin structure (Rothbart & Strahl 2014; Prakash & Fournier 2018). 
In this thesis, I will mainly focus on histone modifications, which are involved in the DNA 
damage response.  
 
D. DNA DAMAGE SIGNALING AND REPAIR 
 
In the following chapter, I mainly refer to events described in mammals, unless stated 
otherwise. Chapter III.D.7 summarizes the state of knowledge of the DNA damage response in 
Drosophila.  
 
1. REPAIR OF DNA DSBS 
 
DSBs are hazardous to the genomic integrity and need to be repaired immediately. There are 
two main pathways to repair DNA DSBs, namely Non-Homologous End Joining (NHEJ) and 
Homologous Repair (HR). The pathway choice depends on different factors, including cell cycle 
state, cell type and organism. For example, HR depends by its nature on a homologous region 
and is therefore restricted to late S- or G2-phase, when sister chromatids can serve as 
homology partners. In yeast, HR is the predominant pathway, possibly because yeast cells rely 
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more on error-free repair than multicellular organisms, which generally prefer the NHEJ 
pathway (Shrivastav et al. 2008; Kinner et al. 2008). 
In Drosophila, HR is assumed to be the preferred pathway as well (Rong & Golic 2003; Preston 
et al. 2006; Marin-Vicente et al. 2015), even in heterochromatin, with its high density of 
repetitive sequences (Chiolo et al. 2011; P. C. Caridi et al. 2017; C. P. Caridi et al. 2018), also 
see III.D.7). 
To initiate the DNA break repair via NHEJ, a Ku complex is tethered to the broken ends, forming 
a ring around the DNA and diffusing to the inside to enable other repair factors to bind. Ku 
binding facilitates the fusion of the broken ends and supports the recruitment of additional 
factors, like DNA-PK, which in turn recruits Artemis, a nuclease that can process DNA ends 
before ligation by a complex consisting of Lig4, Xrcc4 and Xlf. Besides the classical NHEJ 
pathway, there is an alternative, Ku-independent NHEJ pathway. In this error-prone pathway, 
repair is mediated with the help of very short homology sequences of only few base pairs and 
in dependence of MRN and CtIP, components, which are also relevant in HR (reviewed in H. H. 
Y. Chang et al. 2017). If damage is repaired by HR, MRN is recruited to the break site together 
with CtIP, leading to a long-range resection of DNA resulting in 3’ overhangs. These overhangs 
are rapidly bound by RPA, which is later replaced by Rad51, supported by Brca2. This filament 
then initiates the homology search forming heteroduplex DNA with the homologous DNA 
molecule of the intact sister chromatid to enable the replication of the damaged DNA filament. 
Afterwards, the invading strands are resolved and ligated (reviewed in Hiom 2010). 
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FIGURE 5: REPAIR OF DNA DSBS BY HOMOLOGOUS REPAIR (HR) OR NON-HOMOLOGOUS END JOINING 
(NHEJ). IN BOTH CASES, THE DNA DAMAGE RESPONSE IS INITIATED BY PHOSPHORYLATION OF H2A.X BY 
ATM. FOR HR, DNA ENDS ARE BOUND BY THE MRN COMPLEX AND LATER ON PROCESSED TO 
3’OVERHANGS, WHICH ARE BOUND BY RPA AND REQUIRED BY AN HOMOLOGY-DEPENDENT DNA REPAIR 
PROCESS. FOR NHEJ, THE KU COMPLEX IS RECRUITED TO THE BREAK SITE, FOLLOWED BY THE 
RECRUITMENT OF DNA-PKCS. DNA ENDS ARE THEN PROCESSED AND LIGATED IN A FAST, BUT ALSO 
ERROR-PRONE MANNER (FIGURE ADAPTED FROM BRANDSMA & GENT 2012). 
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2. RECOGNITION OF DSBS 
 
DNA damage can occur in response to endogenous factors or exogenous factors. Examples for 
endogenous factors could be the generation of reactive metabolic substances, like reactive 
oxygen species (ROS). ROS are oxygen-containing reactive molecules, which can be generated 
during metabolic processes and which can lead to the oxidation of DNA (Dickinson & C. J. Chang 
2011). Other substances could also lead to alkylation of DNA, to the formation of DNA adducts 
or to the loss of DNA bases. Examples for exogenous factors could be reactive substances in 
the environment or irradiation by UV light, which can lead to the modification or loss of 
nucleotides or to the breakage of the DNA backbone in either one strand (nick) or in both 
strands (DSB) (reviewed in Ciccia & Elledge 2010; De Bont 2004). Due to the disconnection of 
the DNA strand, DSBs are particularly harmful to the genome integrity and have to be 
recognized and repaired immediately. One of the first events after DSB occurrence is the 
recruitment of the MRN complex, which is composed of Mre11, Rad50 and Nbs1 and which 
recruits and activates ATM. In addition to MRN, other DSB sensor proteins, which are rapidly 
recruited to breaks, are Parp1, Ku70/Ku80, and, in case of ssDNA, RPA (Ciccia & Elledge 2010). 
ATM, in turn, phosphorylates many other damage-associated proteins like H2A.X, Mdc1, 
53BP1, Brca1, Mre11, Rad50 and Nbs1 (Shiloh 2014; Tripathi et al. 2018; Ranjha et al. 2018). 
Besides ATM, other DNA damage kinases have been identified, namely ATR and DNA-PK. Even 
though they can act redundantly, each of them has specific roles. ATM, for example, is recruited 
by Nbs1 of the MRN complex and is the major kinase during HR. In contrast to this, DNA-PK is 
recruited by Ku and predominates in NHEJ. ATR recruitment is, in contrast to ATM and DNA-
PK, not limited to damage caused by DSBs and occurs in presence of RPA-coated ssDNA by 
Atrip. Here, ATR is activated in response to replicational stress by arrested replication forks (I. 
M. Ward & Chen 2001; Blackford & Jackson 2017; Saldivar et al. 2017). 
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FIGURE 6: EARLY EVENTS AFTER DNA DAMAGE RECOGNITION (FIGURE ADAPTED FROM HARTLERODE ET 
AL. 2012). IF THE DSB IS REPAIRED BY HR, THE MRN IS RECRUITED FIRST, LEADING TO THE ACTIVATION 
OF ATM AND SUBSEQUENT PHOSPHORYLATION (P) OF H2A.X. THIS LEADS TO THE RECRUITMENT OF 
MDC1 AND FURTHER RECRUITMENT AND ACTIVATION OF ATM (UPPER PANEL). IF THE DSB IS REPAIRED 
BY NHEJ, THE KU COMPLEX CONSISTING OF KU70 AND KU80 IS RECRUITED TO THE BREAK, LEADING TO 
THE RECRUITMENT OF DNA-PKCS, WHICH PHOSPHORYLATES (P) H2A.X (LOWER PANEL). 
 
This C-terminal phosphorylation of H2A.X (H2A.V in Drosophila) by DNA damage-activated 
kinase ATM, but also by ATR or DNA-PK then recruits additional Mdc1 (mu2 in Drosophila) to 
the break site, which in turn leads to an enrichment of MRN at the break site and further 
recruitment and activation of ATM and subsequent phosphorylation of H2A.X. This feedback 
loop leads to an amplification and expansion of the signal (Savic et al. 2009; Podhorecka et al. 
2010; Georgoulis et al. 2017). In total, H2A.X contributes with about 2-25% to the mammalian 
H2A pool, and is distributed along the whole genome (Rogakou et al. 1998; Kinner et al. 2008), 
therefore, the phosphorylation signal can be amplified and distributed over long distances. 
Besides the role of H2A.X in DNA damage, studies in mammals showed, that H2A.Z is 
incorporated into regions spanning few kilobases around the DSB in a p400-depenent manner. 
This was shown to have critical functions in repair-associated processes like the formation of 
open chromatin conformation, the deposition of post-translational histone modifications, the 
recruitment of complexes like BRCA and Ku and the regulation of DNA resection prior to HR (Xu 
et al. 2012). Another study in yeast showed, that incorporation of H2A.Z at sites around DSBs 
is also required to translocate the DSB to the periphery of the nucleus to enable efficient DNA 
repair (Horigome et al. 2014). To facilitate the exchange at break sites, H2A.Z is marked by 
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SUMOylation in yeast and mammals, which is the conjugation to a small ubiquitin-like protein 
(Kalocsay et al. 2009; Fukuto et al. 2018). 
To investigate the dynamics of factors recruited to sites of DNA damage, an extensive real-time 
immunofluorescence analysis was performed on HeLa cells with EGFP-tagged DNA repair 
proteins under their own regulatory sequences. In this study, they identified clusters of 
proteins according to their kinetics after induction of DNA damage. Among the first cluster, 
which was recruited within the first seconds, were proteins involved in early steps of DSB repair 
(Ku70, Lig4, Rad50, ATM, Mdc1), Parp1 and proteins binding to the PARylation mark, histone 
deacetylases, and chromatin remodelers (Smarca5, Smarcad1). Only 10 to 20 min after damage 
induction, proteins involved in the HR pathway were recruited (Rpa1, Rad51) (Aleksandrov et 
al. 2018). This order of events has important implications in the regulation of DNA damage. For 
example, in the first seconds, factors to prime chromatin for repair are recruited and deposit 
post-translational modifications or remodel chromatin. Only lateron, the repair machinery for 
the complex and highly regulated repair pathways like HR are recruited. In addition, they were 
able to show that early events regulate the onset of later events (e.g. the removal of Parp1 is 
connected to the initiation of HR (Aleksandrov et al. 2018). The first changes in the DNA damage 
response have also been described in an “access–repair–restore” model (Soria et al. 2012) 
which will be discussed in III.D.3. 
 
3. THE “ACCESS–REPAIR–RESTORE” (ARR) MODEL 
 
Chromatin undergoes various changes in response to damage to maintain genomic integrity 
and to enable proper DNA repair.  
To overcome the chromatin barrier composed of nucleosomes and chromatin-associated 
proteins, and to allow repair factors to access the break, it has been proposed that chromatin 
is first subject to a local remodelling process, which renders it more accessible for the repair 
machinery. This process was first observed in 1991 (Smerdon 1991) and further studied later 
in the lab of Geneviève Almouzni, where it was termed the “access–repair–restore” model 
(Soria et al. 2012). Interestingly, increasing numbers of studies showed that one of the earliest 
steps is the recruitment of histone deacetylases like the NuRD complex (Smeenk et al. 2010) 
and histone methyltransferases like Suv39h1 (Ayrapetov et al. 2014), which presumably lead 
to the establishment of repressive chromatin in proximity to the break site. This step, which 
occurs already in the very first minutes after DSB recognition prior to the decondensation step 
described before, might be important to block transcription of genes affected by the break. 
After that, repressive marks are released, and chromatin is then turned into a more open state 
to facilitate the association of repair factors. 
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FIGURE 7: CHROMATIN STRUCTURE AFTER DSB RECOGNITION (FIGURE ADAPTED FROM GURSOY-
YUZUGULLU, HOUSE & PRICE 2016). WITHIN THE FIRST MINUTES, CHROMATIN BECOMES COMPACTED 
AND REPRESSIVE TO INHIBIT TRANSCRIPTION FROM DAMAGED REGIONS. THIS CHROMATIN STATE IS 
CHARACTERIZED BY THE RECRUITMENT OF FACTORS THAT DEACETYLATE AND DEMETHYLATE CHROMATIN, 
DEPOSIT REPRESSIVE HISTONE MARKS LIKE DI- AND TRI-METHYLATION OF LYSINE 9 ON HISTONE H3 AND 
BY THE DEPOSITION OF H2A.Z. AFTERWARDS, A MORE RELAXED CHROMATIN ORGANIZATION IS 
ESTABLISHED TO ALLOW THE RECRUITMENT OF REPAIR FACTORS AND TO FACILITATE THE REPAIR PROCESS, 
WHICH IS ACHIEVED BY REMOVAL OF H2A.Z AND ACETYLATION OF H4. 
 
4. SPREADING OF THE H2A.X PHOSPHORYLATION MARK 
 
Phosphorylation of H2A.X is first initiated at the DSB and then propagates along the DNA. Over 
time, the phosphorylation signal is not only amplified, but also spreads over long distances. This 
process is mediated through a feedback mechanism illustrated in Figure 8. In this feedback 
loop, Mdc1, a DNA damage checkpoint mediator (Stewart et al. 2003) is recruited by 
phosphorylated H2A.X, leading to further recruitment of the MRN complex, which in turn 
enhances the phosphorylation of H2A.X by ATM. 
  
Remarkably, the phosphorylation mark can spread over long distances from the break, up to 
300 kb in yeast and up to 2 MB in mammals (C.-S. Lee et al. 2014; Iacovoni et al. 2010), however, 
the mechanism of spreading is not yet understood. The spreading event is not uniformly along 
the chromosome, but may appear rather discontinuous and asymmetrical (Shroff et al. 2004; 
Iacovoni et al. 2010, see Figure 9).  
 
FIGURE 8: FEEDBACK LOOP OF DAMAGE SIGNALING 
MEDIATED BY H2A.X PHOSPHORYLATION: RE-
COGNITION OF DNA DSBS LEADS TO THE RECRUIT-
MENT OF MRN, WHICH RECRUITS AND ACTIVATES 
KINASES LIKE ATM. ATM PHOSPHORYLATES 
H2A.X, LEADING TO THE BINDING OF MDC1 AND 
THE MRN COMPLEX, WHICH, IN TURN, LEADS TO 
RECRUITMENT AND AMPLIFICATION OF MORE 
ATM, RESULTING IN THE SPREADING AND AMPLIFI-
CATION OF THE PHOSPHORYLATION MARK AROUND 
DSBS. 
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FIGURE 9: TIME COURSE OF H2A.X PHOSPHORYLATION IN MAMMALIAN CELLS FROM 15 MIN TO 60 MIN 
30 TO 40 KB AROUND THE DSB. THE PHOSPHORYLATION SIGNAL INCREASES IRREGULARLY AT REGIONS 
CLOSE TO THE BREAK SITE AND WITH SOME DELAY AT REGIONS MORE DISTAL FROM THE BREAK SITE. 
FIGURE FROM SHROFF ET AL. 2004. 
In addition to this, spreading of H2A.X phosphorylation overlap with TADs and spreading seems 
to be controlled and limited by cohesion, which usually defines the borders of TADs (Caron et 
al. 2012). In addition to this, spreading of H2A.X phosphorylation signaling has also been 
observed in trans on centromeric regions in yeast, which were analyzed after introducing DSBs 
into specific sites of the chromosome. Interestingly, an increase of phosphorylated H2A.X was 
observed on intact chromosomes, which might be due to clustering of centromeres in yeast 
nuclei (C.-S. Lee et al. 2014), which are generally clustered at the periphery of the nucleosome 
(T. Mizuguchi et al. 2015). 
 
 
 
FIGURE 10: H2A.X PHOSPHORYLATION IN 
YEAST. A DSB WAS INSERTED IN CHRO-
MOSOME 2 CLOSE TO THE CENTROMERIC 
REGION. FROM THIS, SPREADING OF THE 
PHOSPHORYLATION SIGNAL WAS OBSERVED 
TO CENTROMERIC REGIONS OF OTHER 
CHROMOSOMES. CHROMATIN IMMUNO-
PRECIPITATION WAS PERFORMED WITH 
CROSSLINKING (X-CHIP) AND UNDER NA-
TIVE CONDITIONS WITHOUT CROSS-LINKING 
(N-CHIP). FIGURE ADAPTED FROM C.-S. 
LEE ET AL. 2014. 
 
 - Introduction - 
 19 
To date, two possible models of spreading are discussed: either by moving along the DNA in 
cis, continuously adding additional marks to the neighboring H2A.X containing nucleosomes, 
or by establishing transient chromosomal contacts through dynamic loop formation, which 
leads to the spreading of the phosphorylation mark to spread over distances. In principle, these 
scenarios should be distinguishable in time-resolved analyses of the signal development: in the 
first model, the signal would be expected to increase laterally from the break site towards the 
periphery, mediated by the feedback mechanism described in Figure 8. In the second case, the 
signal would augment more globally (Erdel 2017), see Figure 11) by a not yet identified 
mechanism. To investigate these possibilities in more detail, mathematical models for the 
spreading behavior of post-translational histone modifications have been developed 
(Tommasino et al. 2015; Erdel & Greene 2016; Jost & Vaillant 2018). After comparison of 
experimental data with the model, calculations including the spreading over three-dimensional 
DNA loops were more close to the measured data, supporting the model of spreading by DNA 
looping (Tommasino et al. 2015). This model would include the activity of activated ATM, which 
could diffuse away from the damage region to close intact DNA regions, facilitated by the 
formation of repair clusters. The formation of these clusters is not yet well understood, but 
could be mediated by cohesin, a complex with the ability to connect DNA strands using its ring 
structure. It has been shown that cohesion is recruited to DSBs in yeast and human (Ünal et al. 
2004; Ström et al. 2004; S.-H. Lee & C.-H. Kim 2002) and that ATM phosphorylates a subunit of 
cohesin upon damage induction (S.-T. Kim et al. 2002). 
 
FIGURE 11: POSSIBLE SPREADING MECHANISMS OF THE H2A.V PHOSPHORYLATION SIGNAL: IN MODEL A 
THE PHOSPHORYLATION SIGNAL IS TRANSMITTED ALONG THE DNA, LEADING TO AN AMPLIFICATION OF 
THE SIGNAL FROM THE BREAK TO THE PERIPHERY BY THE PREVIOUSLY DESCRIBED FEEDBACK MECHANISM. 
IN MODEL B THE PHOSPHORYLATION SIGNAL IS TRANSMITTED IN TRANS, TO DNA REGIONS, WHICH WERE 
BROUGHT IN CLOSE PROXIMITY BY DNA LOOPING. RED CIRCLES INDICATE PHOSPHORYLATED H2A.X-
CONTAINING NUCLEOSOMES, GREY CIRCLES INDICATE NON-PHOSPHORYLATED H2A.X-CONTAINING 
NUCLEOSOMES; ARROWS INDICATE THE SPREADING OF THE PHOSPHORYLATION SIGNAL. THE LOWER 
PANEL SHOWS THE SPREADING DIRECTION OF PHOSPHORYLATION WITH INTENSITIES EITHER INCREASING 
FROM THE DSB TO THE PERIPHERY (LEFT) OR MORE EVENLY DISTRIBUTED ALONG THE DNA (RIGHT).  
All these points could argue for a combination of both models, where the phosphorylation mark 
might spread along the chromosome fiber but could also be amplified by spatial contacts of 
chromosomal domains, leading to an increased signal at regions, which are more frequently 
close to other DNA regions due to sequences bound by DNA linking proteins like cohesion, 
which also limits and defines regions of H2A.X phosphorylation spreading. Figure 9 shows an 
example of an H2A.X phosphorylation time course in mammalian cells, where phosphorylation 
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signals increase from the break site towards the periphery, but also show irregular signal 
amplifications of regions with higher or lower phosphorylation signals. 
 
 
 
5. DEPHOSPHORYLATION OF H2A.X 
 
Several studies in yeast and mammals showed that gH2A.X appear about 15 min after DSB 
induction and is removed again after approximately one to two hours (Kinner et al. 2008). This 
is accomplished by protein phosphatase 2A (PP2A) in mammals, and dephosphorylation can 
occur on monomeric H2A.X, as a dimer with H2B or incorporated into nucleosomes 
(Chowdhury et al. 2005). 
However, it is still under debate whether dephosphorylation of H2A.X is performed on 
chromatin or after removal from the break site. However, considering the observation, that 
PP2A colocalizes at damage sites together with gH2A.X, it seems probable that PP2A 
dephosphorylates H2A.X directly at the site of damage (Chowdhury et al. 2005). Furthermore, 
photobleaching experiments of GFP-labeled H2A.X showed, that the mobility of incorporated 
H2A.X is not particularly high, indicating that turnover is not a predominant process in cells 
(Siino et al. 2002). In contrast to this, phosphorylated H2A.V in flies is believed to be removed 
by the Dom/Tip60 histone exchange complex, that was first shown to acetylate gH2A.V 
followed by exchange of H2A.V/H2B dimers by unphosphorylated H2A.V/H2B (Kusch 2004). 
Similarly, in yeast, Ino80 has been shown to remove phosphorylated H2A.X from chromatin 
(Bao 2011). 
FIGURE 12: MODEL OF H2A.X PHOSPHO-
RYLATION SPREADING WITHIN DNA 
DAMAGE FOCI, WHICH ARE REGULATED BY 
BINDING OF COHESIN (FIGURE ADAPTED 
FROM CARON ET AL. 2012). THE UPPER 
BINDING PROFILES OF COHESIN (PURPLE) 
TOGETHER WITH ANTAGONIZING PROFILES 
OF H2A.X PHOSPHORYLATION (RED), 
WHICH COULD BE DELIMITED BY 
CHROMATIN-ASSOCIATED FACTORS (BLUE). 
THESE PROFILES RESULT FROM THE 
ORGANIZATION OF DNA INTO DNA 
DAMAGE FOCI, WHICH INCLUDE THE DNA 
DSB (BLACK TRIANGLE) AND ADDITIONAL 
LOOPS OF DNA, AND WHICH ARE 
ACCOMPLISHED THROUGH BINDING OF 
COHESIN (PURPLE CIRCLES) (RED CIRCLES, 
LOWER PANEL). TRANSCRIBED REGIONS (IN 
GREEN) ARE OUTSIDE OF THE DNA DAMAGE 
FOCI AND EXCLUDED FROM THE SPREADING 
EVENT OF H2A.X PHOSPHORYLATION. 
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6. OTHER DNA DAMAGE-ASSOCIATED POST-TRANSLATIONAL HISTONE MODIFICATIONS 
 
In addition to gH2A.X, other DNA damage-associated post-translational histone modifications 
have been described. The following table summarizes the modifications that have been linked 
to DSBs in mammals. 
TABLE 1: DNA DAMAGE-ASSOCIATED POST-TRANSLATIONAL HISTONE MODIFICATIONS IN MAMMALS; S: 
SERINE, K: LYSINE, P: PHOSPHORYLATION, UB: UBIQUITINOYLATION, ME: METHYLATION, ME2/ME3: DI-
/TRI-METHYLATION, AC: ACETYLATION 
Modification Enzyme  Reference 
H2A.XS139p ATM, ATR, DNA-PKcs Blackford & Jackson 2017 
H2A.X  Tip60 Chailleux et al. 2010 
H2A/H2A.Xub  Rnf8/Rnf168 Huen et al. 2007; Kolas et al. 
2007; Mailand et al. 2007; 
Doil et al. 2009 
H2AXK119ub Ring1B/Ring2 
Brca1 
Xie et al. 2010; Q. Zhu et al. 
2011 
H2BK120ub Rnf20-Rnf40 Moyal et al. 2011 
H3ub and H4ub Cul4-Ddb-Roc1 H. Wang et al. 2006 
H3K36me2 Metnase/SETMAR Fnu et al. 2011 
H3K79me Dot1 Wakeman et al. 2012 
H3K9me3 Suv39h1 Ayrapetov et al. 2014  
H4K5ac  
H4K8ac  
H4K12ac  
H4K16ac 
Hat1, Tip60, Atf2, Hpa2, 
p300 HAT, 
Gcn5, Pcaf, Elp3, Sas2 
reviewed in Dhar et al. 2017 
H4K16ac Mof X. Li et al. 2010 
H4K20me2 Set8/Suv4-20 Jorgensen et al. 2013 
 
 
7. DNA REPAIR IN DROSOPHILA 
 
In Drosophila, DSB can be repaired via both pathways, HR and NHEJ, depending on the cell cycle 
state and cell type. In Drosophila tissues, whose cells are predominantly in G1, NHEJ is the 
preferred pathway in heterochromatic regions. In contrast to this, HR is preferred in 
heterochromatin of Drosophila cell culture cells, which are predominantly in S/G2 (reviewed in 
P. C. Caridi et al. 2017). Rong et al studied the repair of DSBs in the Drosophila premeiotic 
germline, which were induced by the expression of a specific endonuclease SceI (Rong & Golic 
2000) and repaired by HR using the homologous chromosome as repair template (Rong & Golic 
2003). The preference of DSB repair via homology search in Drosophila was also observed in 
several other studies (Adams et al. 2003; LaRocque et al. 2007; Do et al. 2014). 
Another study using SceI to introduce DSBs was performed to investigate repair pathway choice 
in different developmental stages of the germ line, revealing that NHEJ only becomes 
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predominant at late stages before meiosis, whereas single-strand annealing, a pathway relying 
on homology search similar to HR, is more prevalent at very early stages and less frequent 
lateron (Preston et al. 2006). 
For HR, resection of DNA ends is first initiated by the MRN complex and carried on by CtIP/Sae2 
and later by Exo1 or Dna2/Blm (reviewed in Symington & Gautier 2011). The resected 3’ ends 
are then bound by the Rad51 orthologue spn-A and after homology search and synthesis of the 
broken DNA strand, the Holliday junctions are resolved (Sekelsky 2017). In Drosophila, DSBs 
induced by X-rays into heterochromatic regions are repaired by HR but are translocated out of 
the heterochromatic domain before Rad51 binding to the resected DNA strand (Chiolo et al. 
2011). Repair by NHEJ, on the other hand, is initiated by the recruitment of the Ku complex 
consisting of Ku70 and Ku80, or the Drosophila orthologues Irbp and Ku80, respectively. 
However, unlike in mammals, the catalytic subunit of the complex, DNA-dependent protein 
kinase (DNA-PK), does not exist in Drosophila. Then, end processing is performed by Artemis 
and ligated by Lig4, Xrcc4, and Xlf, which have all been identified in Drosophila (reviewed in 
Sekelsky 2017). 
Besides the repair of DNA DSBs, other pathways have been investigated in Drosophila. For 
example, Drosophila embryo extract (see III.E) was used to investigate the nucleotide excision 
repair (NER) pathway (Gaillard et al. 1997), which is generally used to remove UV-induced 
damage and bulky adducts (Luijsterburg & van Attikum 2011). In this assay, chromatin was 
assembled in vitro on UV-irradiated DNA. Interestingly, nucleosomes were not only assembled 
in regular arrays starting from the NER target site, but also the plasmid was repaired by extract 
components (Gaillard et al. 1997). 
 
8. THE CHROMATIN REMODELING SUBUNIT ACF1 AND ITS ROLE IN DNA DAMAGE  
 
In general, Iswi-containing chromatin remodeling factors are responsible for the regular 
spacing of nucleosomes by sliding nucleosomes along the DNA (reviewed in Längst & Becker 
2001). Besides this, Iswi remodelers, and in particular ACF with the mammalian Acf1 orthologue 
BAZ1A were shown several times to be involved in DNA damage (Lan et al. 2010; Sánchez-
Molina et al. 2011; Aydin et al. 2014; Oppikofer et al. 2017). It has been shown that CHRAC 
accumulates at DSBs and interacts with the Ku complex, which is recruited to DNA ends as a 
component of the NHEJ pathway. In fact, it has been postulated that CHRAC assists the 
accumulation of Ku at the break site (Lan et al. 2010). 
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Acf1 contains a WAC domain, a DDT domain and a PHD finger domain, required for interaction 
with DNA, with Iswi, and with core nucleosomes, respectively (Fyodorov & Kadonaga 2002; 
Hogan & Varga-Weisz 2007). Analysis with Acf1 mutant constructs showed that the N-terminal 
part including the WAC and DDT domain is responsible for the accumulation at DNA break sites 
after damage (Lan et al. 2010). 
 
E. CHROMATIN RECONSTITUTION IN VITRO 
 
In the past, various approaches to assemble nucleosomes in vitro have been performed at 
different levels of complexity. The simplest system is salt gradient-mediated assembly, which 
can be performed in the absence of any additional assembly factors. Here, histones are either 
purified or recombinantly expressed and histone octamers are stabilized in high salt buffer, 
which covers the positive charge of the highly basic histones. In the presence of DNA, 
nucleosomes can be formed by gradually decreasing the salt concentration, which leads to the 
transfer of the positively charged octamers onto negatively charged DNA. A less efficient 
approach to assemble nucleosomes is the careful titration of histones to DNA in low salt buffer  
(Ruiz-Carrillo et al. 1979; Stein et al. 1979). 
In addition to this, assembly can be performed by addition of purified histone chaperones to 
the octamers, like nucleoplasmin (Laskey et al. 1977; Earnshaw et al. 1980), polyglutamic acid 
(Stein et al. 1979) or other negatively charged supplements, to improve nucleosome formation 
by shielding the positive charge of histones and prevent unspecific aggregations at 
physiological salt concentrations (reviewed in Laskey & Earnshaw 1980). 
Finally, chromatin can be reconstituted by crude cell extracts. Chromatin in vitro reconstitution 
by cell extracts is a cell-free tool developed in 1977 by Laskey et al using Xenopus embryo 
extract to study chromatin assembly and transcription (Laskey et al. 1977). In parallel to this, a 
FIGURE 13: ACF1 CAN INTERACT WITH 
SUBUNITS OF THE KU COMPLEX (FIGURE 
ADAPTED FROM LAN ET AL. 2010). THE KU 
COMPLEX, CONSISTING OF KU70 AND 
KU80, WAS SHOWN TO HAVE THE ABILITY 
TO INTERACT WITH ACF1, A COMPONENT 
OF THE CHRAC COMPLEX CONSISTING OF 
ACF1, THE MAMMALIAN ISWI HOMOLOG 
SNF2H, AND CHRAC17 AND CHRAC15, 
WHICH ARE THE MAMMALIAN HOMO-
LOGUES OF DROSOPHILA CHRACH14 AND 
CHRAC16. THIS INTERACTION WAS SHOWN 
TO BE IMPORTANT FOR EFFICIENT RECRUIT-
MENT OF KU TO THE DSB, WHICH IS 
NECESSARY FOR EFFICIENT REPAIR BY NHEJ. 
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similar approach was developed using Drosophila embryo extract (Nelson et al. 1979). 
Obtaining sufficient amounts of Drosophila embryos for extract preparation is straight forward, 
as Drosophila cultures can be maintained in large amounts and availability is not season-
dependent, as it is for Xenopus embryos (Rodriguez-Campos et al. 1989). 
In addition to this, extract from mammalian cells was used to reconstitute chromatin in vitro 
(Krude et al. 1993). Compared to the other in vitro systems, in mammalian cell extract, 
chromatin reconstitution is coupled to replication (Krude & Knippers 1993), whereas with 
Xenopus extract, replication-dependent and -independent chromatin assembly can occur 
(Almouzni & Méchali 1988; Almouzni et al. 1990). However, the preparation of Xenopus and 
mammalian extracts are laborious and material is limited (Rodriguez-Campos et al. 1989). In 
addition to this, in vitro systems using mammalian extract had to be supplied with additional 
histones to enable proper chromatin assembly. Therefore, Becker and Wu developed 1992 a 
protocol for chromatin assembly in vitro using Drosophila extract from preblastoderm embryos 
(Becker & Wu 1992), which results in very stable and reproducible extracts producing 
nucleosomes with physiological spacing. Due to the high demand of protein during the first 
very rapid cell division cycles in Drosophila embryos, this extract contains massive amounts of 
maternally deposited factors and provides sufficient amounts of histones and remodeling 
factor to reconstitute chromatin. These factors are deposited in specific reservoirs until 
required. H2A, H2B and H2A.V, for example, have been shown to be gathered in lipid droplets 
(Z. Li et al. 2012; Z. Li et al. 2017). However, extracts prepared from preblastoderm embryos 
are not capable of transcription, unlike extracts from postblastoderm embryos. 
Figure 14 shows a simplified scheme of the embryo extract preparation, which is used in this 
thesis to reconstitute chromatin on recombinant DNA. Embryos during the first 1.5 h after egg 
laying (AEL) are collected and dechorionated. After several washing steps (not shown), the 
embryos are homogenized, and the homogenate is separated by ultracentrifugation into a lipid 
layer, a nuclei-containing pellet and a clear cytoplasmic extract, which is collected and frozen 
in liquid nitrogen until used for chromatin assembly on recombinant DNA. In this case, DNA 
was coupled to paramagnetic beads to facilitate isolation of reconstituted chromatin for 
analysis by Western blot or mass spectrometry. 
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FIGURE 14: PRINCIPLE OF EMBRYO EXTRACT PREPARATION FROM PREBLASTODERM 0 TO 1.5 H OLD 
EMBRYOS AS PREVIOUSLY DESCRIBED IN BECKER & WU 1992 AND CHROMATIN IN VITRO 
RECONSTITUTION. DECHORIONIZED EMBRYOS ARE HOMOGENIZED AND EXTRACT IS SEPARATED BY 
ULTRACENTRIFUGATION. RECOMBINANT DNA (HERE IMMOBILIZED ON PARAMAGNETIC BEADS) IS USED 
FOR CHROMATIN IN VITRO RECONSTITUTION BY THE EXTRACT. 
 
F. OBJECTIVE OF THIS THESIS 
 
In this thesis, I employed the chromatin in vitro reconstitution system to establish a tool for 
DNA damage-associated investigations in vitro.  
The project is structured into three parts: In the first part, I characterized the in vitro 
reconstituted chromatin. In the second part, I explored the recruitment of factors to sites of 
damage by isolating chromatin immobilized on solid phases, dissected rapid events in a time- 
and location-resolved manner and investigated DNA damage-associated events on predefined 
nucleosomes composed of canonical, variant, or mutated histones. In the third part I explored 
the role of Iswi-containing remodelers, in particular ACF and RSF, in the incorporation and 
turnover of H2A.V  
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IV. MATERIALS 
 
A. CHEMICALS 
 
4-OHT (Sigma) 
Acetic acid (VWR) 
Acetyl-CoA (Sigma) 
Acrylamide Rotiporese Gel 30 (Roth) 
Agarose (Bio & Sell) 
Ammonium acetate (Roth) 
Ammonium bicarbonate (Sigma) 
Ammonium sulfate (VWR) 
Ampicillin (Roth) 
Aprotinin (Genaxxon) 
ATP (Roche) 
Bromophenol blue (Serva) 
BSA (Sigma or New England Biolabs) 
Calcium chloride (Sigma) 
Chloramphenicol (Roth) 
Complete Protease Inhibitor Cocktail Tablets (Roche) 
Coomassie Brilliant Blue (Sigma) 
Creatine Phosphate (Sigma) 
DAPI (Invitrogen) 
DMSO (Sigma) 
DTT (Roth) 
ECL Advance Western Blotting Detection Kit (VWR) 
EDTA (Sigma) 
Effectene Transfection Reagent (Qiagen) 
EGTA (Sigma); 
Ethanol (Sigma) 
Ethidium bromide (Sigma) 
FBS (Sigma) 
Glycerol (VWR) 
Glycine (Diagonal) 
Glycogen (Roth) 
Guanidine hydrochloride (Sigma) 
Hepes (Roth) 
HEPES (Serva) 
Hydroxyurea (Sigma) 
IPTG (Roth) 
Isopropanol (Sigma) 
L-lysine monohydrochloride (Sigma) 
LB Agar (Serva) 
Leupeptin (Genaxxon) 
Magnesium chloride (VWR) 
Methanol (Sigma) 
N-Lauroylsarcosine (Sigma) 
NDS (Dianova) 
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NGS (Dianova) 
NP-40 (Igepal CA-630) (Sigma)  
Orange G (Sigma) 
Paraformaldehyde (Life Technologies) 
Penicillin/Streptomycin (Sigma) 
Pepstatin (Genaxxon) 
PMSF (Sigma) 
Potassium chloride (VWR) 
Power up SYBR Green (Life technologies) 
Rotiporese® Gel 30 (Roth) 
Schneider’s Drosophila medium (Life Technologies) 
SDS (Serva) 
Sodium bicarbonate (Sigma) 
Sodium carbonate (Sigma) 
Sodium chloride (Neolab or Serva) 
Sodium deoxycholate (Sigma) 
Sodium hypochlorite solution (VWR) 
Spermidine (Sigma) 
Spermine (Sigma) 
TEMED (Sigma) 
Thiourea (Sigma) 
Tris (Diagonal) 
Triton X-100 (Sigma) 
Tween 20 (Sigma) 
Wortmannin from Penicillium Fumiculosum (Sigma) 
β-glycerophosphate (Sigma) 
β-mercaptoethanol (Sigma) 
 
 
B. ENZYMES 
 
Apyrase (New England Biolabs) 
Creatine Kinase (Sigma) 
DNA Polymerase I, Large (Klenow) Fragment (New England Biolabs) 
LysC (Wako) 
Micrococcal Nuclease (Sigma) 
Pfu Turbo DNA Polymerase (Agilent) 
Phusion High-Fidelity DNA Polymerase (New England Biolabs) 
PmII (Life technologies) 
Proteinase K (Diagonal) 
Restriction enzymes (New England Biolabs, unless specified otherwise) 
RNase A (Sigma) 
SgrDI (Life technologies) 
T4 DNA Ligase (New England Biolabs) 
Trypsin (Promega) 
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C. KITS 
 
Biotin-Nick Translation Mix (Sigma) 
DNeasy Blood & Tissue Kit (Qiagen)  
ECL Advance Western Blotting Detection Kit (VWR) 
ENLITEN rLuciferase/rLuciferin Reagent A (Promega) 
Genelute PCR Clean-Up Kit (Sigma) 
Gibson Assembly Master Mix (Biolabs) 
Immobilon Western Chemiluminescent HRP Substrate (Merck Millipore) 
MEGAscrip T7 Transcription Kit (Thermo)  
NEBNext Ultra II DNA Library (New England Biolabs) 
Nucleobond PC 500 (Macherey-Nagel) 
NucleoSpin Gel and PCR Clean-up (Macherey-Nagel) 
NucleoSpin Plasmid Mini Kit (Macherey-Nagel) 
RNeasy Mini Kit (Qiagen) 
 
D. CONSUMABLES 
 
Amicon Ultra-4 (Merck Millipore) 
Complete, Mini EDTA-free (Sigma) 
Membrane filters nitrocellulose (Roth) 
Membrane filters pore size 0.2 µm and 0.45 µm (Roth) 
Milles-HPF HV Filter, 0.45 µm (Merck Millipore) 
Miracloth (VWR) 
Protran membran BA85 (VWR) 
Slide-A-Lyzer Mini Dialysis Unit (Life technologies) 
Spectra/Por 3 MWCO 3.5 kDa dialysis membranes (VWR) 
Whatman cellulose chromatography paper (Sigma) 
 
E. FLY POPULATION 
 
Agar-Agar (Die Gewürzmühle Brecht) 
Apple juice (Discounter) 
Cellulose (Arndt) 
Dry yeast, Fermipan rot (Hobbybäcker) 
Styrofoam dishes (Margret Lutz) 
Yeast extract (BD Biosciences) 
 
F. MARKERS 
 
DNA Ladder 1 kb (New England Biolabs) 
DNA Ladder 100 bp (New England Biolabs) 
Protein-Marker IV (VWR) 
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G. COLUMNS AND RESINS 
 
Agencourt AMPure XP beads (Beckman Coulter) 
Anti-FLAG M2 Agarose beads (Sigma) 
Dynabeads M280 Streptavidin (Life technologies) 
HiTrap Q HP (VWR) 
HiTrap SP Colums (VWR) 
Mini quick spin DNA columns (Sigma) 
Protein A or G Sepharose, beads (Elisabeth Kremmer, Helmholtz Center Munich) 
TopTip C18 stage tips (Glygen) 
 
H. NUCLEOTIDES 
 
2'-Deoxyguanosine-5'-O-(1-thiotriphosphate) (Enzo Life Sciences) 
5'-Adenylylimodiphosphat AMPPNP (Sigma) 
Biotin-14-dATP (Life technologies) 
Biotin-16-dUTP (Sigma) 
dATP, dTTP, dCTP, dGTP (Bioline) 
dNTP mix (NEB) 
Thymidine-5´O-(1-thiotriphosphate) (Enzo Life Sciences) 
 
 
I. PLASMIDS AND FOSMIDS 
 
FlyFosmids 019611 and 019829 (Pawel Tomancak, MPI Dresden, Germany, published in 
Ejsmont et al. 2009) 
pBluescript-13x5SrRNA (kind gift from Axel Imhof, BMC Martinsried, Germany, published in 
Völker-Albert et al. 2016) 
pET15b-H2A, pET15b-H2B (kind gift from Felix Müller-Planitz, BMC Martinsried, Germany, 
published in Klinker, Haas, et al. 2014) 
pFBDM-6xHis-Iswi-Acf1-Flag (generated by Silke Krause, BMC Martinsried, Germany) 
pRM-3xHA-AsiSI-ER (kind gift from Gaelle Legube, Toulouse, France, published in Massip et al. 
2010) 
pRSET-A-H2A.V (kind gift from Jürg Müller, MPI Martinsried, Germany, sequence listed in XI.A. 
pRSET-A-H2A.VE, pRSETA-H2A.V-3xFlag, pRSETA-H2A.VDC, pRSETA-H2A.VE-3xFlag, pRSETA-
3xFlag-H2A.V, pRSETA-3xFlag-H2A.VDC, pRSETA-3xFlag-H2A.VE (generated in this thesis using 
site-directed mutagenesis, see IV.J.1 and V.E.3)  
pUC18 (published in Yanisch-Perron et al. 1985) 
pUC18-25x601 (published in Klinker, Mueller-Planitz, et al. 2014) 
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J. OLIGONUCLEOTIDES 
 
1. OLIGONUCLEOTIDES TO INSERT POINT MUTATIONS  
(ordered at Biomers, Germany) 
Introduction of stop codon to produce DC-term H2A.V 
Fw: GGCAAAAAAGAAGAAACCGTTCAGTAGCCGCAGCGTAAAGG 
Rv: CCTTTACGCTGCGGCTACTGAACGGTTTCTTCTTTTTTGCC 
S à E exchange in N-term 3xFlag H2A.V and untagged H2A.V 
Fw: GCGTAAAGGTAATGTTATTCTGGAACAGGCCTATTAAGGATCCG  
Rv: CGGATCCTTAATAGGCCTGTTCCAGAATAACATTACCTTTACGC  
S à E exchange in C-term 3xFlag H2A.V 
Fw: GCGTAAAGGTAATGTTATTCTGAGCCAGGCCTATGATTATAAGGATCACG 
Rv: CGTGATCCTTATAATCATAGGCCTGGCTCAGAATAACATTACCTTTACGC 
 
2. INSERTS TO INTRODUCE 3XFLAG TAGGED H2A.V 
 
Sequence to introduce N-terminal 3xFLAG into pRSET-A-H2A.V (GeneCust): 
TCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGGATTATAAAGATCATGAT
GGTGATTATAAAGATCATGATATTGATTATAAAGATGATGATGATAAAGCAGGCGGTAAAG
CAGGTAAAGATAGCGGTAAAGCAAAAGCAAAAGCCGTTAGCCGTAGCGCACGTG 
Sequence to introduce C-terminal 3xFLAG into pRSET-A-H2A.V (GeneCust): 
AGGCCTATGATTATAAAGATCATGATGGTGATTATAAAGATCATGATATTGATTATAAAGAT
GATGATGATAAATAAGGATCCGAGCTC 
 
3. OLIGONUCLEOTIDES FOR QPCR AMPLIFICATION 
 
FlyFos019611 
Control region 1 fw: GGACCTGCTAGTGTCCTGCG 
Control region 1 rv: GCAGATGGAACATTCCGTTCTGCG 
Control region 2 fw: GGCAGGCGACTGTTTGCC 
Control region 2 rv: GCCAACACGTTGGAGGCG 
Distance 500 bp 1 fw: GGCTGCGCCCTGTGC 
Distance 500 bp 1 rv: GCTGTTCCCTGGTGCTTC 
Distance 1500 bp 1 fw: CCGGATGGCTCAGGCATCG 
Distance 1500 bp 1 rv: GCAGGAAGCGGCGGC 
Distance 3000 bp 1 fw: GGGTGATAGTGTTGAGAAGACCTCTCG 
Distance 3000 bp 1 rv: CCAGATACTCTTCGACCGAACGCC 
Distance 500 bp 2 fw: CGGACGAGAAGTGGTAAGAGGAGC 
Distance 500 bp 2 rv: CGACATAGAAACGTGTGCGTGGC 
Distance 1500 bp 2 fw: CCAATGCACACACTCGAACTCACC 
Distance 1500 bp 2 rv: CCACGAAGATGTCGGTAAACATTTGCG 
Distance 3000 bp 2 fw: CCAGGGACCATCTCCACCTCC 
Distance 3000 bp 2 rv: CGGCACACAAACTGTTTCGCC 
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FlyFos019829 
Control region 1 fw: GGGCTACGTGTTTTGCTCGTGG 
Control region 1 rv: CGTCCTTTTCCCCAAGATAGAAAGGC 
Control region 2 fw: GGCCCGTTTGTCAGAAAAAGAGCC 
Control region 2 rv: GCCAGTCCAAGACGGTAACGC 
 
 
4. OLIGONUCLEOTIDES TO AMPLIFY DNA FROM GENOMIC DNA TO GENERATE RNAI 
 
Tip60 
Fw: TAATACGACTCACTATAGGGGAA CTC TGT CAT TAC GTA GAA GAG AAA C 
Rv:  TAATACGACTCACTATAGGGCCTACAACTCCGCAGACAC 
Ku70 
Fw: TAATACGACTCACTATAGGGCCCCAGATAATGGGGAAGATAAG 
Rv:  TAATACGACTCACTATAGGGTCT ATG CGC TTG TCC TGT TG 
Ku80 
Fw: TAATACGACTCACTATAGGGCAA TTA AGC CCA CAC CG 
Rv: TAATACGACTCACTATAGGGAAA TGG TTG TGC TAC TGC 
 
 
K. ANTIBODIES 
1. MONOCLONAL PRIMARY ANTIBODIES 
 
(from Elisabeth Kremmer, Helmholtz Center Munich) 
 
a-Ku70 Peptide 1, 6B2    rat, WB 1:5 
a-Ku70 Peptide 1, 12B8    rat, WB 1:5 
a-Ku70 Peptide 2, 5H4    rat, WB 1:5 
a-Ku80 Peptide 1, 8E7    rat, WB 1:5 
a-Ku80 Peptide 2, 8B11    rat, WB 1:5 
a-Acf1, 3F1      rat, WB 1:5 
a-Acf1, 8E3     rat, WB 1:5 
a-HA, 12CA5     mouse, WB 1:5  
a-Chrac14, 5C7     rat, WB 1:5 
a-Chrac16, 6G6     rat, WB 1:5 
a-DomA+B, 2G5     rat, WB 1:5 
a-DomA, 24C10     rat, WB 1:5 
a-DomB, 4H4     mouse, WB 1:5 
a-Tip60, 2C4     mouse, WB 1:5 
a-Tip60, 6H1     rat, WB 1:5 
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2. COMMERCIAL PRIMARY ANTIBODIES  
 
a-H2AvD p S 137 (Biomol)    rabbit, WB 1: 5000 
a-H3 antibody ab1791 (Abcam)   rabbit, WB 1: 20000 
a-H4 antibody ab10158 (Abcam)   rabbit, WB 1: 5000 
a-H4K16ac (Millipore)    rabbit, WB: 1:10.000  
a-H4K16ac (Active Motif)   rabbit, WB: 1:500  
a-poly(ADP-ribose) antibody ab14459 (Abcam) mouse, WB: 1:1000 
 
3. PRIMARY ANTIBODIES GENERATED IN OUR LABORATORY OR IN OTHERS 
 
a-Acf1 rb2 (Jain, Baldi, Zabel, Straub & Becker 2015) 
rabbit, WB 1:2500 
a-H2A (kind gift from Jürg Müller, MPI Martinsried, Munich, Germany)   
      rabbit, WB 1: 2000 
a-H2A.V (Börner & Becker 2016)   rabbit, WB 1:500 
a-H2AvDpS137 (kind gift from R. Scott Hawley, Kansas, USA, (Lake et al. 2013)   
      mouse, WB 1: 20000 
a-Iswi rb2 (unpublished)    rabbit, WB 1:2500 
a-Rsf1 (Jain, Baldi, Zabel, Straub & Becker 2015) rabbit, WB 1:2000 
 
 
4. SECONDARY ANTIBODIES AND STAINING REAGENTS 
 
a-mouse Cy3     donkey, IF: 1:2500 
a-mouse IgG-HRP-linked Whole AB (VWR) sheep, WB: 1:20 000 
a-mouse IRDye 680RD (LI-COR Biosciences) goat, WB: 1:10 000 
a-rabbit Alexa488    donkey, IF: 1:2500  
a-rabbit IgG-HRP-linked Whole AB (VWR) donkey, WB: 1:20 000 
a-rabbit IRDye 800CW (LI-COR Biosciences goat, WB: 1:10 000 
a-rat IgG-HRP-linked Whole AB (VWR)  goat, WB: 1:20 000 
a-rat IRDye 800CW (LI-COR Biosciences)  goat, WB: 1:10 000 
DAPI (Invitrogen)    IF: 1:500 
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V. METHODS 
A. DROSOPHILA POPULATION  
1. PREPARATION OF APPLE JUICE AGAR PLATES AND YEAST PASTE 
 
Apple juice agar plates (about 200 plates): 1460 g agar was dissolved in 32 L deionized water, 
then 14 L apple juice and 2 L molasses were slowly added while stirring. The agar was stirred 
to chill down to less than 70°C and 1120 mL 10% (w/v) Nipagin (dissolved in ethanol) were 
added. Plates were then poured using styrofoam dishes of 225 cm x 175 cm x 25 cm size 
(Margret Lutz GmbH & Co. KG) with about 1 cm of agar, and stored after polymerization of the 
agar in clean plastic bags at 4°C. 500 g dry yeast were dissolved in 750 mL ddH2O and 4.2 mL 
propionic acid (Sigma) and stored at 4°C. 
 
2. PREPARATION OF EMBRYO BOXES TO MAINTAIN THE DROSOPHILA POPULATION 
 
Embryos from overnight plates were collected, washed in 70% EtOH and transferred to small 
Whatman papers to dry. Meanwhile, cellulose tissues were distributed to plastic boxes of about 
30 cm x 30 cm x 10 cm and soaked with 425 mL - 450 mL of an embryo nutrition suspension 
composed of 77 g inactivated yeast, 50 g sugar, 12 mL 10% (w/v) Nipagin (dissolved in ethanol), 
4.8 mL ortho-phosphoric acid, 0.6 mL propionic acid and 430 mL water. The Whatman papers 
with embryos were transferred onto the soaked cellulose tissues and the boxes with embryos 
were closed with lids consistent of grids to allow air circulation. The boxes were then kept at 
25°C and appropriate humidity for 10 days until the embryos reached the adult stage. After 
hatching, flies in the boxes were transferred in to collection cages and kept at 25°C and 
appropriate humidity. Agar plates stocked with yeast paste were added and changed regularly. 
 
B. SAMPLE PREPARATION FOR CHROMATIN IN VITRO RECONSTITUTION 
1. DROSOPHILA EMBRYO EXTRACT (DREX) PREPARATION  
 
DREX was prepared from preblastoderm Oregon-R embryos 0-90 min AEL according to Becker 
& Wu 1992 with the following modifications:  
After collection of 0-90 min old embryos, the embryos were dechorionated in 200 mL embryo 
wash buffer and 60 mL 13% sodium hypochlorite (VWR) for 3 min at room temperature while 
stirring. Embryos were rinsed for 5 min with cold water and transferred into a glass cylinder 
with embryo wash buffer. After settling of the embryos, the buffer was decanted, and the 
embryos were washed first in 0.7% NaCl and then in extract buffer EX10. 
- Methods - 
 
 34 
After the last wash, embryo wash buffer was decanted, and embryos were homogenized with 
one stroke at 3000 rpm and 10 strokes at 1500 rpm using Schuett homgenplus, (Schuett-
biotec). The homogenate was adjusted to a final MgCl2concentration of 5 mM and centrifuged 
for 15 min at 27000 g at 4°C. The white lipid layer was discarded, and the supernatant was 
centrifuged for 2 h at 245000 g at 4°C. The clear supernatant was isolated with a needle and 
syringe, leaving the lipid layer and pelleted nuclei in the tube. 
 
embryo wash buffer  
0.7% NaCl 
0.04% Triton X-100 
 
 
 
 
 
 
 
 
 
EX-10 
10 mM KCI 
10 mM HEPES pH 7.6 
1.5 mM MgCl2 
0.5 mM EGTA 
10% glycerol 
10 mM β-glycerophosphate 
1 mM DTT 
0.2 mM PMSF 
1 mM aprotinin 
1 mM leupeptin 
1 mM pepstatin
 
2. DEPLETION OF DREX 
 
For depletion of DREX from Acf1, monoclonal Acf1 8E3 or 3F1 antibodies were pre-coupled to 
protein G beads washed in PBS overnight on a rotating wheel at 4°C using 15 mL antibody per 
200 µL protein G beads. Beads were then blocked in 5% BSA in PBS for 1h on a rotating wheel 
at 4°C and washed 5 times in EX10 buffer on a rotating wheel at 4°C. For depletion, 100 µL 
beads were added to 200 µL of extract and incubated for 3 h on a rotating wheel at 4°C. 
Afterwards, beads were pelleted for 2 min at 500 g and the supernatant was transferred to 
another 100 µL fresh blocked and antibody coupled beads for a second round of depletion for 
3 h on a rotating wheel at 4°C. Afterwards, the supernatant was transferred to fresh tubes, 
snap frozen and stored at -80°C. Protein concentrations were in the range of about 30 mg/mL. 
 
3. DROSOPHILA TRANSCRIPTION EXTRACT PREPARATION (TRAX) 
 
For Drosophila transcription extract preparations, embryos from 0 to 12 h after egg laying were 
collected and stored at 4°C until 76 g were collected. Embryos were dechorionated as 
described in V.B.1 and rinsed with 1L embryo wash solution, then with distilled tap water and 
then dried with paper towel. Then, the embryos were resuspended in about 2 mL/g embryos 
of Buffer 1 and homogenized using the Yamato LH-21 homogenizer at 1000 rpm two passes. 
The homogenate was then passed through a funnel with a single layer miracloth and diluted 
with additional buffer 1 to a final volume of 5 mL/g embryos. Nuclei were then pelleted at 
10 000 g for 15 min at 4°C, supernatants and lipids were removed and the outer layer of the 
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pellet was resuspended with buffer AB to a final concentration of 1 mL/g embryos without 
resuspending the lower layer of the pellet consisting of lipids. The last centrifugation step was 
repeated, and the pellet was then dissolved using a 40 mL B Dounce homogenizer. Then, 1/10 
of the homogenate volume of room temperature ammonium sulfate pH 7.9 was added and the 
homogenate was mixed by inversion and centrifuged first for 20 min at 25 000 g and then for 
2 h at 140 000, each time at 4°C. The supernatant beyond the lipid layer was removed with a 
syringe and a needle and supplied with 0.3 g per mL supernatant of finely grounded ammonium 
sulfate powder while stirring. After that, the supernatant was centrifuged for 20 min at 4°C at 
25 000 g. The pellet was then resuspended in buffer C to a final concentration of 0.2 mL/g 
embryos using a dounce homogenizer and dialyzed for 4 h against 2 L of buffer C. The protein 
concentration was 14 mg/ml.  
 
Buffer 1 
15 mM HEPES pH 7.6 
10 mM KCl 
2 mM MgCl2 
0.5 mM EGTA 
0.1 mM EDTA 
350 mM sucrose 
1 mM DTT 
0.2 mM PMSF 
1 mM NaMBS 
1x Roche complete protein inhibitors 
 
 
 
 
 
 
 
 
 
Buffer AB 
15 mM HEPES pH 7.6 
110 mM KCl  
2 mM MgCl2 
0.1 mM EDTA  
1 mM DTT 
0.2 mM PMSF 
1 mM NaMBS 
1x Roche complete protein inhibitors 
 
Buffer C 
20% glycerol 
25 mM HEPES pH 7.6 
100 mM KCl 
2 mM MgCl2 
0.1 mM EDTA 
1 mM DTT 
0.2 mM PMSF 
1 mM NaMBS 
1x Roche complete protein inhibitors 
 
 
4. PREPARATION OF IMMOBILIZED DNA 
 
Depending on the assay, either free (circular or linearized) DNA or immobilized DNA was used. 
As free DNA, pUC18 or FlyFosmids 019829 and 019611 were used. For linearization, pUC18 or 
FlyFosmid 019611 were restricted with XbaI, or FseI, respectively. For immobilization, 5’ 
overhangs generated after restriction were filled up with biotinylated nucleotides by Klenow 
(exo-) in the following reaction: 50 µM biotinylated dATP and/or dUTP were used together with 
200 µM of the remaining dNTPs. To avoid unspecific degradation by nucleases in the extract, 
one unbiotinylated nucleotide was replaced by thio-dTTP or thio-dGTP, at 200 µM final 
concentration. The fill-up reaction was performed with 0.3 U/µL Klenow (exo-) in 1x NEB2 for 
1h at 37°C. To introduced biotinylated nucleotides by nick translation, circular pUC18 DNA was 
incubated in different ratios with Biotin-Nick Translation Mix (Sigma) for 90 min at 15°C (either 
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2 µg DNA in 32 µL ddH2O supplied with 8 µL mix or 10 µg DNA in 16 µL ddH2O supplied with 
4 µL mix). To remove unincorporated nucleotides, DNA was either purified over G50 Sepharose 
columns (Roche) or with the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel).  
For immobilization of biotinylated DNA, a coupling mix was prepared as follows: 30 ng/µL 
biotinylated DNA in 1x binding and washing buffer were added to Dynabeads M-280 
Streptavidin beads (Life technologies), which were prewashed once with PBS-BSA-NP40 and 
twice with 2x Binding and washing Buffer. The optimal binding ratio of beads : biotinylated DNA 
was determined in a previous titration to be 30 µL slurry : 1 µg DNA. Beads and coupling mix 
were incubated over night at 4°C while rotating. The efficiency of biotinylation was tested in a 
missing band test with 300 ng of input DNA and 10 µL of coupling mix after biotinylation 
(corresponding to 300 ng DNA before immobilization) analyzed on a 1% (w/v) agarose gel 
(0.5x TAE buffer, 0.5 μg/mL ethidium bromide). 
 
2x binding and washing buffer  
2 M NaCl 
50 mM Tris–HCl pH 8.0 
1 mM EDTA 
 
0.5x TAE buffer  
20 mM Tris pH 7.6 
10 mM acetic acid 
0.5 mM EDTA 
 
5. HISTONE EXPRESSION AND PURIFICATION 
 
Arrays were reconstituted from recombinant Drosophila histones purified according to Klinker, 
Haas, et al. 2014 with the following modifications: due to the lower pI, histone H2A.V and its 
tagged versions were purified in buffer Sau-0 instead of Sau-200. Histone H3 and H4 were kind 
gifts from Catherine Regnard (prepared by the purification of inclusion bodies). 
 
Sau-0 
40 mM sodium acetate pH 5.2 
1 mM EDTA pH 8 
10 mM lysine 
Add fresh  
7.5 M urea 
5 mM DTT  
 
Sau-1000 
40 mM sodium acetate pH 5.2 
1 mM EDTA pH 8 
10 mM lysine 
1 M NaCl 
Add fresh 
7.5 M urea 
5 mM DTT 
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6. OCTAMER RECONSTITUTION 
 
For octamer reconstitution, ratios of the corresponding histones were titrated to reach final 
ratios of H2A:H2B:H3:H4  1.2:1.2:1:1. After titration, histones were pooled, lyophilized and 
resuspended in Unfolding buffer to final concentrations of 4.7 mg/mL for H2A and H2B, and 
4.0 mg/mL for H3 and H4, respectively. The histones were dialyzed against Refolding buffer at 
4°C overnight. Octamers were purified by Size exclusion chromatography in Refolding buffer 
on a Hiload 16/600 Superdex 200 column (Sigma). 
 
Unfolding buffer 
7 M guanidine hydrochloride 
20 mM Tris pH 7.5 
10 mM DTT 
 
 
 
 
Refolding buffer 
10 mM Tris pH 7.5 
2 M NaCl 
1 mM EDTA 
5 mM DTT 
 
 
 
7. RECONSTITUTION OF RECOMBINANT NUCLEOSOME ARRAYS 
 
Nucleosomes were reconstituted by salt gradient dialysis as follows: 100 µL reactions 
consistent of 10 µg DNA, around 10 µg octamer (optimal octamer amounts were determined 
after titration), 20 µg BSA, 0.1% Igepal CA-630, 10 mM Tris pH 7.6, 2 M NaCl, 1 mM EDTA were 
transferred into dialysis cups (Slide-A-Lyzer; MWCO 3500, Thermo Fisher) and placed in 300 mL 
high salt buffer. Salt concentration was decreased constantly at room temperature by pumping 
3L of low salt buffer into the 300 mL high salt buffer using a peristaltic pump (Minipulse 
evolution, Gilson, mode 8.4 rpm). After the gradient, the dialysis cups were dialyzed 2 h at room 
temperature against low salt buffer. Quality of nucleosome assembly was assessed by limited 
MNase digestion. 
 
low-salt buffer  
10 mM Tris pH 7.6 
50 mM NaCl 
1 mM EDTA 
0.05% Igepal CA-630 
0.01% β-mercaptoethanol 
 
high-salt buffer  
10 mM Tris-HCl pH 7.6 
2 M NaCl 
1 mM EDTA pH 8.0 
0.05% Igepal CA-630 
0.1% β-mercaptoethanol
 
 
 
 
- Methods - 
 
 38 
C. IN VITRO CHROMATIN ASSEMBLY AND ANALYSIS 
 
1. STANDARD CHROMATIN ASSEMBLY REACTION 
 
When chromatin assembly was performed on immobilized DNA, beads with DNA were first 
blocked for 1 h on a rotating wheel at 4°C in PBS-BSA-NP40 buffer and washed twice in EX-50 
buffer supplied with 0.05% Igepal. For chromatin assembly, 1 µg of free or immobilized 
recombinant DNA or recombinant nucleosome arrays were incubated with 40 µL (for gH2A.V 
spreading reactions) or 60 µL DREX supplied with 10 mM β-glycerophosphate and ATP 
regenerating buffer and filled up to a total volume of 120 µL with EX50 buffer and incubated at 
26°C.  
 
PBS-BSA-Igepal  
PBS with 0.05% BSA (w/v)  
and 0.05% Igepal (v/v)              
 
ATP regenerating buffer  
3 mM ATP 
30 mM creatine phosphate 
10 μg/mL creatine kinase 
3 mM MgCl2 
1 mM DTT 
 
 
EX-50 
50 mM KCI 
10 mM HEPES pH 7.6 
1.5 mM MgCl2 
0.5 mM EGTA 
10% glycerol 
10 mM β-glycerophosphate  
1 mM DTT 
0.2 mM PMSF 
1 mM aprotinin 
1 mM leupeptin 
1 mM pepstatin 
 
2. LIMITED MNASE DIGESTION AND SUPERCOILING ASSAY 
 
To assess chromatin assembly by limited MNase digestion, 1 µg DNA was supplied with 40 µL 
to 80 µL DREX supplied with ATP regenerating buffer and filled up to a total volume of 140 µL 
with EX50 buffer. Chromatin assembly was then performed for 6 h at 26°C. Then, 200 µL MNase 
mix was added to each reaction and 110 µL aliquots were removed after 15 s, 30 sec and 90 s 
and transferred to fresh tubes with 40 µL MNase stop solution to stop MNase digest by 
chelating Ca2+ ions in the reaction. Afterwards, the tubes were supplied with 2 µL RNase and 
incubated for 30 min at 37°C. Then, SDS up to a final concentration of 0.2% (w/v) and 10 µL 
proteinase K was added and protein digest was performed overnight at 37°C. On the next day, 
DNA was pelleted by ethanol precipitation, eluted in TE buffer and supplied with DNA sample 
buffer including Orange G, and separated on 1.5% agarose (w/v) in 0.5x TAE buffer at 100 volts. 
DNA was then stained with 12.5 µg ethidium bromide / 100 mL TAE buffer for 20 min at room 
temperature. 
For the supercoiling assay, 1.5 µg DNA was supplied with 60 µL to 90 µL DREX supplied with 
ATP regenerating buffer and filled up to a total volume of 200 µL with EX50 buffer. Chromatin 
 - Methods - 
 39 
assembly was then performed at 26°C and stopped after 10 min, 30 min, 60 min, and 180 min 
by transferring 40 µL of the reaction to 10 µL MNase stop solution. Afterwards, samples were 
treated with RNase and proteinase K and DNA was purified as described before. Gel 
electrophoresis after DNA elution in TE buffer and addition of DNA sample buffer including 
Orange G or bromophenol blue was then performed on 1.2% agarose (w/v) in 1x in Tris/glycine 
buffer at 100 volts. DNA was then stained with 12.5 µg ethidium bromide / 100 mL TAE buffer 
for 20 min at room temperature. 
 
MNase mix 
5 mM CaCl2 and 12 U/mL MNase in EX50 
 
MNase stop solution 
100 mM EDTA pH 8.0 
2.5% N- lauroylsarcosine 
 
RNase A (10mg/mL) 
10 mM Tris pH 7.5 
15 mM NaCl 
heated to 100°C for 15 min  
 
Proteinase K (10 mg/mL) 
in 50 mM Tris pH 8.0, 5 mM CaCl2 and 50% 
glycerol 
 
 
 
 
TE buffer  
10 mM Tris pH 7.5 
1 mM EDTA pH 8 
 
6x DNA sample buffer 
60% glycerol (v/v), filled up with TE buffer 
add spatula tip of Orange G or  
bromophenol blue 
 
0.5x TAE buffer  
20 mM Tris pH 7.6 
10 mM acetic acid 
0.5 mM EDTA 
 
1x in Tris/glycine buffer 
25 mM Tris 
200 mM glycine 
 
3. CHROMATIN IMMUNOPRECIPITATION 
 
Chromatin immunoprecipitation was performed on standard chromatin assembly reactions, 
unless indicated otherwise. Formaldehyde crosslinking was performed for 10 min at 26°C with 
concentrations of 0.01% or 0.1% formaldehyde, for histones, or chromatin remodeling factors, 
respectively. 
To capture fast spreading events, formaldehyde crosslinking was performed with 0.1% 
formaldehyde for 3 min at 26°C. Crosslinking was quenched by addition of 125 mM glycine for 
5 min at 26°C. Then, after addition of 1.5 mM CaCl2, chromatin was fragmented by MNase 
treatment for 15 min at 30°C, with 1.2 U per µg DNA for chromatin assembled from 
endogenous nucleosomes, and 2.4 U per µg DNA for chromatin assembled from recombinant 
nucleosomes, respectively. MNase digestion was stopped by chelating the Ca2+ ions with 
10 mM EDTA. Chromatin was then filled up with RIPA to 500 µL per 1 µg DNA. Then, pre-
clearing was performed by incubation with 30 µL slurry of protein A or G beads (depending on 
which was used for the immunoprecipitation later) washed with RIPA for 1 h on a rotating 
wheel at 4°C. Then, beads were pelleted after centrifugation at 500 g for 2 min, the supernatant 
was transferred into fresh tubes, split for immunoprecipitation and supplied with the 
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corresponding antibody. Amounts of chromatin and antibody used per ChIP as well as usage of 
protein A or G beads are listed in Table 2. For monoclonal rat antibodies, protein G beads were 
washed with PBS and precoupled to antibody overnight on a rotating wheel at 4°C (1.5 mL 
antibody per 30 µL beads).  
TABLE 2: ANTIBODY CONCENTRATIONS AND BEADS USED FOR CHROMATIN IMMUNOPRECIPITATION 
antibody Amount per µg DNA Beads used for pre-clean and IP 
a-H2A.V (Anton Eberharter) 4 µL per 0.5 µg A:G mix 50:50 
a-gH2A.V (Rockland) 3 µL per 0.5 µg A:G mix 50:50 
a-H4K16ac (Active motif) 6 µL per 1 µg  A:G mix 50:50 
a-H2A (Müller laboratory) 8 µL per 1 µg A:G mix 50:50 
a-H3 (Abcam) 3 µL per 1 µg A:G mix 50:50 
a-Acf1 rb2 15 µL per 1 µg A:G mix 50:50 
a-Iswi rb2 15 µL per 1 µg A:G mix 50:50 
a-Ku70 (mix of 6B2, 12B8 and 5H4) precoupled G 
a-Ku80 (mix of 8E7 and 8B11) precoupled G 
a-Acf1 8E3 precoupled G 
 
a-Ku70 Peptide 1, 6B2, rat, WB 1:5 
a-Ku70 Peptide 1, 12B8, rat, WB 1:5 
a-Ku70 Peptide 2, 5H4, rat, WB 1:5 
a-Ku80 Peptide 1, 8E7, rat, WB 1:5 
a-Ku80 Peptide 2, 8B11, rat, WB 1:5 
 
Chromatin samples including the antibody were incubated overnight on a rotating wheel at 
4°C, supplied with 30 µL protein A or G beads according to Table 2 and incubated for 3 h on a 
rotating wheel at 4°C. Then, beads were washed 5 times with RIPA, each for 10 min on a 
rotating wheel at 4°C and then, after removal of supernatant, supplied with 100 µL TE including 
10 µg RNaseA. After incubation of 30 min at 37°C while shaking, samples were supplied with 
0.5% SDS and 100 µg proteinase K. De-crosslinking was then performed at 68°C and 800 rpm 
for 2 h, followed by 37°C and 800 rpm overnight. DNA was then purified using the Genelute 
PCR Clean-Up Kit (Sigma) and eluted in 30 µL TE buffer. 
 
RIPA buffer (adapted from Abcam) 
150 mM sodium chloride 
1.0% NP-40 (or Triton X-100) 
0.5% sodium deoxycholate  
0.1% SDS  
50 mM Tris pH 8.0  
 
 
TE buffer  
10 mM Tris pH 7.5 
1 mM EDTA pH 8
 
RNase A (10mg/mL) 
10 mM Tris pH 7.5 
15mM NaCl 
heated to 100°C for 15 min  
 
 
Proteinase K (10 mg/mL) 
50 mM Tris pH 8.0 
5 mM CaCl2 
50% glycerol 
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4. QUANTITATIVE REAL-TIME PCR AND DNA SEQUENCING 
 
For qPCR, DNA purified after chromatin immunoprecipitation was diluted 1:30 in ddH2O. All 
measurements were performed in triplicates using 2 µL of diluted DNA, 5 µM of each, forward 
and reverse primer, and Power up SYBR Green in 10 µL total volume. Concentrations were 
determined in reference to a standard curve of input DNA of 0.00025 ng, 0.0025 ng, 0.025 and 
0.25 ng. For next generation sequencing, libraries were prepared using NEBNext Ultra II DNA 
Library (New England Biolabs) according to manufacturer’s instructions and sequenced by the 
Laboratory for Functional Genome Analysis (LAFUGA) platform, Gene Center Munich, Germany 
using an Illumina HiSeq1500 sequencer in approximately 1 million single-end reads for 
FlyFosmid DNA and 40 million single-end reads for genomic DNA. Mapping and normalization 
was performed by Tamás Schauer as follows: Reads were mapped using bowtie2 (version 2.2.9) 
against the reference genome (version dm6) and multi-mapping reads were excluded (MAPQ 
> 1). Read coverages were calculated using R/Bioconductor packages (version 3.6) and were 
normalized by the total number of reads mapped to the control FlyFosmid (unless indicated 
otherwise). The normalized profiles were visualized in the IGV browser (version 2.3.82). 
 
5. MASS SPECTROMETRY ANALYSIS  
 
For Acf1 depletion, 70 µL protein G sepharose beads pre-coupled to 8E3 or 3F1 antibody, 
blocked with BSA and washed with EX10, were incubated with 140 µL extract for 3 h at 4°C on 
a rotating wheel. Afterwards, beads were washed 5 times with EX50 buffer supplied with 2 mM 
DTT and prepared for mass spectrometry analysis as follows:  
100 µL 4 M urea in 100 mM Tris pH 8 supplied with 1 µg LysC was added to the beads and 
incubated for 1.5 h at 28°C while shaking. The supernatant was transferred into a new vial and 
beads were washed twice with 200 µL 100 mM ammonium bicarbonate and both supernatants 
were combined with the first supernatant to obtain 500 µL per tube. Then, DTT was added to 
a final concentration of 2 mM and trypsin digestion was performed with 2 µg trypsin per tube 
overnight at 30°C. On the next day, iodoacetamide was added to a final concentration of 
10 mM and samples were incubated for 30 min at room temperature in the dark. Samples were 
then acidified with 5% trifluoroacetic acid (v/v) and desalted with TopTip C18 stage tips 
(Glygen) as follows: tips were prepared by washing twice with 50 µL methanol and 5 times with 
70 µL 0.2% (v/v) trifluoroacetic acid. Then, samples were loaded onto the C18 stage tips, 
washed twice with 70 µL 0.2% (v/v) formic acid and dried by an additional round of 
centrifugation. Elution was performed with 2x 100 µL 70% (v/v) acetonitrile and 0.1% (v/v) 
formic acid. Samples were then vacuum dried, dissolved in 20 µL 0.2% (v/v) formic acid and 
analyzed by Andreas Schmidt (Protein Analysis Unit ZfP, LMU Munich) with LC MS/MS using the 
Triple TOF 6600 system (Sciex). 
For chromatin samples on immobilized DNA, standard chromatin assembly reactions were 
prepared as described. After assembly for 15 min or 3 h, beads were washed with EX50 buffer 
(w/o proteinase inhibitors) supplied with 2 mM DTT and beads and input samples were filled 
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up with the same buffer up to 20 µL. Then, samples were incubated at 56°C for 35 min to 
reduce disulfide bonds, cooled down to room temperature and supplied with urea in 100 mM 
Tris pH 8 and iodoacetamide to final concentrations of 5 M, or 10 mM, respectively, and 
incubated for 35 min in the dark at room temperature while shaking. Samples were then diluted 
with 100 mM ammonium bicarbonate to a final concentration of 1 M urea and 5 µg trypsin was 
added to each SN or input sample and 1 µg trypsin to each beads sample and incubated 
overnight at 30°C. Beads were then collected on paramagnetic devices and supernatants were 
transferred to fresh vials. Beads were washed twice with 70 µL 0.2% formic acid (v/v) and 
supernatants from washing were combined with the previous supernatant from digestion. 
Samples were then acidified with trifluoroacetic acid to pH 2-3 and desalted with C18 stage tips 
as described before. The eluate was again vacuum dried, dissolved in 20 µL 0.2% (v/v) formic 
acid and analyzed by Andreas Schmidt (Protein Analysis Unit ZfP, LMU Munich) with LC MS/MS 
using the Triple TOF 6600 system (Sciex). 
For the analysis of post-translational histone modifications, the following modified chromatin 
assembly reactions were set-up to decrease the abundance of free unincorporated histones: 
1 µg of free linearized or circular DNA or preassembled arrays of H2A.V or H2A.VDC 
nucleosomes on linearized or circular DNA were incubated with 8 µL DREX supplied with 10 mM 
β-glycerophosphate and ATP regenerating buffer and filled up to a total volume of 40 µL with 
EX50 buffer and incubated at 26°C for 15 min or 3 h. Samples were then snap frozen in liquid 
nitrogen and analyzed by Christian Feller, ETH Zurich, Switzerland. 
 
D. CELL CULTURE METHODS 
 
1. MAINTENANCE AND MODIFICATION OF DROSOPHILA SCHNEIDER CELLS 
 
Stable transfection with AsiSI was performed using Drosophila S2_DGRC cells maintained in 
Schneider’s Drosophila medium supplemented with penicillin, streptomycin and 10% (v/v) fetal 
calf serum at 26°C. Stable transfection was performed with Effectene Transfection Reagent 
(Qiagen) according to manufacturer’s instructions. 2-3 days after transfection, 10 µg/mL 
puromycin was added to select for cells, which incorporated the construct including a 
puromycin resistance gene. In parallel, a control transfection without DNA was performed and 
treated with puromycin-containing medium in parallel. When the cells of the control 
transfection died due to the lacking resistance, AsiSI-transfected cells were transferred to 
Schneider’s Drosophila medium supplemented with penicillin, streptomycin and 10% (v/v) fetal 
calf serum and maintained at 26°C. For SDS-PAGE, cells were washed with PBS, resusupended 
in 100 µL urea sample buffer per 2*106 cells and boiled at 95°C for 5 min. 
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PBS 
140 mM NaCl 
3 mM KCl 
10 mM Na2HPO4  
2 mM KH2PO4 
 
 
Urea sample buffer 
9M urea 
1% SDS 
25 mM Tris pH 6.8 
1 mM EDTA 
0.02% bromophenol blue 
100 mM DTT
 
2. INDUCTION OF DSBS INTO THE GENOME OF STABLY TRANSFECTED ASISI CELLS 
 
1*106 SL2 cells were supplied with CuSO4 to a final concentration of 5 mM and incubated for 
24 h at 26°C. Then 4-OHT was added to a final concentration of 300 nM and cells were 
incubated for additional 4 h at 26°C. 
 
3. KNOCK DOWN OF TIP60, KU70, AND KU80 
 
Appropriate target regions for RNAi against Tip60, Ku70 and Ku80 were determined using 
http://www.flyrnai.org/cgi-bin/DRSC_gene_lookup.pl. The following amplicons were used: 
Tip60 RNAi: DRSC18661; Ku70 RNAi: DRSC29386; Ku80 RNAi: DRSC26861. The genomic region 
of interest was amplified from genomic DNA isolated from W1118 flies by Phusion High-Fidelity 
DNA Polymerase (New England Biolabs) according to manufacturer’s instructions with the 
following PCR program: 
 2 min 99°C  
 
 10 sec 99°C 
 20 sec 50°C 
15 sec 72°C  (30 cycles) 
 
5 min 72°C 
 
4 µL of the PCR product were analysed by gel electrophoresis to confirm successful PCR 
amplification. To generate dsRNA, in vitro transcription was performed with the MEGAscrip T7 
Transcription Kit (Thermo) and purified using the RNeasy Mini Kit (Qiagen) according to 
manufacturer’s instructions. 
For knock down, 1*106 cells were resuspended in 1 mL Schneider’s Drosophila medium (Life 
Technologies) supplemented with penicillin, streptomycin and incubate with 10 µg dsRNA for 
30 min at room temperature while shaking. Then 3 mL Schneider’s Drosophila medium 
supplemented with penicillin, streptomycin and 10% (v/v) fetal calf serum was added and 
incubated for 4 days at 26°C.  
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4. IF STAINING OF ASISI TRANSFECTED SL2 CELLS  
 
First, DSBs were induced as described in V.D.2 using 1*106 cells in 5 mL Schneider’s Drosophila 
medium supplemented with penicillin, streptomycin and 10% (v/v) fetal calf serum. After 
resuspension of cells, 100 µL were transferred to 3-well coverslips and left for 1 h to allow them 
settling. Then cells were washed in a coplin jar with PBS for 5 min at room temperature, fixed 
by adding 100 µL 3.7% (v/v) formaldehyde in PBS for 10 min, and washed again twice in PBS for 
5-10 min. Afterwards, cells were permeabilized in a coplin jar with ice-cold PBS with 0.25% 
Triton for 6 min on ice. After washing again twice in PBS for 5-10 min, the coverslips were dried 
with Whatman paper and 100 µL PBS with 0.1% Triton and 5% NDS was added for blocking. 
After 2 h of incubation at room temperature, the slides were washed in PBS and 100 µL 
antibody solution (polyclonal rabbit-H2A.V and monoclonal mouse-gH2A.V, both diluted in PBS 
with 0.1% Triton, 5% NDS and 5% non-fat milk) were added to the cover slips. Slides were 
incubated in a wet chamber (consisting of a wet towel in a closed box) overnight at room 
temperature), and then washed again twice in PBS with 0.1% Triton for 5-10 min and dried with 
Whatman paper. Then 100 µL of antibody solution (donkey-anti-mouse Cy3 and donkey-anti-
rabbit Alexa488 diluted in PBS with 0.1% Triton, 5% NDS and 5% non-fat milk) was added and 
incubated in a slide holder for 1-2 h protected from light. Then, slides were washed again twice 
in PBS with 0.1% Triton, stained with DAPI in PBS for 10 min, washed with PBS for 5-10 min and 
dried by gently tapping the slides onto a paper towel. Afterwards, 1 drop of Vectashield 
mounting medium was applied to the cells and covered with a coverslip. After slightly pressing 
the coverslip onto the slide, the coverslip was sealed with clear nail polish and dried for 30 min 
at room temperature and protected from light. The slides were stored in the dark at 4°C. 
 
E. STANDARD LABORATORY METHODS 
 
1. SDS-PAGE AND WESTERN BLOT ANALYSIS 
 
Samples were supplied with LaemmLi buffer, heated up to 95°C for 5 min, and separated on 
SERVAGel TG PRiME precast gels in running buffer according to the manufacturer’s 
instructions. As a size standard, 5 µL of Protein-Marker IV was loaded. Then, gels were either 
analyzed by Coomassie staining or processed for Western blot analysis. For Coomassie staining, 
the gel was fixed for 15 min in SDS Gel fix solution and then stained in 15 mL SDS Gel Coomassie 
staining solution supplied with 500 µL Coomassie staining. For Western blot, proteins were 
transferred onto nitrocellulose membranes (Protran membran BA85) using the Mini Trans-
Blot® Electrophoretic Transfer Cell (BioRad) for 90 min at 400 mA according to the 
manufacturer’s instructions. After transfer, membranes were blocked in 5% BSA in TBS-T for 
30-60 min on a shaker at room temperature and then incubated overnight on a shaker at 4°C. 
Antibody concentrations are listed in IV.K. The next day, membranes were washed three times 
in TBS-T for 5 min at room temperature and then incubated for 1-2 h with secondary antibodies 
on a shaker at room temperature. Secondary antibodies coupled to Horseradish Peroxidase for 
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chemiluminescence detection using the ECL system or secondary antibodies coupled to 
infrared dyes were used. The former were diluted 1:20 000 in 5% BSA in TBS-T, the latter 
1:10 000 in TBS-T. After washing five times in TBS-T for 10 min at room temperature, signal was 
either detected by the ECL detection system using Immobilon Western Chemiluminescent HRP 
Substrate (Merck Millipore) according to the manufacturer’s instructions and scanned by the 
ChemiDoc (BioRad) or by the Licor detection system.
5x LaemmLi buffer  
250 mM Tris-HCl pH 6.8 
10% SDS(w/v) 
50% glycerol (v/v) 
0.1% bromophenol blue (w/v) 
10% β-mercaptoethanol (v/v) 
 
SDS Gel fix solution  
50% ethanol (v/v) 
10% acetic acid (v/v) 
 
SDS Gel Coomassie staining 
solution 
5% ethanol 
7.5% acetic acid 
 
 
 
 
Coomassie staining 
0.25% Coomassie B G250 
 
Running buffer 
25 mM Tris 
200 mM glycine 
0.1% SDS 
 
Transfer buffer 
25 mM Tris 
200 mM glycine 
 
TBS 
25 mM Tris pH 8 
3 mM KCl  
140 mM NaCl 
 
TBS-T 
TBS with 0.1% Tween-20 
 
 
2. OBTENTION OF FLYFOS DNA  
 
FlyFosmids of the genomic fosmid libraries of Drosophila melanogaster were obtained from the 
Tomancak laboratory in Dresden (Ejsmont Nature Methods 2009). DNA containing E.coli 
cultures transformed with FlyFos019611 or FlyFos019829 were stored in 30% glycerol stocks 
at -80°C. For FlyFosmid amplification, few cells from the glycerol stocks were transferred with 
a spatula into LB medium and 17 µg/mL chloramphenicol and incubated 8h in a shaker at 37°C. 
Then, 5 mL of the culture where transferred into 500 mL flasks with LB medium and 17 µg/mL 
chloramphenicol, supplied with arabinose to a final concentration of 0.1% (w/v) and incubated 
overnight in a shaker at 37°C. The cells were then harvested by centrifugation at 2800 g for 
15 min and FlyFosmid DNA was purified using the Nucleobond PC 500 kit (Macherey-Nagel). 
 
LB medium 
1% peptone (w/v) 
0.5% yeast extract (w/v) 
1% NaCl (w/v) 
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3. INTRODUCTION OF POINT MUTATIONS INTO H2A.V CONSTRUCTS 
 
Introduction of point mutations were performed according to a protocol adapted from the 
QuikChange Site-Directed Mutagenesis Kit (Agilent) and mutagenesis primers were designed 
according to the guidelines of this manual. 
After incubation with 1 µL DpnI for 1 h at 37°C to degrade the methylated non-mutated DNA 
template, competent E.coli DH5a cells were transformed with 2 µL of the PCR reaction and 
plated onto Ampicillin containing LB agar plates. After overnight incubation of the plates at 
37°C, colonies were picked, and cells were amplified in 5 mL ampicillin containing overnight 
cultures for subsequent DNA purification using the NucleoSpin Plasmid Mini Kit. The success of 
introducing the desired point mutations was assessed by sequencing at Eurofins Genomics 
GmbH with appropriate primers offered by the company. 
 
Agar plates 
LB medium 
2% Agar (w/v) 
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VI. RESULTS 
 
A. CHARACTERIZATION OF IN VITRO RECONSTITUTED CHROMATIN 
 
1. CHARACTERIZATION OF IN VITRO RECONSTITUTED CHROMATIN  
 
In this thesis, extract obtained from preblastoderm Drosophila embryos as described in III.E 
was used to reconstitute chromatin in vitro from endogenous factors. To this end, DNA with 
various volumes of extract was incubated in presence of an ATP regenerating system to ensure 
sufficient energy supply during the ATP-dependent remodeling processes. 
To confirm the formation of regular nucleosome arrays with physiological spacing, chromatin 
was treated with micrococcal nuclease (MNase), which targets linker DNA between 
nucleosomes, and digestion was stopped after various time points. Then, DNA was purified and 
analyzed by gel electrophoresis. 
Limited MNase digests resulted in the formation of characteristic DNA fragment ladders, which 
represent the DNA associated with mono-, di-, tri-, or oligo-nucleosomes, depending on the 
extend of digestion. From this ladder, a repeat length of approximately 170 bp was determined, 
leading to a linker length of about 20 bp. In addition to this, limited MNase digestion was used 
to assess the quality of chromatin assembly using different ratios of extract to DNA, which was 
titrated accordingly for every extract preparation. Here, the extend of the ‘MNase ladder’ 
reflecting more complete chromatin assembly improved by increasing the amount of extract, 
resulting in more defined nucleosome arrays and increasing numbers of oligo-nucleosomes (n, 
see Figure 15). 
 
 
To assess proper formation of nucleosomes with left-handed DNA wrapped around the histone 
octamer (see III.A.1), Supercoiling Assays were performed. Nucleosome assembly introduces 
FIGURE 15: LIMITED 
MNASE DIGESTION FOR 
15 SEC, 30 SEC, AND 
90 SEC AFTER IN VITRO 
CHROMATIN RECONSTI-
TUTION WITH 40 µL, 
60 µL, AND 80 µL EXTRACT 
PER 1 µG DNA AND 
ANALYSIS OF PURIFIED DNA 
AFTER GEL ELECTRO-
PHORESIS (N INDICATES THE 
NUMBER OF OLIGO-NU-
CLEOSOMES, WITH N=1: 
MONO-NUCLEOSOMES, 
N=2: DI-NUCLEOSOMES, 
ETC.). 
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DNA negative toroidal supercoils into circular DNA. The compensatory positive plectonemic 
supercoils are relaxed by endogenous topoisomerases in the extract. After removal of the 
nucleosomes by proteinase digestion, the toroidal supercoils are converted in their 
plectonemic forms. For each nucleosome one superhelical turn is introduced in the plasmid, 
which can be resolved on agarose gels (Keller 1975; Becker & Wu 1992). Here, chromatin was 
assembled in vitro on supercoiled plasmid DNA using Drosophila embryo extract for 10 min, 
30 min, 60 min, and 180 min and after assembly, DNA was purified and analyzed by gel 
electrophoresis (see V.C.2).  
 
 
FIGURE 16: SUPERCOILING ASSAY AFTER IN VITRO CHROMATIN ASSEMBLY WITH DROSOPHILA EMBRYO 
EXTRACT FOR 10 MIN, 30 MIN, 60 MIN, AND 180 MIN. FOR INPUT, SUPER-COILED PLASMID DNA WAS 
USED. AFTER 10 MIN, PLASMID DNA IS IN A RELAXED STATE DUE TO TOPOISOMERASES IN THE EXTRACT. 
OVER TIME, SUPERCOILS ARE INTRODUCED BY NUCLEOSOME ASSEMBLY, WHICH CAN BE RESOLVED BY GEL 
ELECTROPHORESIS. 
Due to its compact conformation, supercoiled input DNA (purified from bacteria) runs faster in 
an agarose gel than the relaxed plasmid after addition of extract. However, for each assembled 
nucleosome, a positive supercoil is introduced. As a conclusion, the supercoiling assay can be 
used to visualize the assembly of nucleosomes on supercoiled plasmid DNA, with increasing 
numbers of nucleosomes from 30 to 180 min. 
To enable purification of in vitro reconstituted chromatin for analysis, recombinant DNA was 
immobilized to paramagnetic beads by biotin-streptavidin coupling. For this, DNA ends with 5’ 
overhangs were filled up with biotinylated nucleotides at either one end or both ends for 
subsequent immobilization to streptavidin-coupled beads at either one end, or both ends, 
respectively (Sandaltzopoulos et al. 1994). It has been shown earlier that DNA ends bound to a 
bead surface by biotin-streptavidin interaction are not recognized as ‘free ends’ (Postow et al. 
2008). Immobilization was controlled by the ‘missing band’ test, in which DNA in the 
supernatant after immobilization to paramagnetic beads was analyzed in comparison to input 
DNA before immobilization. Correct immobilization was then confirmed with restriction 
enzymes, which detach DNA fragments in the case of one-sided immobilized DNA but not in 
the case of both-sided immobilized DNA (see Figure 17). 
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FIGURE 17: MISSING BAND TEST TO CONFIRM COMPLETE AND CORRECT IMMOBILIZATION OF 
BIOTINYLATED DNA TO PARAMAGNETIC STREPTAVIDIN BEADS. LEFT: INPUT DNA BEFORE 
IMMOBILIZATION IN COMPARISON TO DNA IN SUPERNATANT (SUP) FOR DNA IMMOBILIZED AT ONE END 
OR BOTH ENDS. RIGHT: TREATMENT OF IMMOBILIZED DNA WITH RESTRICTION ENZYMES LEADING TO 
EITHER DETACHMENT OF DNA FROM BEADS (IN CASE OF ONE END IMMOBILIZED DNA) OR LEAVING BOTH 
FRAGMENTS ATTACHED (IN CASE OF BOTH ENDS IMMOBILIZED DNA). PURPLE DASHED LINES. INDICATE 
SITES OF RESTRICTION). 
To confirm the proper assembly of nucleosomes on immobilized DNA, chromatin was 
assembled in vitro as described in III.E and analyzed by SDS gel electrophoresis followed by 
Coomassie staining. The bands of the histone octamer are visible on both fragments, with one 
end or both ends immobilized. However, the band of streptavidin runs at the same height than 
H4. In addition to this, the band of H2A.V runs at the same height than H2B. Beads without 
immobilized DNA did not show histones or extract proteins, but the streptavidin band only 
(compare Figure 23). 
 
 
FIGURE 18: SDS GEL ELECTROPHORESIS AND COOMASSIE 
STAINING OF IN VITRO RECONSTITUTED CHROMATIN ON 
DNA IMMOBILIZED AT EITHER ONE END (ONE) OR BOTH 
ENDS (BOTH) AFTER PURIFICATION VIA PARAMAGNETIC 
BEADS. 
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To furthermore verify the formation of nucleosomes, limited MNase digestion was performed 
on immobilized chromatin after chromatin in vitro reconstitution on DNA immobilized at either 
one end or both ends (see Figure 19). After purification of DNA and gel electrophoresis, bands 
corresponding to mono- and di-nucleosomes were detected, demonstrating the formation of 
nucleosomes on immobilized DNA fragments.  
 
 
 
 
2. DETERMINATION OF IN VITRO INCORPORATED H2A.V BY DROSOPHILA EMBRYO 
EXTRACT 
 
To determine the amount of incorporated H2A.V in comparison to canonical H2A, I performed 
Western blot analysis on chromatin assembled on recombinant DNA next to nucleosomes 
reconstituted with either only H2A or H2A.V. These were used as reference, as the ratio of H2A 
or H2A.V to H4 was assumed to be 1. The double band detected with antibody against H2A.V 
in the chromatin samples results from the phosphorylated and unphosphorylated form of 
H2A.V, which will be investigated in more detail in VI.B. 
 
 
 
Western blot analysis of reconstituted chromatin revealed that about a quarter of H2A is 
replaced by H2A.V, similar to what has been described in vivo (H2A.V in 25% of nucleosomes, 
FIGURE 19: LIMITED MNASE DIGESTION ON 
IMMOBILIZED CHROMATIN. CHROMATIN ASSEMBLY 
WAS PERFORMED AT ONE END OR BOTH END 
IMMOBILIZED DNA AND TREATED WITH MNASE FOR 
15 SEC, 30 SEC, OR 8 MIN. DNA WAS THEN 
PURIFIED AND ANALYZED BY GEL ELECTROPHORESIS. 
 
FIGURE 20: WESTERN BLOT 
ANALYSIS OF HISTONES H2A 
AND H4 (UPPER PANEL) AND 
HISTONES H2A.V AND H4 
(LOWER PANEL) OF CHRO-
MATIN ASSEMBLED ON DNA 
IMMOBILIZED AT ONE END IN 
COMPARISON TO RECOMBI-
NANT HISTONE OCTAMERS 
CONSISTING OF EITHER H2A 
(UPPER PANEL) OR H2A.V 
(LOWER PANEL) AND 
DROSOPHILA EMBRYO EX-
TRACT.  
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www.flybase.org, 27.04.2018). Unexpectedly, similar values were obtained for the canonical 
histone H2A, suggesting that H2A contributes with only about a quarter to the constitution of 
in vitro reconstituted nucleosomes. However, H2A and H2A.V are the only H2A-like histones 
known in Drosophila, which could contribute to the formation of nucleosomes and no other 
H2A variants are known so far. Furthermore, Coomassie staining of nucleosomes after in vitro 
reconstitution showed octamers in comparable ratios, excluding the formation of tetramers 
instead of octamers. An explanation for this conflicting result might be differences in Western 
blot detection between endogenous histones from embryo extract, e.g. due to post-
translational modifications, and recombinant histones purified from bacteria cultures.  
TABLE 3: SIGNAL INTENSITIES OF H2A, H2A.V AND H4 FROM FIGURE 20 QUANTIFIED BY IMAGE 
STUDIO™ LITE SOFTWARE, LI-COR BIOSCIENCES. INTENSITY RATIOS OF H2A AND H2A.V AGAINST H4 
FROM ASSEMBLED CHROMATIN IMMOBILIZED AT ONE END (OEB) OR BOTH ENDS (BEB) FOR 2 MIN, 5 MIN, 
OR 15 MIN AND EMBRYO EXTRACT WERE NORMALIZED TO THE RATIO OF RECOMBINANT OCTAMER WITH 
EITHER H2A OR H2A.V TO DETERMINE THE CONTRIBUTION OF H2A OR H2A.V, SHOWN IN PERCENT. 
 
Intensity 
H2A 
Intensity 
H4 
Normalized 
to H4 
Average Normalized to 
recombinant 
octamer ratio 
embryo extract  277000 337000 0.82 0.74 27% 
423000 651000 0.65 
  
recombinant octamer  71900 48700 1.48 2.72 100% 
357000 178000 2.01 
  
858000 183000 4.69 
  
oeb 2 min 108000 211000 0.51 
 
19% 
oeb 5 min 179000 239000 0.75 
 
27% 
oeb 15 min 216000 294000 0.73 
 
27% 
beb 2 min  121000 160000 0.76 
 
28% 
beb 5 min 222000 220000 1.01 
 
37% 
beb 15 min 254000 246000 1.03 
 
38%  
Intensity 
H2A.V 
Intensity 
H4 
Normalized 
to H4 
Average Normalized to 
recom-binant 
octamer ratio 
embryo extract 520000 327000 1.59 1.41 44% 
726000 588000 1.23 
  
recombinant octamer  287000 110000 2.61 3.18 100% 
955000 196000 4.87 
  
1970000 964000 2.04 
  
oeb 2 min 418000 496000 0.84 
 
27% 
oeb 5 min 414000 542000 0.76 
 
24% 
oeb 15 min 566000 788000 0.72 
 
23% 
beb 2 min  221000 329000 0.67 
 
21% 
beb 5 min 507000 545000 0.93 
 
29% 
beb 15 min 459000 430000 1.07 
 
34% 
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FIGURE 21: CONTRIBUTION OF H2A OR H2A.V DETERMINED IN TABLE 2 FROM ASSEMBLED CHROMATIN 
IMMOBILIZED AT ONE END (OEB) OR BOTH ENDS (BEB) FOR 2 MIN, 5 MIN, OR 15 MIN AND EMBRYO 
EXTRACT (IN PERCENT). 
 
3. EVALUATION OF ATP DEPENDENCY IN CHROMATIN RECONSTITUTION 
 
To evaluate the role of ATP on chromatin reconstitution, I performed chromatin assembly 
reactions in the absence of ATP. To remove endogenous ATP, apyrase was added to the extract 
before assembly. Quantification of ATP concentrations before and after addition of apyrase 
using a bioluminescence detection reagent (ENLITEN rLuciferase/rLuciferin Reagent A, 
Promega) revealed an approximate 100-fold decrease of ATP from 41 µM to 0.3 µM. 
TABLE 4: ATP CONCENTRATIONS OF DROSOPHILA EMBRYO EXTRACT BEFORE AND AFTER TREATMENT 
WITH APYRASE DETERMINED BY CHEMILUMINESCENCE. 
 nM ATP 
Extract before apyrase treatment 40716 
Extract after apyrase treatment 342 
 
As in VI.A.1, supercoiling assays were performed to investigate nucleosome formation in 
presence and absence of ATP after 10 min, 30 min, 60 min, and 180 min assembly time (see 
Figure 22). In presence of ATP, the formation of nucleosomes led to the formation of 
supercoiled plasmid DNA over time (compare also VI.A.1, Figure 16). However, in absence of 
ATP, no supercoiling of the plasmid was observed. Instead, a DNA band presumably resulting 
from nicked DNA was observed in all samples. It is possible, that these nicks were introduced 
by topoisomerases, which could not be ligated in the absence of ATP. Therefore, the question, 
if nucleosomes formed in the absence of ATP, was not addressable with this approach. 
However, it has been shown, that prior to proper nucleosome formation, histones associate 
27
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with DNA in a “non-nucleosomal histone-DNA intermediate” (Torigoe, Urwin, Ishii, Smith & 
Kadonaga 2011), which is lateron transform into a mature nucleosome in an Acf1- (and 
therefore presumably ATP-) dependent manner. It can be assumed, that in the absence of ATP, 
no mature nucleosomes are formed, but rather premature assemblies of histone proteins to 
DNA, which are processed in presence of ATP. 
 
FIGURE 22: SUPERCOILING ASSAY AFTER IN VITRO CHROMATIN ASSEMBLY WITH DROSOPHILA EMBRYO 
EXTRACT FOR 10 MIN, 30 MIN, 60 MIN, AND 180 MIN IN PRESENCE AND ABSENCE OF ATP. FOR INPUT, 
SUPERCOILED PLASMID DNA WAS USED. AFTER 10 MIN, PLASMID DNA IS IN A RELAXED STATE DUE TO 
TOPOISOMERASES IN THE EXTRACT. OVER TIME, SUPERCOILS ARE INTRODUCED BY NUCLEOSOME 
ASSEMBLY, WHICH CAN BE RESOLVED BY GEL ELECTROPHORESIS. 
 
In addition to the supercoiling assay, limited MNase digestion was performed as described in 
VI.A.1. However, no MNase ladders were obtained in the absence of ATP, except of a blurry 
mono-nucleosomal band. Instead, a smear of fragmented DNA was detected (not shown). This 
observation might be explained by the missing Acf1 activity, which is required for the 
establishment of spaced nucleosomes, a prerequisite of distinct MNase ladders. In addition to 
this, as mentioned before, the establishment of mature nucleosomes was also shown to 
depend on Acf1 (Varga-Weisz et al. 1997; Torigoe, Urwin, Ishii, Smith & Kadonaga 2011). When 
analyzing chromatin assembled in absence of ATP by SDS-PAGE followed by Coomassie 
staining, histones were detected similar to the control experiment in presence of ATP. 
However, as discussed before, it is not clear if these octamers are assembled into nucleosomes.  
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FIGURE 23: CHROMATIN ASSEMBLED IN PRESENCE AND ABSENCE OF ATP. UPPER PANEL: COOMASSIE 
STAINING AFTER SDS-PAGE OF CHROMATIN ASSEMBLED IN PRESENCE OR ABSENCE OF ATP FOR 1 H, 3 H, 
OR 6 H. AS A NEGATIVE CONTROL, ASSEMBLY WAS PERFORMED FOR 6 H WITH BEADS ONLY (C). LOWER 
PANEL: SAMPLES OF UPPER PANEL WERE BLOTTED AND THE MEMBRANE WAS PROBED WITH ANTI-H2A.V 
ANTIBODY. 
 
Western blot analysis revealed that in the absence of ATP, H2A.V can still be detected on 
chromatin assembled in the absence of ATP (Figure 23). However, it is not clear whether H2A. 
V is incorporated into nucleosomes or only associated to be incorporated by ATP-dependent 
remodeling complexes like Dom/Tip60. However, considering the bivalent role of H2A.V 
comprising H2A.X and H2A.Z function, it is possible that part of H2A.V is randomly incorporated 
into nascent chromatin like H2A.X, to serve as an evenly distributed DNA damage sensor, 
whereas additional H2A.V is specifically incorporated into specific regions to regulate gene 
expression in an ATP-dependent manner. Due to the free end of DNA immobilized at one end 
and the resulting DNA damage response (see III.B.3 and III.B.5), incorporated H2A.V was 
phosphorylated in presence of ATP, which can be detected by an antibody specific for the C-
terminal phosphorylation mark and by the double band detected by the antibody against 
H2A.V, which is able to detect the unphosphorylated, as well as the phosphorylated form 
(Figure 23, Figure 27). 
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To investigate, if H2A.V incorporation into preassembled nucleosome arrays by histone 
exchange can be observed in this in vitro system, I incubated H2A arrays with extract, which 
was either depleted of ATP with apyrase as described before or supplied with an ATP 
regenerating system. These H2A arrays consist of recombinant nucleosomes on immobilized 
arrays of 25 601 Widom sequences (Klinker, Mueller-Planitz, et al. 2014), which exhibit a 
nucleosome positioning sequence to favor the generation of regular nucleosome arrays 
(Lowary & Widom 1998, see Figure 24). 
 
 
 
To assure, that detected H2A.V after incubation with extract results from nucleosome turnover 
instead of incorporation on gaps between recombinant nucleosomes, quality controls prior to 
immobilization to the beads were performed, to aim for complete occupation of all 601 Widom 
sequences with recombinant nucleosomes. 
The extend of nucleosome formation was probed by restriction enzyme digestion of target sites 
either within the Widom 601 sequence (Figure 25) or with target sites in the linker DNA 
between the Widom 601 sequences (Figure 26) as described in Klinker, Mueller-Planitz, et al. 
2014; Maier et al. 2008. In the former case, the target site was only accessible in cases, where 
nucleosome assembly was not complete, leading to fragmented Widom 601 arrays, which were 
not occupied by nucleosomes.  
FIGURE 24: GENERATION OF IMMOBILIZED 
ARRAYS OF RECOMBINANT NUCLEOSOMES 
CONSISTING OF EITHER H2A OR H2A.V OR 
H2A.VE. NUCLEOSOMES WERE ASSEMBLED BY 
SALT-GRADIENT DIALYSIS FROM RECOMBINANT 
OCTAMERS ONTO BIOTINYLATED DNA 
FRAGMENTS CONSISTING OF WIDOM 601 
SEQUENCES (PURPLE) AND THEN IMMOBILIZED 
TO STREPTAVIDIN-COUPLED PARAMAGNETIC 
BEADS. FRAGMENTS RESULTING FROM THE 
PLASMID BACKBONE WERE NOT IMMOBILIZED 
AND REMAINED IN THE SUPERNATANT. DURING 
NUCLEOSOME ASSEMBLY, THESE BACKBONE 
FRAGMENTS WERE USED AS COMPETITOR 
DNA, WITH LOWER NUCLEOSOME AFFINITY 
THAN THE WIDOM 601 SEQUENCE ARRAYS TO 
BIND EXCESS NUCLEOSOMES. 
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FIGURE 25: QUALITY CONTROL OF NUCLEOSOME ASSEMBLY ON WIDOM 601 SEQUENCES BY ALUI 
RESTRICTION PRIOR TO IMMOBILIZATION. THE TARGET SITE OF ALUI IS WITHIN THE WIDOM 601 
SEQUENCE AND HENCE ONLY ACCESSIBLE IN THE ABSENCE OF NUCLEOSOMES. THEREFORE, WITH 
INCREASING ASSEMBLY DEGREE ACCOMPLISHED BY INCREASING AMOUNTS OF NUCLEOSOMES, LESS OF 
THE 601 ARRAY IS DEGRADED. IN ADDITION, FRAGMENTS RESULTING FROM THE BACKBONE OF THE 
VECTOR INCLUDING THE WIDOM 601 ARRAY, ARE DETECTABLE IN THE GEL (COMPETITOR DNA). 
NUCLEOSOME-FREE DNA (-) WAS ADDED AS A CONTROL AND IS COMPLETELY DEGRADED BY ALUI. 
 
In the latter case, restriction enzyme digestion resulted in mono-nucleosomes, which were 
analyzed by native gel electrophoresis (Figure 26). Incomplete assembly led to the formation 
of protein-free 601 fragments, which run faster than mono-nucleosomes, as demonstrated by 
the control sample with free Widom 601 arrays (-). 
 
 
FIGURE 26: QUALITY CONTROL OF NUCLEOSOME ASSEMBLY ON WIDOM 601 SEQUENCES BY AVAI 
RESTRICTION PRIOR TO IMMOBILIZATION. THE TARGET SITE OF AVAI IS IN BETWEEN THE WIDOM 601 
SEQUENCES GENERATING EITHER FREE WIDOM 601 SEQUENCES OR MONO-NUCLEOSOMES, WHICH CAN 
BE SEPARATED BY NATIVE GEL ELECTROPHORESIS. NUCLEOSOME-FREE DNA (-) WAS ADDED AS A CONTROL 
AND IS DIGESTED INTO FREE WIDOM 601 SEQUENCES AND FRAGMENTS RESULTING FROM THE BACKBONE 
OF THE VECTOR INCLUDING THE WIDOM 601 ARRAY (COMPETITOR DNA). WITH INCREASING ASSEMBLY 
DEGREE, FIRST THE WIDOM 601 SEQUENCES, AND THEN THE COMPETITOR DNA BECOMES OCCUPIED BY 
NUCLEOSOMES, AS VISIBLE FROM THE SIZE SHIFT. 
After the quality controls, arrays were immobilized to paramagnetic beads and used for 
chromatin in vitro assembly. However, only low amounts of H2A.V were incorporated in 
presence or absence of ATP, suggesting that exchange of H2A by H2A.V was not accomplished 
to a high extent in either case. 
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Interestingly, we observed that in absence of ATP, Acf1 was enriched on chromatin. This 
observation was also made for other remodeling factors like Iswi, the ATPase subunit of ACF 
(Figure 27).  
 
 
 
To investigate, if this enrichment was physiological or due to unspecific “sticking” of protein to 
beads or DNA, assembly reactions were performed with changing environments in presence 
and absence of ATP. If the enrichment was caused by unspecific binding, the effect would most 
likely not be reversed in presence of ATP. However, if the enhanced binding is caused by 
trapping of Acf1, which was recruited to nucleosomes to catalyze their sliding reaction but 
cannot perform this reaction in absence of ATP, this enrichment should be reversible in 
presence of ATP. Indeed, when chromatin was assembled first in absence of ATP and then ATP 
was added, (Figure 29, lane 3), Acf1 levels were reduced again to levels comparable to those, 
where chromatin was assembled in presence of ATP from the beginning (Figure 29, lane 4 and 
5). In contrast, Acf1 levels in chromatin assemblies in absence of ATP remained higher (Figure 
29, lane 1 and 2), and increased after removal of ATP (Figure 29, lane 6 compared to lane 4). 
This observation supports the hypothesis of trapped Acf1. However, it cannot be excluded, that 
the enrichment of protein binding is caused by the inhibition of chromatin bound proteasome, 
which have been reported to remove protein aggregates from chromatin (doctoral thesis 
Moritz Völker Albert, BMC Munich, Germany). 
FIGURE 28: CHROMATIN 
ASSEMBLED IN PRESENCE 
AND ABSENCE OF ATP. IN 
ADDITION TO THE BEAD 
SAMPLES, ABOUT 14% OF 
SUPERNATANT (SN) WAS 
LOADED. AFTER SDS-
PAGE, PROTEINS WERE 
BLOTTED AND THE MEM-
BRANE WAS PROBED WITH 
ANTIBODIES AGAINST 
DOMB, ACF1 AND ISWI.  
 
FIGURE 27: CHROMATIN ASSEMBLED IN PRESENCE 
AND ABSENCE OF ATP ON EITHER FREE DNA OR ON 
PREASSEMBLED RECOMBINANT H2A NUCLEOSOMES. 
AFTER SDS-PAGE, PROTEINS WERE BLOTTED AND 
THE MEMBRANE WAS PROBED WITH ANTIBODIES 
AGAINST ACF1, H2A.V, H4 AND gH2A.V. 
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4. STABILITY OF CHROMATIN REMODELERS IN RECONSTITUTED CHROMATIN 
 
To investigate the stability of chromatin-associated factors after assembly, I analyzed the 
immobilized chromatin samples after washes with different stringencies, using wash buffers 
including 50 mM, 100 mM and 200 mM KCl. Acf1 remained associated with chromatin after 
washing with 50 mM and 100 mM KCl but dissociated substantially after washing with 200 mM 
KCl. A similar behavior was observed for Iswi, suggesting that both components dissociate as a 
complex. Furthermore, DomB displayed the weakest association, which was already 
considerably decreased after washing with 100 mM KCl (not shown here). 
 
 
5. EXCHANGE OF H2A.V IN NUCLEOSOMES  
 
As already mentioned in III.B.5 and 0, Kusch et al showed, that exchange of phosphorylated 
H2A.V by unmodified variant histone was mediated by the Dom/Tip60 complex, to remove the 
phosphorylation mark upon repair of DNA damage. Prior to phosphorylation, H2A.V becomes 
acetylated by Tip60, the HAT subunit of the complex, on lysine 5  (Kusch 2004). In addition to 
this, they show that exchange of H2A.V is enhanced in the presence of acety-CoA. Kusch et al. 
also showed, that nucleosomal H2A is replaced by H2A.V at heat shock promoters (Kusch et al. 
FIGURE 29: CHROMATIN ASSEMBLED IN PRESENCE 
AND ABSENCE OF ATP. CHROMATIN WAS 
ASSEMBLED ON IMMOBILIZED DNA IN EITHER 
PRESENCE OR ABSENCE OF ATP FOR 3 H EACH AND 
THEN TRANSFERRED INTO REACTIONS WITH OR 
WITHOUT ATP OR DIRECTLY PREPARED FOR SDS-
PAGE (SEE DESCRIPTION). AFTER BLOTTING, THE 
MEMBRANE WAS PROBED WITH ANTIBODIES 
AGAINST ACF1, H2A.V AND H4. 
 
FIGURE 30: STABILITY OF IN VITRO ASSOCIATED 
CHROMATIN REMODELING FACTORS AFTER 
CHROMATIN IN VITRO ASSEMBLY. CHROMATIN 
WAS ISOLATED VIA PARAMAGNETIC BEADS AND 
WASHED WITH BUFFERS OF 50 MM, 100 MM, 
OR 200 MM KCL AND ANALYZED BY SDS-PAGE. 
AS NEGATIVE CONTROLS, CHROMATIN ASSEMBLY 
WAS PERFORMED WITH BEADS ONLY (- DNA). 
AFTER BLOTTING, THE MEMBRANE WAS PROBED 
WITH ANTIBODIES AGAINST ACF1, ISWI AND H3.  
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2014). To investigate, if histone exchange can also occur in vitro, I preassembled arrays of 
recombinant nucleosomes with octamers consisting of H2A or H2A.V or a phosphomimic 
mutant of H2A.V (H2A.VE), with its serine of the C-terminal SQAY-motif replaced by negatively 
charged glutamine to mimic the phosphorylation, as described in VI.A.3 (also see Figure 24).  
 
 
FIGURE 31: SDS-PAGE FOLLOWED BY COOMASSIE STAINING OF RECOMBINANT NUCLEOSOMES 
ASSEMBLED ACCORDING TO FIGURE 24. FOR EACH TYPE OF NUCLEOSOME, TWO DIFFERENT CONCENTRA-
TIONS WERE LOADED. 
 
Indeed, as shown in Figure 32, H2A.V incorporation into H2A arrays, which had been assembled 
to lower saturation (leaving free DNA between nucleosomes) was higher, suggesting that either 
histone exchange is more efficient under those circumstances or, more likely, nucleosomes 
containing endogenous H2A.V were assembled between recombinant nucleosomes on the 
array. As turnover of H2A and H2A.V is reported to be an acetylation-dependent process, I 
performed the turnover reactions in presence of acetyl-CoA and butyrate, a histone 
deacetylase inhibitor, to promote turnover.  
 
  
 
However, addition of acetyl-CoA and butyrate did not improve incorporation of H2A.V (Figure 
32 and Figure 33) suggesting that the coenzyme was not limiting the reaction. Conceivably, a 
lack of histone exchange is due to the fact that the DOM-A complex containing DomA and the 
acetyltransferase Tip60 (Kusch 2004; Kusch et al. 2014) is not abundant in preblastoderm 
embryos (Ruhf et al. 2001). In support of this notion, DomA was not detected in the chromatin 
assembly extracts by Western blot or mass spectrometry. 
 
FIGURE 32: CHROMATIN ASSEMBLY 
ON PREASSEMBLED RECOMBINANT 
H2A NUCLEOSOMES WITH INCREA-
SING ASSEMBLY DEGREE AND IN 
PRESENCE OR ABSENCE OF ACETYL-
COA AND BUTYRATE. AFTERWARDS, 
CHROMATIN WAS ANALYZED BY SDS-
PAGE, PROTEINS WERE BLOTTED 
AND MEMBRANES WERE PROBED 
WITH ANTIBODIES AGAINST gH2A.V, 
H2A.V AND H4. 
 
 
H4 
H3 
H2B 
H2A.VE 
H2A.V 
H2A 
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FIGURE 33: QUANTIFICATION OF SIGNAL INTENSITIES OF FIGURE 32 BY IMAGE STUDIO™ LITE SOFTWARE, 
LI-COR BIOSCIENCES. INTENSITIES OF H2A.V AND gH2A.V WERE NORMALIZED TO H4. 
To circumvent this problem, chromatin assembly reactions were supplemented with an extract 
derived from nuclei of 0-12 h old embryos as a potential source of H2A.V exchange remodelers. 
This extract is transcriptionally active and therefore called TRAX. However, in contrast to 
preblastoderm embryo extract (here called DREX), TRAX is not capable of assembling 
nucleosomes on DNA. TRAX was added to nucleosome fibers either made of nucleosomes 
assembled by salt gradient dialysis (Figure 34, left and middle) or by prior DREX assembly 
(Figure 34, right). Supplementing DREX with TRAX did not increase incorporation of H2A.V into 
recombinant H2A arrays. In contrast, incorporation in presence of both extracts seemed to be 
decreased and DREX or TRAX alone showed a higher capability to incorporate H2A.V than both 
in combination (Figure 34, left). Again, addition of acetyl-CoA and butyrate did not increase the 
effect (Figure 34, middle).  
To visualize the exchange of H2A.V by another H2A.V molecule, a tagged form was generated 
in which three Flag-tags were fused to the N-terminus of H2A.V and used for octamer assembly. 
However, the tag perturbed octamer formation and only H3-H4 tetramers and 3xFlag-H2A.V-
H2B dimers were obtained (data not shown). Therefore, it was not possible to track the 
exchange of recombinant, preassembled H2A.V by endogenous H2A.V but only turnover of 
canonical H2A. 
Unexpectedly, we observed that H2A.V incorporated by TRAX was not phosphorylated, as the 
typical H2A.V double band can only be detected on chromatin assembled with DREX and 
missing in chromatin assembled with TRAX (Figure 34, left and middle). This observation could 
be explained either by a strong phosphatase, which efficiently removes the phosphorylation 
mark from H2A.V, by an effective turnover mechanism, which removes phosphorylated H2A.V 
from chromatin, or by lack of kinase activity in TRAX. To solve this question, chromatin was 
reconstituted first in vitro from endogenous histones and then incubated with either DREX or 
TRAX. Remarkably, incubation of chromatin containing phosphorylated H2A.V with TRAX, did 
not remove the phosphorylation mark (Figure 34, right). Therefore, the first two possibilities 
pointing towards the removal of the phosphorylation mark seemed to be disproven. Instead, 
TRAX does not seem to be capable to phosphorylate H2A.V and the ability to recognize free 
DNA ends and initiate the damage response seems to be exclusive for DREX. However, each 
experiment shown in Figure 34 was only performed once and need further investigation to 
confirm this hypothesis. 
 - Results - 
 61 
    
FIGURE 34: CHROMATIN ASSEMBLY WITH PREBLASTODERM DROSOPHILA EMBRYO EXTRACT (DREX) OR 
NUCLEAR TRANSCRIPTION EXTRACT (TRAX). LEFT: DREX ONLY OR INCREASING AMOUNTS OF TRAX OR 
TRAX ONLY WERE ADDED TO RECOMBINANT H2A-BEARING NUCLEOSOME ARRAYS. MIDDLE: EITHER 
DREX OR TRAX WERE ADDED TO RECOMBINANT H2A ARRAYS AND INCUBATED IN PRESENCE OR ABSENCE 
OF ACETYL-COA AND BUTYRATE. RIGHT: CHROMATIN WAS FIRST RECONSTITUTED ON DNA AND THEN 
INCUBATED WITH EITHER DREX OR TRAX. AS INPUT, H2A ARRAYS BEFORE CHROMATIN ASSEMBLY WAS 
LOADED. AFTERWARDS, CHROMATIN WAS ANALYZED BY SDS-PAGE, PROTEINS WERE BLOTTED AND 
MEMBRANES WERE PROBED WITH ANTIBODIES AGAINST ACF1, ISWI, H2A.V, H4 AND H3. 
 
6. INCORPORATION AND TURNOVER IN A GENOMIC BACKGROUND 
 
To investigate the distribution of H2A and H2A.V in a genomic background, ChIP-Seq 
experiments were performed against H2A or H2A.V on recombinant arrays of H2A or H2A.V 
nucleosomes before and after addition of extract. For this purpose, recombinant arrays of H2A 
or H2A.V nucleosomes were assembled on FlyFosmids. After sequencing, normalization was 
performed by Tamás Schauer to the total number of reads (Figure 35).  
Panel (1) and (2) show the distribution of H2A or H2A.V nucleosomes after SGD in absence of 
extract. As expected, these profiles are highly similar, as dialysis does not differentiate between 
the two types of nucleosomes. Panel (3) and (4) show profiles after addition of DREX to the 
recombinant arrays, leading to differences in nucleosome distribution (subtracting the signals 
from panel (3) and (4) from panels (1) and (2), respectively [shown in (1) – (3) and (2) – (4)]). 
The similarity of the difference patterns shows that nucleosome remodeling activity in the 
extract changes nucleosome positions independent of the type of H2A variant.  
To visualize turnover reactions, where H2A nucleosomes are exchanged by H2A.V nucleosomes 
or vice versa, tracks before addition of extract were compared to tracks after addition of 
extract, detecting potentially exchanged nucleosome (H2A in case of H2A.V arrays and vice 
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versa) [(1) – (4) and (2) – (5)]. The similarity of all difference profiles suggests, that the DREX 
cannot perform H2A- or H2A.V-specific turnover reactions. In addition to this, incorporation of 
H2A.V by the extract did not resemble the genomic organization described by Zhang and Pugh 
(Zhang & Pugh 2011), presumably because the extract is deficient in transcription, which might 
be required for re-organization of H2A.V by chromatin remodelers. Altogether, it appears that 
DREX is not capable to distinguish and specifically incorporate histone variant H2A.V, but rather 
deposits H2A.V-containing nucleosomes in parallel to H2A-containing nucleosomes. This 
random distribution resembles the incorporation of H2A.X, which is distributed along the 
genome as a DNA damage sensor. Specific enrichment to regulate transcription similar to H2A.Z 
was not observed here and might require transcription. Nevertheless, the reorganization of 
nucleosomes is highly consistent among the different arrays and seems to be sequence-
dependent. However, we were not able to identify a correlation to genic or intergenic regions 
or other connections to explain this observation. 
 
 
 
FIGURE 35 (NEXT PAGE): CHIP-SEQ PROFILES OF RECOMBINANT ARRAYS OF H2A [PANEL (1, 3), AND 
(4)] OR H2A.V [PANEL (2, 5), AND (6)] NUCLEOSOMES BEFORE [PANEL (1) AND (2)] AND AFTER [PANEL 
(3) TO (6)] CHROMATIN ASSEMBLY. CHIP WAS PERFORMED AGAINST H2A [PANEL (1, 3), AND (5)] OR 
H2A.V [PANEL (2, 4, 6)]. TO ILLUSTRATE THE DIFFERENCES BETWEEN TRACKS, SIGNAL INTENSITIES 
ALONG THE TRACKS WERE SUBTRACTED, WITH (1) – (2) SHOWING DIFFERENCES BETWEEN RECOMBINANT 
ARRAYS AFTER SALT GRADIENT DIALYSIS (SGD, 1) – (3) AND (2) – (4) SHOWING DIFFERENCES BEFORE 
AND AFTER ASSEMBLY WITH DREX, (3) – (4) AND (5) – (6) SHOWING DIFFERENCES OF H2A AND H2A.V 
DISTRIBUTION AFTER ASSEMBLY AND (1) – (4) AND (2) – (5) SHOWING TURNOVER AFTER CHROMATIN 
ASSEMBLY. SIGNALS WERE NORMALIZED TO TOTAL READS. 
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7. A SEARCH FOR H2A VARIANT-SPECIFIC CHROMATIN INTERACTORS 
 
To investigate, if remodeling factors interact differently with nucleosomes bearing variant H2A, 
arrays were formed by salt-gradient dialysis with either canonical H2A or H2A.V or mutated 
forms of H2A.V, immobilized to paramagnetic beads and incubated with DREX. Reconstituted 
chromatin was then purified and analyzed by mass spectrometry (collaboration with Andreas 
Schmidt, Protein Analysis Unit ZfP, LMU Munich). 
Two sets of experiments were performed: The first data set was performed in triplicates using 
three different extract preparations and measured after washing with EX-50. However, no 
significant hits were identified as specific binders for H2A or H2A.V arrays (not shown). Figure 
36 shows the enrichment of chromatin-associated factors on arrays composed of H2A 
nucleosomes or H2A.V nucleosomes compared to embryo extract. In both experiments, ACF 
(consisting of Acf1 and Iswi) was enriched. In addition, the Ku complex (consisting of Irbp and 
Ku80) was enriched in response to the free ends of the arrays, which will be investigated in 
more detail in the next chapter see (VI.B.1 and VI.B.2). Relatedly, Mre11, a component of the 
MRN complex and shown to be recruited to DSBs (III.D.2), was enriched at chromatin. H2B 
forms dimers with H2A and H2B and was also enriched. TFAM is a mitochondrial transcription 
factor (Flybase.org; 22.06.2018), which was recruited to H2A- and H2A.V-containing arrays.  
 
FIGURE 36: ENRICHMENT OF CHROMATIN-ASSOCIATED FACTORS ON ARRAYS COMPOSED OF H2A 
NUCLEOSOMES OR H2A.V NUCLEOSOMES COMPARED TO EMBRYO EXTRACT (INPUT) MEASURED BY MASS 
SPECTROMETRY. THE EXPERIMENT WAS PERFORMED IN THREE REPLICATES USING THREE INDEPENDENT 
EXTRACT PREPARATIONS. HIGH INTENSITIES ARE INDICATED IN RED, LOW INTENSITIES IN BLUE. A FULL LIST 
OF PROTEINS AND THEIR ENRICHMENT VALUES ARE LISTED IN XI.B.1.A). 
Due to phosphorylation of H2A.V triggered by the free end of the array (see III.B.5 and VI.A.3; 
will be further investigated in VI.B.3), no further analyses of the phospho-mimetic form of 
H2A.V were performed. Instead, nucleosomes including a C-terminally truncated form of H2A.V 
was included in the second data set, lacking the phosphorylation motif. 
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The second experiment included more stringent washing conditions and were measured in 
collaboration with Andreas Schmidt by a data-independent mass spectrometry analysis named 
SWATH (Sequential window acquisition of all theoretical fragment ion spectra), which allows a 
more sensitive, robust and quantitate analysis of complex protein samples (Gillet et al. 2012). 
As before, three DREX preparations were used in biological replicates. Data after mass 
spectrometry analysis was analyzed by Tamás Schauer as follows: Protein intensity values were 
log2-transformed, median normalized and filtered by a low intensity threshold. Statistical 
analysis was performed by fitting a linear model using the limma R package. Moderated t-
statistics were calculated by empirical Bayes moderation. For the identification of significantly 
enriched proteins, p-value cutoffs and log2-fold change cutoffs were applied as indicated. The 
heatmap was generated using the pheatmap R package. Under these conditions, only few H2A 
variant-specific binders were identified, as shown in Figure 37. CG4951, for example, showed 
a preference for H2A.V nucleosomes relative to the canonical H2A nucleosome. In this 
experiment the presence or absence of the C-terminus of H2A.V did not make any difference. 
Unfortunately, CG4951 is not yet described and no information about this protein is available 
yet. Scully (scu) is a mitochondrial 3-hydroxyacyl-CoA dehydrogenase type-2 (Uniprot: O1840; 
29.12.2017) and the interaction of this protein with H2A.V is of unclear significance. CG18067 
showed a preference towards H2A or the C-terminally truncated form of H2A.V. It seems 
therefore, that the C-terminus interfered with binding of this factor to the nucleosome. 
Unfortunately, CG18067 has also not been characterized so far (Uniprot: A1ZBU8; 29.12.2017) 
and interaction with nucleosomes is presumably not physiological. We therefore conclude, that 
the extract does not discriminate considerably among nucleosomes consisting of canonical H2A 
or its variant, which is in line with the observation obtained after ChIP seq (VI.A.6). 
 
 
 
 
B. CHARACTERIZATION OF A DNA DAMAGE RESPONSE INITIATED BY DNA 
BREAKS 
 
Unless indicated otherwise, all mass spectrometry analyses in this chapter were performed in 
collaboration with Andreas Schmidt by data-independent mass spectrometry analysis 
(SWATH). Data after mass spectrometry analysis was analyzed by Tamás Schauer as follows: 
Protein intensity values were log2-transformed, median normalized and filtered by a low 
FIGURE 37: COMPARISON OF CHROMATIN-ASSOCIATED 
FACTORS ON ARRAYS COMPOSED OF H2A NUCLEOSOMES, 
H2A.V NUCLEOSOMES, AND H2A.VDC NUCLEOSOMES 
MEASURED BY MASS SPECTROMETRY. THE EXPERIMENT WAS 
PERFORMED IN THREE REPLICATES USING THREE 
INDEPENDENT EXTRACT PREPARATIONS. HIGH INTENSITIES 
ARE INDICATED IN RED, LOW INTENSITIES IN BLUE. A FULL 
LIST OF PROTEINS AND THEIR ENRICHMENT VALUES ARE 
LISTED IN XI.B.1.B). 
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intensity threshold. Statistical analysis was performed by fitting a linear model using the limma 
R package. Moderated t-statistics were calculated by empirical Bayes moderation. For the 
identification of significantly enriched proteins, p-value cutoffs and log2-fold change cutoffs 
were applied as indicated. Gene ontology terms were obtained from the org.Dm.eg.db R 
package (version: 3.5.0). Scatterplots were plotted by R base graphics and heatmaps using the 
pheatmap R package. 
 
1. RECRUITMENT OF FACTORS TO FREE DNA ENDS 
 
To test for the recruitment of chromatin-associated factors to free DNA ends during chromatin 
in vitro reconstitution, mass spectrometry analysis was performed after assembly on DNA 
immobilized at either one end or both ends. To control for unspecific protein binding to beads, 
a beads-only control without immobilized DNA was included. 
 
FIGURE 38: PROTEINS DETECTED ON IMMOBILIZED DNA BY MASS SPECTROMETRY ANALYSIS. 
NORMALIZED LOG-TRANSFORMED VALUES OF PROTEINS ON DNA IMMOBILIZED AT ONE END (OEB) AND 
ON DNA IMMOBILIZED ON BOTH ENDS (BEB) WERE PLOTTED AGAINST THE BEAD CONTROL. PROTEINS 
ASSOCIATED WITH DNA DAMAGE ARE COLORED IN PURPLE (LEFT DIAGRAM), AND RIBOSOMAL PROTEINS 
ARE COLORED IN GREEN (RIGHT DIAGRAM). A FULL LIST OF PROTEINS AND THEIR ENRICHMENT VALUES 
ARE LISTED IN XI.B.2.A). 
 
After subtraction of bead control, proteins were plotted in Figure 38, with the relative 
enrichment on the fragment immobilized at one end (y-axis) versus the relative enrichment on 
the fragment immobilized on both ends (x-axis). The experiment was performed in three 
biological replicates (three independent extract preparations). Proteins on the top right corner 
are enriched on both DNA fragments, which are mostly associated with DNA damage (purple 
data points, left diagram). Of those 77 DNA damage-associated proteins, only two show a 
preference for the one end bound DNA fragment, namely Ku70 (also known as Irbp) and Ku80. 
Proteins on the left bottom corner are mainly found in the bead control samples and are mostly 
Ku70 
 
Ku80 
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associated with ribosomal proteins (green data points, right diagram), indicating that these 
proteins were particularily prone to unspecific binding to beads, which is decreased in presence 
of DNA-coupled beads. 
The DNA damage-associated proteins of Figure 38 are listed in Table 5. Amongst those, we 
found a multitude of DNA damage factors associated with the HR pathway (e.g. the MRN 
complex consisting of Mre11, Rad50 and Nbs1) and the NHEJ pathway (e.g. Ligase4, Ku complex 
consisting of Ku70/Irbp and Ku80, see III.D.1).  
 
TABLE 5: DNA DAMAGE-ASSOCIATED FACTORS AND THEIR ENRICHMENT OVER CONTROL BEADS. DNA 
DAMAGE-ASSOCIATED FACTORS FROM FIGURE 38 ARE LISTED AND ENRICHMENTS OVER CONTROL BEADS 
WERE DETERMINED BY SUBTRACTION OF NORMALIZED LOG-TRANSFORMED INTENSITIES OF PROTEINS ON 
DNA IMMOBILIZED AT ONE END (OEB) OR ON DNA IMMOBILIZED AT BOTH ENDS (BEB) MINUS BEAD 
CONTROL. THE PROTEINS ARE RANKED ACCORDING TO THE HIGHEST DIFFERENCE BETWEEN OEB-CONTROL 
AND BEB-CONTROL. 
FlyBase  
polypeptide ID 
FlyBase 
symbol 
Diff. 
oeb-
control 
Diff. 
beb-
control 
FlyBase  
polypeptide 
ID 
FlyBase 
symbol 
Diff. 
oeb-
control 
Diff.  
beb-
control 
FBpp0080322 Ku80 3.62 1.03 FBpp0087924 Cul1 1.76 1.58 
FBpp0081861 Irbp 3.28 0.94 FBpp0309805 alien 0.74 0.60 
FBpp0290882 rad50 2.19 1.13 FBpp0311371 Jafrac1 -0.61 -0.75 
FBpp0304413 E(bx) 0.83 -0.18 FBpp0082177 pic -0.16 -0.30 
FBpp0089041 Prosalpha7 -0.38 -1.39 FBpp0077927 CSN3 2.15 2.04 
FBpp0079437 Trx-2 0.25 -0.74 FBpp0305644 Rpn10 1.09 0.98 
FBpp0077263 gkt 1.39 0.49 FBpp0087756 FANCI 2.14 2.06 
FBpp0079802 mre11 2.58 1.69 FBpp0088021 Rpt1 -0.30 -0.33 
FBpp0076890 Rpt6 0.68 -0.11 FBpp0074246 CG8142 1.84 1.89 
FBpp0072041 DNA-ligI 0.00 -0.76 FBpp0079565 me31B 0.34 0.40 
FBpp0308486 Not1 0.67 -0.08 FBpp0083399 Fancd2 1.70 1.79 
FBpp0306426 His2Av 2.24 1.58 FBpp0311247 rept 1.12 1.21 
FBpp0291433 CG30382 0.14 -0.51 FBpp0312066 RpS3 -3.41 -3.31 
FBpp0082987 14-3-3 
epsilon 
0.36 -0.28 FBpp0078478 Gnf1 1.35 1.47 
FBpp0078449 Prosbeta7 0.00 -0.61 FBpp0311114 RfC38 1.76 1.88 
FBpp0076312 Mcm7 1.43 0.81 FBpp0308680 Ald 0.12 0.26 
FBpp0309113 Dsor1 0.53 -0.07 FBpp0079609 RfC3 1.19 1.34 
FBpp0085703 FK506-bp2 -0.60 -1.19 FBpp0290448 CSN4 0.71 0.87 
FBpp0086223 Fen1 0.62 0.05 FBpp0079641 cdc2 0.27 0.49 
FBpp0305067 ben 1.10 0.54 FBpp0087583 Uba1 1.47 1.70 
FBpp0297182 nbs -0.36 -0.91 FBpp0075277 DNApol-
delta 
0.18 0.42 
FBpp0081820 Tctp -0.29 -0.82 FBpp0288389 eIF4G 0.16 0.41 
FBpp0073989 Prosalpha4 -0.12 -0.57 FBpp0312031 Rpt3 0.21 0.46 
FBpp0089395 PCNA 0.17 -0.27 FBpp0071172 Caf1-180 1.27 1.53 
FBpp0311982 Rpt2 0.93 0.51 FBpp0304598 Top2 3.85 4.12 
FBpp0075382 Prosbeta2 -0.23 -0.64 FBpp0305164 Dek -0.81 -0.53 
FBpp0071117 Trxr-1 -0.32 -0.73 FBpp0073120 RfC4 1.00 1.31 
FBpp0078756 Hel25E 1.23 0.82 FBpp0311276 Uev1A 0.42 0.76 
FBpp0080787 Top3alpha 0.91 0.52 FBpp0087821 CSN7 -0.25 0.12 
FBpp0078331 Snr1 0.08 -0.29 FBpp0112608 Parp -0.24 0.13 
FBpp0082180 timeout 0.02 -0.27 FBpp0079710 Nup107 0.02 0.42 
FBpp0303628 eIF-4a 0.97 0.70 FBpp0288680 Rrp1 3.18 3.62 
FBpp0300790 wds -1.88 -2.15 FBpp0082511 Caf1 0.62 1.17 
FBpp0086400 Prosbeta1 0.48 0.22 FBpp0310470 spel1 1.24 1.85 
FBpp0306599 Rpn2 0.27 0.01 FBpp0072658 CG12018 0.49 1.16 
FBpp0073678 Lig4 1.02 0.78 FBpp0081704 pont 1.14 1.94 
FBpp0076804 Txl 0.61 0.42 FBpp0110174 tefu -0.68 0.22 
FBpp0078631 Marcal1 0.37 0.19 FBpp0289675 cdc2c -0.71 0.59 
FBpp0083658 CSN6 0.60 0.42     
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To test for the kinetics of the recruitment of factors to DNA ends, the experiment described in 
Figure 38 was repeated including an early and late time point (15 min versus 3 h assembly time) 
with DNA fragments immobilized at either one end (oeb) or both ends (beb) to streptavidin-
coated paramagnetic beads. The experiment was performed in seven biological replicates from 
seven independent extract preparations. To evaluate the reproducibility among the seven 
replicates, a principle component analysis was performed (Figure 40). 
We then investigated the changes of factor recruitment as a function of time, here focusing on 
the one-side-immobilized fragment only, which is similar to the analysis by Völker-Albert et al 
to identify the kinetics of factors during chromatin assembly (Völker-Albert et al. 2016). The 
volcano blot in Figure 39 shows early chromatin binders on the left (blue) and late chromatin 
binders on the right (red).  
 
 
FIGURE 39: CHROMATIN PROTEINS ENRICHED ON DNA IMMOBILIZED AT ONE END AFTER 15 MIN (BLUE) 
VERSUS AFTER 3 H (RED) OF ASSEMBLY. A FULL LIST OF PROTEINS (ALSO INCLUDING PROTEINS ENRICHED 
ON DNA IMMOBILIZED AT BOTH ENDS) AND THEIR ENRICHMENT VALUES ARE LISTED IN XI.B.2.B). 
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Consistent with the data published, the DNA repair proteins Lig4, RpA-70 and H2A.V/H2B were 
identified as late binders. The late enrichment of H2A.V and H2B is intriguing. As discussed 
before, H2A.V does not seem to be incorporated in a targeted and remodeler-dependent 
manner. However, it might be that H2A.V and H2B, which have been shown to be incorporated 
as dimers like H2A.Z-H2B in yeast and mammals (Kusch et al. 2014; G. Mizuguchi 2004; Luk et 
al. 2010) are already associated to chromatin for later incorporation. H2A.Z-H2B dimers are 
generally associated to chaperones like Chz1 or Swr2 in yeast or Yl1 in mammals (Billon & Côté 
2012; Obri et al. 2014; Latrick et al. 2016; Liang et al. 2016). 
 
 
FIGURE 40: PRINCIPAL COMPONENT ANALYSIS OF CHROMATIN SAMPLES ON DNA IMMOBILIZED AT EITHER 
ONE END (OEB) OR BOTH ENDS (BEB) AFTER 15 MIN OR AFTER 3 H ASSEMBLY TIME. CHROMATIN SAMPLES 
AFTER 15 MIN, OR AFTER 3 H FORM ONE CLUSTER, WITH THE EXCEPTION OF FOUR OUTLIERS (LEFT, 
MARKED WITH DASHED LINE), WHICH WERE EXCLUDED IN FURTHER ANALYSES (RIGHT). A FULL LIST OF 
PROTEINS AND THEIR ENRICHMENT VALUES ARE LISTED IN XI.B.2.B). 
The majority of the samples (24 out of 28) were distributed in two main clusters, one composed 
of the data from the 15 min assembly time point (red and green), and one from the data derived 
from 3 h assembly (blue and violet). The four samples outside of these clusters were not 
included in the analysis (see box in grey dashed lines, Figure 40). 
The MRN complex consisting of Mre11, Rad50 and Nbs, however, as well as the ACF complex 
consisting of Acf1 and Iswi, were identified as early binders (after 15 min) in Völker-Albert et 
al. (Völker-Albert et al. 2016), but were enriched after 3 h in our mass spectrometry data under 
comparable reaction conditions. In contrast, Western blot analysis revealed the strongest 
enrichment of ACF at 5 min and a decreased recruitment at later time points (Figure 41 and 
Figure 42). However, the decrease of ACF only seems to occur within the first 30 minutes and 
only moderately. It could therefore be, that the sensitivity and the temporal resolution is not 
sensitive enough, leading to the observed discrepancies. I contrast to this, the increase of 
H2A.V was consistent and striking in both mass spectrometry experiments as well as in the 
Western blot analysis. In our data, the Ku complex was associated to chromatin very early and 
remaining associated over hours. In our mass spectrometry analysis, Irbp and Ku80 were not 
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significant in Figure 39 using a stringent p-value cut-off of 0.003. However, using a p-value cut-
off of 0.01 would identify the Ku complex as late binders. In Völker-Albert et al. (Völker-Albert 
et al. 2016). Ku was categorized as a late binder and only recruited at late time points. In our 
experiments, chromatin assembly was performed in presence of β-glycerophosphate to inhibit 
dephosphorylation of H2A.V. It cannot be excluded that addition of this phosphatase inhibitor 
has an effect on the kinetics of Ku. The association of Ku to free DNA will be discussed in more 
detail in VII.B. 
 
FIGURE 41: CHROMATIN ASSEMBLY ON DNA IMMOBILIZED AT ONE END FOR 5 MIN, 10 MIN, 30 MIN, 
60 MIN, OR 180 MIN. THE EXPERIMENT WAS PERFORMED IN TWO REPLICATES, USING TWO INDEPENDENT 
CHROMATIN PREPARATIONS. AFTER SDS-PAGE, PROTEINS WERE BLOTTED AND MEMBRANES WERE 
PROBED WITH ANTIBODIES AGAINST ACF1, KU70, ISWI, gH2A.V, H2A.V, AND H4. 
 
 
FIGURE 42: RELATIVE ENRICHMENT OF SIGNAL INTENSITIES OF ACF1, KU70, ISWI, gH2A.V, H2A.V, AND 
H4 AFTER 5 MIN, 10 MIN, 30 MIN, 60 MIN, OR 180 MIN ASSEMBLY ON DNA IMMOBILIZED AT ONE END 
IN REFERENCE TO THE INTENSITIES AFTER 5 MIN. SIGNAL INTENSITIES WERE QUANTIFIED FROM FIGURE 
41 BY IMAGE STUDIO™ LITE SOFTWARE, LI-COR BIOSCIENCES. 
  
H2A.V
H4
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FIGURE 43: ENRICHMENT OF CHROMATIN-ASSOCIATED FACTORS AFTER 15 MIN OR AFTER 3 H ON DNA 
IMMOBILIZED AT ONE END OR AT BOTH ENDS FROM SEVEN BIOLOGICAL REPLICATES. OUTLIERS INDICATED 
IN FIGURE 40 WERE REMOVED. HIGH INTENSITIES ARE INDICATED IN RED, LOW INTENSITIES IN BLUE. A 
FULL LIST OF PROTEINS AND THEIR ENRICHMENT VALUES ARE LISTED IN XI.B.2.B). HEATMAP A SHOWS 
SIGNIFICANTLY ENRICHED PROTEINS (USING THE STATISTICAL PARAMETERS INDICATED IN VI.B) AFTER 
COMPARISON OF THE DIFFERENCES BETWEEN 3 H VERSUS 15 MIN ON DNA IMMOBILIZED AT ONE END 
VERSUS BOTH ENDS, HEATMAP B SHOWS SIGNIFICANTLY ENRICHED PROTEINS (USING THE STATISTICAL 
PARAMETERS INDICATED IN VI.B) AFTER COMPARISON OF THE DIFFERENCES BETWEEN ONE END VERSUS 
BOTH ENDS AFTER 15 MIN VERSUS AFTER 3 H.  
As already observed in Figure 38 the Ku complex was significantly enriched at both time points, 
after 15 min and 3 h assembly on DNA immobilized at one end. In addition, we observed that 
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the RPA complex showed a substantial enrichment after 3 h, but not after 15 min. An 
explanation for the late enrichment of RPA might be the fact, that RPA binds ssDNA (Liptak & 
Loria 2015). DNA resection, however, is a well-controlled and time-consuming process, which 
might not be accomplished after 15 min. Ku, however, has been shown to be able to interact 
with ssDNA and dsDNA, with a preference for dsDNA (Mimori & Hardin 1986). 
 
 
FIGURE 44: VOLCANO PLOT WITH LOG10 P VALUES (Y-AXIS) AND LOG FOLD DIFFERENCE (X-AXIS) AFTER 
COMPARISON OF CHROMATIN-ASSOCIATED FACTORS ON DNA IMMOBILIZED AT ONE END OR AT BOTH 
ENDS FROM SEVEN BIOLOGICAL REPLICATES. INTENSITIES WERE MEASURED BY MASS SPECTROMETRY 
AFTER 15 MIN ASSEMBLY (LEFT) AND AFTER 3 H ASSEMBLY (RIGHT). OUTLIERS INDICATED IN FIGURE 40 
WERE REMOVED. A FULL LIST OF PROTEINS AND THEIR ENRICHMENT VALUES ARE LISTED IN XI.B.2.B). 
 
2. GENERATION AND CHARACTERIZATION OF KU ANTIBODIES 
 
To confirm Ku enrichment by Western blot analysis, monoclonal antibodies against Ku70 and 
Ku80 were generated in collaboration with Elisabeth Kremmer (Helmholtz Center Munich, 
Germany).  
For the identification of suitable immunogens to generate monoclonal antibodies, the amino 
acid sequences of Ku70 (Flybase: Irbp, FBpp0081861, 07.06.2018) and Ku80 (Flybase Ku80, 
FBpp0080322, 07.06.2018) were screened by Dr. Anette Jacob (Peps 4 LS GmbH, Heidelberg, 
Germany). Two peptides for each protein were chosen for the generation of monoclonal rat 
antibodies and designed by Peps 4 LS GmbH for rat immunization: 
Ku70-1:  SEDEEDVSMKRDYHG 
Ku70-2:  QDWNNTENTADEQK 
Ku80-1:  TLRDTQQPRPWAQN 
Ku80-2:  YDNDKEDKMLKDKN 
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Elisabeth Kremmer (Helmholtz Zentrum Munich) then generated 126 primary tissue cultures 
of single hybridoma cell lines, with supernatants against peptides Ku70-1, Ku70-2, Ku80-1, and 
Ku80-2 (Table 6). 
 
TABLE 6: GENERATION OF RAT MONOCLONAL ANTIBODIES. 126 PRIMARY TISSUE CULTURES OF 
HYBRIDOMA CELLS AFTER RAT IMMUNIZATION WITH KU70-1, KU70-2, KU80-1, AND KU80-2 WERE 
OBTAINED AND SCREENED IN WESTERN BLOT ANALYSIS. TWO OF EACH PEPTIDE WERE SELECTED AND 
SUBCLONED AS STABLE CELL LINES. OF THOSE, FIVE STABLE CELL LINES WERE GENERATED.  
 
Ku70-1 Ku70-2 Ku80-1 Ku80-2 
obtained primary tissue cultures 58 10 34 24 
subcloned as stable cell lines 2 2 2 2 
stable cell lines 2 (6B2, 12B8) 1 (5H4) 1 (8E7) 1 (8B11) 
 
After an initial screening of supernatants obtained from these 126 primary tissue cultures by 
Western blot using DREX (not shown), the two most specific ones for each peptide were 
selected and subcloned as stable cell lines for antibody production. Of those, five stable cell 
lines were maintained for antibody production. Specificity and sensitivity of those antibodies 
was then tested using DREX, in vitro-assembled chromatin on DNA immobilized either at one 
or at both ends, wt Schneider cell extract and Schneider cell extract after Ku70 RNAi or Ku80 
RNAi treatment (Figure 45). 
 
FIGURE 45: WESTERN BLOT ANALYSIS TO INVESTIGATE THE SPECIFICITY AND SENSITIVITY OF 
MONOCLONAL ANTIBODIES AGAINST KU70 AND KU80. M: MARKER; 1: DREX; 2, 3: IN VITRO-
ASSEMBLED CHROMATIN ON DNA IMMOBILIZED EITHER AT ONE (2) OR AT BOTH (3) ENDS; 4, 5: 
DROSOPHILA S2 WHOLE CELL EXTRACTS FROM EITHER WT (4) OR KD (5) CELLS. KU70 KD CELLS WERE 
USED TO TEST 12B8, 6B2, AND 5H4, KU80 KD CELLS WERE USED TO TEST 8B11 AND 8E7. MEMBRANES 
WERE PROBED WITH SUPERNATANTS FROM STABLE CELL LINES 12B8, 6B2, 5H4, 8B11, AND 8E7. 
ASTERISKS INDICATE BANDS OF KU70 AND KU80. 
 A prominent low-molecular weight signal was detected with all supernatants, which could be 
a degradation product of Ku70 or 80 or an abundant and chromatin-associated low-molecular 
weight protein, which is recognized by the antibodies. However, these antibodies specifically 
recognized the subunits of the Ku complex associated to chromatin or in whole cell extracts 
and were used for all Western blot analyses in this thesis. Furthermore, these antibodies were 
able to detect Ku in ChIP (Figure 51). The most specific antibodies were used for Western blot 
analysis and chromatin immunoprecipitation in the following experiments. First, Western blot 
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analysis was performed to analyze Ku enrichment at DSBs in a time course of chromatin 
assembly/maturation. Consistent with the mass spectrometry result, enrichment of Ku was 
limited to the fragment with the free end and almost completely absent when DNA was 
immobilized at both ends. Furthermore, it remained associated to the fragment at constant 
levels over the time course of 15 min to 240 min.   
 
 
FIGURE 46: CHROMATIN ASSEMBLY ON DNA IMMOBILIZED AT ONE END OR BOTH ENDS FOR THE 
INDICATED TIMES. THE EXPERIMENT WAS PERFORMED IN TWO BIOLOGICAL REPLICATES, USING TWO 
INDEPENDENT EXTRACT PREPARATIONS. AFTER SDS-PAGE, PROTEINS WERE BLOTTED AND MEMBRANES 
WERE PROBED WITH ANTIBODIES AGAINST ACF1, KU70, H2A.V, H4, AND gH2A.V. 
As shown in Figure 46 and Figure 47, immobilization of DNA triggered the phosphorylation of 
H2A.V, despite of the immobilization of the biotinylated fragment to the beads. 
 
 
 
 
At early time points (here: 15 min), phosphorylation of H2A.V was decreased in the both-sided-
immobilized fragment compared to the one-side-immobilized fragment. However, at later time 
points, phosphorylation levels among the two fragments were equal (Figure 48).  
biotin
streptavidin
FIGURE 47: LEFT: 
ILLUSTRATION OF BIOTINY-
LATED DNA COUPLED TO 
STREPTAVIDIN-COATED 
BEADS;  
RIGHT: CHROMATIN AS-
SEMBLY ON DNA IMMOBI-
LIZED AT ONE END OR BOTH 
ENDS. AFTER SDS-PAGE, 
PROTEINS WERE BLOTTED 
AND MEMBRANES WERE 
PROBED WITH ANTIBODIES 
AGAINST gH2A.V AND H4. 
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FIGURE 48: RELATIVE ENRICHMENT OF SIGNAL INTENSITIES OF H2A.V AND gH2A.V AFTER 15 MIN, 60 
MIN, OR 240 MIN ASSEMBLY ON DNA IMMOBILIZED AT ONE END OR BOTH ENDS NORMALIZED TO H4 IN 
REFERENCE TO THE INTENSITIES AT ONE END IMMOBILIZED DNA AFTER 15 MIN FROM FIGURE 46 
QUANTIFIED BY IMAGE STUDIO™ LITE SOFTWARE, LI-COR BIOSCIENCES. 
We suspect, that biotinylation itself already initiated the phosphorylation as insertion of 
biotinylated nucleotides into intact plasmids by nick translation triggered phosphorylation of 
H2A.V (Figure 49). Here, the Biotin-Nick Translation Mix (Sigma) was used using different 
amounts of circular plasmid DNA per reaction to aim for optimal levels of incorporated 
biotinylated nucleotides. After biotinylation DNA was immobilized to streptavidin-coupled 
beads and the supernatant after coupling was tested to determine the efficiency of 
biotinylation (Figure 49, top). Immobilized DNA was then used for chromatin assembly in vitro 
and probed by Western blot analysis to investigate the phosphorylation of H2A.V (Figure 49, 
bottom). Unfortunately, efficient immobilization was only possible with high levels of nick 
translation-mediated biotinylation, which led to the phosphorylation of H2A.V. 
 
 
 
 
In addition to this, other approaches to isolate intact DNA without obvious damage (e.g. circular 
chromatin) without induction of H2A.V phosphorylation were not successful, impeding the 
investigation of chromatin-associated factors to damaged DNA in relation to intact DNA (see 
VII.D). 
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FIGURE 49: TOP: AGAROSE GEL OF CIRCULAR DNA 
IN THE SUPERNATANT AFTER COUPLING TO 
STREPTAVIDIN-COATED BEADS. BEFORE, BIOTI-
NYLATED NUCLEOTIDES WERE INSERTED USING A 
NICK TRANSLATION KIT AND TWO DIFFERENT 
AMOUNTS OF DNA PER REACTION. AS A NEGATIVE 
CONTROL, UNTREATED DNA WAS INCUBATED WITH 
BEADS TO CONTROL FOR UNSPECIFIC BINDING OF 
DNA TO BEADS. BOTTOM: CHROMATIN ASSEMBLY 
ON DNA IMMOBILIZED AFTER INSERTION OF 
BIOTINYLATED NUCLEOTIDES BY NICK TRANSLATION. 
AFTER SDS-PAGE, PROTEINS WERE BLOTTED AND 
MEMBRANES WERE PROBED WITH ANTIBODIES 
AGAINST gH2A.V AND H4. 
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To localize the Ku complex at break sites and visualize the distribution of gH2A.V, both features 
were mapped by ChIP-Seq on chromatin assembled on two FlyFosmids including different 
Drosophila genomic sequences (Figure 50): One FlyFosmid, in this case FlyFos019829, was 
intact in the control and in the damage reaction. FlyFos019611 was either circular (control 
reaction) or cut by FseI (damage reaction).  
 
FIGURE 50: EXPERIMENTAL SETUP TO CAPTURE H2A.V PHOSPHOYLATION AND KU RECRUITMENT AT 
DSBS. FLYFOSMIDS WERE INCUBATED WITH DREX. IN EACH REACTION, ONE OF THE FLYFOSMIDS 
REMAINED CIRCULAR (CONTROL FLYFOSMID), WHILE THE OTHER FLYFOSMID WAS EITHER CIRCULAR 
(CONTROL REACTION, BLUE) OR LINEARIZED (DAMAGE REACTION, RED).  
 
In addition to the break introduced into the genomic region of FlyFos1096611, another break 
was introduced into the backbone, which was not mapped in the following sequencing data 
(Figure 51). After formaldehyde-crosslinking and MNase fragmentation to fragments of mainly 
mono-nucleosomes and few di-nucleosomes, samples were analyzed by ChIP-Seq with 
antibodies against H3, H2A.V, gH2A.V and Ku as described in V.C.3 and V.C.4. 
Histones H3 and H2A.V were evenly distributed along both FlyFosmids in the control and 
damage reactions. Only around the break sites, signals in a region of about 2 kb decreased after 
120 min assembly. This loss of signal could be a result of nucleosome removal, as it has been 
proposed for yeast and mammals (Goldstein et al. 2013; Tsukuda, Fleming, Nickoloff & Osley 
2005; Shroff et al. 2004; Morrison & Shen 2009). On the other hand, the loss of signal could 
also result from DNA degradation, either by random nucleases degrading the accessible DNA 
or by DNA damage-associated nucleases, which generate regions of ssDNA during the progress 
of DNA repair. Considering the loss of signal in the input, it is likely that it is indeed a loss of 
DNA rather than nucleosome removal. However, the loss of DNA will be discussed in more 
detail in VI.B.5. 
Interestingly, at early time points (15 min), Ku was specifically enriched in close proximity to 
the break site. This enrichment was no longer detected after 2 h, even though Ku remained 
bound to the DNA fragment with the free end up to 4 h (Figure 46). However, ChIP-seq of Ku 
was only performed once and requires additional replicates to confirm this observation. In 
addition to this, phosphorylation of H2A.V was highly increased after 10 min over the entire 
mapped FlyFosmid including the FseI cut and remained high. Remarkably, no phosphorylation 
was detected on the circular control FlyFosmid in the same reaction, suggesting that the 
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phosphorylation signal only spreads along the DNA in cis, but is not transferred to intact DNA 
in the same reaction. Unfortunately, H3 ChIP was generally not highly efficient, leading to a 
diminished quality of sequencing profiles for H3, particularly in the control reaction (Figure 51). 
 
FIGURE 51: CHIP-SEQ ON CHROMATIN ASSEMBLED FOR 10 MIN OR 120 MIN ON A MIX OF CIRCULAR 
CONTROL FLYFOSMIDS AND ON TARGET FLYFOSMIDS, WHICH ARE EITHER CIRCULAR (CONTROL) OR 
LINEARIZED BY RESTRICTION WITH FSEI. CHIP WAS DONE WITH ANTIBODIES AGAINST H3, H2A.V, 
gH2A.V, AND KU. THE GREEN ARROWS INDICATE THE FSEI CLEAVAGE SITES IN THE TARGET FLYFOSMID. 
READS WERE NORMALIZED TO THE CONTROL FLYFOS. 
  
Enrichment of Ku in proximity to the break site was also confirmed by qPCR. Enrichment was 
normalized to a control region on the intact control FlyFosmid. In this experiment, both break 
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sites were addressed, the break in the genomic region and the break in the FlyFosmid vector 
backbone. Assembly was performed for 2 h (Figure 52). 
The upper panel shows the control conditions with both FlyFosmids intact. As expected, signals 
of H3 and H2A.V ChIP are evenly distributed along the target FlyFosmid and neither signals of 
H2A.V phosphorylation or Ku are increased. In contrast to this, in the lower panel, showing the 
damage reaction, Ku is clearly enriched at the sites close to the break site and gH2A.V signals 
are augmented at 1500 bp to 3000 bp distances from the break site, but also at the more fare 
located control region, due to spreading along the DNA from the break site. Surprisingly, H2A.V 
signal around the break site is increased compared to the control region (here at 1500 and 
300 bp from cut’). Interestingly, however, signals of H2A.V and gH2A.V, but also of H3 are lost 
at loci close to the break site, which might be due to DNA resection (VI.B.5, Figure 72). 
Analogous observations were made in additional ChIP experiments with similar conditions (not 
shown). 
 
 
FIGURE 52: CHIP-QPCR ON CHROMATIN ASSEMBLED FOR 2 H ON CIRCULAR CONTROL FLYFOSMIDS AND 
ON TARGET FLYFOSMIDS, WHICH ARE EITHER CIRCULAR (CONTROL REACTION) OR LINEARIZED (DAMAGE 
REACTION). ANTIBODIES AGAINST H3, H2A.V, gH2A.V, AND KU80 WERE USED. % OF INPUT WAS 
DETERMINED AND NORMALIZED TO THE CONTROL FLYFOSMID. THE EXPERIMENT WAS PERFORMED IN ONE 
BIOLOGICAL REPLICATE. 
  
 
To investigate the kinetics of factors recruited to in vitro reconstituted chromatin, I performed 
Western blot analysis after 2 min, 15 min, 45 min, 120 min and 240 min assembly time. As a 
control, beads lacking DNA were incubated with DREX under assembly conditions to control for 
unspecific binding of proteins to beads (Figure 53). H2A.V and H4 signals constantly increased 
from 2 min to 45 min and remain at a constant level until 240 min, monitoring the kinetics of 
the assembly reaction. Acf1 and Ku70 association followed the same kinetics on the DNA with 
one free end. Ku70 was not associated to DNA with both ends tethered to the beads, consistent 
with the mass spectrometry analysis (Figure 44).  
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FIGURE 53: TIME COURSE OF ASSOCIATION OF ACF1, KU AND HISTONES H2A.V AND H4 TO IN VITRO 
RECONSTITUTED CHROMATIN OVER TIME ON DNA BEARING A FREE END. 120-MIN TIME POINTS WITH 
BEB CHROMATIN AND BEADS LACKING DNA SERVE AS REFERENCE. ASSEMBLY WAS PERFORMED FOR 2 
MIN, 15 MIN, 45 MIN, 120 MIN, AND 240 MIN AND CHROMATIN WAS THEN ISOLATED VIA 
PARAMAGNETIC STREPTAVIDIN BEADS. KU70 IS RECRUITED ALREADY AFTER 2 MIN AND REMAINS 
ASSOCIATED FOR AT LEAST 240 MIN. ASSOCIATION OF ACF1 AND HISTONES H2A.V AND H4 INCREASE 
OVER TIME. DREX (EXTRACT) WAS USED AS INPUT IN TWO DIFFERENT AMOUNTS OF APPROXIMATELY 60 
µG AND 300 µG TOTAL PROTEIN. A PROTEIN STANDARD WAS LOADED (M), WITH PROTEIN SIZES 
INDICATED ON THE LEFT. 
 
3. CHARACTERIZATION OF H2A.V PHOSPHORYLATION IN RESPONSE TO DNA DSBS 
 
As already mentioned in VI.A.2 and VI.A.3 Western blot analysis of H2A.V, which is incorporated 
into recombinant DNA, reveals a double band in chromatin assembled on DNA with a free end, 
pointing to C-terminal phosphorylation. 
 
 
 
To confirm that the slower-migrating band was indeed due to phosphorylation, immobilized 
chromatin was incubated with alkaline phosphatase. After SDS-PAGE and blotting, the 
membrane was probed with antibody specific for the C-terminal phosphorylation of H2A.V. As 
expected, gH2A.V was exclusively detected on chromatin, and not in DREX. Additionally, this 
mark disappeared completely after treatment with alkaline phosphatase. 
 
 
 
 
H2A.V
H4
H2A.V 
octamer
embryo 
extract
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FIGURE 54: WESTERN BLOT ANALYSIS OF IN 
VITRO RECONSTITUTED CHROMATIN ON DNA 
IMMOBILIZED AT ONE END (OEB) OR BOTH 
ENDS (BEB). RECOMBINANT HISTONE OCTA-
MERS CONTAINING HOMOGENOUS H2A.V 
AND DREX SERVE AS CONTROLS. THE 
MEMBRANE WAS PROBED WITH ANTIBODIES 
AGAINST H2A.V AND H4. 
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To evaluate the specificity of H2A.V phosphorylation, we performed assembly reactions linear 
or circular plasmid, or on linear DNA coupled to paramagnetic beads with one end. In the 
absence of DNA or in chromatin assembled on circular DNA, H2A.V phosphorylation was not 
detected (Figure 56, lane 1 and 3). However, in presence of linear DNA, either free or 
immobilized on beads, approximately 30-50% of incorporated H2A.V became phosphorylated 
(Figure 56, lane 4, 6 and 7). In lane 4 and 7, excess unphosphorylated H2A.V present in DREX 
was not separated from H2A.V incorporated into nucleosomes and contributes to a higher ratio 
of unphosphorylated H2A.V compared to lane 6, were chromatin was purified on the magnet 
and thus only separated from un-incorporated H2A.V (Figure 56, lane 5). 
 
 
 
 
 
 
FIGURE 55: WESTERN BLOT ANALYSIS 
OF IN VITRO RECONSTITUTED CHRO-
MATIN AND DREX WITH AND WITH-
OUT TREATMENT WITH ALKALINE 
PHOSPHATASE. THE MEMBRANE WAS 
PROBED WITH gH2A.V SPECIFIC 
ANTIBODY. 
 
 
FIGURE 56: WESTERN BLOT ANALYSIS OF IN 
VITRO RECONSTITUTED CHROMATIN ON 
LINEAR OR CIRCULAR PLASMID, OR ON LINEAR 
DNA COUPLED TO PARA-MAGNETIC BEADS 
WITH ONE END. AS CONTROL, CHROMATIN 
ASSEMBLY WAS PERFORMED WITH BEADS 
ONLY. MEMBRANES WERE PROBED WITH 
ANTIBODIES AGAINST H2A.V, H3, H4, AND 
gH2A.V. LANE NUMBERS ARE INDICATED 
BELOW. SN: SUPERNATANT; B: BEADS; THE 
FOLLOWING SAMPLES WERE LOADED: LANES 
1 AND 2: BEADS ONLY CONTROL REACTION, 
WITH SN IN LANE 1 AND B IN LANE 2; LANE 3 
AND 4: CIRCULAR (LANE 3) OR LINEARIZED 
(LANE 4) PLASMID DNA; LANE 5 AND 6: 
CHROMATIN ASSEMBLY ON IMMOBILIZED 
DNA WITH SN IN LANE 5 AND B IN LANE 6; 
CHROMATIN ASSEMBLY ON SOLUBLE LINEA-
RIZED DNA AND BEADS WITH SN IN LANE 7 
AND B IN LANE 8; THE EXPERIMENT WAS 
PERFORMED IN TWO BIOLOGICAL REPLICATES 
USING EXTRACTS FROM INDEPENDENT 
PREPARATIONS (REPLICATE 1: TOP; 
REPLICATE 2: BOTTOM) 
 
 - Results - 
 81 
According to the previous observations, phosphorylation of H2A.V can only be initiated in the 
presence of DNA breaks. However, after initiation of H2A.V phosphorylation, it has been shown 
in yeast and mammals, that an activation cascade leads to amplification and spreading of the 
gH2A.V signal around the break site (J.-A. Kim et al. 2007; Savic et al. 2009; J. Li et al. 2012; C.-
S. Lee et al. 2014). To investigate if H2A.V bearing a phospho-mimetic amino acid in place of 
SQAY can trigger further H2A.V phosphorylation in absence of free DNA ends, I pre-assembled 
nucleosomes consisting of H2A.V or a phospho-mimetic form of H2A.V in different ratios on 
circular DNA. The portion of spiked in H2A.VE were 0%, 1%, 5%, 10% and 100%. However, 
incorporation of phospho-mimetic nucleosomes did not lead to phosphorylation of H2A.V, 
leading to the conclusion that the phosphorylation mark by itself is not sufficient to initiate the 
spreading event. 
 
 
As observed in Figure 51, the phosphorylation signal in response to free DNA ends spreads over 
several kilobases along the DNA in cis but was not transferred to DNA fragments lacking free 
ends in the same reaction. To confirm this observation, chromatin was assembled on DNA 
immobilized at one end with either circular or linear soluble DNA in the same reaction. After 
separating immobilized DNA from the DNA in the supernatant, the phosphorylation status of 
H2A.V on beads and in the supernatant (containing soluble chromatin and excess H2A.V) was 
analyzed (Figure 58, left). The appearance of H2A.V phosphorylation was strictly correlated to 
the presence of free DNA ends. Additionally, consistent with the result obtained in Figure 51, 
the phosphorylation signal was only detected in the supernatants containing linear, but not 
circular DNA. Altogether, these results led to the hypothesis illustrated in Figure 58 (right), 
suggesting that spreading of the H2A.V phosphorylation mark only spreads along DNA in cis, 
but not in trans onto intact DNA.  
FIGURE 57: WESTERN BLOT ANALYSIS OF 
IN VITRO RECONSTITUTED CHROMATIN 
ON CIRCULAR DNA WITH PREASSEM-
BLED NUCLEOSOME ARRAYS CONSISTING 
OF H2A.V NUCLEOSOMES OR PHOSPHO-
MIMETIC H2A.V NUCLEOSOMES IN 
DIFFERENT RATIOS. AS POSITIVE CON-
TROL, CHROMATIN ASSEMBLY WAS PER-
FORMED ON LINEARIZED DNA WITH 
PREASSEMBLED NUCLEOSOME ARRAYS 
CONSISTING OF H2A.V. MEMBRANES 
WERE PROBED WITH ANTIBODIES 
AGAINST H2A.V, gH2A.V AND H4.  
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FIGURE 58: LEFT: WESTERN BLOT ANALYSIS OF IN VITRO RECONSTITUTED CHROMATIN ON FREE CIRCULAR 
OR LINEAR AND IMMOBILIZED DNA IN ONE REACTION. MEMBRANES WERE PROBED WITH ANTIBODIES 
AGAINST H2A.V, gH2A.V, H3 AND H4. RIGHT: H2A.V PHOSPHORYLATION (RED STAR) DOES NOT 
SPREAD IN TRANS FROM IMMOBILIZED DNA ONTO FREE CIRCULAR DNA. 
 
To elucidate, if spreading in trans can be triggered by DNA cross-bridging proteins, I 
preincubated two different FlyFosmids with BAF (kind gift from the Gerlich laboratory in 
Vienna, Austria, see Samwer et al. 2017) or ParB (kind gift from the Gruber laboratory in 
Lausanne, Switzerland, see Gruber & Errington 2009) prior to chromatin assembly. BAF is a 
DNA- and protein-binding factor, which is implicated in processes like chromatin structure, 
gene regulation, and nuclear assembly (reviewed in Segura-Totten & Wilson 2004). ParB is a 
bacterial DNA-binding protein (Gruber & Errington 2009). 
For each reaction one circular control FlyFosmid and one either circular or linearized target 
FlyFosmid, was pre-incubated with 0.1 µM or 1 µM ParB or BAF (or in absence of cross-binding 
protein as a control). To demonstrate DNA-coupling efficiencies of both proteins, immobilized 
DNA was incubated with soluble DNA fragments and incubated with ParB or BAF. As binding of 
ParB was reported to be diminished in high salt conditions, beads were washed with 200 mM 
NaCl buffer. Beads and supernatant, as well as the eluate after incubation with ParB were then 
analyzed on agarose gels (Figure 59). In presence of 1 µM ParB, soluble DNA was coupled to 
immobilized DNA and was eluted after washing with 200 mM NaCl. For BAF, DNA was already 
coupled to immobilized DNA by 0.1 µM BAF, but efficiency was increased by addition of 1 µM 
BAF. However, after addition of BAF, DNA bands unclear, pointing to a degradation of DNA 
upon addition of BAF. 
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FIGURE 59: DNA CROSS-BRIDGING EFFICIENCIES TESTED WITH PARB (LEFT) AND BAF (RIGHT) WITH 
EITHER 0.1 µM OR 1 µM PROTEIN (OR IN ABSENCE OF PROTEIN AS A CONTROL). DNA IMMOBILIZED TO 
BEADS WAS INCUBATED WITH SOLUBLE DNA. SUPERNATANT AFTER INCUBATION WITH PROTEIN (SN) AND 
BEADS WERE LOADED AFTER PROTEIN DIGESTION. IN CASE OF PARB, AN ELUTION WITH 200 MM NACL 
BUFFER WAS PERFORMED. FOR PARB, BINDING WAS PERFORMED WITH CIRCULAR PLASMID DNA, 
LEADING TO A SUPERCOILED AND RELAXED CONFORMATION OF THE PLASMID (LEFT). FOR BAF, 
LINEARIZED SOLUBLE DNA WAS USED (RIGHT). HOWEVER, COUPLING EFFICIENCIES WERE REPEATED WITH 
CIRCULAR AND LINEARIZED DNA IN BOTH CASES WITH SIMILAR COUPLING EFFICIENCIES. 
To investigate the spreading of H2A.V phosphorylation, assemblies were analyzed by SDS-PAGE 
and Western blot analysis (Figure 60). Assemblies performed on circular FlyFosmids did not 
lead to the induction of H2A.V phosphorylation, independent from the addition of BAF.  
However, in the assemblies performed on circular and linear FlyFosmid, addition of cross-
bridging protein led to a concentration-dependent increase of the phosphorylation signal, 
indicating that the cross-bridging activity of ParB and BAF led to the spreading of the H2A.V 
phosphorylation signal from the linear to the circular DNA fragment.  
 
FIGURE 60: CHROMATIN ASSEMBLY AFTER INCUBATION WITH DNA CROSS-BRIDGING BAF OR PARB. 
EACH ASSEMBLY REACTION WAS PERFORMED ON ONE CIRCULAR CONTROL FLYFOSMID AND ONE EITHER 
CIRCULAR OR LINEARIZED TARGET FLYFOSMID, WHICH WERE INCUBATED WITH 1 µM PARB, 0.1 µM BAF, 
OR 1 µM BAF PRIOR TO ASSEMBLY. AS A CONTROL, BOTH SCENARIOS WERE PERFORMED IN ABSENCE OF 
CROSS-BINDING PROTEIN. THE MEMBRANE WAS. PROBED WITH ANTIBODIES AGAINST gH2A.V AND H4. 
To confirm this hypothesis, ChIP-Seq analysis was performed with antibodies against H2A.V and 
gH2A.V. Because of the slightly stronger increase in phosphorylation upon addition of BAF 
compared to ParB, the following ChIP-Seq experiment was performed with BAF using the same 
concentrations as before (Figure 61). Profiles obtained after H2A.V ChIP showed evenly 
distributed incorporation of H2A.v along both FlyFosmids. In addition to this, chromatin 
assembled on circular FlyFosmids did not show phosphorylation of H2A.V, neither in presence 
nor in absence of BAF. In the damage reaction including the linearized FlyFosmid, gH2A.V 
signals increased and upon addition of BAF, H2A.V phosphorylation was detected on the 
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control FlyFosmid. This observation indicates, that spreading of the H2A.V phosphorylation 
mark can spread in trans to circular DNA in presence of cross-binding proteins.  
 
FIGURE 61: CHIP-SEQ ON CHROMATIN ASSEMBLED ON A MIX OF CIRCULAR CONTROL FLYFOSMIDS AND 
ON TARGET FLYFOSMIDS, WHICH ARE EITHER CIRCULAR (CONTROL) OR LINEARIZED BY RESTRICTION WITH 
FSEI AND PRE-INCUBATED WITH 0.1 µM OR 1 µM BAF (OR NO BAF AS A CONTROL). CHIP WAS DONE 
WITH ANTIBODIES AGAINST H2A.V AND gH2A.V. THE GREEN ARROWS INDICATE THE FSEI CLEAVAGE 
SITES IN THE TARGET FLYFOSMID. SIGNALS WERE NORMALIZED TO THE NUMBERS OF READS. FOR H2A.V, 
ALL PROFILES ARE SHOWN IN THE SAME DATA RANGE. FOR gH2A.V ADJUSTED DATA SCALES WERE USED 
FOR BACKGROUND SIGNAL (CONTROL REACTION) AND FOR PHOSPHORYLATION SIGNAL AFTER RESTRICTION 
(FSEI) AS INDICATED. ALL gH2A.V PROFILES BEFORE DATA RANGE ADJUSTMENTS ARE SHOWN IN XI.C. 
 
However, these experiments are preliminary and need to be confirmed in further replicates. In 
addition to this, BAF purification should be optimized to avoid uncontrolled DNA damage by 
nucleases. To allow proper normalization, ChIP experiments in presence of standard DNA 
should be performed. 
 Due to the lower increase of phosphorylation observed in presence of ParB compared to the 
increase observed in BAF, spreading of H2A.V phosphorylation in trans in presence of ParB has 
not yet been investigated. However, as DNA degradation was not observed in presence of ParB, 
spreading of H2A.V phosphorylation in trans in presence of ParB should be repeated to 
complement this study.  
I observed the presence of gH2A.V phosphorylation at the earliest assembly time (10 min, see 
Figure 51), suggesting that the recognition of the free end is very fast. A precise kinetics of this 
reaction cannot be performed since the chromatin assembly reaction is slow by comparison. 
To capture early events in DNA damage recognition, we preassembled nucleosome arrays 
consisting of H2A.V nucleosomes. This allowed us to monitor the kinetics of gH2A.V appearance 
during the first few minutes of incubation in DREX. Western blot analysis against C-terminal 
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phosphorylation revealed, that H2A.V phosphorylation can be detected with this antibody 
about 6 min after addition of extract (Figure 62). 
 
 
 
 
FIGURE 63: EXPERIMENTAL SETUP TO CAPTURE THE EARLY ONSET OF H2A.V PHOSPHORYLATION. 
PREASSEMBLED NUCLEOSOME ARRAYS CONSISTING OF H2A.V NUCLEOSOMES WERE INCUBATED WITH 
DREX AND PHOSPHORYLATION WAS STOPPED BY FORMALDEHYDE CROSSLINKING. IN EACH REACTION, 
ONE OF THE FLYFOSMIDS REMAINED CIRCULAR (CONTROL FLYFOSMID), WHILE THE OTHER FLYFOSMID 
WAS EITHER CIRCULAR (CONTROL REACTION, BLUE) OR LINEARIZED (DAMAGE REACTION, RED).  
 
To capture the very rapid phosphorylation of H2A.V, conditions to efficiently stop the spreading 
process at early time points were optimized. Inhibition of phosphorylation by wortmannin, 
apyrase, and AMP-PNP did not immediately stop the phosphorylation, as tested by Western 
blot, therefore, a fast and efficient cross-linking step with formaldehyde was performed. This 
procedure enabled the analysis of phosphorylation at early time points after addition of extract. 
In addition to this, reactions with different restriction enzymes were performed to obtain 
spreading profiles of the H2A.V phosphorylation, which were initiated at different sites. In 
contrast to Figure 62, time points were adjusted to 30 sec, 120 sec, and 600 sec, to disseminate 
the early H2A.V phosphorylation events. The experimental setup is illustrated in Figure 63: In 
each reaction, one of the FlyFosmids remained circular (control FlyFosmid), while the other 
FlyFosmid was either linearized using RsrII (two target sites in the genomic insert of FlyFosmid 
019611), FseI (one target site in the genomic insert and one target site in the backbone, which 
was not mapped), or SgrDI (two target sites in the genomic insert of FlyFosmid 019829). In 
parallel to the described damage reactions (red), a control reaction was performed, with both 
FlyFosmids intact (blue). Induction of H2A.V phosphorylation was tested by Western blot 
analysis and showed an increase of H2A.V phosphorylation over time, but no signal in the 
negative control using circular FlyFosmids (Figure 64). 
FIGURE 62: H2A.V PHOSPHORYLATION ON PREASSEMBLED 
H2A.V ARRAYS AFTER 2 SEC, 30 SEC, 120 SEC, 360 SEC, 
AND 900 SEC AFTER ADDITION OF DREX. MEMBRANES 
WERE PROBED WITH ANTIBODIES AGAINST gH2A.V, H4, 
AND H2A.V.  
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Profiles of these samples obtained by ChIP-Seq against gH2A.V are shown in Figure 65. As 
before, H2A.V ChIP was performed in parallel to confirm the equal assembly of H2A.V 
nucleosomes (not shown). As expected, no phosphorylation was observed in the control 
reaction with two circular FlyFosmids and in the damage reactions on the circular control 
FlyFosmids. On the linearized FlyFosmids, H2A.V phosphorylation signals increased after 120 
sec, with different profiles according to the location of the break: RsrII treated FlyFosmids 
showed an increase in proximity to the RsrII target sites, and FseI treated FlyFosmids showed 
an increase in proximity to the FseI target site, respectively. Considering the spreading models 
of the H2A.V phosphorylation signal along DNA (described in III.D.4), this observation speaks in 
favor of a phosphorylation spreading event, which is initiated at the break site and propagates 
along DNA (see Figure 11, model A).  
 
FIGURE 65: CHIP-SEQ OF H2A.V PHOSPHORYLATION AFTER 30 SEC, 120 SEC, AND 600 SEC AFTER 
ADDITION OF DREX TO PREASSEMBLED H2A.V ARRAYS ON A CIRCULAR CONTROL FLYFOSMID AND A 
LINEARIZED TARGET FLYFOSMID. IN THE CONTROL REACTION, BOTH FLYFOSMIDS WERE CIRCULAR. 
DIFFERENT RESTRICTION ENZYMES WERE USED TO DISSEMINATE THE PHOSPHORYLATION INITIATED AT 
DSBS IN DIFFERENT LOCATIONS INDICATED WITH ARROWS. READS WERE NORMALIZED TO THE CONTROL 
FLYFOS. 
  
Unfortunately, we were not able to address the kinetics of H2A.V phosphorylation, as 
phosphorylation increased rapidly from 120 sec to 600 sec. In addition, a previous experiment 
performed in comparable conditions, displayed a high extent of phosphorylation after 120 sec, 
FIGURE 64: H2A.V PHOSPHORYLATION ON PRE-
ASSEMBLED H2A.V ARRAYS ON A CIRCULAR CONTROL 
FLYFOSMID AND A LINEARIZED TARGET FLYFOSMID AFTER 
30 SEC, 120 SEC, AND 600 SEC AFTER ADDITION OF 
DREX. IN THE CONTROL REACTION, BOTH FLYFOSMIDS 
WERE CIRCULAR. DIFFERENT RESTRICTION ENZYMES 
WERE USED TO DISSEMINATE PHOSPHORYLATION 
INITIATED AT DSBS IN DIFFERENT LOCATIONS (ALSO SEE 
FIGURE 65). MEMBRANES WERE PROBED WITH 
ANTIBODIES AGAINST gH2A.V AND H4.  
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leading to the assumption that the increase of phosphorylation after initiation proceeds very 
fast. Therefore, to draw conclusions about the kinetics of H2A.V phosphorylation, additional 
replicates with more resolved time points are required. 
In Drosophila, two kinases have been identified, which phosphorylate H2A.V in response to 
DNA damage, Tefu and Mei-41, which are the orthologues of ATM and ATR, respectively 
(Madigan et al. 2002). An orthologue of DNA-PK has not yet been identified in Drosophila so far 
(Sekelsky et al. 2000; Sekelsky 2017). 
To investigate whether the recruitment of DNA damage factors like the Ku complex depend on 
the gH2A.V signal, I added kinase-specific inhibitors to the extract prior to assembly which 
prevent H2A.V phosphorylation. The following inhibitors were used in a final concentration of 
10 µM (kind gifts from Gyula Timinszky, Ludwig-Maximilians-Universität München, Germany):  
• ATMi (KU55933) 
• ATRi (VE-821) 
• DNA-PKi (NU7441) 
These inhibitors were added, alone or in combination, prior to addition of DNA to the 
chromatin assembly reaction. The phosphorylation was monitored after 15 min or 60 min of 
the assembly reaction. As a control, chromatin assembly was performed in presence of an 
equivalent volume of DMSO, which was used to dissolve the inhibitors (Figure 66).  
 
 
FIGURE 66: CHROMATIN ASSEMBLY IN PRESENCE OF KINASE INHIBITORS FOR 15 MIN OR 60 MIN. AS 
CONTROL, CHROMATIN WAS ASSEMBLED IN PRESENCE OF DMSO. 
However, none of the inhibitors were able to prevent the phosphorylation of H2A.V, as 
concluded from the appearance of the double band in all samples. This observation could either 
be explained by either inactive or unfunctional inhibitors, which might not be functional for the 
Drosophila orthologues or by another kinase, which could exist in Drosophila and might bear 
redundant functions in DNA damage signaling. However, it is likely, that these inhibitors, which 
are specific against the human orthologues, fail to inhibit the not well conserved Drosophila 
kinases, as it has already been shown for KU55933 (Mitchell & Friesen 2012). Unfortunately, 
inhibitors against Drosophila kinases are not yet available. 
Therefore, H2A.V phosphorylation was inhibited by wortmannin, a broad-range PI3K inhibitor 
(Paull et al. 2000). In presence of wortmannin, no phosphorylation of H2A.V was detected 
(Figure 67). Analysis of factors associated to chromatin revealed that Ku recruitment does not 
depend on H2A.V phosphorylation. To confirm this observation nucleosome arrays were 
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assembled from histone octamers containing a C-terminally truncated version of H2A.V, which 
cannot be phosphorylated in response to DNA damage (H2A.VDC), and with nucleosomes 
containing H2A. In both cases, Ku70 was recruited to the same extent in response to free DNA 
ends in the absence of H2A.V phosphorylation (Figure 68). Likewise, the association of Acf1 and 
Iswi, components of the ACF complex, and for Dom, a component of the Dom/Tip60 complex 
did not depend on the H2A.V C-terminus. 
 
 
 
 
 
 
 
 
- + Wortmannin
H2A
H4
Acf1
γH2A.V
H2A.V
Iswi
Ku70
Ku80
FIGURE 67: CHROMATIN ASSEMBLY IN ABSENCE (-) OR PRESENCE (+) 
OF WORTMANNIN, A BROAD-RANGE PI3K INHIBITOR. THE NEGATIVE 
CONTROL WAS SUPPLIED WITH DMSO, WHICH WAS USED TO 
DISSOLVE WORTMANNIN. MEMBRANES WERE PROBED WITH 
ANTIBODIES AGAINST ACF1, ISWI, KU70, KU80, H2A.V, gH2A.V, 
H2A, AND H4. 
 
FIGURE 68: RECRUITMENT OF PROTEINS FROM 
DREX TO NUCLEOSOME ARRAYS UNIFORMLY 
CONSISTING EITHER OF H2A OR H2A.V OR 
H2A.VDC NUCLEOSOMES. MEMBRANES WERE 
PROBED WITH ANTIBODIES AGAINST DOMB, ACF1, 
ISWI, KU70, gH2A.V, H2A.V, AND H4. 
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4. DNA DSBS CAN BE SPECIFICALLY INTRODUCED INTO GENOMIC DNA OF S2 CELLS 
 
All of the experiments performed so far describe the damage-associated processes in vitro, 
where DSBs are represented by free DNA ends. However, the damage reaction is performed in 
a cell-free system and outside of the nucleus. In addition of this, cellular proteins, which are 
not present in the nucleus under physiological conditions, could interfere with processes 
leading to false conclusions. Therefore, we aimed to recapitulate processes in response to DNA 
DSBs in vivo. 
The Laboratory of Gaelle Legube in Toulouse developed a system to introduce DNA DSBs in a 
time-resolved manner and at specific sites in the genome. For this purpose, the endonuclease 
AsiSI was expressed under a copper sulfate (CuSO4)-inducible promoter and fused to an 
estrogen receptor hormone binding domain. After induction of expression by CuSO4, addition 
of 4-hydroxytamoxifen (4-OHT) initiated the translocation of otherwise cytoplasmic 
endonuclease into the nucleus to generate DNA DSBs at its target sites. A further feature of the 
system is that the nuclease has been furnished with an Auxin-inducible-degron (AID). This 
allows to induce rapid degradation of the endonuclease to stop generation of DNA DSBs by 
Auxin addition (described in Massip et al. 2010). 
  
 
The target site of AsiSI GCGATCGC is CpG methylation-sensitive, so that many of the sites in 
mammalian cells are not cleaved due to methylation. However, Drosophila SL2 cells lack this 
DNA modification. The AsiSI target motif GCGATCGC occurs 1632 times in the Drosophila 
genome, and potentially, all of these sites can be targeted by AsiSI, leading to a dramatic 
induction of DNA damage.   
 To trigger conditions, in which DSBs are efficiently induced but do not lead to apoptosis, we 
aimed to tune the cleavage by regulating the expression and translocation of AsiSI in different 
conditions: 
 
FIGURE 69: DSBS INDUCED 
BY TRANSLOCATION OF ASISI 
INTO THE NUCLEUS (FIGURE 
ADAPTED FROM MASSIP ET 
AL. 2010). ADDITION OF 4-
HYDROXYTAMOXIFEN (4-
OHT), WHICH BINDS TO THE 
ESTROGEN (ER) RECEPTOR 
HORMONE BINDING DOMAIN 
FUSED TO ASISI, LEADS TO 
ITS TRANSLOCATION INTO 
THE NUCLEUS, WHERE IT 
SPECIFICALLY CLEAVES AT 
THE TARGET SITES. 
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- SL2 AsiSI cells untreated were not supplied with CuSO4 and 4-OHT 
- SL2 AsiSI cells + 4-OHT were only supplied with 300 nM 4-OHT and incubated for 1 h 
to induce translocation of leaky expressed AsiSI into the nucleus 
- SL2 AsiSI cells +4-OHT +CuSO4 were supplied with 5 mM CuSO4 and incubated over 
night to induce expression of AsiSI and then supplied with 300 nM 4-OHT and 
incubated for 1 h to induce translocation of AsiSI into the nucleus 
As a control, cells were treated in parallel with ethanol, which was used to solve 4-OHT. As 
expected, cell viability decreased upon introduction of DSBs, from 92% for control cells to 88% 
for cells only treated with 4-OHT and particularly in the case of induced expression of AsiSI and 
4-OHT treatment, with a viability of 62%. Introduction of DNA DSBs were visualized by 
immunostaining using gH2A.V as a marker for damaged chromatin. 
 
FIGURE 70: IMMUNOFLUORESCENCE OF CELLS TREATED WITH ETHANOL (CONTROL), 4-OHT, OR 4-OHT 
AND CUSO4 USING ANTIBODIES AGAINST H2A.V (GREEN) AND gH2A.V (RED). NUCLEI WERE STAINED 
WITH HOECHST. 
As expected, the cells showed an induction-dependent damage response, with background 
signal in untreated cells. A small number of damage foci were induced in the presence of 4-
OHT suggesting that the promoter was not tightly repressed in the absence of CuSO4. This 
indicates that leaky expression of AsiSI already leads to sufficient levels to trigger DNA damage 
dependent gH2A.V foci. In contrast to this, induction of expression with CuSO4 prior to 
induction of translocation into the nucleus led to a fulminant DNA damage response and 
enormous levels of H2A.V phosphorylation. These observations correlated with cell viability. 
In parallel to the generation and characterization of the stable AsiSI cell line, I aimed to 
elucidate the role of Acf1, Ku70, or Ku80 in DNA damage signaling. For this purpose, I generated 
dsRNA and tested the knock down efficiencies by RNA interference (RNAi) in wt S2 cells. 
Successful RNAi construct would then be used in combination with AsiSI-transfected cells after 
induction of DSBs. As a control, cells were either treated in parallel but without addition of 
dsRNA or with GST RNAi. The viability of these cell populations before induction of DSBs 
decreased from 95% in control cells in absence of RNAi to 83% in Acf1 RNAi cells, 74% in GST 
RNAi cells, 77% in Ku70 RNAi cells, and 78% in Ku80 RNAi cells. 
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The generation of DSBs in the stably transfected AsiSI cell line was performed once. To confirm 
the observations shown in Figure 70 and to fine-tune the induction settings, I performed 
replicates using different titrations of induction with 4-OHT and CuSO4. Unexpectedly, the 
detection of gH2A.V foci was no longer possible with this cell line, regardless of the fact that 
the cell line was stably transfected. We suspect, that the generated cell line was not sustainable 
due to the leaky expression of AsiSI and the continual generation of breaks, which might have 
led to the silencing of the AsiSI locus to protect the genome. Due to this technical issue, we 
were not able to continue this in vivo approach. 
 
5. INVESTIGATION OF RESECTION AT DNA ENDS   
 
As previously mentioned, the ChIP signal of histones decreases close to the break site, 
suggesting the removal of nucleosomes as has been proposed for yeast and mammals 
(Goldstein et al. 2013; Tsukuda, Fleming, Nickoloff & Osley 2005; Shroff et al. 2004; Morrison 
& Shen 2009). However, the fact that the DNA at this position is also reduced in the ChIP input 
rather suggests that the DNA is being lost during the incubation an DREX for extended times.  
It is not clear if this DNA is degraded, either by random nucleases degrading the accessible DNA 
or by DNA damage-associated nucleases, which generate regions of ssDNA during the process 
of ‘resection’ associated with homologous recombination.  
The resection process is initiated by the CtIP-MRN complex (Sartori et al. 2007) and extended 
by exo1 and dna2 nucleases leading to 3’ overhangs (Symington & Gautier 2011). These 
overhangs are then immediately bound by single-strand-binding proteins like RPA and later on 
by rad51 (Wyatt & West 2014). Next-generation sequencing of input DNA after fragmentation 
with Covaris focused acoustics (to avoid DNA degradation by MNase), loss of DNA was detected 
in regions of 0.4 kb - 1 kb flanking each DNA end. However, due to the nature of Illumina 
sequencing sample preparation, dsDNA is favored over ssDNA, which might lead to a loss of 
signal from ssDNA fragments. This hypothesis is in line with the fact that DNA at these sites was 
detectable at later time points with qPCR, which allows amplification of ssDNA. 
FIGURE 71: KNOCK DOWN OF KU80 AND 
ACF1 IN DROSOPHILA SCHNEIDER CELLS 
USING KU80 RNAI AND ACF1 RNAI. GST 
RNAI SERVED AS A NEGATIVE CONTROL. 
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FIGURE 72: RESECTION OF CHROMATIN FLANKING FREE DNA ENDS ANALYZED BY SEQUENCING OF 
MNASE- OR COVARIS-SHEARED CHROMATIN AFTER 10 MIN OR 120 MIN ASSEMBLY. COVARIS SHEARING 
WAS PERFORMED FOR 25 MIN AT 100 WATTS IN 12X12 FIBRE TUBES USING THE COVARIS S220 SYSTEM. 
To explore this question further, I performed various experiments to identify ssDNA using 
either single-strand-specific nucleases or recombinant single-strand-binding proteins. 
Unfortunately, all attempts failed but, as further discussed in VII.A. Due to the lack of 
appropriate controls, the existence of ssDNA could not be excluded. I therefore applied an 
approach published by Langerak et al (Langerak et al. 2011), where ssDNA and dsDNA is treated 
with the double-strand-specific restriction enzyme ApoI, leaving ssDNA intact. Subsequent 
amplification of regions including the ApoI target site only leads to amplification if the site is 
not cleaved in case of ssDNA. dsDNA, however, cannot be amplified as the amplicon is cleaved 
by ApoI (Figure 73). 
 
FIGURE 73: QPCR AMPLICON OF 140 BP INCLUDING THE APOI TARGET SITE. AFTER CLEAVAGE WITH 
APOI, AMPLIFICATION WITH PRIMERS (RED ARROWS) IS NOT POSSIBLE. SSDNA IS NOT CLEAVED BY APOI 
AND CAN BE AMPLIFIED BY QPCR. 
To confirm the specificity and efficiency of ApoI digest, DNA fragments of about 200 bp 
including the ApoI target site were generated as either dsDNA or ssDNA and incubated with 
ApoI under the same conditions that were lateron used for the experiment. As shown in Figure 
74, ssDNA was not affected upon ApoI treatment, however, dsDNA was cleaved.  
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Linearized plasmid DNA including ApoI target sites proximal to the DNA ends before or after 
incubation with DREX to potentially generate ssDNA was treated with ApoI or buffer only as a 
negative control. Amplification of purified DNA after assembly with primers flanking the break 
site or a more distal site including the ApoI site (No 1 control) was performed. As a negative 
control, another control site lacking the ApoI target site was analyzed in parallel (No 2 control). 
Signal intensities were normalized to the No 2 control site and plotted in Figure 75. To our 
surprise, ApoI treatment prevented amplification of all templates, with or without treatment 
with DREX, suggesting that no ssDNA was introduced in proximity to the break, and that all 
target regions remained double-stranded.  
 
FIGURE 75: QPCR ANALYSIS OF REGIONS 170 BP AND 750 BP FROM THE BREAK SITE BEFORE (NO 
RESECTION) AND AFTER (RESECTION) INCUBATION OF LINEARIZED DNA WITH DREX BEFORE OR AFTER 
TREATMENT WITH APOI. 
FIGURE 74: ACRYLAMIDE GEL OF SSDNA 
AND DSDNA BEFORE (-) AND AFTER (+) 
APOI TREATMENT TO CONFIRM THE 
SPECIFICITY OF APOI FOR DSDNA.  
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Due to the previous control experiment to control specific and efficient restriction at ApoI sites 
only at dsDNA, we conclude that the ApoI target site remained double-stranded without 
generation of ssDNA. It is possible, that DNA resection is performed on both strands, or that 
resected DNA ends consisting of ssDNA are processed by (unspecific) nucleases. However, 
discrepancies with the data obtained before suggesting the existence of ssDNA in proximity to 
the break are further investigated in VII.A. 
 
6. RECRUITMENT OF THE REMODELING FACTOR ACF1 TO DNA BREAKS 
 
As discussed in the previous chapter, during DNA repair nucleosomes are removed from the 
break site to generate space for DNA repair. This process is mediated by chromatin remodeling 
factors, which have the ability to shift nucleosomes, remove nucleosomes from chromatin or 
replace histones for specific histone variants in an ATP-dependent manner. Indeed, all four 
chromatin remodeling families, namely the Swi/Snf, Chd, Ino80, and Iswi families, have already 
been implicated in the DNA damage response (reviewed in Price & D’Andrea 2013). 
Acf1, a Drosophila remodeling component of the ACF complex, which belongs to the ISWI 
family, has been found to be implicated in the DNA damage response as well. Interestingly, as 
mentioned in the introduction, Acf1 has been shown to interact with DNA damage proteins, to 
mention the Ku complex as one example. The interaction of Acf1 with Ku80, a component of 
the Ku complex, has been shown in our lab by a former PhD student Dhawal Jain in 
immunoprecipitation experiments using nuclear extract prepared from Drosophila embryos. In 
addition to that, I also observed Acf1 co-immunoprecipitated using monoclonal antibodies 
against Ku70 and Ku80 (Figure 76), which is in line with data obtained in mammalian cells, 
where Acf1 was shown to directly interact with Ku70 (Lan et al. 2010). 
 
We therefore wondered if Acf1 might be enriched at break sites, as it could potentially be 
recruited by Ku to remove nucleosomes at the break site. Unfortunately, Dhawal Jain, a former 
PhD student in our lab, revealed that attempts to localize binding sites of chromatin remodelers 
by chromatin immunoprecipitation are prone to yield false positive signals, henceforth called 
“phantom peaks” (Jain, Baldi, Zabel, Straub & Becker 2015). These artefactual ChIP peaks arise, 
FIGURE 76: CO-IMMUNOPRECIPITATION OF 
ACF1, KU80, AND KU70. AS NEGATIVE 
CONTROL, EXTRACT WAS INCUBATED WITH 
BEADS ONLY (CONTR.) AND EXTRACT BEFORE 
IMMUNOPRECIPITATION WAS USED AS INPUT. 
MEMBRANES WERE PROBED WITH ANTIBODIES 
AGAINST ACF1, KU70, KU80, H3, AND H4. 
ASTERISKS INDICATE THE BAND FOR KU70, 
WHICH WAS CONSISTENTLY DETECTED AT 
HIGHER MOLECULAR WEIGHT IN ALL EXTRACT 
SAMPLES COMPARED TO IP OR CHROMATIN 
SAMPLES. 
 
 
 - Results - 
 95 
when the crosslinking of protein to a target site is not efficient. It is possible, however, that 
Acf1 binds tighter to DNA break site, which I have tested in the following experiments. 
The specificity of the Acf1 antibodies for immunoprecipitation has been established before 
(Jain, Baldi, Zabel, Straub & Becker 2015). I performed ChIP with monoclonal or polyclonal 
antibodies directed against the C-terminus of Acf1 on either control DREX or on an extract from 
which Acf1 had been depleted by multiple rounds of antibody-bead adsorption. Chromatin 
assembly was performed on a linearized FlyFosmid (here FlyFos019611) for 15 min, as Acf1 
recruitment was shown to be higher at earlier time points (compare Figure 41). Formaldehyde 
cross-linking was performed for 10 min at 0.1% and chromatin was fragmented to mono-
nucleosomes by MNase digestion. After ChIP, immunoprecipitated DNA was purified and 
analyzed by qPCR using primers defining amplicons at defined distances from the break site of 
a linearized FlyFosmid (Figure 77). As expected, ChIP yielded 7-15 times less DNA upon Acf1 
depletion, depending on the antibody used for ChIP, suggesting that ACF1-chromatin 
interactions can indeed be monitored in this in vitro experiment. However, ChIP-qPCR signals 
were comparable for the different loci, suggesting that Acf1 binding is not promoted by a close 
distance to the break, at least not within 3 kb around the break. 
 
FIGURE 77: QPCR ANALYSIS OF REGIONS 500 BP, 1500 BP, 3000 BP, OR DISTAL TO THE BREAK SITE 
AFTER CHIP AGAINST ACF1 USING MONOCLONAL (8E3) OR POLYCLONAL (RB2) ANTIBODIES AFTER 
CHROMATIN ASSEMBLY WITH ACF1-DEPLETED EXTRACT (ACF1 DEPL) OR CONTROL EXTRACT (CONTROL). 
However, in Western blot analysis probing chromatin-associated Acf1 versus unbound factor, 
I observed that only a small fraction of Acf1 is associated to chromatin (compare Figure 28). 
We therefore considered that, due to excess Acf1 in the extract all chromatin binding sites are 
saturated with the remodeler, precluding the detection of any additional enrichment at the 
DNA ends. To avoid this, I titrated the volume of DREX in chromatin reconstitution between 20 
- 60 µL of extract per 1 µg DNA. Figure 78 shows yields normalized to input after chromatin 
immunoprecipitation with monoclonal or polyclonal anti-Acf1 antibody for the corresponding 
extract titrations relative to the distal control region on the linearized FlyFosmid distant from 
the break.  
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Interestingly, in immunoprecipitations performed with the monoclonal antibody 8E3, Acf1 
seemed to be about 3 to 7 times enriched 1500 bp away from the break for all tested titrations 
and about 3.5 times enriched 500 bp away from the break for 40 µL and 60 µL extract per 1 µg 
DNA. However, this enrichment was not reproduced in immunoprecipitations performed with 
the polyclonal antibody, were only minor, but consistent enrichments over the control regions 
were observed (about 1.2 – 1.4 x).  
Unfortunately, Acf1 ChIP is very inefficient and signals not robust, presumably due to the 
particularly short residence time below 500 ms of Iswi chromatin remodelers in chromatin 
(Erdel & Rippe 2012). To overcome this issue and improve the robustness of Acf1 ChIP, I used 
different cross-linking strategies by varying formaldehyde concentrations and adding additional 
protein-protein cross-linking reagents prior to formaldehyde to capture transient and complex 
interactions. However, these attempts did not improve the yields nor consistency of results. 
In conclusion, Acf1 seems to show a preference towards DNA ends with a potential role in DNA 
repair, supported by the interaction with the Ku complex. However, due to its very general 
function of chromatin assembly and nucleosome spacing in the early phases of development 
(Chioda et al. 2010). Acf1 is assumed to be evenly distributed along chromatin and only seems 
to be marginally enriched at particular sites under specific conditions. 
 
7. FURTHER POST-TRANSLATIONAL HISTONE MODIFICATIONS AROUND DNA BREAKS 
 
As introduced before, other post-translational histone modifications besides the C-terminal 
phosphorylation of H2A.V (H2A.X in mammals) have been connected to the DNA damage 
response.    
However, only few of them have been studied in Drosophila. One example is the N-terminal 
acetylation of H2A.V, which is required for efficient turnover of phosphorylated H2A.V after the 
DNA damage response (Kusch 2004). To obtain a general information about damage-
dependent post-translational histone modifications in this in vitro system, I collaborated with 
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FIGURE 78: RELATIVE 
ENRICHMENTS AFTER QPCR 
ANALYSIS OF REGIONS 
500 BP, 1500 BP OR 3000 
BP FROM THE BREAK SITE IN 
RELATION TO A DISTAL 
REGION ON THE SAME 
FLYFOSMID. CHROMATIN 
ASSEMBLY WAS PER-
FORMED WITH 20 µL, 
40 µL, OR 60 µL DREX 
AND MONOCLONAL (8E3) 
OR POLYCLONAL (RB2) 
ANTIBODIES AGAINST ACF1 
WERE USED FOR CHIP. 
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Christian Feller (ETH Zurich) who analyzed my samples by advanced mass spectrometry. I 
performed two types of experiments: first, I assembled chromatin on either circular or 
linearized plasmids in DREX adding lowest-possible amounts of DREX for assembly so that a 
maximal fraction of soluble histones would be assembled into nucleosomes. In a second 
experiment I assembled histone octamers on the plasmids containing exclusively the H2A.V 
variant, or H2A.VDC, lacking the ‘gamma’ phosphorylation epitope by salt gradient dialysis. All 
plasmids, either protein-free or bearing nucleosomes were incubated for 15 min or 3 h in DREX 
under chromatin assembly conditions. The experiments were done with three independent 
extract preparations as biological replicates.  
Figure 79 and Figure 80 show relative enrichments of histone peptides bearing defined 
modifications as indicated on linearized versus circular DNA after normalization to their 
intensities in the sample ‘H2A.V preassembled on circular DNA, 15 min’. In Figure 79 
nucleosomes were assembled from endogenous factors contained in DREX and in Figure 80 
DNA was preassembled with nucleosomes bearing H2A.V on the left side, or the H2A.VDC, on 
the right side, respectively. 15 min and 3 h time points are indicated in pink and, purple, 
respectively, representing early and late time points. 
Remarkably, the histone methylation marks H3K9me3, H3K27me2, H3K36me2 and H4K20me2 
showed a substantial enrichment of about 5- to 12-fold on linear DNA after assembly with 
endogenous histones at 15 min assembly time, all decreasing after 3 h assembly time. Only the 
H4K20me1 mark did not decrease at later time points but increased about 2-fold in both 
samples. H4K20me1 has already been described in embryo extract by Scharf et al. (Scharf et al. 
2008), where it was linked to chromatin maturation and let to deacetylation of H4. 
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A similar situation was detected on nucleosome arrays after incubation in chromatin assembly 
extract (Figure 80). Here, H3K36me2, H3K9me2/me3, H3K27me2 and H4K20me2 were 
enriched in both cases, with enrichments scored for H2A.V nucleosomes (with approximately 
2.5- to 8.5-fold for 15 min) versus H2A.VDC nucleosomes (with approximately 1.5- to 3-fold for 
15 min). After 3 h assembly, most of the methylation marks decreased again, in parts even 
more than the reference intensity of H2A.V at 15 min. Remarkably, H2A.VK4ac was decreased 
to approximately 0.5-fold on full length H2A.V after 15 min but increased after 3 h on full length 
H2A.V as well as on C-terminally truncated H2A.V at both time points (Figure 80). This 
observation would argue for a constraining role of the C-terminus on this modification, 
indicating that the absence of the C-terminus or a C-terminal modification leads to an increase 
of N-terminal acetylation of H2A.V, in particular at early time points. Interestingly, a 
dependency of H2A.V acetylation of H2A.V on damage-dependent C-terminal phosphorylation 
was described in Kusch et al (Kusch 2004). Other modifications with a striking dependency on 
the C-terminus are H3K36me2, H3K9me2/me3, H3K27me2 and H4K20me2, with a higher 
abundance in presence of the C-terminus, particularly at the early time point. H3K36me2 has 
already been linked to DNA damage in mammals, and is deposited by Metnase/SETMAR and is 
beneficial for the recruitment of Nbs1 and Ku70 (Fnu et al. 2011).  
 
FIGURE 79: RELATIVE ENRICH-
MENT OF HISTONE MODIFI-
CATIONS AFTER CHROMATIN 
ASSEMBLY ON FREE LINEA-
RIZED DNA OVER CIRCULAR 
DNA AFTER 15 MIN (RED) OR 
AFTER 3 H (PURPLE). ALL 
INTENSITIES ARE NORMALIZED 
TO THE INTENSITY OF H2A.V 
ON CIRCULAR DNA AFTER 15 
MIN ASSEMBLY. 
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FIGURE 80: RELATIVE ENRICHMENT OF HISTONE MODIFICATIONS AFTER CHROMATIN ASSEMBLY ON 
LINEARIZED ARRAYS WITH PREASSEMBLED H2A.V OR H2A.VDC NUCLEOSOMES OVER CIRCULAR ARRAYS 
AFTER 15 MIN (RED) OR AFTER 3 H (PURPLE). ALL INTENSITIES ARE NORMALIZED TO THE INTENSITY OF 
H2A.V ON CIRCULAR DNA AFTER 15 MIN ASSEMBLY. 
Surprisingly, several damage-dependent histone modifications seem to appear only very 
transiently, despite the persisting H2A.V phosphorylation mark, which might be explained by 
the presumably either missing or very inefficient repair of DSBs in the system. However, these 
methylation marks could have a very general impact on chromatin formation, which might be 
harmful if maintained over longer time periods compared to the maybe more specific 
phosphorylation mark, which seems to be more tolerable over the time course of 3 h. 
All intensities for free DNA and nucleosome arrays on circular and linearized DNA for 15 min 
and 3 h normalized to ‘H2A.V preassembled on circular DNA, 15 min’ are summarized in Figure 
79 and Figure 80 with appropriate scales.  
 
 
FIGURE 81 (NEXT PAGE): RELATIVE INTENSITIES OF HISTONE MODIFICATIONS AFTER CHROMATIN 
ASSEMBLY ON FREE CIRCULAR (PLASMID, BRIGHT BLUE) OR LINEARIZED (DARK BLUE) DNA, WHICH WAS 
EITHER FREE (WHITE) OR PREASSEMBLED WITH RECOMBINANT H2A.V (GREEN) OR H2A.VDC (YELLOW) 
NUCLEOSOMES AFTER 15 MIN (BRIGHT RED) OR AFTER 3 H (DARK RED). ALL INTENSITIES ARE NORMALIZED 
TO THE INTENSITY OF H2A.V ON CIRCULAR H2A.V ARRAYS AFTER 15 MIN ASSEMBLY.  
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C. INFLUENCE OF ISWI REMODELING COMPLEXES ON CHROMATIN 
RECONSTITUTION 
 
All mass spectrometry analyses in this chapter were performed in collaboration with Andreas 
Schmidt by data-independent mass spectrometry analysis (SWATH). Data after mass 
spectrometry analysis of Acf1 interactors was analyzed by Tamás Schauer as follows: Protein 
intensity values were log2-transformed, median normalized and filtered by a low intensity 
threshold. Statistical analysis was performed by fitting a linear model using the limma R 
package. Moderated t-statistics were calculated by empirical Bayes moderation. For the 
identification of significantly enriched proteins, p-value cutoffs and log2-fold change cutoffs 
were applied as indicated. Heatmaps were generated using the pheatmap R package. 
 
1. IDENTIFICATION OF ACF1 INTERACTORS BY CO-IMMUNOPRECIPITATION 
 
To identify Acf1 interactors, rat monoclonal antibodies raised against an epitope in the Acf1 N-
terminus (3F1) or C-terminus (8E3) were coupled to protein G beads and incubated with DREX. 
After gentle washes, bound protein was analysed by mass spectrometry. The experiment was 
performed in seven replicates using seven different extract preparations. As a control, DREX 
was incubated with beads only. Figure 82 shows a principle component analysis, demonstrating 
a high reproducibility among the biological replicates, but striking differences between the 
depletions performed with the different antibodies. 
 
The proteins enriched after the immunoprecipitations characterized in Figure 82 are shown in 
the following heatmaps (Figure 83 and Figure 85). The Venn diagram illustrated proteins 
identified as common or antibody-specific interactors (Figure 84). 
 
 
FIGURE 82: PRINCIPAL COMPONENT ANALYSIS 
OF DREX IMMUNOPRECIPITATIONS WITH 
ANTIBODIES AGAINST THE N-TERMINUS (3F1) 
OR THE C-TERMINUS (8E3) OF ACF1. AS 
CONTROL, BEADS ONLY WERE INCUBATED WITH 
DREX. 
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FIGURE 83: ENRICHMENT OF PROTEINS IMMUNOPRECIPITATED WITH ANTIBODIES AGAINST THE N-
TERMINUS (3F1) AND THE C-TERMINUS (8E3) OF ACF1. AS CONTROL, BEADS LACKING ANTIBODY WERE 
INCUBATED WITH EMBRYO EXTRACT. INTENSITIES WERE MEASURED BY MASS SPECTROMETRY FROM SEVEN 
BIOLOGICAL REPLICATES. HIGH INTENSITIES ARE INDICATED IN RED, LOW INTENSITIES IN BLUE. THE RED 
BOX MARKS THE SIX COMMON INTERACTORS OF FIGURE 84. A FULL LIST OF PROTEINS AND THEIR 
ENRICHMENT VALUES ARE LISTED IN XI.B.3.A). 
 
 
 
 
As expected, the CHRAC complex consisting of Acf1, Iswi, Chrac14 and Chrac16 (Varga-Weisz 
et al. 1997) was pulled down with both antibodies. In addition to this, RPA2, a component of 
the RPA complex, and Ribosomal protein S29 (RpS29) were identified as common interactor in 
both immunoprecipitations (Figure 83, red box). RpS29 is a small ribosomal protein, which is 
located in the cytoplasm and in the endoplasmic reticulum. Its interaction with Acf1 therefore 
does not seem to a physiological phenomenon, as Acf1 is a nuclear protein. However, the 
interaction with Rpa2 might be physiologically relevant, as Acf1 might be able to interact with 
Ku (see VI.B) and Ku has been shown to interact with RPA in Drosophila (Guruharsha et al. 
2011). However, Ku proteins were not found enriched in the Acf1 immunoprecipitants in this 
experiment. 
In addition to the six common interactors, many interactors exclusive for the N-terminal or C-
terminal specific antibodies were identified and listed in Table 7 (also see Figure 85). 
control	 3F1 8E3
 
FIGURE 84: VENN DIAGRAM ILLUSTRATING PROTEINS 
IDENTIFIED BY IMMUNOPRECIPITATIONS WITH ANTIBODIES 
AGAINST THE N-TERMINUS (3F1) OR THE C-TERMINUS (8E3) 
OF ACF1. 33 PROTEINS WERE IDENTIFIED AS SPECIFIC 
INTERACTORS WITH ANTIBODY 3F1, 20 PROTEINS AS SPECIFIC 
INTERACTORS WITH 8E3. 6 PROTEINS WERE IDENTIFIED AS 
INTERACTORS WITH BOTH ANTIBODIES. IDENTIFIED PROTEINS 
ARE LISTED IN TABLE 7. 
 
 - Results - 
 103 
TABLE 7: IDENTIFIED INTERACTORS BY MASS SPECTROMETRY USING ANTIBODIES AGAINST THE N-
TERMINUS (3F1) OR THE C-TERMINUS (8E3) OF ACF1. 
Common interactors 
Acf1 
Iswi 
Chrac14 
Chrac16 
RPA2 
RPS29 
3F1 specific interactors 8E3 specific interactors 
 atms  
 Atu  
 CG13175  
 CG2091  
 CG3542  
 CG3909  
 CG4119  
 CG4849  
 Ctr9  
 Dyak\Ef1beta  
 Dyak\Ef1gamma  
 ecd  
 eEF1alpha1  
 eEF1delta  
 Etl1  
 His2A 
 His3 
 hyx  
 Kap-alpha1  
 Karybeta3  
 Klp10A  
 mdlc  
 mod  
 msn  
 Nap1  
 Phf7  
 pont  
 Prp8  
 Ran  
 Ranbp9  
 sle  
 Tailor  
 Vta1 
 
 Bruce  
 Cdc16  
 Cdc27  
 CG12391  
 CG13185  
 CG30122  
 CG4751  
 CG6617  
 Dyak\GE13051  
 Fcp1 
 
 ida  
 kis  
 PPP4R2r  
 puf  
 RanBPM  
 row  
 timeout  
 tou  
 Ubqn  
 woc 
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FIGURE 85: ENRICHMENT OF PROTEINS IMMUNOPRECIPITATED WITH ANTIBODIES AGAINST THE N-
TERMINUS (3F1) OR THE C-TERMINUS (8E3) OF ACF1. AS CONTROL, BEADS ONLY WERE INCUBATED WITH 
DREX. INTENSITIES WERE MEASURED BY MASS SPECTROMETRY FROM SEVEN BIOLOGICAL REPLICATES. 
HIGH INTENSITIES ARE INDICATED IN RED, LOW INTENSITIES IN BLUE. A FULL LIST OF PROTEINS AND THEIR 
ENRICHMENT VALUES ARE LISTED IN XI.B.3.A). 
control	 3F1 8E3
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To evaluate these findings, GO term analyses were performed. Common interactors (Acf1, Iswi, 
Chrac14, Chrac16) define the CHRAC complex (Varga-Weisz et al. 1997; Eberharter et al. 2001). 
In addition to that, some interactors involved in chromatin organization were identified as 
interactors with N-terminal binding antibodies, leading to the assumption that these proteins 
may rather bind to more C-terminal Acf1 sequences. One example is Nap1, a core histone 
chaperone, which has already been functionally connected to Acf1 (genetic interaction 
described in Fyodorov et al. 2004). As Nap1 is known to interact with core histones, the 
identified interactions with histones H2A and H3 might be due to indirect interactions via Nap1 
(Ito et al. 1996). Etl1 (Smarcad1 in mammals, Fun30 in yeast) is an ATP dependent helicase of 
the SNF2/SWI2 family (Fnu et al. 2011). In yeast, it has been associated with DNA damage and 
promotes DNA end resection at DSBs during DNA repair (Costelloe et al. 2012). Previous mass 
spectrometry analysis identified Atms, Ctr9 and Hyx to interact with each other in Drosophila 
(Guruharsha et al. 2011) and might therefore act in a complex to regulate transcription. 
Furthermore, other GO-terms associated with Acf1 interactors isolated with the N-terminus-
specific antibody were ‘nucleic acid metabolism’/’(m)RNA metabolism’, ‘gene expression’ and 
‘splicing’. On the other hand, the GO term associated with Acf1 interactors isolated with the C-
terminus-specific antibody was ‘ubiquitin-mediated proteolysis’. The significance of this in 
unclear and cross-reactivity of antibodies with proteins including similar sequences cannot be 
excluded.  
Unfortunately, in this experiment Ku70 and Ku80 were not detected. However, in a previous 
experiment performed in triplicates, where beads coupled to monoclonal Acf1 antibody 8E3 
against the C-terminus were analysed by mass spectrometry, Ku70 and Ku80 were identified 
and Ku80 was enriched compared to the control reaction with beads only, but due to the high 
variability among replicates, this enrichment was not significant (Figure 86). Besides this, the 
identified interactors were largely consistent with the interactors in the previous experiment. 
- Results - 
 
 106 
 
This discrepancy might be due to a very weak interaction between Ku and Acf1, why may be 
detected or not depending on the washing stringency or sample preparation. However, it has 
been shown that Ku interacts with the RPA complex, therefore the detection of Rpa2 might be 
due to some indirect interaction of RPA with Acf1 via Ku. 
 
2. DEPLETION OF ACF1 FROM DREX 
 
 To investigate the role of Iswi remodelling complexes in chromatin reconstitution, I performed 
assembly reactions with extract, which was depleted from the remodelling factor of interest, 
either by immunoprecipitating the factor of interest from wildtype DREX or by preparation of 
DREX from mutant embryos. In the following experiments, we are focusing on the accessory 
subunits of the chromatin remodelling complexes ACF and RSF, namely Acf1, and Rsf1, 
respectively. 
DREX was depleted from Acf1 by immunodepletion using rat monoclonal antibody (8E3), which 
detects and epitope in the Acf1 C-terminus (obtained from E. Kremmer (Helmholtz Center 
Munich). Depletion was performed by two rounds of immunoaffinity adsorption of extract 
protein with antibodies coupled to Protein G Sepharose 4 Fast Flow beads (GE Healthcare). As 
control, DREX of the same batch was treated in the same way, except that the beads lacked 
antibody. Figure 87 and Figure 88 shows that two rounds of immunodepletion, lead to an 
almost complete depletion of Acf1. This extract was used in the following chromatin assemblies 
to investigate the role of Acf1 in chromatin reconstitution. 
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FIGURE 86: VOLCANO 
PLOT WITH LOG10 P VAL-
UES (Y-AXIS) AND LOG FOLD 
DIFFERENCE (X-AXIS) AFTER 
COMPARISON OF PROTE-
INS IMMUNOPRECIPITATED 
WITH ANTI-ACF1 ANTIBO-
DY 8E3 VERSUS CONTROL 
FROM THREE BIOLOGICAL 
REPLICATES. KU70 (IRBP) 
AND KU80 ARE MARKED IN 
GREEN. A FULL LIST OF 
PROTEINS AND THEIR 
ENRICHMENT VALUES ARE 
LISTED IN XI.B.3.B).  
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FIGURE 88: SIGNAL INTENSITIES OF ACF1 DEPLETION WITH MONOCLONAL 8E3 ANTIBODIES OR BEADS 
ONLY (CONTROL) FROM FIGURE 87 QUANTIFIED BY IMAGE STUDIO™ LITE SOFTWARE, LI-COR 
BIOSCIENCES NORMALIZED TO THE INPUT. 
 
 
3. CHROMATIN RECONSTITUTION USING DREX IMMUNODEPLETED FROM ACF1 
 
To investigate the role of Acf1 chromatin was assembled using DREX depleted from Acf1 as 
described in VI.C.2. 
Figure 89 shows a supercoiling assay performed with control extract (+Acf1) and Acf1-depleted 
extract (-Acf1) as described in VI.A.1. In both conditions, the transformation of different states 
from relaxed to supercoiled plasmid DNA was observed over time, suggesting that Acf1 
depletion does not prevent reconstitution of nucleosomes in vitro. 
control
input
Acf1 depletion
1st 2nd SN 1st 2nd SN
Acf1
H3
FIGURE 87: DEPLETION OF 
DREX AS DESCRIBED IN THE 
TEXT. AS INPUT, EXTRACT BE-
FORE DEPLETION WAS LOA-
DED, AS WELL AS BEADS FROM 
THE 1ST ROUND AND 2ND 
ROUND OF DEPLETION, AND 
EXTRACT AFTER TWO ROUNDS 
OF DEPLETION (SN). THE 
MEMBRANE WAS PROBED 
WITH ANTIBODY AGAINST 
ACF1.  
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FIGURE 89: SUPERCOILING ASSAY AFTER IN VITRO CHROMATIN ASSEMBLY WITH ACF1-DEPLETED DREX 
FOR 10 MIN, 30 MIN, 60 MIN, AND 180 MIN. FOR INPUT, SUPERCOILED PLASMID DNA WAS USED (C). 
AFTER 10 MIN, PLASMID DNA IS IN A RELAXED STATE DUE TO TOPOISOMERASES IN THE EXTRACT.  
Previous analyses have shown by supercoiling analysis that Acf1 facilitates depositions of 
nucleosomes and considerably enhances nucleosome reconstitution in an in vitro reaction 
composed of recombinant DNA, purified histone octamers, and recombinant Nap1 in presence 
or absence of recombinant Acf1 (Ito et al. 1999; Khuong et al. 2017; Fei et al. 2015; Torigoe et 
al. 2013). However, this effect was not observed here after Acf1 depletion, which might 
indicate that either the function of Acf1 was taken over by another factor in the extract or 
residual Acf1 after depletion was sufficient to deposit nucleosomes to a similar extent onto the 
recombinant DNA. To investigate the regularity of the nucleosome fiber after chromatin 
reconstitution with Acf1-depleted extract as described in VI.C.2, I performed limited MNase 
digestion. However, the quality of MNase ‘ladders’ obtained for control extract, as well as for 
Acf1-depleted extract, were poor. It is possible, that unspecific binding of Acf1 or another 
factor to the control beads leads to its depletion in the control extract, which results in a 
restrained formation of properly spaced nucleosome fibers. 
To see, if Acf1 has an effect on the incorporation of H2A.V, I preformed chromatin 
reconstitution with control or depleted extract on either preassembled arrays of recombinant 
H2A-bearing nucleosomes or on nucleosome-free DNA, both immobilized to paramagnetic 
beads, to enable chromatin purification after assembly. Western blot analysis against 
incorporated H2A.V did not show significant differences in the levels of H2A.V incorporation, 
neither in the case of free DNA, where chromatin is reconstituted from endogenous factors, 
nor in the case of preassembled H2A arrays, where H2A-containing nucleosomes could 
potentially be replaced by H2A.V-containing nucleosomes. Similarly, no difference in H2A.V 
turnover was observed after incubation with preassembled H2A.VE, the phospho-mimetic form 
of H2A.V.  
In addition to this, phosphorylation levels were not altered on chromatin assembled with Acf1-
depleted extract, either because Acf1 is not involved in turnover of H2A.V after 
phosphorylation as suggested by previous experiments (discussed in III.B.6) or because 
phosphorylation of newly incorporated unphosphorylated H2A.V happens to the same extent 
as phosphorylated H2A.V is removed from chromatin. Unfortunately, as already mentioned in 
VI.A.5, it was not possible to distinguish preassembled recombinant and newly deposited 
endogenous H2A.V from the extract, as the reconstitution of 3xFlag-tagged H2A.V 
nucleosomes failed. 
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FIGURE 90: CHROMATIN ASSEMBLY WITH ACF1-DEPLETED EXTRACT (- ACF1) OR CONTROL EXTRACT 
(+ACF1) ON FREE DNA (LEFT) OR ON PREASSEMBLED ARRAYS OF RECOMBINANT H2A (LEFT AND RIGHT), 
H2A.V OR H2A.VE NUCLEOSOMES (RIGHT). MEMBRANES WERE PROBED WITH ANTIBODIES AGAINST 
ACF1, ISWI, H2A.V, gH2A.V, H3, AND H4. 
In contrast to this bulk analysis, however, ChIP-qPCR on chromatin assembled by Acf1-depleted 
extract showed an effect on H2A.V levels upon Acf1 depletion (Figure 91). Here, levels of H2A.V 
and gH2A.V were decreased on chromatin reconstituted with Acf1 depleted extract versus 
chromatin reconstituted with control extract after normalization to input DNA. The experiment 
was performed in triplicates using three independent extract preparations as biological 
replicates and isolated DNA was analysed by qPCR targeting different loci at the control 
FlyFos019829 or at the linearized FlyFos019611. To our surprize, H2A.V and gH2A.V levels were 
increased upon Acf1 depletion at all tested loci. To exclude the possibility of a general effect 
due to altered ChIP efficiencies caused by changes in chromatin structure upon Acf1 depletion, 
I examined the levels of histone H4 acetylation on lysine 16 (H4K16ac) upon Acf1 depletion, as 
this modification is assumed to be Acf1-independent. As expected, levels of H4K16ac were 
comparable in both conditions (Figure 92). It is therefore possible that Acf1 has modest effects 
on the H2A.V levels in chromatin, but Western Blot analysis might not be sensitive enough to 
identify the effect. The mechanism, through which Acf1 could influence the amount of 
incorporated H2A.V is still elusive.  
 
 
H2A.V
H4
Acf1
Acf1-+ -+
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FIGURE 91: CHIP-QPCR ON CHROMATIN ASSEMBLED WITH ACF1-DEPLETED EXTRACT AND WITH 
CONTROL EXTRACT ON CIRCULAR CONTROL FLYFOS019829 AND ON LINEARIZED FLYFOS019611. 
REGIONS 500 BP, 1500 BP, AND 3000 BP FROM THE BREAK AS WELL AS A DISTAL REGION ON THE LINEAR 
FLYFOS019611 WERE ANALYZED. AS A CONTROL, A REGION ON THE CIRCULAR FLYFOS019829 WAS 
INCLUDED. ANTIBODIES AGAINST H2A.V, gH2A.V, AND ACF1 WERE USED. % OF INPUT WAS 
DETERMINED AND RATIOS OF ACF1-DEPLETED EXTRACT TO CONTROL EXTRACT WERE PLOTTED. ERROR 
BARS SHOW STANDARD DEVIATIONS FROM THREE BIOLOGICAL REPLICATES USING THREE DIFFERENT 
EXTRACT PREPARATIONS. 
 
 
FIGURE 92: CHIP-QPCR ON CHROMATIN ASSEMBLED WITH ACF1-DEPLETED EXTRACT AND WITH 
CONTROL EXTRACT ON CIRCULAR CONTROL FLYFOS019829 AND ON LINEARIZED FLYFOS019611. % OF 
INPUT IS SHOWN ANALYZING A REGION 500 BP FROM THE BREAK AS WELL AS A DISTAL REGION ON THE 
LINEAR FLYFOS019611. AS A CONTROL, A REGION ON THE CIRCULAR FLYFOS019829 WAS INCLUDED. 
ANTIBODIES AGAINST gH2A.V AND H4K16AC WERE USED. TO CONTROL FOR UNSPECIFIC BINDING TO 
THE BEADS, A BEAD-ONLY CONTROL WITHOUT ANTIBODY WAS INCLUDED. 
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To analyse the effect of Acf1 depletion on chromatin composition, chromatin was reconstituted 
on immobilized DNA in control extract or Acf1-depleted extract, purified on the magnet and 
bound proteins analysed by mass spectrometry. As an input reference, control extract and 
Acf1-depleted extract were analysed before addition of DNA. Figure 93 shows a sector of a 
heatmap after clustering similarly affected hits together. All measurements were performed in 
duplicates, using different extract preparations as biological replicates. As expected, Iswi, the 
ATPase subunit of ACF, was strongly co-depleted in the input as well as in the chromatin 
samples. In addition to this, in both replicates DNApol-α180, was strongly depleted in the input 
samples. DNApol-α180 is a polymerase, which has been linked to the NHEJ repair pathway 
(Flybase.org; 27.12.2017), like the Ku complex, which is consistent with our hypothesis, that 
Acf1 might have a functional interaction with Ku and might be involved in DNA damage repair. 
Co-depletion of CG5757 (unknown function), CG14476 (Glucosidase subunit) and rump (mRNA 
localization) was consistent in both replicates, however, there was no obvious functional 
connection (Flybase.org; 27.12.2017).  
Analysis of chromatin-associated factors revealed that ACF (consisting of Acf1 and Iswi), 
CG8142, Gnf1, and the Ku complex (Irbp and Ku80) were decreased on chromatin samples. 
CG8142 and Gnf1 are involved in replication (Flybase.org; 27.12.2017). Interestingly, while the 
reduced recovery of Acf1 and Iswi in chromatin is due to their depletion in the input extract, 
the reduced association of the Ku complex with chromatin cannot be explained in this way 
since the co-depletion is not efficient. This leads to the assumption that Ku association to 
chromatin might be connected to Acf1. It might be possible that the remodelling function of 
ACF is required for efficient recruitment of Ku, as already postulated in mammals (Lan et al. 
2010). In contrast, some factors, which are depleted in the input samples, are recruited to 
chromatin at similar levels. Examples are CG14476, CG5757 and rump, and also recruitment of 
DNApol-α180 to chromatin was not significantly affected upon Acf1 depletion. This observation 
might be explained by a saturated pool of these factors at this embryonic stage, where most 
chromatin factors are available in excess to be equipped for the very rapid initial 
preblastodermal replication cycles during embryo development (Mahowald & Hardy 1985). 
- Results - 
 
 112 
 
FIGURE 93: HEAT MAP OF PROTEINS ASSOCIATED WITH CHROMATIN ASSEMBLED FROM ACF1-DEPLETED 
EXTRACT (-ACF1) OR CONTROL EXTRACT (+ACF1). AS INPUT, EXTRACT BEFORE ASSEMBLY WAS ANALYZED. 
INTENSITIES WERE MEASURED BY MASS SPECTROMETRY FROM TWO BIOLOGICAL REPLICATES. 
RSF, a complex consisting of Iswi and Rsf1, has been shown to be involved in the incorporation 
of H2A.V during heterochromatin formation (Hanai et al. 2008). To test, if Rsf1, the accessory 
subunit, has an influence on H2A.V incorporation in the in vitro system, chromatin was 
reconstituted with an extract prepared of Rsf1-mutant embryos (Rsf1-mutant DREX). Figure 94 
shows a Western blot analysis of Rsf1-mutant DREX in comparison with wt DREX and Schneider 
cell extract. In Rsf1 mutant DREX, no band for Rsf1 was detected. However, lower bands in the 
Rsf1-mutant extract were recognized, which could be unspecific or degradation products of 
Rsf1.  
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However, incorporation of H2A.V in vitro was not altered in the absence of Rsf1. To exclude, 
that the Iswi-containing complexes ACF and RSF could exhibit redundant functions, Rsf1 mutant 
extract was depleted of Acf1 as described before. However, chromatin assembly using Rsf1 
mutant extract depleted from Acf1 did not show any differences in H2A.V levels, suggesting 
that neither Rsf1 nor Acf1 are involved in H2A.V incorporation and that both remodelling 
factors do not exhibit redundant functions in the incorporation of H2A.V. 
 
 
  
 
4. CHROMATIN ASSEMBLY USING DREX PREPARED FROM ACF1- MUTANT EMBRYOS 
 
For a better interpretation of the function of Acf1 on chromatin and to eliminate the influence 
of co-depleted factors, DREX from acf1 null mutant embryos were prepared. As expected and 
already shown for Acf1-depleted extract, limited MNase digestion revealed a lack of 
nucleosome fiber regularity in the absence of Acf1, confirming that Acf1, and not any co-
immunoprecipitated factor is responsible for the establishment of regular chromatin arrays. 
This was confirmed in a rescue experiment, were addition of recombinant ACF rescued the 
S2 cells wt DREX
Rsf1
Rsf1 KO DREX
SN beads
wt Rsf KO wt Rsf KO
- + - + - + - + Acf1
Acf1
H2A.V
H4
FIGURE 94: EXTRACT 
OBTAINED FROM DROSO-
PHILA SCHNEIDER CELLS (S2 
CELLS), DREX FROM WILD-
TYPE (WT DREX) AND FROM 
RSF1 MUTANT EMBRYOS 
(RSF1 KO DREX) WAS 
ANALYZED BY WESTERN BLOT 
IN THREE DIFFERENT CON-
CENTRATIONS. THE MEM-
BRANE WAS PROBED WITH 
ANTIBODY AGAINST RSF1. 
 
 
FIGURE 95: CHROMATIN 
ASSEMBLY USING WILD-
TYPE (WT) OR RSF1 MU-
TANT (RSF KO) EXTRACT 
EITHER DEPLETED FROM 
ACF1 (-ACF1) OR IN PRE-
SENCE OF ACF1 (+ACF1). 
SUPERNATANT (SN) AND 
CHROMATIN (BEADS) 
WERE LOADED. MEM-
BRANES WERE INCU-
BATED WITH ANTIBODIES 
AGAINST DOMB, ACF1, 
H2A.V, AND H4.  
 
 
- Results - 
 
 114 
regularity to some extent. However, in contrast to this, DREX prepared from Rsf1- embryos did 
not show a defect in the establishment of regular nucleosome arrays.  
  
FIGURE 96: LIMITED MNASE DIGESTION FOR 15 SEC, 30 SEC, AND 90 SEC AFTER IN VITRO CHROMATIN 
RECONSTITUTION WITH CONTROL EXTRACT, ACF1 MUTANT EX-TRACT (ACF1-) OR ACF1 MUTANT EXTRACT 
SUPPLIED WITH RECOMBINANT ACF (ACF1 RESCUE) AND ANALYSIS OF PURIFIED DNA AFTER GEL 
ELECTROPHORESIS. 
 
 
FIGURE 97: LIMITED MNASE DIGESTION FOR 15 SEC, 30 SEC, AND 90 SEC AFTER IN VITRO CHROMATIN 
RECONSTITUTION WITH CONTROL EXTRACT, ACF1 MUTANT EXTRACT (ACF1-) OR RSF1 MUTANT EXTRACT 
(RSF1-) AND ANALYSIS OF PURIFIED DNA AFTER GEL ELECTROPHORESIS. 
 
Dhawal Jain, a former PhD student in our lab, identified regions of regularly phased nucleosome 
arrays in the Drosophila genome and discovered, that some of these regions depend on the 
presence of Acf1. These regions share a common motif, characterized by a central ATACG 
sequence (Baldi et al. 2018). To see, if this data from in vivo analysis of 2-8 h old embryos can 
be reproduced in vitro, I performed chromatin reconstitution on genomic DNA with wt and 
acf1- DREX. After assembly, DNA was fragmented by MNase digestion and purified. Sando Baldi 
in our lab established a nucleosome dyad density map by NGS. The following results were pre-
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published in Baldi et al. 2018. In Figure 98 reads obtained from Next generation sequencing 
were aligned around the ATACG motifs. Chromatin assembled by wt DREX showed extensive 
regular phased nucleosome arrays around the motif with about 4-5 nicely positioned 
nucleosomes on either site. In absence of Acf1, however, the nucleosomes flanking the motif 
remained well positioned but the remaining nucleosomes did no longer form regularly spaced 
arrays. This effect was partially rescued by addition of recombinant ACF, leading to well 
positioned regions around the motif with about 2-3 nucleosomes on each site. 
 
FIGURE 98: CHROMATIN ASSEMBLY ON GENOMIC DNA FROM DROSOPHILA BG3-C2 CELLS USING DREX 
FROM WILDTYPE EMBRYOS (WT DREX) OR FROM ACF1 MUTANT EMBRYOS IN ABSENCE (ACF1 DREX) OR 
PRESENCE (ACF1 DREX + ACF) OF RECOMBINANT ACF. READS AFTER MNASE-SEQ WERE ALIGNED TO 
THE ATACG SITES (TOP) OR TO SU(HW) BINDING SITES (BOTTOM). FIGURE FROM BALDI ET AL. 2018. 
The mechanism of nucleosome spacing is not yet fully understood. however, it is assumed that 
insulator proteins act as alignment to position nucleosomes in respect to the insulator protein 
(Fu et al. 2008). Examples for Drosophila insulators are Su(Hw), Ctcf, Beaf and Gaga (J. Yang & 
Corces 2012). Figure 98 shows the reads after MNase-Seq from chromatin assembled in 
presence or absence of Acf1 were aligned to the binding motif of Su(Hw). Interestingly, a similar 
effect as for the alignment to the ATACG motif can be observed: nucleosome arrays are 
obtained in an Acf1-dependent manner and the decline in regularity of nucleosome arrays in 
acf1- mutants can be rescued by addition of recombinant ACF. Furthermore, similar to the 
situation at the ATACG motif, nucleosomes flanking the Su(Hw) binding site are not affected 
and remain positioned in wt and acf1- conditions. To summarize, Acf1 seem to be required for 
the formation of regularly spaced nucleosome arrays.  
However, the respective protein which binds to the ATACG motif and constitutes a boundary 
against which ACF can phase nucleosomes is not yet known. To identify this protein, 
recombinant DNA including the ATACG motif was prepared by Sandro Baldi and immobilized to 
paramagnetic beads. Subsequently, chromatin assembly reactions were performed and 
chromatin assembled on these motifs was isolated for mass spectrometry in collaboration with 
Falk Butter in Mainz. As a negative control, recombinant DNA with mutated ATACG regions was 
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used. Interestingly, one hit was identified as an ATACG binding protein, CG7372 (termed 
Phaser), a zinc finger-containing protein. To confirm the obtained data, Sandro Baldi performed 
knock down experiments in Drosophila Schneider cells and analysed the effect of nucleosome 
array formation at Su(Hw) and ATACG sites upon knock down of Su(Hw), and Phaser, 
respectively. Interestingly, he observed that array formation around Su(Hw) binding sites, and 
ATACG motif sites, depends on Su(Hw), and Phaser, respectively (Figure 99). In addition to this, 
in both cases, knock down of Acf1 remarkably dampened the establishment of regular arrays 
around these sites (not shown).  
 
 
FIGURE 99: MNASE-SEQ PROFILES FROM DROSOPHILA SCHNEIDER CELLS AFTER KNOCK DOWN (KD) OF 
GST AS A CONTROL, AS WELL AS SU(HW) AND CG7372. READS AFTER MNASE-SEQ WERE ALIGNED TO 
THE ATACG SITES (TOP) OR TO SU(HW) BINDING SITES (BOTTOM) FIGURE FROM BALDI ET AL. 2018. 
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VII. DISCUSSION 
 
A. DNA REPAIR IN DROSOPHILA EMBRYOS 
 
Preblastoderm Drosophila embryos contain high levels of maternally deposited factors, which 
have the ability to reconstitute chromatin in vitro on recombinant DNA in presence of an ATP-
regenerating buffer (Becker & Wu 1992). The in vitro chromatin assembly system has been 
useful to uncover novel principles once before; the nucleosome sliding factors NURF, CHRAC 
and ACF have been identified in it and purified from it (Tsukiyama & Wu 1995; Varga-Weisz et 
al. 1997; Ito et al. 1997). In this thesis, I applied this in vitro chromatin assembly approach to 
dissect processes at free DNA ends. I showed, that this system is able to recognize free DNA 
ends and to initiate a DNA damage response.  
To efficiently repair DNA by NHEJ, the Ku complex and DNA-PKcs were shown to be essential 
to join and Lig4, Xrcc4, and Xlf to ligate the DNA ends in mammals. These factors are called the 
core factors, which are required for efficient DNA ligation in vitro (Ogiwara & Kohno 2011). 
Besides this, an alternative NHEJ pathway exists, also named microhomology-mediated end 
joining, which can occur in the absence of Ku and DNA-PK (Katsura et al. 2007). However, in 
this pathway, besides the presence of short homology stretches of a few base pairs, other 
factors are required, namely Fen1, Lig3, Mre11, Nbs1, Parp1 and Xrcc1 (Sharma et al. 2015). 
For HR, important factors in mammals are the MRN complex, CtIP, Exo1, Blm, and Dna2 (Liu & 
J. Huang 2016). In this in vitro system, I was able to identify Lig4, Fen1, Mre11, Nbs1 and Parp1 
enriched at free ends. However, Xrcc4, Lig3, Xlf, Exo1, Dna2 and Xrcc1 were not identified in 
this study, even though these proteins exist in Drosophila (flybase.org, 05.06.2018). 
Furthermore, DNA-PKcs and CtIP have not been identified in Drosophila. Blm was shown to be 
required for HR in Drosophila (Adams et al. 2003). In our experiments, Blm was identified as an 
interactor with H2A.V nucleosomes (but not recruited to H2A.VDC) but was not enriched at 
DNA breaks. It is possible that (the C-terminus of) H2A.V presents a recruitment platform of 
Blm but requires additional damage-associated factors to be stably recruited at the break site 
in Drosophila. In mammals, Blm was shown to be recruited in two phases, in an early phase 
together with the MRN complex, ATM, and gH2A.X and in a late phase with Xrcc4 and Rad51. 
Furthermore, recruitment of Blm was shown to be dependent on MRN and ATM (Tripathi et al. 
2018). In our mass spec data, MRN was only enriched after 3 h and only showed a slight 
preference for free ends (which might be due to the damage reaction initiated by H2A.V 
phosphorylation on the fragment immobilized at both ends, discussed in VII.D). ATM (Tefu in 
Drosophila) was not enriched at breaks. In Drosophila, the recruitment of Blm is not yet well 
understood. However, it is possible, that in Drosophila Blm recruitment to breaks depends on 
ATM and MRN and was therefore not observed in our study. 
In contrast to extracts obtained from Drosophila, Xenopus extracts are obtained from oocytes 
(Glikin et al. 1984). In addition, Xenopus extracts exhibit autonomous cell cycles (Hara et al. 
1980; Blow & Laskey 1986; Hutchison et al. 1987; Murray & Kirschner 1989). Drosophila 
preblastodermal embryo extracts represent a combination of cell cycle states. These are in 
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particular M- and S-phase, as G-phases are omitted in the first cell divisions during Drosophila 
development (reviewed in Farrell & O'Farrell 2014). This implies that cell cycle-dependent 
processes like the DNA repair pathway choice cannot be reproduced in this in vitro system. 
Instead, it can be assumed, that combinations of repair processes occur in parallel, which would 
be separated in vivo. For example, resection performed as a step prior to HR is regulated by 
cyclin-dependent kinases (reviewed in Kakarougkas & Jeggo 2014; Aparicio et al. 2014; 
Chapman et al. 2012; Shibata 2017; Ceccaldi et al. 2016)). In mammals, it has been shown that 
the damage-associated complexes Ku and MRN are recruited to DSBs with in the first seconds 
to minutes (Aleksandrov et al. 2018; Kochan et al. 2017; G. Yang et al. 2018) and it has been 
shown that MRN and Ku can accumulate at the same break (Britton et al. 2013). 
If DNA repair is accomplished by HR, Ku, which generally initiates the NHEJ pathway, is removed 
from DSBs by post-translational modification and proteasomal (K.-J. Lee et al. 2016; Shibata 
2017). However, in our mass spectrometry analysis, we detected Ku associated to DNA for 
hours and additionally observed an enrichment of the ssDNA-binding protein RPA at the free 
ends, which is recruited to resected DNA during HR. This co-occupation of HR-and NHEJ-specific 
complexes at the same time suggests that the cell-cycle-dependent pathway choice is not 
accomplished in this in vitro system. Strikingly, Ku was shown to inhibit resection and is 
therefore believed to have a regulatory function in the initiation of resection (Mimitou & 
Symington 2010). However, if DNA end resection was inhibited by Ku, RPA binding would have 
been constrained. Nevertheless, it is possible, that instead of Ku dissociation, the postulated 
translocation of Ku away from the break allowed DNA end resection. 
Preblastodermal Drosophila embryos undergo rapid cell divisions, with the first 14 cell divisions 
performed in about 1.5 hours. To achieve this, the cell cycle is shortened by omitting the gap 
phases and shortening the S phases (Farrell & O'Farrell 2014). Therefore, the processes have 
to be highly efficient and it could be assumed, that the cell does not spend much time on 
elaborate repair processes but eliminates nuclei affected by DNA damage via apoptosis.  
Intriguingly, the H2A.V phosphorylation signal was not removed within the investigated time 
frames of up to six hours. It has been shown, that H2A.X phosphorylation persists if DSBs are 
not repaired (Chowdhury et al. 2005; Goodarzi et al. 2008; Eberlein et al. 2015). We therefore 
hypothesized, that DSBs were not efficiently repaired in this in vitro system. For this purpose, 
chromatin was assembled on linearized DNA fragments and purified for further analysis by gel 
electrophoresis and PCR. To answer this, I performed PCR-based experiments to identify 
ligation products after chromatin assembly on linearized DNA fragments. I then isolated the 
DNA and performed PCR reactions with primers flanking the break site and only amplifying 
after re-ligation of the linearized fragment. However, I was not able to detect an amplification 
product, either because ligation was not accomplished by the extract, or because resection of 
the free ends by the extract prevented primer annealing or amplification of the PCR product. 
Intriguingly, Lig4 was detected in our analysis and was reported to be highly flexible and able 
to detect DNA ends in any composition (Lieber 2010), but may be inactive in DREX. It has also 
been suggested that the removal of the H2A.X phosphorylation mark may signal the 
accomplishment of a certain repair step and to regulate the process of repair, instead of 
representing the successful repair (Keogh et al. 2006; Moon et al. 2010). Further work is 
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required to determine how far the repair process proceeds in the preblastoderm chromatin 
system. 
 
B. THE ROLE OF KU IN THE DNA DAMAGE RESPONSE 
 
Besides the MRN complex, Ku is an important DSB sensor and recruited to break sites within 
seconds (G. Yang et al. 2018; Aleksandrov et al. 2018), where it serves as a scaffold protein for 
other damage-associated proteins and helps to link broken DNA ends together. Furthermore, 
there is increasing evidence, that Ku also has functions in the regulation of the DNA damage 
response by influencing the activity of ATM or affecting apoptosis (reviewed in Fell & Schild-
Poulter 2015). Ku was shown to be loaded onto DNA as a ring composed of the Ku70 and Ku80 
subunits. However, how Ku is associated to DNA is not clear. One hypothesis, resulting from in 
vitro studies and the ring-shaped structure of Ku, suggests that Ku is loaded at the break and 
slides along DNA away from the break (de Vries et al. 1989; Walker et al. 2001). With this 
mechanism, sequential loading of several Ku proteins per break site would be possible. 
However, high-resolution immunofluorescence imaging in mammalian cells revealed, that only 
one Ku complex per break site is loaded and joined quickly to connect the DSB (Britton et al. 
2013). To investigate the importance of Ku in the DNA damage response, I tried to deplete the 
extract from Ku by immunodepletion with monoclonal antibodies generated in this thesis or by 
incubating the extract with an excess of immobilized DNA fragments including free DNA ends.  
However, both approaches were not efficient enough to remove considerable amounts of Ku 
from the extract. It was therefore not possible to investigate the Ku-dependence of processes 
in the DNA damage response. However, it has been shown in previous studies that Ku binding 
to DNA ends is required for the recruitment of many factors, like DNA-PKcs or Lig4, Xlf and Xrcc 
forming the ligase complex, or other proteins like Mdc1 or Nbs1 of the MRN complex or Parp1 
(reviewed in Fell & Schild-Poulter 2015). In addition to this, Ku was shown to interact with Acf1 
(Lan et al. 2010; Chiu et al. 2017). 
It is likely that this interaction facilitates the recruitment of remodeling complexes to the DSB 
to remodel chromatin at the break site. The recruitment of chromatin remodelers to DSBs, 
which function in the sliding or eviction of nucleosomes, in the exchange of histones and its 
variants have been investigated in several studies (reviewed in Rother & van Attikum 2017; 
Jeggo et al. 2017). To investigate, if, due to this interaction, Acf1 is enriched at DSBs in vitro, I 
performed ChIP-qPCR analysis using monoclonal and polyclonal antibodies against the C-
terminus of Acf1, but no enrichment of Acf1 at DNA ends was observed. However, ACF is highly 
abundant in the extract and only a fraction of approximately one sixth to one seventh is 
incorporated into chromatin. We therefore wondered, if this excess of Acf1 could conceal a 
possible specific recruitment and repeated the CHIP experiment after titration of DREX. With 
this approach, we observed a significant enrichment of Acf1 at DNA ends (500 bp and 1500 bp 
from the break, see Figure 78), but this observation was not reproducible with the polyclonal 
antibody, which only showed a minor enrichment. In vivo, Acf1 enrichment at breaks has been 
observed in mammals (Lan et al. 2010). It may be, that binding of Acf1 to DNA ends is not direct 
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but mediated through other proteins. However, Acf1 is known as a general nucleosome spacing 
factor (Jain, Baldi, Zabel, Straub & Becker 2015; Scacchetti et al. 2018) and is therefore 
presumably also recruited to interior sites away from DNA breaks.  
Removal of Ku is mediated via ubiquitylation and degradation via the proteasome (Postow 
2011; Brown et al. 2015). In our in vitro system, Ku remained associated to the DNA, as 
demonstrated by Western blot analysis. However, ChIP-Seq profiles revealed, that the 
accumulation of Ku in proximity to the break is no longer detectable after 3 h. This striking 
observation could be either due to a possible translocation of Ku away from the break site (see 
above) or due to decreased ChIP efficiencies after epitope-masking by ubiquitylation. 
 
C. DNA END RESECTION AND THE INVESTIGATION OF SSDNA IN VITRO  
 
In this thesis, I showed by ChIP-qPCR, that Ku can be detected at regions 500 bp away from the 
break site and ChIP-seq analysis confirmed a sharp peak of Ku at early time points (10 min after 
addition of DREX). This finding is in line with previous findings, showing that Ku forms sharp 
peaks at break sites (Britton et al. 2013). However, histones H3 and H2A.V decreased at these 
sites, suggesting that nucleosomes were removed by remodeling or eviction, which is in line 
with previous findings, showing that Ku binds to nucleosome-depleted regions (Britton et al. 
2013). 
It is also possible, that the loss of signal for H2A.V and H3 is due to the loss of DNA through 
nucleases in the extract that may degrade one DNA strand in reactions reminiscent of 
resection, or both strands. The wrapping of ssDNA around histone octamers has been observed 
in vitro (Palter et al. 1979; Adkins et al. 2017), but the existence of nucleosomes on ssDNA in 
vivo is still controversial (Adkins et al. 2017; T.-H. Huang et al. 2018). 
Interestingly, I reproducibly identified the RPA complex specifically enriched at free ends after 
3 h of incubation, but not after 15 min. A plausible explanation for this would be that nucleases 
in the extract resect the DNA ends, leading to the recruitment of RPA to the remaining ssDNA. 
The delayed enrichment of RPA at free ends indicates that this is a slow and maybe well 
controlled event, which serves the purpose to prepare the DNA ends for the homologous 
recombination repair pathway. Analysis of linearized purified DNA after assembly by gel 
electrophoresis also revealed a smear instead of a clear band, suggesting that DNA ends were 
processed by endogenous nucleases.  
In line with this, ChIP-Seq data of input DNA after fragmentation with MNase or Covaris showed 
a loss of signal covering a region of 0.8-2 kb around the break site. Due to the nature of library 
preparation for DNA sequencing, where adapters are ligated to double-stranded DNA 
fragments only, signals can only be obtained from dsDNA, not from ssDNA. Possibly, the 
discrepancies between qPCR data of Ku, where signals were obtained 500 bp from the break, 
and sequencing data, where input signals are decreased at this area, can be explained by the 
differential detection of single-stranded DNA with either method. Therefore, it could also be 
possible, that the generation of ssDNA counteracts the existence of nucleosomes, but still 
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allows Ku to bind. However, it has been shown, that the affinity of Ku to ssDNA is much lower 
compared to dsDNA (Ono et al. 1994). 
To test for the presence of ssDNA around the break sites, I purified chromatin from embryo 
extract and treated it with several ss-specific exonucleases, like Mung bean nuclease and ExoI. 
Afterwards, fragments were probed by PCR, only amplifying fragments, which were not 
targeted by the nucleases (dsDNA). With this approach, no difference compared to the input 
DNA before resection and therefore no enrichment of ssDNA around the break was identified. 
I then performed ChIP experiments after addition of recombinant RPA (kind gift from Christoph 
Kurat, BMC Munich), to isolate ssDNA. Again, no ssDNA was identified. In Drosophila 
melanogaster, 48 genes are annotated with the GO term ‘single strand-binding’, encoding for 
proteins like Brca2, subunits of DNApol-alpha, Ercc1, Rad50, Rad51, RPA, Xpc (mus201 in 
Drosophila), or Xrcc2 (flybase.org, 29.05.2018). Of those, I detected Rad50 and RPA at breaks 
and found mus201 generally associated with chromatin (but not at breaks) after in vitro 
reconstitution. Therefore, it may well be that these proteins shield the ssDNA and therefore 
prevent binding of RPA to DNA. To circumvent this problem, DNA was purified after incubation 
with DREX, fragmented with AluI, and incubated with recombinant RPA. However, ChIP using 
calmodulin-coupled beads to isolate the calmodulin-binding tag fused to RPA did not lead to 
the isolation of ssDNA fragments. However, due to the lack of true positive controls, I could not 
exclude that the RPA prep was non-functional under the applied conditions. 
As an alternative approach, I used ApoI as a double-strand-specific nuclease (Langerak et al. 
2011). Using amplicons consisting of either dsDNA or ssDNA, I was able to confirm the 
functionality and specificity of the enzyme. However, unexpectedly, no ssDNA could be 
detected. To sum up, ChIP data (ChIP-qPCR and ChIP-seq) as well as the detection of a single-
strand-specific protein complex RPA support the hypothesis of DNA end resection, creating 
ssDNA around the break site. Experiments to specifically detect ssDNA did not confirm this 
observation. One possibility is that the data supporting the presence of ssDNA were misleading. 
Another possibility could be that ssDNA cannot be detected in vitro, due to secondary 
structures or other technical issues. 
 
D. DETECTION OF DAMAGE-SPECIFIC CHANGES IN RECONSTITUTED CHROMATIN  
 
To analyze chromatin-associated factors, recombinant DNA was immobilized to facilitate 
purification of chromatin after assembly in vitro. I tethered a linear plasmid either by one end 
(oeb) or at both ends (beb) through a biotin-streptavidin linkage, hoping that the tethered ends 
would be inaccessible to the DNA damage recognition system as described (Postow et al. 2008). 
While this was true for Ku binding, the beb chromatin still collected gH2A.V, showing that the 
end was still recognized. As a control for proteomic analysis one would ideally like to use a 
circular DNA. However, it was not possible to tag intact circular DNA for chromatin purification, 
as insertion of biotinylated nucleotides already resulted in the initiation of a DNA damage 
response, revealed by the phosphorylation of H2A.V. Other approaches to purify chromatin on 
circular plasmids were tried, for example isolation via GST-LexA using a plasmid with a LexA 
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binding site (Hamperl et al. 2014). However, isolation of chromatin with via GST-LexA was 
inefficient, either due to poor binding of LexA to its binding site or due to inefficient purification 
of GST-LexA on glutathione beads. Another approach was to immunopurify chromatin with 
antibodies against histones. However, this approach was also very inefficient, most likely due 
to the excess of a soluble histone pool competing for the incorporated histone pool. 
Precipitation of chromatin with MgCl2 (Ritzi et al. 1998) or absorption to hydroxylapatite 
(Hilbrig & Freitag 2011) did not lead to the desired result as high protein concentrations in the 
extract led to enormous co-precipitation of proteins. Another approach tried was size-exclusion 
chromatography using columns prepared of Sephacryl from S-400 to S-1000. Chromatin 
reconstituted on plasmids exhibit a molecular weight of about 4 MDa (calculation performed 
on the assumption of 15 nucleosomes on a pUC18 plasmid of about 2.7 kb with 262 kDa per 
nucleosome (PlopperRensselaer Polytechnic Institute George Plopper 2014); no additional 
chromatin-associated proteins included). However, chromatin remodeling complexes are huge 
and have been shown to exhibit molecular weights in a similar range (e.g. Dom/Tip60 with 
> 2 MDa (Ruhf et al. 2001) leading to a vast amount of background, as judged from the control  
SEC lacking a chromatinized plasmid. Another limitation of this approach was the volume, 
which should not exceed 10% of the column volume for good resolution. Chromatin assembly 
reactions contain 1 µg DNA in 120 µL volume. It turned out that fractions containing the DNA 
did not contain sufficient concentrations of nucleosomes for further analysis by mass 
spectrometry, shown by Coomassie staining of gels containing the fractions of interest.  
To summarize, it was not possible to isolate chromatin for mass spectrometry analysis in a way 
other than coupling via biotin-streptavidin linkage. This means, that it was not possible to 
generate a purified chromatin sample which did not induce H2A.V phosphorylation. However, 
this drawback allowed us to distinguish between a phosphorylation-dependent or a DNA end-
dependent recruitment. 
 
E. THE ROLE OF H2A.V PHOSPHORYLATION 
 
The initial phosphorylation of H2A.X is performed by ATM, which is recruited by the DSB sensor 
complex MRN, or DNA-PK, which consists of the early DSB sensor complex Ku and DNA-PKcs 
(Barnum & O'Connell 2015; Kinner et al. 2008; J.-S. Kim et al. 2005). Phosphorylation of H2A.X 
is reported to be one of the first marks at DSBs and believed to serve as an anchor for DNA 
damage protein containing the BRCT domain, which recognizes phosphorylated proteins like 
gH2A.X (Kobayashi 2004). Examples for proteins with BRCT domains are Parp1, Brca1, 53BP1, 
Mdc1 or Nbs1 (Leung & Glover 2011). Indeed, Parp1 and Nbs1 were identified on in vitro 
reconstituted chromatin. Mdc1 (mu2 in Drosophila) is present in DREX but was not identified 
as a chromatin-associated factor, conceivably because it is recruited only transiently or in low 
stoichiometry (House et al. 2014; Blackford & Jackson 2017), also see Figure 8). 
However, it has been shown in mammals, that in the absence of (phosphorylated) H2A.X, Nbs1, 
53BP1 and Brca1 are still recruited to the break (Celeste, Fernandez-Capetillo, et al. 2003). In 
addition to this, Ku was also reported to be recruited to free DNA in vitro (Blier et al. 1993; 
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Downs & Jackson 2004; Radhakrishnan & Lees-Miller 2017; Anisenko et al. 2017), which is 
consistent with my observations, that Ku recruitment does not depend on histone 
modifications or variants. Therefore, it can be assumed that Ku recruitment does not depend 
on gH2A.V. For the other proteins, however, we were not able to address this question, as it 
was not possible to satisfactorily purify intact DNA without inducing the phosphorylation 
cascade (see above). 
ATM was shown to be activated after addition of phospho-mimetic H2A.XE, a mutant, which 
mimics the phosphorylated form of H2A.X and can constitutively activate the DNA damage 
response (Kobayashi et al. 2009). To see, whether the phosphorylation mark is sufficient to 
trigger the initiation of the damage response including the spreading of H2A.V phosphorylation, 
we investigated the phosphorylation of nucleosome arrays on circular (undamaged) DNA, 
which consisted of nucleosomes bearing recombinant H2A.V mixed in increasing ratios with 
nucleosomes bearing the phospho-mimetic form of H2A.V (H2A.VE), after incubation with 
DREX. However, the H2A.V phosphorylation mimic provided as a ‘seed’ did not trigger the 
amplification of the signal by further H2A.V phosphorylation in the absence of free DNA (Figure 
57). This may be because the phospho-mimetic form was not recognized as a damage signal, 
or because a component of the amplification cascade was lacking in our system. Even though 
the exchange of serine for negatively charged glutamic acid is a commonly employed to mimic 
phosphorylation in various systems (Kotova et al. 2011; Celeste, Difilippantonio, et al. 2003; 
Celeste, Fernandez-Capetillo, et al. 2003; Kobayashi et al. 2009), it is not clear, if the H2A.V 
phospho-mimetic form H2A.VE of Drosophila was recognized as a DNA damage signal mark by 
proteins in DREX. For example, Celeste et al showed, that BRCA1, 53BP1, and Nbs1 were not 
recruited to the sites of damage, when H2A.X was replaced by its mimetic form (Celeste, 
Difilippantonio, et al. 2003; Celeste, Fernandez-Capetillo, et al. 2003). It is possible, that the 
phosphorylation mark itself is not sufficient to trigger a complete damage response. On the 
other hand, it may be that the point mutation cannot entirely mimic the phosphorylation mark. 
Inhibition of phosphorylation by wortmannin or the replacement of H2A.V by its C-terminally 
truncated form did not affect the recruitment levels of Ku. Ku binding occurs independently 
from H2A.V phosphorylation and even independent from H2A.V nucleosomes. Furthermore, 
H2A.V phosphorylation in the absence of free DNA ends did not lead to Ku recruitment. These 
findings are in line with the current literature, suggesting that Ku binding only depends on free 
DNA ends (Downs & Jackson 2004; G. Yang et al. 2018; Emerson et al. 2018; Radhakrishnan & 
Lees-Miller 2017). Our detailed investigation of post-translational histone modifications in 
nucleosomes including H2A.V or H2A.VDC revealed the enrichment of some modifications 
depended on the H2A.V C terminus. These post-translational histone modifications usually 
serve as targets to recruit specific factors to chromatin, which can perform specific functions 
(reviewed in Rothbart & Strahl 2014; Yun et al. 2011; Musselman et al. 2012; Swygert & 
Peterson 2017). Mdc1, for example, recognizes and is recruited by phosphorylated H2A.X 
through its BRCT domain in mammals (Stucki et al. 2005). This recruitment is important for the 
spreading and amplification of the gH2A.X signal, as described in III.D.4 and VII.E. Other 
examples for histone modifications, which are recognized by readers are lysine methylations, 
which are recognized by proteins including domains like Tudor, Chromo, PHD, or WD40 (Yun et 
al. 2011). As an example, 53BP1 bears a Tudor domain, that can bind to methylated lysine 79 
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on histone H3 or to methylated lysine 20 on histone H4 at DSBs (Huyen et al. 2004; Iwabuchi 
et al. 2006). 
Despite the lack of a general investigation on histone modifications in preblastodermal 
Drosophila embryos, epigenetic modifications are not expected to be highly abundant in early 
stages of development as they are believed to be erased to reset the epigenetic memory. As 
an example, heterochromatin is only established after the syncytial state and preblastoderm 
embryos only contain few modifications like acetylation marks on H3K27 and H4. (discussed in 
Lindeman et al. 2011; Sarmento et al. 2004; Zheng et al. 2016). In addition to this, methylation 
of H3K27 was shown to be maternally transmitted and can be detected in preblastoderm 
embryos (Zenk et al. 2017). 
Methylation as well as acetylation on H3K9 was only detected at later stages (Yuan & B. Zhu 
2012). Furthermore, the onset of dosage compensation including the acetylation of H4K16 only 
occurs after the syncytial state (Meller 2003). Therefore, it can be assumed that chromatin of 
preblastoderm embryos are not yet diversified and histone marks are not yet highly abundant. 
Accordingly, intensities identified for histone modifications in in vitro reconstituted chromatin 
were not high, but to our surprise, differences observed between different samples were highly 
reproducible among replicates. Sensitive mass spectrometrical analyses of our collaborator, 
Christian Feller (ETH Zurich) detected DNA damage-dependent histone modifications in 
addition to the C-terminal H2A.V phosphorylation, for example the methylation of H3 
(H3K27me3, H3H36me2 and H3K9me3) in a time-resolved manner. 
However, mass spectrometry analysis of factors recruited to nucleosomes consisting of H2A, 
H2A.V, or H2A.VDC, however, did not reveal many specific interactors. It Is not clear, if this 
result is a consequence of high variability between replicates, leading to a low number of 
significant hits, or due to the nature of the extract, which might not be able to distinguish 
among the variants. The latter argument would be in line with the observation, that 
incorporation of H2A.V does not seem to be specific, as it has been described in Zhang & Pugh 
2011). Parp1 is an important repair factor, which is recruited to sites of damage and deposits 
Poly-(ADP-ribose) units to decondense chromatin. The PARylation mark is recognized by 
proteins including macro domains, like the remodeler Alc1 (Ahel et al. 2009; Gottschalk et al. 
2009). In Drosophila, Parp1 was shown to be recruited by H2A.V and becomes activated upon 
H2A.V phosphorylation (Kotova et al. 2011). In our studies, we were able to identify Parp1 by 
mass spectrometry on immobilized chromatin. However, using an anti-poly(ADP-ribose) 
antibody, which is commonly used in the field, no PARylation of in vitro-reconstituted 
chromatin was detected. A positive control reaction included Parp1, NAD as a 
substrate/coenzyme and DNA to activate the enzyme, leading to auto-PARylation of Parp1 
(Dawicki-McKenna et al. 2015; Langelier et al. 2012; Steffen et al. 2016). We were able to detect 
PARylated Parp1 in our positive control, but no PARylation marks after in vitro assembly. We 
therefore speculated, that Parp1 was inactive in our system, despite the availability of 
(phosphorylated) H2A.V. It is possible, that the activity of Parp1 is regulated by different levels, 
preventing the PARylation of chromatin. As this step is a critical event In the DNA damage 
response, the lack of PARylation goes in line with our hypothesis, that DNA repair is not 
performed in this in vitro system. 
 - Discussion - 
 125 
F. THE ROLE OF THE DOM/TIP60 COMPLEX IN H2A.V INCORPORATION AND 
TURNOVER 
 
Drosophila H2A.V combines features of mammalian H2A.Z and H2A.X and including functions 
of H2A.X in DNA damage signaling and of H2A.Z in promoter definition and the regulation of 
transcription (reviewed in Baldi & Becker 2013). To fulfill these functions, H2A.V should be 
distributed along the genome like H2A.X, to guard the genome, but also has to be specifically 
incorporated into promotor regions like H2A.Z. However, it is not clear, how the distinction 
between these two roles are accomplished. 
In yeast and mammals, H2A.Z was shown to be removed from regions around the DSB by Ino80 
(Papamichos-Chronakis et al. 2011; Alatwi & Downs 2015; Gursoy-Yuzugullu et al. 2015). In 
contrast to this, other studies in yeast and mammals observed incorporation of H2A.Z and 
H2A.X at break sites (Kalocsay et al. 2009; Horigome et al. 2014; Fukuto et al. 2018; Ikura et al. 
2016). It therefore seems obvious, that H2A variants have an important role in the regulation 
of chromatin around DNA breaks. The following model to explain the function of H2A.Z has 
been proposed: First, H2A.Z is believed to be incorporated into chromatin around break sites 
by NuA4-Tip60 to bind the H4 tail of the nucleosome by the acidic patch of H2A.Z and prevent 
its acetylation to keep chromatin in a repressed state. Then, H2A.Z is removed by Ino80 and 
the H4 tail is released and acetylated by Tip60, which leads to a decondensation of chromatin 
to facilitate repair (Gursoy-Yuzugullu, House & Price 2016). 
Strikingly, I observed an enrichment of H2A.V on DNA presenting a free end versus fragments 
where both ends were occluded by immobilization (Table 5). This could be in line with the 
model, suggesting the incorporation of H2A.V to trigger a repressed chromatin state, as it was 
already reported (Swaminathan 2005; Hanai et al. 2008). H2A.V enrichment at free ends was 
particularly high after 3 h, compared to the early time point of 15 min (Table 5, also see XI.B.2.a) 
and XI.B.2.b)). However according to the model described by Gursoy-Yuzugullu, the first 
condensation phase including H2A.Z incorporation is reported to be within the first minutes, 
and subsequently reversed by Ino80 (Gursoy-Yuzugullu, House & Price 2016), which was not 
reproduced in our analysis and may be explained our inability to detect Ino80 in our chromatin 
analyses. However, the mechanism as well as the responsible factors responsible for the 
incorporation of H2A.V were not identified.  
As discussed in the previous chapters, Dom/Tip60 was reported to be vital for H2A.V 
incorporation and turnover (Kusch 2004; Lu et al. 2007; Kusch et al. 2014). In our lab, it has 
been shown that the different splice forms of Dom, DomA and DomB, have different functions 
in the incorporation or exchange of H2A.V. These functions are not redundant and specific 
mutants of either of the variants are embryonic lethal (Börner & Becker 2016). To disseminate 
the distinct functions of the splice forms, the study was performed in the Drosophila germarium 
with splice variant-specific knock down in different cells of oogenesis. With this approach, a 
DomB-dependent incorporation of H2A.V was demonstrated in germline and somatic cells, as 
well as a Dom-independent incorporation for endoreplicating germline nurse cells (Börner & 
Becker 2016). In contrast to this, removal of H2A.V was performed in a DomA-dependent 
manner from chromatin of nurse cells.  
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To follow up on these and other studies on the role of Dom/Tip60 (Kusch 2004; Lu et al. 2007; 
Kusch et al. 2014), I aimed to perform chromatin assembly reactions in the absence of 
Dom/Tip60. However, the Dom/Tip60 complex is essential and Dom mutants are not viable 
(Ruhf et al. 2001), precluding extract preparation of Dom/Tip60 mutants. In addition, 
immunodepletion of embryonic extract from Domino or Tip60 did not work efficiently, neither 
using antibodies against the protein itself nor using antibodies against tagged Domino, after 
preparation of extract from embryos homozygous for tagged Domino. Consequently, 
chromatin assembly reactions in the absence of Dom/Tip60 were not possible and I could not 
address the role of Dom/Tip60 in this system. 
 
G. CONCLUDING EVALUATION OF THE IN VITRO SYSTEM TO INVESTIGATE DNA 
DAMAGE AND OUTLOOK    
 
In this work, I demonstrated that damage-associated events can be reproduced in this in vitro 
system, making it a powerful tool to investigate the DNA damage response under defined 
conditions. However, some aspects were not solved due to technical issues, like the 
comparison of ‘damaged’ versus ‘intact’ chromatin, as isolation of chromatin without inducing 
H2A.V phosphorylation was not successful. Also, cell cycle- or transcription-dependent events 
or processes, which are not active in preblastoderm embryos cannot be investigated with this 
tool and might require additional approaches. Despite these drawbacks, many aspects were 
elucidated in this project, like the recruitment of chromatin remodelers in reconstituted 
chromatin, the identification of Acf1 interactors, as well as the role of Iswi remodeling 
complexes on chromatin reconstitution, the identification of H2A variant-specific chromatin 
interactors and the characterization of a DNA damage response by analyzing the recruitment 
of factors to free DNA ends, the H2A.V phosphorylation in response to DNA DSBs, and 
additional post-translational histone modifications around DNA breaks. As a conclusion, 
chromatin in vitro reconstitution with Drosophila embryo extract was proven to be a powerful 
tool to analyze chromatin changes upon recognition of DNA DSBs in a time- and locus-resolved 
manner. However, some questions remain to be addressed. For instance, in the field of damage 
recognition and repair, it is still unclear how gH2A.V spreading is performed. Also, can repair by 
this extract be performed after addition of missing factors? If yes, is it possible to influence the 
repair pathway? What is the mechanism of repair in cells lacking relevant factors like DNA-PK? 
Is Ku required? How is enrichment of Acf1 at DNA breaks achieved and what is its role? Is H2A.V 
specifically incorporated at DNA breaks? And if so, how is this information transmitted and 
which factors are relevant for this process? Furthermore, can the extract be supplemented 
with factors to specifically incorporate H2A.V at promotor regions?  
Altogether, many aspects are still unsolved, and the potential of this extract can be challenged 
with more questions to be addressed in the future. 
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IX. ABBREVIATIONS 
 
°C   degrees celsius 
LC-MS/MS  liquid chromatography-tandem mass spectrometry 
3C   chromosome conformation capture 
4-OHT    4-hydroxytamoxifen  
53BP1   p53-binding protein 1 
aa   amino acids   
Ac   acetylation 
Acetyl-CoA  acetyl coenzyme A 
Acf1    ATP-dependent chromatin assembly factor 1 
ADP   adenosine diphosphate 
AEL   after egg laying 
AID   auxin-inducible-degron 
Alc1   amplified in liver cancer protein 1 
ATF2    activating transcription factor 2 
ATM    ataxia telangiectasia mutated protein 
atms    antimeros 
ATP    adenosine triphosphate 
ATR    ataxia telangiectasia and Rad3-related protein 
Atrip   ATR-interacting protein 
Atu    another transcription unit 
Baf   barrier-to-autointegration factor 
Baz1A   bromodomain adjacent to zinc finger domain 1a 
Beaf    boundary element associated factor 
beb   both ends bound 
Blm   bloom syndrome protein 
bp   base pairs 
Brca1/2   breast cancer type 1/2 
Brct   Brca1 C-terminal 
Bruce    BIR repeat containing ubiquitin-conjugating enzyme 
BSA   bovine serum albumin 
C   control 
CaCl2   calcium chloride 
Cdc   cell division cycle protein 
Chd   chromodomain-helicase-DNA-binding protein 
ChIP   chromatin immunoprecipitation 
CHRAC    chromatin accessibility complex 
Chz1   chaperone for Htz1 
contr   control 
Ctcf    corrected total cell fluorescence 
CtIP   C-terminal-binding protein interacting protein   
Ctr9    RNA polymerase-associated protein CTR9 homolog 
Cul4   cullin4 
CuS04   copper sulphate 
Da    Dalton 
DAPI   4'.6-diamidino-2-phenylindole   
dATP    deoxyadenosine triphosphate 
dCTP   deoxycytidine triphosphate 
Ddb   DNA damage-binding protein 
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ddH2O   double distilled H2O 
dGTP   deoxyguanosine triphosphate 
DMSO    dimethylsulfoxide 
DNA   deoxyribonucleic acid 
DNA-PK   DNA-dependent protein kinase 
DNA-PKcs  DNA-dependent protein kinase, catalytic subunit 
Dna2   DNA replication ATP-dependent helicase/nuclease 2 
dNTP   deoxynucleotide triphosphate 
Dom   domino 
Dot1   disruptor of telomeric silencing 
DREX   Drosophila embryonic extract 
DSB   double strand break 
dsDNA   double-stranded DNA 
DTT   1.4-dithiothreitol 
dTTP   deoxythymidine triphosphate 
dUTP   deoxyuridine triphosphate 
E. coli   Escherichia coli 
ecd    ecdysoneless 
EDTA   ethylenediaminetetraacetic acid 
eEF1    eukaryotic translation elongation factor 1 alpha 1 
Ef1    elongation factor 1 
EGTA    ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
Elp3   elongator complex protein 3 
ER   estrogen receptor 
et al.   et alii 
Etl1    enhancer trap locus 1 
Exo1    exonuclease 1 
FAIRE   formaldehyde-assisted Isolation of regulatory elements 
FBS   fetal bovine serum 
Fcp1   TFIIF-interacting CTD phosphatase 1 
Fen1   flap endonuclease 1 
FlyFos   fly fosmid 
Fun30   function unknown now 30 
FV   forward 
g   gram      
g    gravitational acceleration 
G1/G0-phase  gap1/gap0-phase 
Gcn5   general control nonderepressible 5 
GO   gene ontology 
GST   glutathione S-transferase 
H2A.V    histone H2A variant 
HA    hemagglutinin 
HAT   histone acetyltransferase 
Hepes    N-(2-hydroxyethyl)piperazine-H´-(2-ethanesulfonic acid) 
Hpa2   histone and other protein acetyltransferase 2 
HR   homologous recombination 
Hsp70    heat shock protein 70 kDa 
Hyx    hyrax 
I    inhibitor 
Ida    imaginal discs arrested 
IF   immunofluorescence 
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IgG   immunoglobulin G 
Ino80    inositol-requiring protein 80 
IP   immunoprecipitation 
IPTG    isopropyl-D-thiogalactopyranoside) 
IR   infrared 
Irbp    inverted repeat binding protein 
Iswi   imitation switch 
k   kilo 
kb   kilobase 
KCl   potassium chloride 
KD   knock down 
kis    kismet 
Klp10A    kinesin-like protein 10A 
KO   knock out 
L   liter 
LB    lysogeny broth 
Lig3   ligase 3 
Lig4   ligase 4 
M   marker 
m   milli  
M   molar 
Mdc1   mediator of DNA damage checkpoint protein 1 
mdlc    midlife crisis 
me   methyl 
Mei-41   meiotic 41 
MgCl2   magnesium chloride 
MNase   micrococcal nuclease 
mod    modulo 
Mof   males absent on the first 
Mre11   meiotic recombination 11 
Mrg15    mortality factor 4 related gene 15 
MRN    Mre11-Rad50-Nbs1 
msn    mishappen 
n   nano 
NaCl   sodium chloride 
NAD   nicotinamide adenine dinucleotide 
NaMBS   sodium m-maleimidobenzoyl-N-hydroxysuccinimide ester 
Nap1   nucleosome assembly protein 1 
Nbs1   nibrin 1 
NDS   normal donkey serum 
NFR    nucleosome-free region 
NGS   normal goat serum 
NHEJ   non-homologous end joining 
NuA4    nucleosome acetyltransferase of histone H4 
NuRD    nucleosome remodeling deacetylase 
oeb    one end bound 
P   phosphate 
p300 HAT  histone acetyltransferase p300 
p400    E1A-associated protein p400 
PAR   Poly-(ADP-ribose) 
ParB   chromosome-partitioning protein B 
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Parp1   Poly-(ADP-ribose) polymerase 1 
PBS   phosphate buffered saline 
Pcaf   P300/CBP-associated factor 
PcG   Polycomb Group 
PCR    polymerase chain reaction 
PEG    polyethylene glycol 
PGC    primordial germ cell 
pH   potential of hydrogen 
PhD   doctor of philosophy 
PHD   plant homeodomain 
Phf7    PHD Finger Protein 7 
PMSF    Phenylmethanesulfonyl fluoride 
Pont    pontin 
PP2A    protein phosphatase 2 
PP4R2r    protein phosphatase 4 regulatory subunit 2-related protein 
PRC1    Polycomb repressor complex 1 
PRC2    Polycomb repressor complex 2 
Prp8    pre-mRNA processing factor 8 
PTM    post-translational modification 
puf    puffyeye 
Rad50   radiation sensitive 50/51 
RanBP   Ran-binding protein 
Ring   really interesting new gene 
RNA    ribonucleic acid  
RNA pol II   RNA polymerase II 
RNAi   RNA interference 
RNAse    ribonuclease 
Rnf8   ring finger protein 8 
Roc1   homeobox-leucine zipper protein   
row    relative of woc 
RPA   replication protein A 
rpm   revolutions per minute 
RpS29   Ribosomal protein S29 
rRNA   ribosomal RNA 
RSF    remodeling and spacing factor 
Rsf1   repressor splicing factor 1 
RV   reverse 
S-phase   synthesis phase 
S2    Drosophila Schneider cells 
Sae2    sporulation in the absence of spo eleven 2 
Sas2   something about silencing 2 
Scu   scully 
SD    standard deviation 
SDS   sodium dodecyl sulphate 
SDS-PAGE  SDS-polyacrylamide gel electrophoresis 
Seq   sequencing    
Set8   SET domain-containing protein 8 
SETMAR  SET Domain And Mariner Transposase Fusion Protein 
Sf21   Spodoptera frugiperda 21 
sle    slender lobes 
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Smarca5 Swi/Snf -related matrix-associated actin-dependent regulator of 
chromatin subfamily A member 5 
Smarcad1 Swi/Snf -related matrix-associated actin-dependent regulator of 
chromatin subfamily A containing DEAD/H box 1 
SN   supernatant 
Snf2h    sucrose nonfermenting-2 homolog 
Snf2l    sucrose nonfermenting-2 like 
spn-A    spindle A 
SRCAP    Snf2-related CBP activator protein 
ssDNA   single-stranded DNA 
ssh   slingshot  
Su(Hw)   suppressor of hairy wing Suv39h1 
Suv4-20  suppressor of variegation 4-20 homolog 
SWATH   sequential window acquisition of all theoretical fragment ion spectra 
Swi/Snf   switch/sucrose non-fermentable 
Swr1/2   Swi2/Snf2-related 1/2  
TAD   topologically associated domains  
TBS   Tris buffered saline 
TE   Tris-EDTA  
Tefu    telomere fusion 
TEMED    N,N,N´,N´-tetramethylethylenediamine 
Tip60   tat interactive protein 60kDa 
tou    toutatis 
TRAX   transcription extract 
TSS    transcription start site 
U   unit 
UAS    upstream activating sequence 
Ub    ubiquitin 
UV   ultraviolet 
v/v    volume per volume 
Vta1   vacuolar protein sorting-associated protein 1 
w/v    weight per volume 
WB   Western blot 
Woc   without children 
wt   wild type 
Xpc   Xeroderma pigmentosum, complementation group C 
Xlf    Xrcc4-like factor 
Xrcc    X-Ray Repair Cross Complementing  
YL1   vacuolar protein sorting-associated protein 72 homolog 1 
γH2A.V    phosphorylated H2A.V 
µ    micro 
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XI. APPENDIX 
 
A. PLASMID SEQUENCES 
 
pRSET-A-H2A.V 
GATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACT 
TTAAGAAGGAGATATACATATGGCAGGCGGTAAAGCAGGTAAAGATAGCGGTAAAGCAAAAGCAAAAGCCGTTAGCCGTA 
GCGCACGTGCAGGTCTGCAGTTTCCGGTTGGTCGTATTCATCGTCATCTGAAAAGCCGTACCACCAGTCATGGTCGTGTT 
GGTGCAACCGCAGCAGTTTATAGCGCAGCAATTCTGGAATATCTGACCGCAGAAGTTCTGGAACTGGCAGGTAATGCAAG 
CAAAGATCTGAAAGTGAAACGTATTACACCGCGTCATCTGCAGCTGGCAATTCGTGGTGATGAAGAACTGGATAGCCTGA 
TTAAAGCAACCATTGCCGGTGGTGGTGTTATTCCGCATATTCATAAAAGCCTGATTGGCAAAAAAGAAGAAACCGTTCAG 
GACCCGCAGCGTAAAGGTAATGTTATTCTGAGCCAGGCCTATTAAGGATCCGAGCTCGAGATCTGCAGCTGGTACCATGG 
AATTCGAAGCTTGATCCGGCTGCTAACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGC 
ATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATCTGGCGTAATAG 
CGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGGACGCGCCCTGTAGCGGCGCAT 
TAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTC 
TTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAG 
TGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTT 
TTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCG 
GTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAA 
CGCGAATTTTAACAAAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTT 
ATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGA 
AGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCA 
GAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGG 
TAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTAT 
TATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCA 
GTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGC 
GGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTC 
GCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCA 
ACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGA 
TAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTG 
GGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAG 
GCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGT 
TTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATC 
TCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGA 
GATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCA 
AGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAGCCGT 
AGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCC 
AGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGG 
GGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCG 
CCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTT 
CCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTC 
GTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTC 
ACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGC 
AGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCG 
TTGGCCGATTCATTAATGCAG 
 
 
pFBDM-6xHis-Iswi-Acf1-Flag to express recombinant ACF in Sf21 cells     
 
AAAGTAGCCGAAGATGACGGTTTGTCACATGGAGTTGGCAGGATGTTTGATTAAAAACATAACAGGAAGAAAAATGCCCC 
GCTGTGGGCGGACAAAATAGTTGGGAACTGGGAGGGGTGGAAATGGAGTTTTTAAGGATTATTTAGGGAAGAGTGACAAA 
ATAGATGGGAACTGGGTGTAGCGTCGTAAGCTAATACGAAAATTAAAAATGACAAAATAGTTTGGAACTAGATTTCACTT 
ATCTGGTTCGGATCTCCTAGGCTCAAGCAGTGATCAGATCCAGACATGATAAGATACATTGATGAGTTTGGACAAACCAC 
AACTAGAATGCAGTGAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCTGCA 
ATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGGGAGGTTTTTTAAAGCAAG 
TAAAACCTCTACAAATGTGGTATGGCTGATTATGATCCTCTAGTACTTCTCGACTCACTTCTTCTTCTTTTTCGAGTTGG 
AACTGGTTGCCACCACCTCGCTCTTCCGCTTTTGACTGGCCTTCGGTTGGGGCGCGGGTGCTGGAGTGTTCGAGCTGGCA 
CTTCCACTTCCAGCGGACACGCTGCCCTTTGGTGCCTTTTTCTTTTTCTCGGCGCGTTCTTTCTCTTCCAGCTCAATGTT 
TTCACGTTCAATAAGGGTAATCAACGTGTTGCAGCGACGCTGTAGCTCCAAAGCGGTTCTAGATTTGATGAACCAGTCAA 
AGCGGAATTGCGGAGAAGCTCTTATAGCCGCTCGCAGCTCTTCGTAGACATTCTCCTTGTCAAAGCCCAACTTGTGAAGC 
ATGCATACCAGAAAGCGATCCTCTATTTCAGTGTAATTCTTGCCCTTGTTATTACCATATTGCAGCCGCAACTGATGGAA 
GGGGGCGCGATACCGCGACATCTTTTGATCCAAAGCCTTCTTAATAGACAATCGCCGTTGAATCTTGCCCTCTCCACGCT 
CAATCTGTCCCATTATTCGCTCAATATCCTGCAACTCAGTGCATCGCTCCCAAAACACGGCGTTGTACTCGATAACCTCC 
TCCGGAGTCTTGCCCTCCACGTCCTTGGCAATGTTGTCAATATCATCCCGACCGTACTTTTCGTTAGCCTTGATGAACTG 
GTTGAAATCGCGCTTGGTCCAGGCAGTGAAACCCTGTGAGAGTAGATTCTCCTTCTCCTGGATCTCTTCCTCGGTAAGCG 
GCTCTGCCTCATCGATCTTGCGCTGCTCCTCGCGCTGCACTTTGGTGGCATCCGATCCTAGTTCCGTGTTCTTGGGCACC 
TTGTAACCAACAGTCTTGCGGAAATAGTAGATTTCCTGGTCGAGCAGCTCAAACAGACGGGGTGGGAAGAACTGAAAGTC 
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CTGAACGATAGGCTGCTTGGGTGGGCGGGGAGCCTTCGGTGCCTTGGGTTCGGAGACACGGAGAGCCTCGCGGAAATAGG 
CATCCACAGCATAGTTGGCTTTGCGTTCACGCTTCGGTGGCTCGATCCAGTTGCCCAGCGCATTTAGCTTTTGCTTCTCG 
CGCCAATCCTCACCCTCGAATTGATATACGGAAGAAGTTCCTGCCTCGCCGTTTGTGTCCATTGTGAACGTCCGCAGCGA 
ACTCTCGCCCAGACTGTCCAGTGCTGCCTTTTGCTCGGCCGTCTTGGCCTCACCGCGCTCCAAAATAACATCGATGTCCT 
CATCGGTAATGTCTGTCTCCTTAGAGCTGAACACTTGGTTAGCTCCAAAACGGATTATATTAAGCATTTCATCCTTGTTC 
AACTGATTGGAGCGGTTGTCAACCAATCTGCCCCCCTGGATGACCATCTTGTCCAGACGGAGCTTGACCTCTGCTCTCTC 
CACGATCTTCTCCTCCACTGTACTTTCGGTGATCAGCCGGAAAACGCGCACTTGCTTCTTTTGACCAATACGATGAGCAC 
GATCCATAGCTTGCAAATCCATTTGAGGATTCCAATCCGAGTCGTAAATGATGACAACATCAGCGGTAGCCAAATTGATA 
CCCAAACCACCGGCTCGGGTGGACAACATGAAGAGAAACTTGGCGCTGTTGTCCATGTTAAATTCCTGAATCTGCCTGTT 
ACGATCTTCGTGCGGCGTCTGACCATCCAGGCGGCAATAGTTGTAGTTGCGCCAGTGACAGTAGTCCTCGAGGATATCCA 
ACATCCTCGTCATTTGTGAGAAAATCAACACACGCGATCCCTGCTCTTGGAGCTTGGGCAGCAGCTTGTCCAGAATAGCC 
ATCTTTCCGGAGTTATACACCAAATGCGTGTCCGTGGTGTATGGCGGACCGGGCTCGGCGCCATCAAACAAATATGGGTG 
GTTGGTGCACTTGCGGAGCTGCATAAGGATGTTCTGCAGTCGCATCTTCTCCACTTTGCCAGCACCGTTCACTACATCAA 
TGTCCTTAAGCAGCACCTTGGTGTACCAGTCGCGTTGCATCTTGGATAGACCCACAAATATTTTCATCTCCTTCTTCGGC 
TTCAGACGCTTCTCCACTTCGGCCTTTAGACGACGGAGCAGGAAAGGTTTCAGCACGGCATGCAAACGCGTAATCAATGC 
ATCGTCACCCAGGCAGGTGTTCGTGTTGAACCATTCGTCAAAATCCTCTGACGAATTAAACACATCGGGCAGCAGGAAAT 
TAAGCAGGGCCCACAGCTCGTGGAGGTTATTCTGCAGCGGAGTACCCGTGATAAGTAGACGATTAGCGGTCTTAAACTCT 
CGCAGAATCTCCGACAGCTTCGACTTCTCGTTCTTGATACGATGCGCCTCGTCGATGACCAAATAGCGCCAGTTGAACTT 
CTTGAATACAGACTTCTCGCGGATACACATCTCATAGGAGGTCACGCAAACGTCCCACTCGCCAGGCATGAGCACATCTC 
TAATGAAGGTGTTACGGGTGTCCTGGTCACCAATAAGGCAGACGGCTCTGAGGGAAGGACACCACTTTTTAAACTCATTT 
ACCCAATTCTGAAGCGTTGACTTTGGCACGATGACGATGTGTGGTCCAGCTTGATTTTTGAAATGCTTGAGGTAACCCAG 
CAGAGATATGGTCTGCAGGGTCTTTCCTAGACCCATTTCATCGGCCAGAATTCCATTGATACCATTTTCGTAAAGCGAAA 
TCATCCAGTTAAGGCCGCGAATCTGGTAGTCACGCATCTCTCCACTTTTGATGTAGGCGGGTGAGGCATCGAAGCGAAAG 
ATCTCCTTGGTGGCCGAGTCTTCCGCCAGCAACTCCTCATCCTCCTCCTGCTCTGTCTTGCGATGACGATGATCGGCCAC 
ATCCTTTTCCTTGTCCTTGTCTTTGATCTTCTTGGGTCTACCCTTAGGCTTCGTGGGACTCTTAGCGCTGTTAGTCATGA 
AGTGGGTGAATATCTCCGTCTGCTTTAGCAGGAAATCAAAGCGCCTACTGCGATCAGCCTCGATTTTGTTGTCGAACTCA 
GCCTCCTTTTCACCGGATGAACTGGTGGCCGCATCTGAAGTCGTCTCGTTCGAGTTCTCTTCGGTTGCCTCCACGGCAGC 
TGTATCTGTTTTGGACATGCCCTGAAAATACAGGTTTTCGGTCGTTGGGATATCGTAATCGTGATGGTGATGGTGATGCA 
TGCGCCCGATGGTGGGACGGTATGAATAATCCGGAATATTTATAGGTTTTTTTATTACAAAACTGTTACGAAAACAGTAA 
AATACTTATTTATTTGCGAGATGGTTATCATTTTAATTATCTCCATGATCTATTAATATTCCGGAGTAGGTCGCGAATCG 
ATACTAGTATACGGACCTTTAATTCAACCCAACACAATATATTATAGTTAAATAAGAATTATTATCAAATCATTTGTATA 
TTAATTAAAATACTATACTGTAAATTACATTTTATTTACAATCACTCGACGAAGACTTGATCACCCGGGATCTCGAGATG 
GCTGGTGGCCTCAACGACATCTTCGAGGCCCAGAAGATCGAGTGGCATGAAGATACTGGTGGATCAGAGAATTTGTATTT 
TCAGGGTGCGGCCGCTATGCCCATTTGCAAGCGGGAAGGATTCGACCTGAATCAGAAGGAGGGCAAGAACGAAACATTCC 
ACGACAACGACCAGGTCTTCTGCTGCTACATCACTAAGCGCATTTTTCGCGACTATGAACACTACTTCCGGCACGTGATG 
GTGATCAACTCAACGGTGTGGCAGTGCGAGGCCACCGGCAAGGAGAACCTCACCTACGAGGAGGCGGTCAAAAGTGAGCG 
GGCGGCTCGCAAGAAGATGGAGCAGTTCAAACAGAGCCTTCGGGCACCCGTCCTTCTGGTTGTGGAGCACGCCCAACAGT 
CGGCGGTCAACACCTTGAACATGATAGTGGCCAAGTTTCTGCGCAAGCGCTACTTTATCGGCGAGGAGGTGTCGGTGCAA 
GCTAAGAAGAACGCCACGTACACGGTGTTGGGTGTCAAGTTGGACAAAAATATGCCGGAACCACTCAATGGTATCTATGA 
GGACACGGACAACCTGGTCTACAGACTACGACCAAACAAGGGCGATCCCAGTGCAGAGCTTGATCTGCCCTTTAGGCAAT 
TACGTCGCTCGCGCATGGAGTTTAACCTGGAAAACCTGAGTATGTTTATAAAGAGCAATGTATCGCGGGTGGATGGACTT 
CTTCGACCCAAGCCAGAGGCATACAAGCAGTACGTGACGGACCCTGGCGTAAACTTCTCCACAATTTTCATTGGCAAAAT 
GCCACGTTATTCTCCCGCTAAGATTAAAAAACCTGACGGCAAGAAGCAATCCACTCTCAACAAATATATTGTCGCCGGTG 
AAGCAACGGCTGCAAAGTCAAAGGCGAAGGCCAAGTCTGATGCTAAATCTCTGGCAGAGGAATTGGAGCGGGTTAAGCGA 
GAAAAAGAGGCCAAGCTTATTGAGTTGGAAAAACAAAAGGCGGAAAAGAAGGCACAGTTGATTGAACGCGTTGAAAACGA 
ATGTAATTTACTGCTTCAAAAGACGGACGACCTGGAGAGAACCGACCAAAAAGTCCTGCCCCGCTACAGACAGATCGTCA 
CATTGCTGCCTGAGCACCTCCTGGGTGATGCCTTCATGATGCGCGAGTTTATGCACACTTACACAGGATTGCTGTCCGGC 
ATCGAGGTGTTCCGTCAGAACCTCAGTTTCTACGAGATGACACGTGCACTGACTGCTCGTGAGATTGCGGGCCCACTATC 
GGACATCCTCCTCGTTCTGCTTGGCACTGTTTTCGATCTGCAAAAAGAAGAGGAGGAGGAATGCGCAGTGACCTACCTCG 
ATCGGGCTGCACAAACTCAGGAGCCCTATTGGAGTATGGCGCAGGCCGCCAAAAGTCACCTTTACGCCAAGAGGCACTTT 
TCCTTTAAGGTAAATGAACTACCATTAGATGCACTGACTCTCAGTGAAGTGCTACGACTGCATCTACTTGGATCCGGAGC 
TTTTGTAAATGAAAAGGCGGAGCGCTGGAGAGTCATGTACCGGAATGGCTACTCGTCAAAAGAAGACCCTGGTCTGGAAC 
TACGTCTGGAACACTCGCACATCCTGCGCATTCTCAAAAATCATTCCGTATATCAGCTAAAGTTTAAGGATATAATGCTC 
CTGATTCGCTGCCTGATGTCCCAAATTATGACATACTCGGGCACGATTAACTTGATTGAGGAGCGTATGGAGCAAACAGC 
AAAGGCCAGGCAAGATCTACGAGCTCTAGTTGTCGGGGAAAATAAGAGATTAGCCGCCGTAGAGATAAACAGGAAAAAAC 
TCACGCAAATGCACCACCTGGAGGTAAATGGCGTTGAGCCTGAAAAGAGGGAAGCGTTGGTCGAGAAATTAAAGAAGAGT 
ATTGCCGAGCTACACGCCCAATCGGATCAGCAACATCGCAAGCACGAGTTGCAGATGCTTAAGTTGCATTCGCAGCTTTT 
CAATTTTTTGGTTTACTTGGGCATGGATAGGTGCTACAGGAAATATTACGTTTTGGAGTCTATGCCTGGGATCTTTGTCG 
AGCATTCGCCGGACAGCCTTGACACTTGTTTGGAGCAACCAATAACAAATAAGTCCCAAATAGAAATTCGTCAGCAGTCT 
GCATTGCCAAAGAATCGCAAGGACCTAAGGGTATATCTACTCAAACTCTACGGAGACGACGAAAAGAAAACTAAGAAAAA 
GGCCAAGCACTCTCTAGAGAACAAGGAGAACCAAGAGCATCGCCTTAACGGCAGTGCAGAACCCATGGATGTCGAATCTG 
ATTCTCCAGAGGCTCCCACTCATTTTGAGCTCTTGATGTGCAGTGGTGACAAACGATCTTGTATTGTGCATGATTCAAGA 
AATGGGCAACGGCAGCGTTGGGCATATATTTACAAAGCCGAGGAGATCGATGAATTAATTAAGGCTCTCAATCCCAATGG 
TCTCCGTGAATATGAACTCCTTCAAGAGCTATCCGTTCTGCGTTCCTTAATCGAACAGCATGCTAAGACCTGCCCAGTAG 
ACTTGCTAAGTCTAGAAAACGAAACAATGCGCAAGAAGTTTATGGCGGCGATGGAATCTGAAACTAACCGTAAATACGGA 
GAAGCAAACTTTGGGTTACCGAATGGGACCGATCTAAACGAAGTGATGCGCTTGCATTTAGTGGATCGAATTATTCAATT 
TGAAAATGATATTTACACTGGTGATCTCGGCCGCCTGAAAGTTAAGGATATGGAAAAGTGGCGAAGTGACTTGCTTGGAG 
GCAATTACGACGCTCAGTGCAAGTTGCAGTGGGGCCCGGGTGGCAAGTTGGAAGATGAAGCTGGTTCTGACAACGAATCC 
CACGAAACTCACGAGGAGGACGATGGCGCACTATTAGGTAAATATGCCAGGAAACCATATCGCGATCCTGGCATGTATTT 
GGCAGCTTCTGCAGACACAAAACCCCTACCAGACAGCGACGATGAGGAGGATCAGCATACGAATGCCGTCTCGATTCCTA 
TCGCCGTGCATAACATGGCCTCGGCCCTTCTGCAAGTGGAGCAGGCTATTGGAAAACGGTTTCTGAAGGAACCCTACGGC 
ATGAAGAAGTGGGACCCCAAGCAGGAGGCTTTAAAACTTGCCTGCGACTCGCGTTTGCACCAGTGGGAAGTTTCGCTAAT 
GGAAAGTACAAGCTTTGCTCAAGTCTTTCTGCACCTAAACATCTTGCACGACTGTATTCAGTGGAGGCGTTCCACCAATA 
AGTCATTATGCAAGGTCTGCAGGCGTGGCAGCGATCCGGAGAAGATGCTGCTGTGCGATGAATGCAACGCTGGCACTCAC 
ATGTTCTGCCTGAAGCCTAAGCTGAGGTCTGTACCCCCGGGCAACTGGTATTGCAATGATTGCGTAAAGAGTCTGGGTCT 
CAGCAATGGTCAAAACGAAAAGGATAAAAAGCAGGCGACAAAGAAGAAACGCAAGTTTATCGTAGAAGAGGAGGATGATG 
AAGCTACAGACGAAGAAGAGGAAGAGAAAAAGGATGACGATATGACCGATGAGGATGCGGAGCACGAGAACGAAAAACAC 
GATGAGGACGTTGAGGACGACGAAAGTGTGACCTCTACCCCCTCATCTTCCAGAGTCAATGGGCGAATTTTAAGGCGACC 
 - Appendix - 
 149 
CCGCACACGGCCAACAAGCAGAAGACTTACTTCGAAAGAGATCGAAGAACATGCTCAGGAAGACGTTGACAGCGGAGACG 
TCAGCGATGACGCATCCTTAACCGCCGGTGAAGATACGATCGAAGACGAGTCAGATGAGGAAAAGGTGTGTCAGAAGTGT 
TTCTACGATGGCGGTGAAATCAAATGTGTGCAATGCAGGCTATTCTTTCACCTGGAATGTGTTCACCTCAAGCGACCGCC 
TCGCACAGATTTCGTTTGTAAAACCTGCAAGCCGATGCCACAACGACCTAGGCGCCGGCACAGTAACATGAATGGTGATC 
ATGACCGCGATGAGGAGGAGCCAAAAGCAAAGCGACCACGTAACTCTTTGCGCCTATCTATCGACAAGACCGCCCGCCCA 
AGCAACGGCAACAACAACAACAATAATAACAACAGCAGCGTCAATAACAACAACCATCGCAGAAGCGGGCGTCGGACGAA 
CGAGCACATGCCGTTGAACAGTGCCGCCTTGTACGATCTGCTTGAGCAGATCATGAAGCACAAGGCCGCTTGGCCGTTTC 
TGCGACCAGTGCTGACATCGGAGGTTCCCGACTACCATCAGATCATCAAAACGCCCATGGATCTAGCTAAAATCAAATCC 
AAGCTAAACATGGGCGCCTACCAGCTAAACGAGGAGCTGCTCAGCGACATTCAGTTGGTGTTTAGAAACTGCGATTTGTA 
CAACGTAGAAGGCAACGAAATATACGACGCTGGTTGTCAACTAGAACGATTCGTGATCGATCGATGTAGGGACATGCAGC 
TACCGTTTAGGCCTAGCGATATGAACGGGGAAGTCAAAGCTTGCGACTACAAGGACGACGACGACAAGACCGGTTGATGC 
TAGCAGCTGATGCATAGCATGCGGTACCGGGAGATGGGGGAGGCTAACTGAAACACGGAAGGAGACAATACCGGAAGGAA 
CCCGCGCTATGACGGCAATAAAAAGACAGAATAAAACGCACGGGTGTTGGGTCGTTTGTTCATAAACGCGGGGTTCGGTC 
CCAGGGCTGGCACTCTGTCGATACCCCACCGAGACCCCATTGGGACCAATACGCCCGCGTTTCTTCCTTTTCCCCACCCC 
AACCCCCAAGTTCGGGTGAAGGCCCAGGGCTCGCAGCCAACGTCGGGGCGGCAAGCCCTGCCATAGCCAGCTTTGTTTAA 
ACAAAGCTGTAGCCAACCACTAGAACTATAGCTAGAGTCCTGGGCGAACAAACGATGCTCGCCTTCCAGAAAACCGAGGA 
TGCGAACCACTTCATCCGGGGTCAGCACCACCGGCAAGCGCCGCGACGGCCGAGGTCTACCGATCTCCTGAAGCAAGGGC 
AGATCCGTGCACAGCACCTTGCCGTAGAAGAACAGCAAGGCCGCCAATGCCTGACGATGCGTGGAGACCGAAACCTTGCG 
CTCGTTCGCCAGCCAGGACAGAAATGCCTCGACTTCGCTGCTGCCCAAGGTTGCCGGGTGACGCACACCGTGGAAACGGA 
TGAAGGCACGAACCCAGTTGACATAAGCCTGTTCGGTTCGTAAACTGTAATGCAAGTAGCGTATGCGCTCACGCAACTGG 
TCCAGAACCTTGACCGAACGCAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGTACA 
GTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTA 
CGCAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAGGTGGCTCAAGTATGGGCATCATTCGCAC 
ATGTAGGCTCGGCCCTGACCAAGTCAAATCCATGCGGGCTGCTCTTGATCTTTTCGGTCGTGAGTTCGGAGACGTAGCCA 
CCTACTCCCAACATCAGCCGGACTCCGATTACCTCGGGAACTTGCTCCGTAGTAAGACATTCATCGCGCTTGCTGCCTTC 
GACCAAGAAGCGGTTGTTGGCGCTCTCGCGGCTTACGTTCTGCCCAAGTTTGAGCAGCCGCGTAGTGAGATCTATATCTA 
TGATCTCGCAGTCTCCGGCGAGCACCGGAGGCAGGGCATTGCCACCGCGCTCATCAATCTCCTCAAGCATGAGGCCAACG 
CGCTTGGTGCTTATGTGATCTACGTGCAAGCAGATTACGGTGACGATCCCGCAGTGGCTCTCTATACAAAGTTGGGCATA 
CGGGAAGAAGTGATGCACTTTGATATCGACCCAAGTACCGCCACCTAACAATTCGTTCAAGCCGAGATCGGCTTCCCGGC 
CGCGGAGTTGTTCGGTAAATTGTCACAACGCCGCGAATATAGTCTTTACCATGCCCTTGGCCACGCCCCTCTTTAATACG 
ACGGGCAATTTGCACTTCAGAAAATGAAGAGTTTGCTTTAGCCATAACAAAAGTCCAGTATGCTTTTTCACAGCATAACT 
GGACTGATTTCAGTTTACAACTATTCTGTCTAGTTTAAGACTTTATTGTCATAGTTTAGATCTATTTTGTTCAGTTTAAG 
ACTTTATTGTCCGCCCACACCCGCTTACGCAGGGCATCCATTTATTACTCAACCGTAACCGATTTTGCCAGGTTACGCGG 
CTGGTCTATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCA 
CTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAA 
TCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGC 
GTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGAC 
TATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTG 
TCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCG 
CTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA 
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCT 
ACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGT 
TACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGC 
AGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAA 
AACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTT 
TAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGA 
TCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGC 
CCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGC 
CGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTT 
CGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCA 
TTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCC 
TCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCA 
TGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGT 
TGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC 
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTT 
CAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCG 
ACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGG 
ATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGT 
AAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCA 
AAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAGA 
ACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGT 
TTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCC 
GGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGC 
GCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCAAATAAGCGTT 
GATATTCAGTCAATTACAAACATTAATAACGAAGAGATGACAGAAAAATTTTCATTCTGTGACAGAGAA 
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B. INTENSITIES IDENTIFIED BY MASS SPECTROMETRY  
 
1. H2A VARIANT-SPECIFIC CHROMATIN INTERACTORS  
(see VI.A.7) 
 
a) H2A –  H2A.V – input 
 
  differences p-values   differences p-values 
Flybase 
polypeptide ID 
Flybase 
symbol 
H
2A
.V
-in
pu
t 
H
2A
-in
pu
t 
H
2A
.V
-in
pu
t 
H
2A
-in
pu
t 
Flybase 
polypeptide ID 
Flybase 
symbol 
H
2A
.V
-in
pu
t 
H
2A
-in
pu
t  
H
2A
.V
-in
pu
t 
H
2A
-in
pu
t 
FBpp0085065 - 0.93 0.40 0.10 0.45 FBpp0307711 HnRNP-K -1.22 -0.56 0.01 0.18 
FBpp0300412 - 0.51 -0.08 0.24 0.85 FBpp0307465 hoip -0.13 0.30 0.73 0.44 
FBpp0304169 - -0.95 0.26 0.20 0.71 FBpp0297875 Hrb27C -0.33 0.92 0.41 0.04 
FBpp0304431 - -0.35 1.69 0.77 0.17 FBpp0084672 Hrb98DE -0.42 -0.67 0.38 0.17 
FBpp0304748 - -1.36 -1.29 0.01 0.01 FBpp0311376 Hsc70-3 1.02 1.35 0.07 0.02 
FBpp0308925 - 0.23 0.62 0.64 0.22 FBpp0307982 Hsc70-4 0.19 0.30 0.64 0.47 
FBpp0082990 14-3-
3epsilon 
-0.17 0.65 0.78 0.29 FBpp0305265 Hsc70Cb 0.12 0.09 0.76 0.82 
FBpp0305137 14-3-
3zeta 
1.16 0.91 0.02 0.06 FBpp0312157 Hsp26 -0.85 -0.97 0.05 0.03 
FBpp0075508 26-29-p -0.25 -0.62 0.52 0.13 FBpp0312159 Hsp27 -1.15 -1.35 0.01 0.00 
FBpp0085204 Acf 4.34 4.41 0.00 0.00 FBpp0073291 Hsp60A 0.75 -0.08 0.16 0.88 
FBpp0071448 Act57B -6.80 -4.87 0.05 0.14 FBpp0305095 Hsp83 -1.28 -2.25 0.03 0.00 
FBpp0311818 Act5C -0.69 0.97 0.65 0.52 FBpp0308671 hyd 1.06 1.44 0.01 0.00 
FBpp0100051 Adh -1.37 -1.81 0.02 0.01 FBpp0113041 Idh 0.70 -0.02 0.17 0.96 
FBpp0112333 Adi1 -0.81 -0.34 0.23 0.60 FBpp0078152 IleRS 1.61 0.80 0.05 0.29 
FBpp0072072 Adk2 -1.38 -0.95 0.03 0.11 FBpp0311679 IM33 0.25 -0.52 0.80 0.60 
FBpp0082816 AdSL -0.43 -0.57 0.33 0.20 FBpp0308804 IMPPP 1.61 1.00 0.08 0.26 
FBpp0083395 AdSS -0.82 -0.82 0.21 0.21 FBpp0088368 Inos 0.76 -0.04 0.21 0.95 
FBpp0086845 AGBE 0.94 0.17 0.10 0.75 FBpp0084842 IntS11 -1.21 -1.23 0.09 0.09 
FBpp0312000 Ahcy 0.36 -0.22 0.37 0.57 FBpp0076094 iPLA2-VIA -1.73 -0.50 0.01 0.40 
FBpp0087757 AIMP1 1.85 1.22 0.03 0.12 FBpp0081861 Irbp 5.10 4.69 0.00 0.00 
FBpp0075318 AIMP2 0.78 0.97 0.09 0.04 FBpp0081736 Irp-1B 0.39 -1.41 0.55 0.05 
FBpp0309215 Akap200 1.88 0.89 0.07 0.35 FBpp0086956 Iswi 4.62 4.64 0.00 0.00 
FBpp0089366 AlaRS -0.55 -0.93 0.35 0.12 FBpp0311371 Jafrac1 -0.07 0.21 0.89 0.66 
FBpp0308680 Ald 0.05 0.00 0.90 1.00 FBpp0081931 Jupiter 1.22 0.72 0.09 0.29 
FBpp0084610 ALiX -0.16 -0.62 0.78 0.28 FBpp0307568 Karybeta3 -1.49 -1.31 0.16 0.21 
FBpp0084812 alph -0.57 -0.62 0.17 0.14 FBpp0086328 Khc -1.14 -0.21 0.02 0.63 
FBpp0071138 alpha-
PheRS 
0.54 -0.46 0.32 0.39 FBpp0303946 Klc 0.21 -0.04 0.56 0.92 
FBpp0072694 alphaCOP -0.82 -1.42 0.10 0.01 FBpp0312027 Klp10A -1.78 -0.83 0.01 0.13 
FBpp0074609 alphaSnap 0.53 0.45 0.39 0.46 FBpp0309092 Klp3A -0.11 0.34 0.85 0.54 
FBpp0076122 alphaTub6
7C 
-0.17 -0.40 0.75 0.46 FBpp0072616 Klp61F 0.61 0.04 0.25 0.93 
FBpp0081153 alphaTub8
4B 
-1.09 -0.66 0.12 0.33 FBpp0078399 kra -2.06 -1.83 0.03 0.05 
FBpp0309387 AMPdeam -0.58 -0.48 0.41 0.49 FBpp0080322 Ku80 4.77 3.91 0.00 0.00 
FBpp0311374 Amun 0.46 0.29 0.43 0.62 FBpp0307248 l(2)09851 -2.86 -0.48 0.03 0.67 
FBpp0291143 AnxB10 1.40 0.21 0.07 0.76 FBpp0080906 La -0.51 -0.05 0.24 0.91 
FBpp0307770 AnxB9 -0.80 -1.69 0.19 0.01 FBpp0312110 Lam -0.58 -0.06 0.25 0.90 
FBpp0082065 Aos1 -1.46 -0.74 0.09 0.36 FBpp0081255 lds -0.10 -0.02 0.77 0.95 
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FBpp0074558 AP-1-
2beta 
-0.83 0.60 0.55 0.67 FBpp0311704 LeuRS 2.02 2.03 0.00 0.00 
FBpp0081592 AP-1mu -1.49 -0.53 0.10 0.54 FBpp0073551 lic -2.34 -1.42 0.01 0.05 
FBpp0293470 ApepP 0.53 0.17 0.22 0.69 FBpp0303481 lig 0.50 1.86 0.56 0.05 
FBpp0311464 apolpp -1.71 -1.01 0.09 0.29 FBpp0293289 Lis-1 2.42 3.01 0.04 0.02 
FBpp0303606 APP-BP1 0.87 0.08 0.27 0.92 FBpp0079621 LManII 0.86 0.52 0.21 0.44 
FBpp0304364 Arf79F 1.92 3.23 0.00 0.00 FBpp0311512 lolal 1.11 1.25 0.13 0.09 
FBpp0304160 ArfGAP3 1.15 2.00 0.10 0.01 FBpp0078561 lost -1.58 -1.44 0.01 0.01 
FBpp0076271 Argk -1.32 -1.49 0.02 0.01 FBpp0288789 lqfR 0.82 1.02 0.22 0.14 
FBpp0073965 ArgRS 1.97 1.97 0.01 0.01 FBpp0073784 Lsd-2 -2.47 -2.46 0.11 0.11 
FBpp0082121 Arp1 -0.88 -1.42 0.06 0.01 FBpp0071553 LSm1 -0.22 -1.53 0.64 0.01 
FBpp0302793 Arp2 -0.17 0.14 0.66 0.72 FBpp0289873 LSm3 0.35 -0.27 0.66 0.73 
FBpp0306212 Arp3 -0.66 -2.02 0.51 0.06 FBpp0310328 LSm7 0.35 0.32 0.39 0.43 
FBpp0080147 Arpc1 -2.75 -4.00 0.10 0.02 FBpp0301732 lwr 2.33 0.90 0.09 0.49 
FBpp0312086 Arpc2 -0.43 -2.49 0.63 0.02 FBpp0292593 LysRS 2.62 1.80 0.00 0.02 
FBpp0078831 Arpc4 -1.32 0.12 0.15 0.89 FBpp0293270 mahj -0.79 -1.33 0.25 0.07 
FBpp0081780 Art1 0.20 0.61 0.60 0.14 FBpp0292313 Mal-B2 1.08 0.67 0.29 0.51 
FBpp0082589 Art3 -0.70 -2.26 0.65 0.16 FBpp0306414 Map205 2.03 1.33 0.06 0.20 
FBpp0305840 Art4 0.06 -0.17 0.92 0.78 FBpp0087613 Map60 2.53 1.73 0.02 0.09 
FBpp0291576 asf1 -1.66 -0.13 0.15 0.90 FBpp0289639 Mapmodu
lin 
1.23 0.18 0.36 0.89 
FBpp0304830 AsnRS -1.03 0.01 0.15 0.99 FBpp0303170 mbf1 2.54 2.15 0.02 0.04 
FBpp0308483 AspRS 2.14 1.46 0.03 0.12 FBpp0081317 Mcm2 -1.54 -0.66 0.02 0.25 
FBpp0085891 Atg7 0.45 0.00 0.47 0.99 FBpp0309417 Mcm3 -1.12 -1.16 0.04 0.04 
FBpp0303150 Atox1 1.04 1.11 0.18 0.16 FBpp0081756 Mcm5 -0.61 -1.52 0.19 0.01 
FBpp0289825 ATPCL -0.64 -1.17 0.14 0.02 FBpp0070913 Mcm6 -0.65 -0.56 0.28 0.35 
FBpp0311086 ATPsynbet
a 
1.05 3.11 0.12 0.00 FBpp0076312 Mcm7 -1.88 -1.65 0.01 0.02 
FBpp0312191 awd 0.27 -0.53 0.53 0.23 FBpp0293887 MCTS1 -0.89 -2.01 0.11 0.00 
FBpp0300517 B52 -0.46 -0.88 0.21 0.03 FBpp0311560 Mdh1 -0.24 -0.82 0.72 0.23 
FBpp0307124 Bacc 1.79 2.40 0.00 0.00 FBpp0079565 me31B -0.95 -0.55 0.15 0.39 
FBpp0305308 baf 1.18 0.86 0.05 0.12 FBpp0288779 MEP-1 2.41 1.81 0.01 0.03 
FBpp0071235 Bap111 2.65 2.36 0.01 0.01 FBpp0085809 MetRS 2.29 1.90 0.02 0.05 
FBpp0086115 Bap55 1.56 0.91 0.08 0.28 FBpp0081882 mgr 0.05 -0.74 0.94 0.30 
FBpp0073572 Bap60 1.92 1.35 0.02 0.08 FBpp0304462 Mi-2 1.14 0.89 0.07 0.15 
FBpp0310394 barr 2.55 2.37 0.02 0.03 FBpp0300803 Mlc-c 1.08 1.71 0.07 0.01 
FBpp0306433 bel -0.88 -1.03 0.17 0.11 FBpp0303950 Mo25 -1.63 -1.91 0.26 0.19 
FBpp0305067 ben -2.35 -2.18 0.01 0.02 FBpp0301951 mod -2.41 -0.91 0.09 0.49 
FBpp0084021 beta-
PheRS 
-0.96 -0.82 0.07 0.11 FBpp0083470 mod(mdg
4) 
2.55 2.31 0.01 0.02 
FBpp0074348 betaCOP -0.50 -0.66 0.45 0.33 FBpp0300514 Moe -1.09 -1.11 0.11 0.11 
FBpp0085720 betaTub5
6D 
0.71 0.53 0.07 0.16 FBpp0075450 mop 0.20 -0.29 0.77 0.66 
FBpp0086896 bic 1.80 1.77 0.07 0.07 FBpp0291706 mor 1.60 1.40 0.02 0.03 
FBpp0082428 BigH1 0.20 0.52 0.69 0.30 FBpp0079802 mre11 3.25 3.02 0.00 0.00 
FBpp0071794 blw -0.31 0.07 0.81 0.96 FBpp0075399 Msh6 -0.62 -0.70 0.27 0.22 
FBpp0074430 bnb 1.56 1.77 0.02 0.01 FBpp0076408 msk -1.25 -0.21 0.35 0.87 
FBpp0305757 brm 1.96 1.92 0.02 0.02 FBpp0293342 msps 1.12 0.82 0.27 0.41 
FBpp0308293 Bub3 1.89 1.57 0.05 0.10 FBpp0304737 Mtor -0.18 0.21 0.75 0.70 
FBpp0310411 bur -1.35 -2.12 0.09 0.02 FBpp0310063 mts -2.27 -1.13 0.11 0.39 
FBpp0087402 Caf1-105 4.71 4.64 0.03 0.03 FBpp0073648 mus101 0.22 -0.37 0.82 0.71 
FBpp0071172 Caf1-180 3.15 2.47 0.02 0.05 FBpp0311887 Naa15-16 -2.02 -1.05 0.00 0.08 
FBpp0082511 Caf1-55 0.93 1.14 0.05 0.02 FBpp0084827 Naa40 -3.09 -1.82 0.00 0.04 
FBpp0306685 Calr -0.64 -0.45 0.37 0.53 FBpp0297132 Nap1 -0.47 -1.40 0.39 0.02 
FBpp0311269 Cam 3.15 3.33 0.02 0.02 FBpp0306828 NAT1 0.67 1.17 0.28 0.08 
FBpp0079795 cana -0.61 1.69 0.59 0.16 FBpp0311231 ncd 2.30 2.33 0.02 0.02 
FBpp0304507 Cand1 -1.78 0.33 0.02 0.60 FBpp0076693 ndl 0.61 0.35 0.27 0.51 
FBpp0290540 Cap-G 1.93 3.10 0.01 0.00 FBpp0309711 Nedd8 -0.73 0.30 0.40 0.72 
FBpp0304563 capt -0.58 0.08 0.33 0.89 FBpp0306756 Nlp 0.82 0.18 0.21 0.77 
FBpp0308803 casp -0.57 1.12 0.44 0.15 FBpp0076451 Nmt -0.85 0.51 0.39 0.60 
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FBpp0309380 Cbs 0.66 0.37 0.15 0.41 FBpp0309175 NO66 2.75 2.13 0.00 0.01 
FBpp0290166 Ccs -0.38 0.20 0.40 0.64 FBpp0072839 Non2 1.18 1.90 0.05 0.00 
FBpp0083684 CCT1 -1.04 -0.61 0.20 0.43 FBpp0078997 nop5 -3.57 -0.68 0.12 0.75 
FBpp0071226 CCT2 -0.42 -0.85 0.31 0.06 FBpp0083625 Nop56 -2.84 -1.23 0.03 0.31 
FBpp0291566 CCT3 -0.49 -1.01 0.29 0.05 FBpp0112220 Nph 0.99 -0.24 0.24 0.76 
FBpp0079992 CCT4 -0.96 -0.94 0.25 0.26 FBpp0289954 Npl4 0.06 0.12 0.92 0.83 
FBpp0087095 CCT5 -0.32 -1.98 0.68 0.03 FBpp0073438 Nrd1 -0.76 -0.14 0.22 0.81 
FBpp0073902 CCT6 -0.56 -1.64 0.22 0.00 FBpp0311095 Nsf2 0.56 -0.71 0.65 0.57 
FBpp0081401 CCT7 -0.73 -1.16 0.07 0.01 FBpp0075699 nst 0.54 1.04 0.39 0.12 
FBpp0087764 CCT8 -0.76 -1.18 0.08 0.01 FBpp0070637 Nsun2 -0.89 0.31 0.27 0.69 
FBpp0072660 Cdc37 0.06 -0.13 0.89 0.76 FBpp0305904 Ntf-2 -1.02 -1.11 0.09 0.07 
FBpp0079641 Cdk1 0.45 0.18 0.41 0.74 FBpp0297079 nudC -0.73 -1.45 0.23 0.03 
FBpp0082085 CG10038 0.22 -0.10 0.55 0.77 FBpp0309144 Nup153 -2.02 -0.15 0.09 0.89 
FBpp0305296 CG10077 -1.34 -0.19 0.32 0.88 FBpp0071905 Nup214 -0.13 -0.45 0.74 0.26 
FBpp0306293 CG10237 -3.32 -2.09 0.01 0.05 FBpp0084188 Nup358 -1.40 -0.90 0.01 0.05 
FBpp0306810 CG10254 -0.43 0.61 0.40 0.24 FBpp0087861 Nup50 -0.87 -0.39 0.07 0.39 
FBpp0073440 CG10347 -2.99 -1.76 0.01 0.09 FBpp0087063 Nup54 -2.42 -1.41 0.00 0.04 
FBpp0075686 CG10418 0.15 0.29 0.83 0.68 FBpp0083195 Nup58 -0.39 -1.22 0.70 0.25 
FBpp0074800 CG10424 1.33 0.63 0.02 0.22 FBpp0309066 Nup62 0.77 1.36 0.17 0.03 
FBpp0293954 CG10565 1.11 1.62 0.02 0.00 FBpp0073659 Nup93-1 0.36 0.91 0.46 0.08 
FBpp0311825 CG10576 -0.89 -0.98 0.23 0.20 FBpp0306915 Nup98-96 1.56 2.08 0.04 0.01 
FBpp0311505 CG10638 0.55 0.02 0.30 0.97 FBpp0072250 Nurf-38 0.49 -0.31 0.36 0.55 
FBpp0304491 CG10680 2.21 2.19 0.04 0.04 FBpp0309320 Obp19c 0.39 0.56 0.55 0.40 
FBpp0073028 CG10863 0.71 -0.22 0.33 0.75 FBpp0300672 p23 -0.43 -0.77 0.45 0.18 
FBpp0077583 CG10869 0.17 0.93 0.73 0.09 FBpp0080111 p38b 0.44 -0.04 0.43 0.94 
FBpp0099759 CG10973 0.14 -0.15 0.88 0.86 FBpp0088069 p47 0.21 0.46 0.53 0.20 
FBpp0292528 CG11089 0.13 -0.24 0.75 0.57 FBpp0083127 P5cr 1.21 0.54 0.03 0.27 
FBpp0304097 CG11134 -1.24 -0.64 0.25 0.54 FBpp0085919 pAbp -0.19 -0.44 0.78 0.53 
FBpp0309343 CG11164 0.74 0.29 0.19 0.58 FBpp0073976 Paf-
AHalpha 
-0.45 -1.58 0.24 0.00 
FBpp0306623 CG11334 0.27 0.15 0.50 0.70 FBpp0305933 Paics -0.11 -0.30 0.78 0.44 
FBpp0084190 CG11858 1.40 1.23 0.01 0.02 FBpp0112608 Parp 1.81 3.11 0.05 0.00 
FBpp0084759 CG11899 0.00 -0.24 1.00 0.55 FBpp0082124 Past1 -1.67 -1.10 0.04 0.15 
FBpp0081444 CG11980 0.97 0.07 0.11 0.90 FBpp0308430 pch2 -1.96 -0.75 0.20 0.61 
FBpp0072658 CG12018 -1.91 -1.16 0.19 0.41 FBpp0089395 PCNA 1.54 0.23 0.17 0.83 
FBpp0087483 CG12129 -1.36 -1.32 0.23 0.25 FBpp0075238 PDCD-5 0.45 0.12 0.50 0.86 
FBpp0078357 CG12171 -0.25 -1.14 0.64 0.05 FBpp0079527 Pen -2.60 -2.07 0.03 0.07 
FBpp0078279 CG1218 -1.47 -0.17 0.14 0.86 FBpp0078852 Pfas 0.29 -0.17 0.50 0.69 
FBpp0082125 CG12279 0.57 0.42 0.12 0.24 FBpp0309825 Pfdn1 0.73 0.43 0.09 0.29 
FBpp0083036 CG12321 -1.12 -0.99 0.03 0.05 FBpp0304954 Pfdn2 1.08 0.47 0.18 0.54 
FBpp0078370 CG1236 0.42 -0.42 0.42 0.42 FBpp0076858 Pfdn4 0.28 1.52 0.66 0.03 
FBpp0312072 CG12702 -1.16 0.62 0.10 0.35 FBpp0290701 Pfdn5 0.52 0.10 0.18 0.79 
FBpp0087406 CG12896 0.76 0.25 0.13 0.60 FBpp0303214 Pfdn6 0.33 0.40 0.46 0.37 
FBpp0307859 CG1354 -0.73 -1.44 0.08 0.00 FBpp0293464 Pfk -1.19 -1.01 0.15 0.21 
FBpp0085260 CG1416 -0.92 -1.34 0.06 0.01 FBpp0303827 Pgd -0.19 -0.44 0.69 0.36 
FBpp0311833 CG14207 0.34 -0.91 0.80 0.51 FBpp0087762 Pgi 0.80 0.32 0.12 0.49 
FBpp0083124 CG14286 0.30 0.20 0.52 0.66 FBpp0306279 Pgk 0.42 0.04 0.27 0.91 
FBpp0308525 CG1440 1.06 0.28 0.12 0.67 FBpp0099920 Pglym78 -0.59 -0.92 0.21 0.07 
FBpp0311823 CG14434 -0.62 -0.89 0.28 0.13 FBpp0075247 Pgm 0.17 -0.30 0.73 0.55 
FBpp0307945 CG14894 0.29 0.85 0.50 0.07 FBpp0072932 PHGPx 0.02 -0.37 0.97 0.40 
FBpp0074368 CG15047 2.13 1.98 0.00 0.01 FBpp0082177 pic 0.95 0.83 0.06 0.10 
FBpp0308695 CG1532 1.07 0.76 0.21 0.37 FBpp0084559 pins -3.03 -0.73 0.00 0.31 
FBpp0077145 CG15439 2.75 2.81 0.01 0.01 FBpp0076285 pix -2.06 -1.11 0.03 0.19 
FBpp0310939 CG15717 -1.67 -1.08 0.03 0.13 FBpp0307466 Pka-C1 -0.60 0.34 0.28 0.53 
FBpp0311370 CG1578 0.44 0.56 0.42 0.30 FBpp0087524 Pka-R2 -2.41 -1.86 0.07 0.15 
FBpp0308869 CG1640 0.55 0.15 0.18 0.70 FBpp0310466 Plap -0.74 -1.07 0.10 0.03 
FBpp0310240 CG1703 -1.61 -1.00 0.04 0.16 FBpp0075693 Pmm2 0.16 -0.82 0.77 0.15 
FBpp0082059 CG17202 1.46 1.28 0.04 0.06 FBpp0305301 poe -1.86 -1.59 0.04 0.07 
FBpp0298837 CG17266 -1.24 -0.78 0.19 0.40 FBpp0307818 Pol32 1.52 1.63 0.03 0.02 
FBpp0073235 CG17333 -0.33 0.61 0.71 0.50 FBpp0099722 polo -0.67 0.23 0.21 0.65 
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FBpp0085374 CG17337 0.46 -0.28 0.38 0.59 FBpp0292357 poly -1.16 -0.66 0.06 0.26 
FBpp0072956 CG17746 0.34 -0.89 0.63 0.22 FBpp0081704 pont 0.12 -0.15 0.77 0.71 
FBpp0080448 CG17904 -0.38 -0.95 0.45 0.08 FBpp0082067 Pp1-87B 2.41 1.93 0.02 0.04 
FBpp0271746 CG18190 -0.99 -1.12 0.25 0.20 FBpp0293227 Pp2A-29B -1.55 -1.27 0.03 0.06 
FBpp0303935 CG18815 -2.09 -2.29 0.04 0.03 FBpp0301546 Pp2B-14D -0.92 -0.53 0.10 0.32 
FBpp0085195 CG1890 1.16 0.48 0.08 0.44 FBpp0312200 Pp4-19C 0.42 -0.29 0.35 0.51 
FBpp0085198 CG1910 -4.35 -3.09 0.07 0.19 FBpp0304082 PpD3 0.23 0.90 0.61 0.07 
FBpp0306729 CG1943 1.95 0.85 0.12 0.47 FBpp0307839 PPP4R2r -0.88 -1.01 0.06 0.04 
FBpp0311995 CG2004 -0.05 0.08 0.92 0.85 FBpp0293248 Prat 1.43 1.20 0.04 0.07 
FBpp0078327 CG2091 -1.96 -1.75 0.01 0.02 FBpp0099895 primo-1 0.28 -0.52 0.64 0.39 
FBpp0309262 CG2200 0.70 -0.14 0.19 0.78 FBpp0082062 Prosalpha
2 
0.66 0.56 0.10 0.15 
FBpp0307424 CG2246 -0.32 0.22 0.49 0.64 FBpp0071451 Prosalpha
3 
0.92 0.38 0.22 0.60 
FBpp0081312 CG2767 1.20 -0.37 0.14 0.63 FBpp0073989 Prosalpha
4 
0.16 0.53 0.66 0.18 
FBpp0311613 CG2852 -0.33 0.28 0.54 0.61 FBpp0086067 Prosalpha
5 
0.43 0.56 0.23 0.13 
FBpp0307127 CG2862 0.04 0.16 0.93 0.76 FBpp0310201 Prosalpha
6 
1.08 0.37 0.13 0.59 
FBpp0086057 CG30105 1.64 2.40 0.01 0.00 FBpp0089041 Prosalpha
7 
0.89 -0.12 0.33 0.89 
FBpp0291433 CG30382 0.75 0.31 0.22 0.60 FBpp0086400 Prosbeta1 0.82 1.44 0.06 0.00 
FBpp0301728 CG30499 -0.55 -0.02 0.42 0.97 FBpp0075382 Prosbeta2 1.42 1.19 0.01 0.02 
FBpp0300161 CG31075 0.38 0.01 0.34 0.98 FBpp0081488 Prosbeta3 0.55 0.16 0.22 0.71 
FBpp0084237 CG31098 -1.02 -0.82 0.30 0.40 FBpp0307141 Prosbeta4 0.56 0.98 0.19 0.03 
FBpp0307202 CG31549 -0.22 -0.93 0.61 0.05 FBpp0087320 Prosbeta5 1.25 0.60 0.05 0.31 
FBpp0308642 CG31673 0.59 0.63 0.14 0.12 FBpp0075119 Prosbeta6 0.92 0.60 0.13 0.30 
FBpp0303949 CG32164 -0.84 -1.30 0.05 0.01 FBpp0078449 Prosbeta7 0.73 0.03 0.27 0.97 
FBpp0070953 CG3226 -1.55 -0.97 0.02 0.11 FBpp0085902 Prp19 1.36 1.34 0.02 0.02 
FBpp0082211 CG32473 1.00 1.45 0.27 0.12 FBpp0100080 Prx5 0.37 -0.11 0.56 0.87 
FBpp0309368 CG32549 -0.53 -2.48 0.57 0.02 FBpp0077368 Prx6005 0.70 -0.31 0.16 0.52 
FBpp0311482 CG33722 -0.03 -0.64 0.95 0.14 FBpp0072583 Psa 0.76 -0.03 0.20 0.96 
FBpp0078978 CG3430 -1.89 -1.39 0.00 0.01 FBpp0086222 Psi 0.78 1.53 0.27 0.05 
FBpp0076204 CG3448 4.60 4.29 0.00 0.00 FBpp0083238 psidin -1.39 -1.46 0.04 0.03 
FBpp0303858 CG3609 1.40 1.15 0.15 0.22 FBpp0077277 Ptpa -1.98 -0.43 0.06 0.66 
FBpp0301181 CG3760 1.22 0.29 0.14 0.71 FBpp0082932 Pxt -0.08 0.05 0.84 0.90 
FBpp0310197 CG3939 -1.89 -0.87 0.09 0.41 FBpp0083611 PyK 0.92 -0.22 0.17 0.72 
FBpp0110481 CG40045 -2.62 0.56 0.16 0.75 FBpp0304178 pzg 1.78 3.40 0.09 0.01 
FBpp0075697 CG4069 -0.61 -0.55 0.44 0.49 FBpp0076788 QC -0.19 -0.37 0.88 0.78 
FBpp0291627 CG4199 1.34 0.66 0.04 0.26 FBpp0309142 r 0.16 -0.36 0.80 0.58 
FBpp0288574 CG42232 5.26 4.34 0.00 0.01 FBpp0083440 r-l -1.11 -1.48 0.01 0.00 
FBpp0080392 CG4278 2.38 0.93 0.03 0.34 FBpp0083503 Rab1 -0.51 -0.12 0.23 0.77 
FBpp0292832 CG42813 -0.27 -0.13 0.64 0.82 FBpp0083414 Rab11 -1.63 -1.77 0.07 0.06 
FBpp0083246 CG4390 1.81 0.97 0.02 0.17 FBpp0307641 Rab2 -0.30 1.98 0.74 0.05 
FBpp0308683 CG4408 0.04 -0.14 0.94 0.80 FBpp0303520 Rab5 -0.69 1.79 0.45 0.07 
FBpp0309989 CG4593 -0.69 -0.97 0.18 0.07 FBpp0311572 Rack1 0.26 0.17 0.65 0.76 
FBpp0304189 CG4603 -0.94 -0.49 0.05 0.26 FBpp0305835 Rad23 -0.43 -0.06 0.52 0.93 
FBpp0311588 CG4646 1.02 -0.76 0.43 0.55 FBpp0293866 rad50 4.20 3.30 0.01 0.02 
FBpp0071743 CG4752 0.98 1.29 0.04 0.01 FBpp0071600 Rae1 2.24 2.72 0.01 0.00 
FBpp0084626 CG4849 -0.77 0.31 0.32 0.68 FBpp0309151 Ran -0.84 -1.13 0.10 0.03 
FBpp0074113 CG4872 0.08 0.19 0.87 0.71 FBpp0309478 Ranbp21 -1.25 -0.37 0.10 0.60 
FBpp0303029 CG5098 3.12 3.51 0.01 0.00 FBpp0307011 RanBP3 -1.26 -0.57 0.08 0.39 
FBpp0085863 CG5174 0.78 0.67 0.19 0.26 FBpp0312218 Ranbp9 -0.46 -0.93 0.32 0.06 
FBpp0079637 CG5355 0.22 0.48 0.62 0.29 FBpp0306292 RanGAP -1.72 -1.35 0.01 0.02 
FBpp0311410 CG5515 -1.57 -0.22 0.02 0.71 FBpp0309791 ras -1.17 -1.67 0.02 0.00 
FBpp0076733 CG5568 -0.29 -0.52 0.70 0.49 FBpp0304602 Rat1 0.66 0.91 0.55 0.41 
FBpp0303030 CG5757 -0.97 -0.41 0.11 0.48 FBpp0076784 Rcc1 4.27 5.17 0.01 0.00 
FBpp0083584 CG6028 0.98 0.71 0.04 0.11 FBpp0076452 RecQ4 -1.37 -0.31 0.12 0.71 
FBpp0303937 CG6084 0.64 -0.05 0.29 0.93 FBpp0302766 REG -0.99 -0.65 0.17 0.35 
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FBpp0079979 CG6180 -1.52 -0.24 0.22 0.84 FBpp0073422 regucalcin 0.33 0.78 0.47 0.11 
FBpp0083213 CG6195 -1.17 -0.08 0.32 0.94 FBpp0311247 rept -0.25 0.05 0.52 0.90 
FBpp0079809 CG6287 1.10 0.26 0.07 0.64 FBpp0079609 RfC3 1.61 1.59 0.01 0.01 
FBpp0080044 CG6523 -0.10 -0.06 0.81 0.89 FBpp0311114 RfC38 1.35 0.69 0.14 0.43 
FBpp0074386 CG6617 0.38 -0.02 0.66 0.98 FBpp0073120 RfC4 2.11 2.59 0.00 0.00 
FBpp0310703 CG6726 0.42 -0.17 0.36 0.70 FBpp0305320 rhea -1.02 -0.07 0.11 0.91 
FBpp0311284 CG6767 -1.10 -1.80 0.18 0.04 FBpp0089130 Rho1 -0.82 -1.54 0.14 0.01 
FBpp0309927 CG6907 -1.35 -1.15 0.16 0.22 FBpp0304185 RhoGDI -0.96 -1.08 0.17 0.13 
FBpp0081996 CG6950 0.40 0.17 0.28 0.64 FBpp0312064 rin 0.09 -0.53 0.88 0.39 
FBpp0311665 CG7182 0.83 0.47 0.11 0.34 FBpp0310006 rngo -0.89 -0.18 0.05 0.66 
FBpp0311891 CG7322 -0.04 -1.11 0.96 0.17 FBpp0079648 RnrL -1.15 -0.27 0.08 0.66 
FBpp0309678 CG7332 -1.58 0.17 0.12 0.86 FBpp0087152 RnrS -0.23 -0.79 0.61 0.11 
FBpp0304957 CG7519 -2.11 -0.57 0.01 0.40 FBpp0086076 robl 0.30 0.71 0.42 0.08 
FBpp0304452 CG7546 -0.57 -0.13 0.25 0.78 FBpp0085156 rod -1.94 -2.61 0.27 0.15 
FBpp0084849 CG7789 -1.00 0.30 0.26 0.72 FBpp0081356 RpA-70 1.45 1.04 0.17 0.31 
FBpp0082183 CG7966 0.03 -0.41 0.96 0.47 FBpp0305226 RPA2 1.22 1.10 0.11 0.14 
FBpp0082187 CG8031 1.06 0.87 0.03 0.06 FBpp0310183 RPA3 1.13 1.58 0.03 0.01 
FBpp0081371 CG8036 1.15 0.32 0.11 0.63 FBpp0310926 RpII140 -1.95 0.53 0.05 0.55 
FBpp0081507 CG8132 1.33 1.76 0.02 0.01 FBpp0309436 RpL11 -1.26 -0.08 0.05 0.89 
FBpp0074246 CG8142 3.04 2.19 0.03 0.09 FBpp0311459 RpL17 -1.63 -2.10 0.18 0.10 
FBpp0081539 CG8149 2.05 1.50 0.03 0.09 FBpp0071808 RpL23 -1.40 -1.02 0.08 0.19 
FBpp0076470 CG8209 -0.50 0.14 0.38 0.80 FBpp0305858 RpL26 -0.05 -1.03 0.95 0.23 
FBpp0081398 CG8223 0.61 1.00 0.17 0.04 FBpp0309280 RpL30 -0.87 -0.63 0.34 0.48 
FBpp0087116 CG8858 -0.34 -0.77 0.56 0.21 FBpp0078416 RpL35A -1.86 -1.55 0.21 0.29 
FBpp0078684 CG8891 -0.43 -0.63 0.30 0.14 FBpp0084617 RpL4 -2.87 -2.20 0.04 0.10 
FBpp0303670 CG8892 -0.45 -0.38 0.45 0.52 FBpp0311121 RpL5 0.52 -0.09 0.52 0.91 
FBpp0074128 CG9132 -0.58 -0.60 0.19 0.18 FBpp0310250 RpL7 -2.20 -0.22 0.13 0.87 
FBpp0311963 CG9135 1.63 0.30 0.10 0.74 FBpp0072802 RpL8 -1.32 -1.18 0.14 0.18 
FBpp0072560 CG9149 0.22 0.00 0.55 1.00 FBpp0309201 RpL9 2.42 2.61 0.05 0.04 
FBpp0309269 CG9281 -2.21 -1.41 0.00 0.04 FBpp0306232 RpLP0 -2.00 -0.98 0.01 0.14 
FBpp0082298 CG9286 -0.40 -0.91 0.46 0.11 FBpp0304265 RpLP1 0.91 0.31 0.21 0.66 
FBpp0296988 CG9391 -0.84 0.44 0.29 0.57 FBpp0086252 RpLP2 0.47 1.01 0.32 0.05 
FBpp0085467 CG9436 0.11 -0.46 0.75 0.21 FBpp0074662 Rpn1 -2.27 -2.43 0.00 0.00 
FBpp0112123 CG9471 -1.56 -1.13 0.03 0.09 FBpp0305644 Rpn10 -1.16 -1.31 0.02 0.01 
FBpp0081343 CG9601 2.18 2.84 0.01 0.00 FBpp0078664 Rpn11 -0.50 0.11 0.30 0.81 
FBpp0075103 CG9674 0.08 0.16 0.84 0.69 FBpp0075068 Rpn12 -0.04 -0.30 0.92 0.42 
FBpp0305784 CG9705 1.04 0.04 0.26 0.96 FBpp0112987 Rpn13 -0.33 -0.34 0.36 0.35 
FBpp0071542 CG9752 0.77 -0.14 0.18 0.80 FBpp0306599 Rpn2 -1.28 0.44 0.15 0.60 
FBpp0308531 Chc -2.01 -2.08 0.02 0.02 FBpp0307804 Rpn3 -1.39 -1.76 0.01 0.00 
FBpp0301152 chic 0.04 -0.23 0.93 0.63 FBpp0078278 Rpn5 -0.16 -1.10 0.71 0.02 
FBpp0083939 CHORD -2.36 -1.41 0.02 0.14 FBpp0297513 Rpn6 -0.24 -1.39 0.69 0.04 
FBpp0099657 Chrac-14 3.58 3.43 0.01 0.01 FBpp0083687 Rpn7 -1.66 -1.33 0.07 0.13 
FBpp0308688 Chrac-16 3.42 2.84 0.02 0.04 FBpp0305141 Rpn8 -1.31 -1.47 0.02 0.01 
FBpp0086590 Ciao1 0.99 1.00 0.07 0.07 FBpp0083861 Rpn9 -0.72 -1.11 0.17 0.05 
FBpp0310070 cib 0.76 0.78 0.18 0.17 FBpp0310720 RpS10b -1.38 -0.70 0.10 0.37 
FBpp0070064 cin 0.67 -0.84 0.49 0.39 FBpp0075612 RpS12 0.17 0.14 0.70 0.76 
FBpp0311360 CkIIalpha -1.65 -2.44 0.21 0.08 FBpp0312104 RpS13 -0.03 -0.10 0.98 0.93 
FBpp0079399 Cks30A 1.30 0.64 0.10 0.40 FBpp0311458 RpS14b 0.95 0.54 0.20 0.45 
FBpp0303003 cl 0.63 0.04 0.24 0.94 FBpp0290052 RpS15Aa -0.98 -1.23 0.10 0.05 
FBpp0305007 Clc 1.84 1.83 0.00 0.00 FBpp0309759 RpS16 -2.58 -2.47 0.11 0.13 
FBpp0305372 clu 0.53 -0.74 0.45 0.31 FBpp0076207 RpS17 -0.13 -0.88 0.86 0.24 
FBpp0292516 CNBP 2.52 1.33 0.05 0.27 FBpp0085586 RpS18 -2.16 -1.54 0.03 0.09 
FBpp0301625 cnn 0.13 0.47 0.82 0.42 FBpp0311350 RpS19a -0.62 0.15 0.38 0.83 
FBpp0307640 coro -1.94 -2.04 0.03 0.02 FBpp0311561 RpS2 -1.43 -0.85 0.13 0.35 
FBpp0308977 Cp1 0.50 -0.27 0.55 0.75 FBpp0307130 RpS21 0.40 0.15 0.50 0.80 
FBpp0071150 Cp36 2.06 2.01 0.02 0.02 FBpp0308991 RpS23 0.09 -0.35 0.92 0.69 
FBpp0071461 cpa -0.37 -0.29 0.50 0.59 FBpp0071846 RpS24 -4.00 -3.90 0.03 0.03 
FBpp0304020 cpb 0.84 0.05 0.08 0.91 FBpp0081846 RpS25 -0.57 -1.15 0.27 0.04 
FBpp0080484 Cse1 -0.58 -0.69 0.29 0.22 FBpp0312181 RpS26 0.96 1.76 0.36 0.11 
FBpp0074841 CSN1b -3.07 -1.59 0.07 0.32 FBpp0310057 RpS28b 0.60 0.44 0.19 0.32 
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FBpp0077927 CSN3 -1.61 -0.78 0.18 0.49 FBpp0312066 RpS3 1.07 0.81 0.10 0.20 
FBpp0290448 CSN4 -1.40 -1.90 0.21 0.10 FBpp0300615 RpS3A 0.68 -0.27 0.46 0.77 
FBpp0082743 CSN5 -1.35 -0.96 0.01 0.03 FBpp0312080 RpS4 -1.61 -1.37 0.01 0.02 
FBpp0083658 CSN6 -0.39 -0.95 0.50 0.12 FBpp0071087 RpS6 -0.94 -1.22 0.07 0.03 
FBpp0087821 CSN7 -2.18 -2.54 0.00 0.00 FBpp0308324 RpS7 -2.53 -2.32 0.02 0.03 
FBpp0083075 CstF64 1.35 1.27 0.05 0.06 FBpp0311987 RpS8 -0.70 -0.56 0.41 0.51 
FBpp0306584 CtBP -0.55 -0.46 0.16 0.23 FBpp0088021 Rpt1 0.05 0.10 0.89 0.79 
FBpp0086732 Ctf4 0.04 0.09 0.93 0.84 FBpp0311982 Rpt2 -0.74 -0.79 0.07 0.05 
FBpp0311740 CTPsyn -0.96 -1.35 0.06 0.01 FBpp0312031 Rpt3 0.48 0.71 0.49 0.32 
FBpp0291369 Cul3 -0.78 -0.98 0.54 0.45 FBpp0293948 Rpt4 -0.73 -0.77 0.07 0.06 
FBpp0290569 Cul4 -2.45 -1.40 0.11 0.33 FBpp0083843 Rpt5 -0.97 -0.90 0.25 0.29 
FBpp0312102 cup -0.87 -0.29 0.13 0.60 FBpp0076890 Rpt6 -0.60 -1.15 0.17 0.02 
FBpp0074017 Cyp1 0.93 0.29 0.07 0.53 FBpp0077362 Rrp1 3.74 2.55 0.05 0.16 
FBpp0086373 CysRS 1.04 0.45 0.04 0.32 FBpp0311555 Rrp40 -0.28 -0.34 0.52 0.43 
FBpp0290739 D1 1.93 1.53 0.04 0.10 FBpp0081601 rump -0.43 0.38 0.34 0.40 
FBpp0084349 Dak1 -0.80 -0.75 0.06 0.07 FBpp0305462 S6k -1.17 -0.19 0.36 0.88 
FBpp0075498 DCTN1-
p150 
-1.13 -1.00 0.12 0.16 FBpp0089284 Sar1 2.80 2.55 0.02 0.03 
FBpp0087722 DCTN2-
p50 
0.58 0.01 0.18 0.98 FBpp0074285 scu 2.79 1.31 0.01 0.14 
FBpp0071098 dec-01 1.37 1.67 0.06 0.02 FBpp0311988 Sec13 -0.11 0.15 0.80 0.73 
FBpp0291138 deltaCOP -2.04 -0.71 0.01 0.29 FBpp0308424 Sec23 -0.23 0.22 0.57 0.60 
FBpp0099688 Df31 1.64 1.38 0.01 0.02 FBpp0303000 Sec24CD -0.18 0.03 0.85 0.97 
FBpp0309535 dgt2 0.12 -0.33 0.81 0.53 FBpp0311417 Sec31 -1.70 -0.46 0.01 0.37 
FBpp0305386 dgt4 1.00 1.64 0.16 0.03 FBpp0086691 SelD -2.23 -1.93 0.01 0.02 
FBpp0308700 dgt5 -1.61 -0.53 0.01 0.28 FBpp0076897 Sep 01 -0.51 0.40 0.39 0.50 
FBpp0304991 Dhc64C -1.74 -1.90 0.07 0.05 FBpp0307454 SerRS -0.25 0.14 0.63 0.80 
FBpp0078625 DhpD -0.12 0.83 0.85 0.20 FBpp0082521 Set 0.53 0.57 0.21 0.18 
FBpp0099973 Dhpr -0.24 -0.26 0.84 0.82 FBpp0293269 SF2 2.32 0.71 0.06 0.53 
FBpp0307849 Dhx15 -1.39 -0.92 0.05 0.16 FBpp0072494 Sf3b3 0.39 0.49 0.55 0.45 
FBpp0311421 Dip-B 1.49 0.99 0.00 0.03 FBpp0296963 Sgt 0.21 -0.01 0.60 0.98 
FBpp0073300 Dlic -0.48 -0.67 0.31 0.17 FBpp0309359 shi -0.96 -0.15 0.11 0.79 
FBpp0076830 DnaJ-1 -0.75 0.42 0.13 0.39 FBpp0311477 Shmt 0.13 -0.10 0.76 0.82 
FBpp0072041 DNAlig1 -1.01 -1.35 0.02 0.00 FBpp0087704 shrb 1.28 0.88 0.17 0.33 
FBpp0073678 DNAlig4 0.60 0.55 0.54 0.58 FBpp0081710 sle 1.50 1.60 0.03 0.02 
FBpp0083514 DNApol-
alpha180 
-1.31 -1.81 0.09 0.03 FBpp0086591 SMC2 2.76 2.70 0.00 0.01 
FBpp0113035 DNApol-
alpha73 
-0.19 -0.25 0.82 0.77 FBpp0074065 SMC3 2.00 2.25 0.00 0.00 
FBpp0075277 DNApol-
delta 
-1.19 -0.90 0.13 0.24 FBpp0081234 SmD2 -1.37 -0.54 0.13 0.52 
FBpp0311418 Dp1 -0.95 -0.81 0.14 0.20 FBpp0079182 SmE -0.06 -0.47 0.91 0.33 
FBpp0311783 dpa -0.59 -0.49 0.25 0.33 FBpp0305596 smid -1.06 -0.82 0.14 0.24 
FBpp0083673 Dph5 -0.81 -0.04 0.16 0.94 FBpp0302954 Smn -1.19 0.53 0.27 0.61 
FBpp0081331 DppIII 0.24 -0.12 0.53 0.75 FBpp0312081 Sms 0.03 0.53 0.96 0.49 
FBpp0079701 Dpy-30L1 1.26 1.13 0.04 0.06 FBpp0078984 smt3 1.25 -0.05 0.32 0.97 
FBpp0072744 dre4 2.85 2.99 0.00 0.00 FBpp0290893 sn -0.13 -0.83 0.83 0.19 
FBpp0082223 Droj2 -0.51 -0.70 0.30 0.17 FBpp0078331 Snr1 1.82 1.60 0.03 0.05 
FBpp0307166 Drp1 -1.66 -1.57 0.02 0.02 FBpp0111906 SNRPG -0.03 0.66 0.94 0.09 
FBpp0308813 Dsp1 2.89 2.91 0.01 0.01 FBpp0077206 Snx1 -1.17 0.36 0.14 0.64 
FBpp0079746 dUTPase 0.77 -0.41 0.31 0.58 FBpp0297300 Snx6 -2.45 -1.26 0.02 0.16 
FBpp0305157 Eb1 0.41 0.58 0.45 0.29 FBpp0075958 Sod1 0.17 0.06 0.65 0.88 
FBpp0311273 eEF1alpha
1 
-0.66 -0.54 0.12 0.19 FBpp0072164 spag -0.29 -0.02 0.51 0.97 
FBpp0311691 eEF1beta 1.04 0.91 0.04 0.07 FBpp0297149 SpdS -0.29 -0.64 0.63 0.30 
FBpp0079542 eEF1delta 0.13 -0.37 0.81 0.50 FBpp0310470 spel1 -1.43 -0.67 0.11 0.44 
FBpp0305182 eEF2 0.09 -0.71 0.85 0.18 FBpp0071184 Sptr 0.24 0.31 0.68 0.59 
FBpp0072082 eEF5 0.33 -0.39 0.58 0.51 FBpp0082320 sqd -0.98 1.32 0.34 0.21 
FBpp0307824 eff -3.72 -2.38 0.04 0.15 FBpp0076244 Srp68 -2.48 -0.54 0.04 0.61 
FBpp0310418 eIF1A 0.43 -0.11 0.57 0.88 FBpp0079211 Ssb-c31a 0.03 0.47 0.94 0.31 
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FBpp0309768 eIF2alpha -0.79 -0.60 0.06 0.13 FBpp0072151 Ssrp 0.91 0.83 0.06 0.08 
FBpp0075700 eIF2beta 0.55 -1.07 0.47 0.18 FBpp0308666 sta -0.94 -0.48 0.25 0.55 
FBpp0307983 eIF2gamm
a 
-0.13 -0.48 0.78 0.32 FBpp0078827 stai 1.24 0.70 0.10 0.34 
FBpp0312226 eIF3a -0.70 -0.81 0.18 0.13 FBpp0077790 Stip1 1.00 1.19 0.05 0.02 
FBpp0086098 eIF3b -0.73 -0.62 0.44 0.51 FBpp0082134 Su(fu) -2.72 -1.41 0.02 0.19 
FBpp0309235 eIF3c -0.86 -0.66 0.43 0.54 FBpp0079252 Su(var)20
5 
2.41 1.46 0.10 0.30 
FBpp0088565 eIF3d1 -1.26 -0.50 0.21 0.61 FBpp0309319 sw 0.96 0.90 0.17 0.20 
FBpp0075104 eIF3e 0.69 1.65 0.61 0.23 FBpp0303744 swm -0.23 -0.35 0.70 0.57 
FBpp0070430 eIF3g1 -1.16 -0.32 0.07 0.59 FBpp0085422 sxc -1.67 -0.26 0.02 0.67 
FBpp0089133 eIF3h -2.66 -1.41 0.05 0.27 FBpp0304719 tacc 1.66 1.75 0.06 0.05 
FBpp0078689 eIF3i 0.33 1.43 0.63 0.06 FBpp0072050 Taldo 0.92 1.00 0.04 0.03 
FBpp0308512 eIF3j 0.63 0.50 0.14 0.23 FBpp0304616 Tbc1d15-
17 
-0.42 1.50 0.68 0.16 
FBpp0075754 eIF3l -3.36 -2.69 0.03 0.07 FBpp0085690 TBCB -0.04 -0.18 0.95 0.78 
FBpp0308985 eIF3m -1.10 -0.71 0.02 0.11 FBpp0081820 Tctp 0.38 0.30 0.29 0.40 
FBpp0303628 eIF4A -0.35 -0.52 0.37 0.19 FBpp0087479 TER94 -0.69 -1.50 0.18 0.01 
FBpp0112403 eIF4B 0.66 1.63 0.22 0.01 FBpp0083355 TFAM 6.15 6.17 0.00 0.00 
FBpp0306017 eIF4E1 -0.30 -0.68 0.69 0.38 FBpp0304751 TfIIS 2.10 1.18 0.05 0.23 
FBpp0288389 eIF4G1 -0.98 -0.17 0.06 0.71 FBpp0312095 ThrRS -0.24 0.06 0.63 0.90 
FBpp0310226 eIF4H1 0.68 -0.04 0.51 0.97 FBpp0082180 timeout -0.28 -1.52 0.76 0.13 
FBpp0089140 eIF5 -0.97 -1.64 0.17 0.03 FBpp0088899 Tm1 1.38 1.93 0.02 0.00 
FBpp0301573 eIF5B -1.39 -0.25 0.05 0.70 FBpp0305273 Tnpo -3.05 -4.15 0.06 0.02 
FBpp0072144 eIF6 -1.54 -1.19 0.12 0.22 FBpp0304598 Top2 6.24 5.12 0.00 0.00 
FBpp0311547 Eip55E 0.16 -0.05 0.66 0.89 FBpp0084950 Tpi 0.55 0.08 0.17 0.83 
FBpp0083354 EloB 1.44 0.30 0.15 0.75 FBpp0310608 TppII 0.39 0.09 0.61 0.91 
FBpp0085725 EloC 0.31 0.85 0.65 0.23 FBpp0304888 tral 0.35 0.85 0.48 0.11 
FBpp0079278 emb -2.70 -1.53 0.02 0.14 FBpp0081461 TrpRS -1.38 -0.72 0.13 0.41 
FBpp0303860 EndoGI 0.68 -0.51 0.31 0.45 FBpp0087398 trsn -0.56 -1.50 0.39 0.04 
FBpp0305267 endos 1.36 0.12 0.20 0.91 FBpp0079437 Trx-2 -0.41 0.29 0.76 0.83 
FBpp0077574 Eno 0.90 0.36 0.11 0.50 FBpp0071115 Trxr-1 0.27 0.16 0.50 0.69 
FBpp0078891 epsilonCO
P 
-0.65 -0.68 0.17 0.16 FBpp0310349 Ts -0.40 0.88 0.46 0.12 
FBpp0304201 eRF1 -2.66 -2.02 0.01 0.03 FBpp0312205 Tsf1 0.28 0.30 0.47 0.45 
FBpp0311174 eRF3 -1.02 -0.15 0.04 0.73 FBpp0072097 tsr 0.14 0.21 0.72 0.59 
FBpp0087164 ERp60 1.23 -0.37 0.16 0.65 FBpp0112273 Ttd14 -1.50 0.41 0.18 0.70 
FBpp0099726 fabp -0.96 -0.96 0.04 0.04 FBpp0087973 TTLL12 -3.30 -1.31 0.03 0.32 
FBpp0308326 faf -1.06 -0.98 0.03 0.04 FBpp0071508 tud -0.87 -0.67 0.40 0.51 
FBpp0307371 FASN1 -0.20 0.48 0.80 0.53 FBpp0304417 Tudor-SN -1.40 -0.67 0.08 0.38 
FBpp0081767 Fdh 0.84 0.26 0.13 0.62 FBpp0082352 twf -0.65 -0.57 0.15 0.20 
FBpp0083551 fit 1.04 0.17 0.36 0.88 FBpp0311386 tws -0.28 -0.57 0.49 0.18 
FBpp0085703 Fkbp12 0.85 -0.04 0.24 0.96 FBpp0076804 Txl 0.98 1.04 0.30 0.28 
FBpp0082574 Fkbp39 -0.65 -0.51 0.17 0.27 FBpp0311757 tyf -0.44 0.39 0.63 0.67 
FBpp0309663 Fkbp59 -0.54 -0.11 0.23 0.79 FBpp0075168 TyrRS 0.21 -0.47 0.59 0.23 
FBpp0075581 flr 1.27 0.82 0.05 0.18 FBpp0077912 tzn 2.50 2.31 0.01 0.02 
FBpp0300445 Fmr1 0.51 1.02 0.35 0.08 FBpp0087583 Uba1 -0.68 -0.71 0.15 0.13 
FBpp0304176 fmt -1.54 -0.51 0.05 0.47 FBpp0076457 Uba2 -0.98 -1.28 0.20 0.11 
FBpp0307904 Fnta 0.03 -0.68 0.94 0.12 FBpp0305606 Uba4 -2.71 -1.30 0.00 0.01 
FBpp0290502 fon 2.47 1.81 0.02 0.08 FBpp0073354 Uba5 -0.95 -0.09 0.23 0.91 
FBpp0294038 Fs(2)Ket -0.65 -0.25 0.10 0.49 FBpp0088522 Ubc10 -3.05 -1.33 0.08 0.40 
FBpp0303129 gammaCO
P 
-0.96 -1.08 0.20 0.16 FBpp0311673 Ubc4 -0.54 0.33 0.50 0.67 
FBpp0304827 gammaTu
b37C 
-0.80 -0.64 0.04 0.08 FBpp0085529 ubl 1.28 0.61 0.13 0.44 
FBpp0099914 Gapdh1 0.92 0.92 0.06 0.06 FBpp0309477 Ubqn -0.37 0.58 0.61 0.42 
FBpp0304864 Gapdh2 1.42 1.06 0.01 0.02 FBpp0292511 Uch -1.03 -0.63 0.11 0.31 
FBpp0308722 Gart 0.14 -0.30 0.70 0.40 FBpp0306000 Uch-L5 -0.70 -0.59 0.09 0.15 
FBpp0311558 Gdi 0.51 -0.55 0.38 0.35 FBpp0311276 Uev1A -0.55 1.04 0.46 0.18 
FBpp0079819 Ge-1 -0.30 -0.95 0.75 0.33 FBpp0086402 Ufc1 -0.75 -0.20 0.52 0.86 
 - Appendix - 
 157 
FBpp0071406 Gip -0.22 -0.67 0.59 0.13 FBpp0075952 Ufd1-like -0.67 -0.55 0.08 0.14 
FBpp0077263 gkt 3.15 2.85 0.01 0.01 FBpp0290913 UGP -1.47 -1.42 0.01 0.01 
FBpp0084240 GlnRS 1.32 0.08 0.01 0.85 FBpp0304650 UK114 0.59 0.62 0.13 0.12 
FBpp0088085 Glo1 0.78 0.24 0.08 0.56 FBpp0081284 unc-45 -0.65 -0.15 0.25 0.78 
FBpp0310754 glob1 1.35 1.23 0.14 0.17 FBpp0311454 und -1.68 -1.94 0.01 0.01 
FBpp0080489 glu 2.62 2.54 0.01 0.01 FBpp0311664 Unr -0.39 0.70 0.38 0.13 
FBpp0083898 GluProRS 2.23 1.39 0.07 0.23 FBpp0087607 Updo 0.24 0.69 0.76 0.38 
FBpp0099923 GlyP -0.15 -0.58 0.74 0.22 FBpp0304059 Usp14 -1.73 -2.27 0.00 0.00 
FBpp0306062 GlyRS -1.06 -1.32 0.05 0.02 FBpp0298309 Usp5 -0.99 -1.06 0.06 0.05 
FBpp0305474 GlyS -3.23 -1.99 0.07 0.23 FBpp0309600 Usp7 -0.59 -1.12 0.57 0.29 
FBpp0071816 Gmer 0.45 1.01 0.41 0.08 FBpp0305353 ValRS -0.71 -0.66 0.13 0.16 
FBpp0099511 Gnf1 3.59 3.13 0.01 0.02 FBpp0311933 Vha13 -2.29 -0.97 0.28 0.64 
FBpp0086371 Got1 1.60 0.66 0.03 0.30 FBpp0311965 Vha26 -0.54 -0.67 0.15 0.09 
FBpp0077536 Got2 0.42 -0.05 0.38 0.91 FBpp0086468 Vha36-1 -1.24 -1.05 0.01 0.02 
FBpp0084623 Gp93 0.55 1.38 0.68 0.32 FBpp0086320 Vha44 -2.14 -1.98 0.02 0.03 
FBpp0305432 Gpdh1 -0.18 -1.11 0.66 0.02 FBpp0290875 Vha55 -0.06 -0.33 0.88 0.36 
FBpp0080649 Grip71 -2.59 -0.36 0.03 0.73 FBpp0307597 Vha68-2 0.02 -0.28 0.96 0.50 
FBpp0308932 gro -0.09 0.50 0.91 0.50 FBpp0307142 VhaSFD -0.83 0.24 0.32 0.77 
FBpp0310520 grsm 0.18 -0.23 0.67 0.58 FBpp0310907 vib -0.68 0.08 0.11 0.84 
FBpp0290201 Gss2 -0.64 -0.24 0.17 0.59 FBpp0112266 vig2 1.36 2.34 0.06 0.00 
FBpp0099824 GstD1 -0.23 0.02 0.70 0.97 FBpp0075690 vih -1.58 -1.37 0.05 0.08 
FBpp0311692 GstE11 -0.65 -0.58 0.70 0.73 FBpp0309623 Vinc -0.87 -0.98 0.31 0.26 
FBpp0291657 GstE13 -1.32 -0.97 0.17 0.30 FBpp0300187 vlc 0.05 1.06 0.92 0.06 
FBpp0085855 GstE6 0.20 -1.29 0.70 0.03 FBpp0077625 Vps29 1.30 2.02 0.34 0.15 
FBpp0076376 GstO1 0.19 1.43 0.78 0.06 FBpp0309628 Vps4 -2.32 -2.29 0.00 0.00 
FBpp0076377 GstO2 0.36 0.89 0.35 0.04 FBpp0305334 Vps60 1.91 2.20 0.01 0.00 
FBpp0099646 GstS1 0.35 0.30 0.53 0.59 FBpp0304416 wac 1.73 0.63 0.17 0.60 
FBpp0288508 hang 3.98 3.19 0.00 0.00 FBpp0084579 wdb -2.37 -1.56 0.00 0.02 
FBpp0078319 Hat1 -0.59 -1.25 0.18 0.01 FBpp0300790 wds 3.85 2.46 0.01 0.04 
FBpp0311793 HBS1 -1.57 -1.01 0.09 0.25 FBpp0112025 wmd 1.35 1.30 0.10 0.11 
FBpp0073173 HDAC1 2.31 1.64 0.00 0.02 FBpp0307570 wrd -0.41 -0.33 0.37 0.46 
FBpp0078756 Hel25E -1.24 -1.14 0.03 0.04 FBpp0083007 WRNexo 1.57 1.26 0.11 0.18 
FBpp0305527 Hex-A -1.40 -0.80 0.13 0.37 FBpp0079472 yip2 1.38 1.38 0.11 0.11 
FBpp0305905 HIP-R 0.50 0.58 0.19 0.14 FBpp0073715 yl -0.14 0.57 0.84 0.41 
FBpp0306426 His2Av 7.28 1.45 0.00 0.07 FBpp0312020 Yp1 0.45 0.19 0.24 0.60 
FBpp0091155 His2B 4.84 4.19 0.00 0.00 FBpp0308710 Yp2 0.73 1.00 0.10 0.04 
FBpp0091112 His3 -1.55 -1.79 0.39 0.32 FBpp0311924 Yp3 0.86 0.43 0.05 0.30 
FBpp0309302 His3.3B -2.12 0.56 0.31 0.78 FBpp0297134 yps 2.84 2.19 0.02 0.05 
FBpp0306146 His4r 3.31 3.49 0.02 0.02 FBpp0099896 zip -1.52 -1.30 0.13 0.19 
FBpp0074365 HisRS -0.33 -1.42 0.56 0.03 FBpp0071277 Zpr1 -3.12 -0.97 0.08 0.55 
FBpp0311598 HmgD 2.67 1.23 0.05 0.31       
 
b) H2A – H2A.V – H2A.VDC 
 
  differences p-values 
 Flybase 
polypeptide 
ID 
 Flybase 
symbol 
H2AV-
H2A 
H2AVDC
-H2A 
H2AVDC 
-H2AV 
H2AV-
H2A 
H2AVDC
-H2A 
H2AVDC 
-H2AV 
FBpp0300412 - -1.02 0.02 1.04 0.07 0.97 0.07 
FBpp0304748 - 0.00 -0.70 -0.70 0.99 0.17 0.17 
FBpp0308925 - 0.13 -0.22 -0.35 0.77 0.61 0.43 
FBpp0087084 128up -0.72 -1.05 -0.33 0.35 0.18 0.66 
FBpp0082987 14-3-3epsilon -0.11 0.04 0.15 0.80 0.92 0.73 
FBpp0305137 14-3-3zeta 0.59 0.00 -0.59 0.25 0.99 0.24 
FBpp0075508 26-29-p 0.22 -0.24 -0.47 0.60 0.56 0.28 
FBpp0087947 ACC -0.35 0.54 0.89 0.47 0.28 0.08 
FBpp0085204 Acf -0.12 -1.07 -0.95 0.79 0.03 0.05 
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FBpp0307803 Acn 0.69 -0.23 -0.91 0.21 0.67 0.10 
FBpp0071448 Act57B 0.88 0.94 0.06 0.22 0.19 0.93 
FBpp0311818 Act5C 0.01 0.25 0.24 0.99 0.60 0.61 
FBpp0100051 Adh 0.89 0.67 -0.23 0.16 0.28 0.71 
FBpp0082816 AdSL -1.16 -0.21 0.96 0.07 0.74 0.13 
FBpp0083395 AdSS -0.81 -0.90 -0.09 0.18 0.14 0.87 
FBpp0075313 AGO2 0.61 0.77 0.16 0.19 0.11 0.73 
FBpp0312000 Ahcy -1.92 0.54 2.46 0.06 0.56 0.02 
FBpp0087757 AIMP1 -0.81 -2.56 -1.75 0.23 0.00 0.02 
FBpp0075318 AIMP2 -0.99 -2.52 -1.53 0.21 0.01 0.06 
FBpp0071969 AIMP3 -0.64 -2.14 -1.50 0.34 0.01 0.04 
FBpp0309215 Akap200 -0.89 -0.20 0.69 0.10 0.69 0.19 
FBpp0089366 AlaRS 0.04 0.12 0.08 0.93 0.78 0.85 
FBpp0308680 Ald -0.12 0.31 0.43 0.82 0.54 0.41 
FBpp0084610 ALiX -0.16 0.27 0.43 0.72 0.55 0.34 
FBpp0072694 alphaCOP -0.35 -0.42 -0.08 0.45 0.36 0.87 
FBpp0076122 alphaTub67C -0.19 0.33 0.52 0.65 0.44 0.23 
FBpp0081153 alphaTub84B -0.58 -0.09 0.49 0.16 0.82 0.23 
FBpp0290266 AMPdeam -1.41 -0.17 1.24 0.09 0.83 0.13 
FBpp0311374 Amun -0.33 0.31 0.64 0.52 0.54 0.22 
FBpp0082065 Aos1 -1.10 -0.80 0.30 0.07 0.18 0.61 
FBpp0074558 AP-1-2beta 0.18 -0.01 -0.19 0.80 0.99 0.79 
FBpp0305942 AP-1gamma 0.67 -0.16 -0.83 0.35 0.82 0.25 
FBpp0301606 APC4 0.68 0.27 -0.41 0.39 0.73 0.60 
FBpp0070907 APC7 0.42 0.07 -0.35 0.53 0.92 0.60 
FBpp0311464 apolpp -0.32 -0.47 -0.14 0.42 0.25 0.72 
FBpp0305852 Arf102F 0.47 -0.04 -0.52 0.49 0.95 0.45 
FBpp0304364 Arf79F 0.25 -0.03 -0.29 0.62 0.95 0.58 
FBpp0304398 ArfGAP1 -0.20 -0.49 -0.29 0.76 0.46 0.66 
FBpp0076271 Argk 0.61 0.17 -0.44 0.20 0.71 0.35 
FBpp0073965 ArgRS -0.93 -3.82 -2.90 0.12 0.00 0.00 
FBpp0304830 AsnRS 1.13 0.73 -0.40 0.07 0.23 0.51 
FBpp0308483 AspRS -0.87 -3.52 -2.64 0.14 0.00 0.00 
FBpp0306920 atms -1.05 0.31 1.36 0.15 0.66 0.07 
FBpp0289825 ATPCL 0.67 0.33 -0.35 0.26 0.57 0.55 
FBpp0311086 ATPsynbeta -0.56 -0.15 0.41 0.51 0.86 0.63 
FBpp0082555 Atx2 -0.10 0.55 0.65 0.86 0.33 0.26 
FBpp0079769 aurB -0.20 -0.56 -0.36 0.63 0.19 0.39 
FBpp0312191 awd -0.27 -0.03 0.24 0.57 0.96 0.61 
FBpp0300517 B52 0.88 0.23 -0.65 0.10 0.65 0.21 
FBpp0305308 baf -0.68 1.49 2.17 0.16 0.01 0.00 
FBpp0084466 ball -0.04 -0.68 -0.64 0.94 0.16 0.19 
FBpp0071235 Bap111 0.54 0.01 -0.53 0.26 0.99 0.27 
FBpp0086115 Bap55 0.26 -0.20 -0.46 0.56 0.66 0.31 
FBpp0073572 Bap60 0.51 0.33 -0.17 0.30 0.49 0.72 
FBpp0310394 barr 0.46 -0.56 -1.02 0.50 0.42 0.15 
FBpp0305067 ben 0.98 0.31 -0.67 0.07 0.55 0.20 
FBpp0085720 betaTub56D -0.16 0.11 0.26 0.71 0.80 0.53 
FBpp0086896 bic 0.46 0.46 0.00 0.45 0.45 1.00 
FBpp0082428 BigH1 -0.89 -2.28 -1.40 0.07 0.00 0.01 
FBpp0081910 Blm 0.17 -0.82 -0.99 0.74 0.13 0.07 
FBpp0071794 blw -0.55 -1.49 -0.94 0.35 0.02 0.12 
FBpp0311234 bol -0.05 0.43 0.48 0.93 0.42 0.37 
FBpp0079417 borr 1.39 0.12 -1.27 0.10 0.88 0.13 
FBpp0307610 brat -0.75 -0.66 0.09 0.27 0.32 0.90 
FBpp0305757 brm 0.49 0.20 -0.29 0.31 0.68 0.54 
FBpp0304073 Bruce -0.93 0.88 1.80 0.20 0.22 0.02 
FBpp0083988 BRWD3 -0.58 2.30 2.88 0.28 0.00 0.00 
FBpp0308293 Bub3 -0.22 -0.05 0.18 0.62 0.92 0.69 
FBpp0085368 BubR1 0.22 -0.81 -1.03 0.75 0.25 0.15 
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FBpp0080450 BuGZ 0.03 0.48 0.45 0.95 0.32 0.35 
FBpp0310411 bur 0.54 0.37 -0.17 0.26 0.43 0.72 
FBpp0309325 Bx -0.90 -0.22 0.68 0.18 0.73 0.31 
FBpp0087402 Caf1-105 0.18 -0.83 -1.01 0.75 0.16 0.10 
FBpp0071172 Caf1-180 -0.40 -1.39 -0.99 0.39 0.01 0.05 
FBpp0082511 Caf1-55 0.04 -0.19 -0.23 0.93 0.67 0.60 
FBpp0311269 Cam -0.11 -0.52 -0.41 0.79 0.22 0.33 
FBpp0304507 Cand1 0.06 -0.43 -0.49 0.90 0.36 0.30 
FBpp0084818 Cap-D2 0.01 -0.71 -0.72 0.98 0.15 0.15 
FBpp0288780 Cap-G -0.38 -1.53 -1.15 0.47 0.01 0.04 
FBpp0099391 capt -0.08 -0.30 -0.22 0.87 0.54 0.66 
FBpp0083684 CCT1 0.21 -0.22 -0.43 0.62 0.62 0.33 
FBpp0071226 CCT2 0.44 -0.24 -0.68 0.38 0.63 0.18 
FBpp0291566 CCT3 -0.02 -0.05 -0.03 0.96 0.92 0.95 
FBpp0079992 CCT4 -0.12 -0.55 -0.43 0.82 0.31 0.43 
FBpp0087095 CCT5 0.30 -0.09 -0.39 0.50 0.83 0.38 
FBpp0073902 CCT6 -0.13 -0.16 -0.03 0.76 0.70 0.94 
FBpp0081401 CCT7 0.24 -0.18 -0.42 0.59 0.69 0.35 
FBpp0087764 CCT8 0.38 -0.13 -0.51 0.42 0.79 0.29 
FBpp0083769 Cdc16 -0.55 -0.53 0.02 0.35 0.36 0.97 
FBpp0305185 Cdc23 0.35 0.43 0.08 0.62 0.55 0.92 
FBpp0305561 Cdc27 0.55 0.25 -0.29 0.34 0.65 0.60 
FBpp0072660 Cdc37 0.57 -0.10 -0.67 0.28 0.85 0.21 
FBpp0289951 Cdc5 0.01 -0.09 -0.10 0.99 0.87 0.86 
FBpp0076371 Cdc6 -0.01 -1.18 -1.18 0.99 0.02 0.03 
FBpp0079641 Cdk1 0.14 -0.28 -0.42 0.73 0.51 0.32 
FBpp0303413 CDK2AP1 -0.14 -1.57 -1.43 0.85 0.04 0.06 
FBpp0305296 CG10077 0.20 -0.88 -1.08 0.66 0.07 0.03 
FBpp0306293 CG10237 0.17 -0.23 -0.39 0.78 0.70 0.52 
FBpp0309810 CG10341 0.02 1.10 1.08 0.97 0.07 0.08 
FBpp0311825 CG10576 0.15 -0.65 -0.80 0.74 0.16 0.09 
FBpp0112044 CG11486 -0.04 0.71 0.74 0.94 0.12 0.11 
FBpp0072658 CG12018 0.19 0.12 -0.07 0.69 0.80 0.88 
FBpp0078279 CG1218 0.78 0.84 0.06 0.21 0.18 0.92 
FBpp0083036 CG12321 0.95 -0.23 -1.19 0.33 0.81 0.23 
FBpp0087300 CG12391 -0.75 -0.26 0.49 0.10 0.55 0.27 
FBpp0305787 CG13025 -0.15 -1.80 -1.65 0.78 0.00 0.01 
FBpp0308521 CG13366 -0.43 0.32 0.74 0.59 0.69 0.35 
FBpp0307859 CG1354 -0.54 -0.90 -0.36 0.44 0.21 0.61 
FBpp0077750 CG13690 0.74 -0.54 -1.28 0.10 0.21 0.01 
FBpp0085260 CG1416 0.03 -0.47 -0.50 0.94 0.30 0.27 
FBpp0311267 CG14215 -0.79 -0.30 0.48 0.13 0.54 0.34 
FBpp0077145 CG15439 0.58 0.35 -0.23 0.36 0.58 0.71 
FBpp0077144 CG15440 -2.37 -0.30 2.07 0.00 0.58 0.00 
FBpp0112211 CG1646 -1.15 0.00 1.15 0.07 1.00 0.07 
FBpp0312121 CG16772 -0.09 0.69 0.79 0.87 0.22 0.17 
FBpp0300672 CG16817 0.35 -0.12 -0.47 0.47 0.80 0.34 
FBpp0310240 CG1703 1.10 0.24 -0.86 0.03 0.60 0.08 
FBpp0085374 CG17337 0.37 0.68 0.31 0.44 0.17 0.51 
FBpp0311847 CG18067 -4.84 0.14 4.99 0.00 0.81 0.00 
FBpp0271746 CG18190 0.17 -0.59 -0.76 0.79 0.38 0.26 
FBpp0303935 CG18815 1.12 0.11 -1.01 0.05 0.84 0.07 
FBpp0304910 CG2034 -0.60 0.34 0.94 0.25 0.50 0.08 
FBpp0078327 CG2091 -0.69 0.12 0.81 0.23 0.83 0.16 
FBpp0311613 CG2852 -0.77 -0.08 0.70 0.10 0.86 0.13 
FBpp0307127 CG2862 -0.71 -1.17 -0.45 0.48 0.26 0.65 
FBpp0290146 CG30122 -0.56 0.04 0.61 0.38 0.94 0.35 
FBpp0085581 CG30151 0.58 0.95 0.37 0.33 0.12 0.53 
FBpp0291433 CG30382 0.38 0.11 -0.27 0.45 0.82 0.59 
FBpp0307202 CG31549 -0.04 0.05 0.09 0.96 0.94 0.89 
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FBpp0303949 CG32164 0.35 -0.64 -0.99 0.55 0.29 0.11 
FBpp0073178 CG32243 0.19 -0.13 -0.32 0.76 0.83 0.60 
FBpp0070953 CG3226 0.43 -0.20 -0.62 0.51 0.75 0.33 
FBpp0078978 CG3430 0.99 0.35 -0.64 0.15 0.59 0.34 
FBpp0076204 CG3448 -0.60 -0.58 0.01 0.26 0.27 0.98 
FBpp0070273 CG3740 -0.59 0.23 0.82 0.37 0.72 0.22 
FBpp0081650 CG3909 -0.37 -1.29 -0.92 0.85 0.50 0.63 
FBpp0288574 CG42232 -0.18 -0.37 -0.18 0.68 0.41 0.68 
FBpp0083246 CG4390 0.09 0.25 0.16 0.89 0.71 0.82 
FBpp0112210 CG4951 3.61 4.13 0.52 0.00 0.00 0.30 
FBpp0303029 CG5098 1.41 1.19 -0.22 0.06 0.10 0.75 
FBpp0309480 CG5162 -0.42 -0.63 -0.21 0.41 0.23 0.68 
FBpp0309317 CG5174 0.16 -0.95 -1.11 0.75 0.08 0.04 
FBpp0303961 CG5199 -0.12 0.33 0.45 0.79 0.48 0.33 
FBpp0079637 CG5355 -0.34 -0.59 -0.26 0.47 0.21 0.57 
FBpp0084281 CG5886 0.24 -1.44 -1.68 0.69 0.03 0.02 
FBpp0303937 CG6084 0.10 0.48 0.38 0.85 0.35 0.46 
FBpp0079979 CG6180 0.02 0.34 0.32 0.96 0.45 0.48 
FBpp0079809 CG6287 -0.63 -0.25 0.38 0.19 0.59 0.42 
FBpp0080044 CG6523 0.44 0.80 0.36 0.66 0.43 0.72 
FBpp0307760 CG6693 -0.28 -0.50 -0.22 0.55 0.29 0.64 
FBpp0311284 CG6767 0.63 0.19 -0.44 0.17 0.67 0.33 
FBpp0293610 CG7546 0.12 0.24 0.12 0.84 0.67 0.83 
FBpp0087347 CG7637 1.28 2.20 0.92 0.03 0.00 0.10 
FBpp0306682 CG7927 -1.34 -0.94 0.40 0.21 0.37 0.70 
FBpp0075353 CG7945 -0.38 0.19 0.57 0.57 0.77 0.39 
FBpp0302568 CG7946 -0.54 -1.38 -0.84 0.43 0.06 0.22 
FBpp0292226 CG7971 -0.30 -0.06 0.25 0.52 0.91 0.60 
FBpp0303962 CG8003 -0.05 -0.67 -0.62 0.92 0.18 0.22 
FBpp0081371 CG8036 -0.57 -0.23 0.34 0.24 0.62 0.48 
FBpp0074246 CG8142 0.06 -0.07 -0.13 0.90 0.87 0.77 
FBpp0087733 CG8243 -0.09 0.44 0.53 0.86 0.36 0.28 
FBpp0087116 CG8858 -0.30 0.01 0.31 0.60 0.99 0.59 
FBpp0309119 CG8963 -0.59 -0.26 0.33 0.39 0.70 0.63 
FBpp0311963 CG9135 0.52 -0.09 -0.61 0.26 0.83 0.19 
FBpp0072610 CG9184 1.06 1.66 0.59 0.41 0.21 0.64 
FBpp0309269 CG9281 0.93 0.34 -0.59 0.07 0.48 0.23 
FBpp0082626 CG9590 -0.34 -2.59 -2.25 0.53 0.00 0.00 
FBpp0081343 CG9601 -0.23 -1.04 -0.82 0.64 0.04 0.11 
FBpp0305785 CG9674 0.49 0.93 0.44 0.49 0.20 0.54 
FBpp0308531 Chc -0.02 -0.51 -0.50 0.97 0.26 0.28 
FBpp0074766 Chd3 0.88 1.00 0.12 0.22 0.17 0.86 
FBpp0301152 chic 0.73 1.25 0.52 0.24 0.06 0.40 
FBpp0308688 Chrac-16 0.11 -1.43 -1.54 0.79 0.00 0.00 
FBpp0310070 cib -0.18 -0.11 0.08 0.70 0.83 0.87 
FBpp0311360 CkIIalpha 0.42 0.60 0.18 0.33 0.17 0.67 
FBpp0305406 CkIIbeta -0.96 0.26 1.22 0.12 0.66 0.06 
FBpp0079399 Cks30A -0.58 -1.27 -0.69 0.40 0.08 0.33 
FBpp0304514 cmet -0.75 -0.62 0.14 0.22 0.31 0.82 
FBpp0292516 CNBP 0.54 -0.38 -0.92 0.28 0.43 0.07 
FBpp0301625 cnn 0.34 -0.03 -0.37 0.46 0.95 0.43 
FBpp0304029 Cnot4 -0.12 0.24 0.36 0.79 0.60 0.44 
FBpp0076299 Cp15 -1.78 0.05 1.83 0.01 0.93 0.01 
FBpp0076300 Cp19 -0.13 0.38 0.51 0.78 0.43 0.30 
FBpp0071148 Cp7Fb -0.23 -0.67 -0.45 0.79 0.43 0.60 
FBpp0080484 Cse1 0.02 -0.28 -0.30 0.96 0.53 0.49 
FBpp0077927 CSN3 -1.69 -1.10 0.59 0.03 0.12 0.39 
FBpp0083658 CSN6 0.47 0.41 -0.06 0.30 0.36 0.89 
FBpp0087821 CSN7 0.90 0.60 -0.30 0.20 0.38 0.65 
FBpp0086732 Ctf4 0.08 -0.90 -0.98 0.89 0.12 0.09 
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FBpp0311740 CTPsyn -0.31 0.21 0.52 0.54 0.68 0.31 
FBpp0072562 Ctr9 -0.37 0.17 0.54 0.57 0.79 0.41 
FBpp0310479 ctrip -2.05 -2.20 -0.15 0.02 0.01 0.85 
FBpp0087924 Cul1 -1.38 -2.64 -1.25 0.38 0.10 0.42 
FBpp0290569 Cul4 0.88 2.41 1.53 0.38 0.03 0.14 
FBpp0312102 cup 0.03 -1.13 -1.16 0.96 0.05 0.04 
FBpp0071822 CycB 0.86 -0.63 -1.49 0.08 0.19 0.01 
FBpp0074017 Cyp1 -0.79 -0.31 0.49 0.08 0.48 0.27 
FBpp0086373 CysRS 0.81 0.06 -0.75 0.25 0.93 0.28 
FBpp0084349 Dak1 0.24 0.26 0.03 0.61 0.57 0.95 
FBpp0112438 Dbp80 0.05 -0.62 -0.68 0.93 0.31 0.27 
FBpp0306615 dco -1.10 -2.00 -0.89 0.11 0.01 0.19 
FBpp0071097 dec-1 0.32 -0.16 -0.47 0.53 0.75 0.36 
FBpp0305164 Dek -0.61 1.29 1.90 0.28 0.03 0.00 
FBpp0082849 Det -0.09 -0.62 -0.54 0.92 0.46 0.52 
FBpp0099688 Df31 -0.26 0.38 0.64 0.63 0.48 0.24 
FBpp0084783 dgt6 0.11 -0.18 -0.29 0.88 0.81 0.70 
FBpp0304991 Dhc64C 0.96 -0.05 -1.01 0.08 0.92 0.07 
FBpp0311766 dhd -0.98 0.54 1.52 0.30 0.56 0.12 
FBpp0307849 Dhx15 -1.82 -1.72 0.10 0.03 0.04 0.90 
FBpp0290598 dl -0.03 0.17 0.20 0.96 0.81 0.77 
FBpp0082996 Dlc90F 1.43 1.36 -0.07 0.05 0.07 0.92 
FBpp0073299 Dlic 0.49 0.16 -0.33 0.63 0.87 0.74 
FBpp0076830 DnaJ-1 0.38 0.65 0.28 0.46 0.21 0.58 
FBpp0072041 DNAlig1 0.20 -0.65 -0.85 0.69 0.21 0.11 
FBpp0073678 DNAlig4 -0.38 -0.16 0.22 0.46 0.75 0.66 
FBpp0075277 DNApol-delta -0.49 -0.58 -0.09 0.36 0.29 0.87 
FBpp0311418 Dp1 0.00 -0.62 -0.62 1.00 0.37 0.37 
FBpp0311783 dpa 0.23 0.22 -0.01 0.61 0.63 0.98 
FBpp0081331 DppIII -1.02 -1.18 -0.16 0.03 0.02 0.72 
FBpp0072744 dre4 -0.41 0.72 1.13 0.38 0.14 0.03 
FBpp0082223 Droj2 0.04 -0.35 -0.39 0.93 0.43 0.38 
FBpp0307166 Drp1 0.30 -0.31 -0.61 0.61 0.59 0.30 
FBpp0309113 Dsor1 0.80 0.21 -0.59 0.14 0.69 0.27 
FBpp0308813 Dsp1 -0.06 -1.30 -1.24 0.90 0.01 0.02 
FBpp0079746 dUTPase 0.88 0.36 -0.52 0.08 0.46 0.29 
FBpp0304413 E(bx) 0.63 0.46 -0.18 0.23 0.38 0.73 
FBpp0305157 Eb1 0.45 -0.17 -0.62 0.34 0.72 0.20 
FBpp0311273 eEF1alpha1 0.05 -0.48 -0.53 0.92 0.34 0.29 
FBpp0311691 eEF1beta 0.01 -0.24 -0.25 0.99 0.58 0.57 
FBpp0079542 eEF1delta 0.46 -0.01 -0.47 0.33 0.99 0.32 
FBpp0305182 eEF2 0.21 0.42 0.21 0.66 0.38 0.66 
FBpp0072082 eEF5 -0.05 0.11 0.16 0.89 0.79 0.69 
FBpp0307824 eff -0.51 -0.68 -0.16 0.42 0.29 0.80 
FBpp0309768 eIF2alpha -0.18 -0.64 -0.46 0.69 0.16 0.30 
FBpp0291521 eIF2Bdelta 0.40 -1.10 -1.50 0.45 0.05 0.01 
FBpp0075700 eIF2beta 1.95 1.45 -0.50 0.01 0.04 0.45 
FBpp0307983 eIF2gamma 0.14 -0.57 -0.72 0.75 0.21 0.12 
FBpp0309235 eIF3c -1.15 -1.32 -0.17 0.12 0.08 0.81 
FBpp0075104 eIF3e 0.23 0.05 -0.18 0.61 0.91 0.69 
FBpp0070430 eIF3g1 -0.22 -0.57 -0.35 0.74 0.40 0.60 
FBpp0071587 eIF3k 0.60 0.01 -0.59 0.23 0.98 0.24 
FBpp0075754 eIF3l -0.15 -0.51 -0.36 0.77 0.32 0.47 
FBpp0303628 eIF4A -0.02 -0.20 -0.18 0.96 0.66 0.69 
FBpp0306017 eIF4E1 0.46 0.03 -0.43 0.36 0.94 0.39 
FBpp0288389 eIF4G1 -0.30 -1.01 -0.71 0.54 0.05 0.16 
FBpp0310225 eIF4H1 0.29 -0.62 -0.91 0.54 0.20 0.07 
FBpp0089140 eIF5 0.55 0.04 -0.51 0.45 0.96 0.48 
FBpp0301573 eIF5B -0.85 -1.20 -0.35 0.16 0.06 0.55 
FBpp0088654 elg1 1.01 0.41 -0.60 0.11 0.50 0.32 
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FBpp0083354 EloB -0.44 0.46 0.91 0.36 0.34 0.07 
FBpp0085725 EloC -0.37 -0.30 0.07 0.45 0.55 0.88 
FBpp0079278 emb 1.12 0.91 -0.20 0.16 0.25 0.79 
FBpp0305267 endos 0.09 0.33 0.24 0.88 0.57 0.67 
FBpp0077574 Eno -0.45 0.29 0.75 0.31 0.50 0.10 
FBpp0304201 eRF1 0.49 0.07 -0.42 0.27 0.88 0.34 
FBpp0311174 eRF3 0.52 0.39 -0.13 0.26 0.39 0.78 
FBpp0099726 fabp 0.07 0.08 0.01 0.88 0.86 0.98 
FBpp0308326 faf -0.15 -1.12 -0.97 0.76 0.03 0.06 
FBpp0083399 Fancd2 -0.60 -1.44 -0.84 0.25 0.01 0.12 
FBpp0087756 FANCI -0.56 -1.26 -0.70 0.26 0.02 0.16 
FBpp0307371 FASN1 -0.88 -0.85 0.03 0.23 0.25 0.97 
FBpp0081767 Fdh -0.06 0.07 0.13 0.91 0.90 0.81 
FBpp0086223 Fen1 -0.39 -2.55 -2.16 0.45 0.00 0.00 
FBpp0073266 feo 0.77 0.36 -0.41 0.25 0.59 0.53 
FBpp0071892 Fib 0.34 -0.47 -0.81 0.45 0.31 0.09 
FBpp0074215 Fim -0.63 -0.14 0.49 0.34 0.83 0.45 
FBpp0271718 Fis1 -0.08 -0.36 -0.28 0.91 0.61 0.69 
FBpp0083551 fit 0.25 0.35 0.10 0.54 0.40 0.81 
FBpp0082574 FK506-bp1 -0.89 1.02 1.90 0.06 0.03 0.00 
FBpp0085703 FK506-bp2 -0.24 0.05 0.29 0.65 0.93 0.58 
FBpp0309663 FKBP59 0.43 0.26 -0.17 0.38 0.59 0.73 
FBpp0311112 flfl -0.79 0.22 1.01 0.18 0.69 0.09 
FBpp0075581 flr -0.23 -0.10 0.14 0.70 0.88 0.82 
FBpp0300445 Fmr1 0.52 -0.23 -0.75 0.46 0.74 0.29 
FBpp0304175 fmt -0.78 -0.12 0.66 0.22 0.85 0.30 
FBpp0290502 fon -1.69 -1.53 0.16 0.01 0.01 0.77 
FBpp0294038 Fs(2)Ket 0.14 -0.54 -0.68 0.79 0.32 0.21 
FBpp0290505 gammaCOP 1.03 0.42 -0.62 0.04 0.37 0.20 
FBpp0304827 gammaTub37C -0.27 -0.90 -0.62 0.54 0.06 0.18 
FBpp0099914 Gapdh1 -0.71 -1.22 -0.50 0.23 0.05 0.39 
FBpp0304864 Gapdh2 -0.50 0.13 0.63 0.29 0.78 0.19 
FBpp0311558 Gdi 0.49 0.55 0.06 0.32 0.27 0.89 
FBpp0079819 Ge-1 -0.37 0.03 0.40 0.55 0.96 0.52 
FBpp0071406 Gip -1.89 -1.35 0.54 0.01 0.06 0.43 
FBpp0077263 gkt -0.52 -0.23 0.29 0.25 0.61 0.51 
FBpp0084240 GlnRS -0.77 -2.90 -2.14 0.18 0.00 0.00 
FBpp0080489 glu -0.20 -1.26 -1.06 0.67 0.02 0.04 
FBpp0083898 GluProRS -1.05 -3.47 -2.42 0.08 0.00 0.00 
FBpp0099923 GlyP 0.75 0.95 0.20 0.11 0.05 0.65 
FBpp0306062 GlyRS -0.17 0.17 0.34 0.79 0.80 0.60 
FBpp0082496 GlyS -0.01 -1.11 -1.09 0.98 0.06 0.06 
FBpp0078478 Gnf1 -0.10 -0.27 -0.17 0.83 0.56 0.70 
FBpp0075793 Grip163 0.44 1.01 0.57 0.46 0.10 0.34 
FBpp0290523 Grip84 -0.49 -0.67 -0.18 0.33 0.19 0.72 
FBpp0073672 Grip91 -0.22 -0.27 -0.05 0.73 0.68 0.94 
FBpp0099824 GstD1 0.65 0.19 -0.46 0.31 0.76 0.47 
FBpp0085855 GstE6 0.12 0.07 -0.05 0.82 0.90 0.92 
FBpp0076377 GstO2 -0.43 0.52 0.95 0.34 0.25 0.05 
FBpp0099646 GstS1 -0.47 0.13 0.59 0.37 0.80 0.26 
FBpp0296978 Gug 0.29 0.76 0.47 0.68 0.29 0.50 
FBpp0302680 gw -0.33 -0.33 0.00 0.49 0.49 1.00 
FBpp0310171 hang 0.66 -1.25 -1.91 0.32 0.07 0.01 
FBpp0078319 Hat1 0.44 -0.16 -0.60 0.41 0.77 0.27 
FBpp0113091 hay 0.25 -1.78 -2.03 0.69 0.01 0.01 
FBpp0311451 Hcf -0.21 -1.13 -0.93 0.63 0.02 0.04 
FBpp0073173 HDAC1 0.01 0.52 0.51 0.98 0.28 0.29 
FBpp0078756 Hel25E -0.19 -0.10 0.09 0.73 0.85 0.87 
FBpp0312011 heph-RZ -0.09 -0.77 -0.68 0.90 0.30 0.36 
FBpp0072593 hfp -0.18 0.16 0.34 0.68 0.71 0.44 
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FBpp0305905 HIP-R -0.18 0.17 0.35 0.74 0.77 0.54 
FBpp0071028 Hira -0.26 -0.68 -0.42 0.62 0.21 0.44 
FBpp0091110 His1:CG33864 -1.04 -3.39 -2.34 0.08 0.00 0.00 
FBpp0091111 His2A -6.04 -5.02 1.01 0.00 0.00 0.10 
FBpp0306426 His2Av 5.51 1.28 -4.24 0.00 0.03 0.00 
FBpp0091155 His2B -0.15 -0.04 0.11 0.76 0.93 0.82 
FBpp0306146 His4r -0.24 0.56 0.80 0.64 0.28 0.13 
FBpp0305939 HisRS 0.02 0.05 0.03 0.97 0.93 0.96 
FBpp0071501 Hmg-2 0.38 0.23 -0.14 0.46 0.65 0.78 
FBpp0307711 HnRNP-K 0.15 -0.45 -0.60 0.78 0.40 0.27 
FBpp0307465 hoip 0.34 -0.13 -0.47 0.42 0.76 0.27 
FBpp0297875 Hrb27C 0.28 0.55 0.27 0.58 0.28 0.59 
FBpp0307982 Hsc70-4 -0.23 0.02 0.25 0.58 0.97 0.56 
FBpp0305265 Hsc70Cb -0.54 -0.40 0.13 0.34 0.47 0.81 
FBpp0312157 Hsp26 0.00 -0.33 -0.33 0.99 0.54 0.55 
FBpp0312159 Hsp27 0.00 -0.14 -0.14 0.99 0.77 0.77 
FBpp0305095 Hsp83 0.19 -0.13 -0.32 0.68 0.78 0.49 
FBpp0078152 IleRS -0.99 -3.53 -2.54 0.10 0.00 0.00 
FBpp0307848 Incenp -0.22 -0.57 -0.35 0.63 0.23 0.45 
FBpp0081861 Irbp -0.44 -0.38 0.06 0.37 0.44 0.90 
FBpp0086956 Iswi -0.06 -0.82 -0.76 0.89 0.08 0.10 
FBpp0311371 Jafrac1 -0.13 0.25 0.38 0.79 0.59 0.43 
FBpp0089165 janA -0.57 0.32 0.89 0.24 0.51 0.08 
FBpp0307568 Karybeta3 0.45 -0.11 -0.56 0.39 0.84 0.29 
FBpp0086328 Khc 0.30 -0.06 -0.36 0.56 0.91 0.49 
FBpp0289115 kis 0.25 0.14 -0.11 0.60 0.77 0.81 
FBpp0303946 Klc -0.50 0.00 0.51 0.23 0.99 0.23 
FBpp0312027 Klp10A -0.24 -0.75 -0.52 0.67 0.19 0.36 
FBpp0309092 Klp3A -0.02 -0.12 -0.10 0.97 0.80 0.83 
FBpp0312148 Klp67A -2.96 -2.07 0.89 0.01 0.06 0.39 
FBpp0078399 kra 0.69 -0.19 -0.88 0.24 0.74 0.14 
FBpp0304367 kst -1.25 -0.05 1.20 0.17 0.95 0.19 
FBpp0080322 Ku80 -0.36 -0.41 -0.05 0.44 0.38 0.91 
FBpp0080906 La -0.50 0.05 0.54 0.39 0.93 0.34 
FBpp0312110 Lam -0.13 -0.19 -0.06 0.75 0.65 0.89 
FBpp0076556 lark 1.59 1.89 0.30 0.08 0.04 0.72 
FBpp0081255 lds -0.30 -0.50 -0.20 0.52 0.29 0.66 
FBpp0311704 LeuRS -1.13 -3.80 -2.67 0.05 0.00 0.00 
FBpp0073551 lic 0.44 -0.34 -0.78 0.29 0.41 0.07 
FBpp0303481 lig -0.06 0.53 0.59 0.91 0.33 0.28 
FBpp0311512 lolal 0.72 0.25 -0.47 0.22 0.66 0.42 
FBpp0078561 lost 0.26 -0.11 -0.37 0.54 0.80 0.39 
FBpp0311908 Lsd-2 -0.01 0.09 0.10 0.98 0.85 0.83 
FBpp0309608 lva 0.76 0.95 0.19 0.44 0.33 0.84 
FBpp0301732 lwr 0.41 0.60 0.18 0.54 0.38 0.78 
FBpp0292593 LysRS -0.83 -3.65 -2.82 0.16 0.00 0.00 
FBpp0087680 Mad1 -0.86 -0.30 0.56 0.14 0.59 0.33 
FBpp0076819 mad2 0.24 -0.23 -0.47 0.71 0.73 0.48 
FBpp0310551 mahe -1.95 -2.49 -0.54 0.02 0.00 0.46 
FBpp0085235 Map205 0.23 -0.56 -0.79 0.68 0.33 0.17 
FBpp0087613 Map60 -1.74 -2.29 -0.54 0.02 0.00 0.40 
FBpp0078631 Marcal1 0.23 -1.16 -1.39 0.67 0.04 0.02 
FBpp0311207 mars 0.05 -0.12 -0.16 0.94 0.84 0.77 
FBpp0293580 mask -0.61 -0.71 -0.10 0.21 0.15 0.84 
FBpp0311400 mats 0.17 -0.43 -0.60 0.76 0.45 0.30 
FBpp0082081 MBD-R2 1.82 0.64 -1.17 0.00 0.24 0.04 
FBpp0082137 mbo 0.49 0.92 0.43 0.33 0.08 0.40 
FBpp0300203 Mccc1 -0.37 0.39 0.76 0.45 0.44 0.14 
FBpp0081317 Mcm2 -0.06 0.25 0.32 0.92 0.68 0.61 
FBpp0070729 Mcm3 -0.50 -0.42 0.08 0.38 0.46 0.88 
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FBpp0070913 Mcm6 -0.67 -0.53 0.14 0.36 0.47 0.84 
FBpp0076312 Mcm7 0.16 -0.45 -0.61 0.78 0.43 0.29 
FBpp0293887 MCTS1 0.51 0.87 0.37 0.26 0.07 0.42 
FBpp0311560 Mdh1 0.07 0.27 0.19 0.87 0.56 0.67 
FBpp0079565 me31B 0.14 -0.39 -0.53 0.79 0.48 0.34 
FBpp0085809 MetRS -1.09 -3.69 -2.60 0.07 0.00 0.00 
FBpp0081882 mgr 0.14 0.86 0.72 0.83 0.20 0.29 
FBpp0304462 Mi-2 0.23 0.11 -0.13 0.63 0.82 0.80 
FBpp0297606 Mlf -0.01 0.00 0.01 0.99 1.00 0.99 
FBpp0303950 Mo25 -0.35 -0.38 -0.03 0.51 0.47 0.95 
FBpp0082692 mor 0.49 0.21 -0.28 0.33 0.67 0.57 
FBpp0079802 mre11 -0.25 -0.53 -0.27 0.60 0.29 0.58 
FBpp0086340 mrj 0.03 0.40 0.37 0.94 0.39 0.43 
FBpp0084256 msi -0.04 0.20 0.24 0.93 0.65 0.59 
FBpp0076408 msk 0.03 -0.71 -0.74 0.95 0.20 0.18 
FBpp0293342 msps -0.33 -1.48 -1.15 0.46 0.01 0.02 
FBpp0304737 Mtor -1.58 0.56 2.14 0.07 0.50 0.02 
FBpp0310063 mts -0.60 -0.66 -0.07 0.31 0.26 0.91 
FBpp0305424 mub -0.02 -1.37 -1.34 0.97 0.02 0.02 
FBpp0111603 mute -0.95 -0.23 0.72 0.13 0.71 0.24 
FBpp0311394 Nacalpha 0.05 -0.69 -0.74 0.94 0.33 0.30 
FBpp0297132 Nap1 0.12 0.00 -0.12 0.79 1.00 0.79 
FBpp0306828 NAT1 -0.06 -0.09 -0.03 0.94 0.92 0.97 
FBpp0297182 nbs 0.01 -0.15 -0.16 0.98 0.80 0.79 
FBpp0311231 ncd -0.25 -1.45 -1.20 0.66 0.02 0.05 
FBpp0309711 Nedd8 0.91 2.20 1.29 0.17 0.00 0.06 
FBpp0305289 NHP2 0.05 1.07 1.02 0.92 0.05 0.06 
FBpp0306756 Nlp 0.19 0.51 0.33 0.72 0.33 0.53 
FBpp0309175 NO66 0.22 -0.12 -0.34 0.61 0.78 0.43 
FBpp0072839 Non2 0.08 0.54 0.46 0.89 0.37 0.45 
FBpp0309274 nonA -1.54 -2.20 -0.66 0.00 0.00 0.12 
FBpp0078997 nop5 0.15 -0.66 -0.81 0.77 0.20 0.12 
FBpp0290083 Nop60B -0.84 0.44 1.28 0.12 0.40 0.03 
FBpp0112220 Nph 0.14 0.33 0.19 0.81 0.59 0.76 
FBpp0312079 Nplp2 -0.33 -0.81 -0.48 0.53 0.13 0.36 
FBpp0297079 nudC 0.44 -0.50 -0.93 0.35 0.29 0.06 
FBpp0079710 Nup107 -0.15 0.20 0.35 0.78 0.72 0.53 
FBpp0310208 Nup160 -1.07 -0.99 0.07 0.08 0.10 0.90 
FBpp0074568 Nup205 -0.93 -1.08 -0.15 0.25 0.18 0.85 
FBpp0071905 Nup214 -0.11 -0.12 -0.01 0.84 0.83 0.99 
FBpp0293235 Nup358 -0.36 0.14 0.50 0.43 0.76 0.29 
FBpp0087938 Nup44A 0.17 -1.34 -1.51 0.75 0.03 0.01 
FBpp0087063 Nup54 -0.82 0.20 1.02 0.17 0.73 0.09 
FBpp0085954 Nup75 -1.16 -1.53 -0.37 0.10 0.04 0.59 
FBpp0073659 Nup93-1 0.82 0.17 -0.65 0.13 0.74 0.22 
FBpp0306915 Nup98-96 -0.12 0.59 0.71 0.83 0.28 0.20 
FBpp0271761 Nurf-38 0.25 0.13 -0.11 0.57 0.76 0.80 
FBpp0088033 Orc1 -0.31 -1.08 -0.77 0.55 0.05 0.15 
FBpp0082329 Orc2 -0.36 -1.13 -0.77 0.47 0.04 0.14 
FBpp0086882 Orc3 -0.01 -1.13 -1.12 0.98 0.02 0.02 
FBpp0072330 Orc4 -0.09 -1.27 -1.18 0.85 0.02 0.02 
FBpp0080120 Orc5 -0.29 -1.41 -1.12 0.52 0.01 0.02 
FBpp0087566 Orc6 0.81 -0.52 -1.33 0.37 0.56 0.15 
FBpp0088069 p47 0.88 0.19 -0.70 0.14 0.75 0.24 
FBpp0085919 pAbp 0.01 -0.51 -0.51 0.99 0.27 0.26 
FBpp0073976 Paf-AHalpha -2.77 -2.89 -0.12 0.00 0.00 0.88 
FBpp0305933 Paics -1.12 0.04 1.16 0.03 0.93 0.02 
FBpp0308411 PAN2 0.57 1.44 0.87 0.30 0.02 0.13 
FBpp0112608 Parp -0.45 -0.25 0.19 0.37 0.61 0.69 
FBpp0308299 Patr-1 -0.28 0.49 0.77 0.59 0.36 0.16 
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FBpp0290074 PCB -0.26 0.63 0.89 0.61 0.23 0.10 
FBpp0308430 pch2 0.29 -0.04 -0.33 0.58 0.94 0.53 
FBpp0078405 Pcmt -0.03 1.25 1.28 0.95 0.04 0.04 
FBpp0089395 PCNA -0.25 -0.16 0.09 0.59 0.73 0.85 
FBpp0086647 pea 0.87 -0.10 -0.98 0.09 0.83 0.06 
FBpp0079527 Pen 0.09 -0.82 -0.91 0.87 0.14 0.11 
FBpp0293516 Pep -0.33 -0.91 -0.58 0.63 0.20 0.40 
FBpp0304954 Pfdn2 -0.29 0.75 1.04 0.56 0.14 0.05 
FBpp0306279 Pgk -0.16 0.27 0.43 0.73 0.56 0.36 
FBpp0099920 Pglym78 0.05 -0.14 -0.19 0.91 0.77 0.68 
FBpp0087914 phr 1.00 1.21 0.22 0.30 0.21 0.82 
FBpp0301844 PI31 -0.07 0.53 0.60 0.89 0.28 0.23 
FBpp0082177 pic 0.17 2.35 2.18 0.73 0.00 0.00 
FBpp0310466 Plap 0.31 -0.56 -0.87 0.55 0.29 0.11 
FBpp0085618 plu 0.66 0.63 -0.03 0.27 0.29 0.96 
FBpp0305301 poe -1.08 -0.59 0.49 0.11 0.37 0.45 
FBpp0099722 polo 0.36 -0.26 -0.62 0.48 0.61 0.23 
FBpp0084115 polybromo 0.86 0.82 -0.04 0.17 0.19 0.95 
FBpp0081704 pont -0.06 -0.56 -0.50 0.88 0.17 0.22 
FBpp0082067 Pp1-87B -0.12 -0.68 -0.56 0.79 0.16 0.25 
FBpp0293227 Pp2A-29B 0.18 -0.40 -0.58 0.74 0.46 0.30 
FBpp0301546 Pp2B-14D -0.41 0.04 0.45 0.51 0.95 0.47 
FBpp0304082 PpD3 -0.61 -0.03 0.59 0.46 0.97 0.48 
FBpp0089154 PPP4R2r -0.50 -0.37 0.13 0.43 0.56 0.84 
FBpp0303849 PpV 0.45 0.36 -0.09 0.41 0.50 0.87 
FBpp0099895 primo-1 0.81 -0.40 -1.21 0.26 0.57 0.10 
FBpp0082062 Prosalpha2 -0.12 0.62 0.74 0.86 0.35 0.27 
FBpp0071451 Prosalpha3 0.00 -0.13 -0.13 0.99 0.79 0.80 
FBpp0073989 Prosalpha4 0.70 0.58 -0.12 0.33 0.42 0.87 
FBpp0086067 Prosalpha5 0.87 0.59 -0.27 0.14 0.30 0.63 
FBpp0310201 Prosalpha6 -0.16 0.03 0.19 0.71 0.94 0.65 
FBpp0089041 Prosalpha7 0.22 0.18 -0.04 0.72 0.77 0.95 
FBpp0086400 Prosbeta1 0.14 -0.85 -0.99 0.79 0.12 0.07 
FBpp0075382 Prosbeta2 -0.12 0.01 0.13 0.81 0.98 0.79 
FBpp0307141 Prosbeta4 -0.37 -1.15 -0.78 0.49 0.05 0.16 
FBpp0087320 Prosbeta5 0.08 -0.78 -0.85 0.88 0.16 0.12 
FBpp0075119 Prosbeta6 -0.34 -0.15 0.19 0.44 0.72 0.67 
FBpp0078449 Prosbeta7 0.77 0.46 -0.31 0.20 0.43 0.60 
FBpp0085902 Prp19 -0.09 0.39 0.47 0.86 0.45 0.35 
FBpp0077368 Prx6005 -0.44 -1.28 -0.84 0.42 0.03 0.14 
FBpp0305823 pum -0.28 1.14 1.43 0.72 0.16 0.09 
FBpp0082932 Pxt -0.19 -0.33 -0.14 0.69 0.50 0.78 
FBpp0083611 PyK -0.21 -0.04 0.17 0.64 0.94 0.70 
FBpp0304178 pzg 1.05 -0.61 -1.66 0.12 0.36 0.02 
FBpp0309142 r -0.10 1.28 1.39 0.83 0.02 0.01 
FBpp0083440 r-l 0.50 0.20 -0.29 0.40 0.73 0.62 
FBpp0083503 Rab1 0.36 0.03 -0.34 0.44 0.95 0.48 
FBpp0083414 Rab11 0.24 0.25 0.01 0.59 0.57 0.98 
FBpp0303520 Rab5 -0.09 -0.08 0.00 0.88 0.88 1.00 
FBpp0300836 Rab7 0.65 0.43 -0.22 0.34 0.52 0.75 
FBpp0311572 Rack1 -1.01 0.86 1.87 0.06 0.10 0.00 
FBpp0290882 rad50 -0.38 -0.49 -0.11 0.46 0.35 0.83 
FBpp0071600 Rae1 0.21 0.76 0.55 0.68 0.16 0.30 
FBpp0309151 Ran -0.10 -0.07 0.04 0.82 0.88 0.93 
FBpp0309478 Ranbp21 -0.29 -0.20 0.09 0.72 0.80 0.91 
FBpp0306292 RanGAP -0.16 -0.59 -0.43 0.75 0.26 0.41 
FBpp0293634 Rbfox1 -0.04 -0.23 -0.19 0.93 0.63 0.69 
FBpp0076784 Rcc1 -1.29 -2.29 -0.99 0.01 0.00 0.04 
FBpp0073058 Rcd5 0.98 0.78 -0.20 0.24 0.35 0.80 
FBpp0081156 Ref1 0.36 1.04 0.68 0.65 0.21 0.40 
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FBpp0302766 REG 0.78 -0.34 -1.12 0.27 0.62 0.12 
FBpp0311247 rept 0.16 -0.42 -0.58 0.74 0.41 0.25 
FBpp0079609 RfC3 0.16 -0.37 -0.53 0.69 0.36 0.20 
FBpp0311114 RfC38 -0.04 -0.31 -0.27 0.92 0.46 0.52 
FBpp0073120 RfC4 0.11 -0.11 -0.22 0.80 0.81 0.62 
FBpp0305319 rhea -0.47 -1.44 -0.97 0.52 0.07 0.20 
FBpp0304185 RhoGDI 0.07 -0.21 -0.28 0.89 0.66 0.56 
FBpp0291753 Rm62 -1.53 -1.05 0.48 0.01 0.05 0.35 
FBpp0310006 rngo -0.30 -1.51 -1.21 0.63 0.03 0.07 
FBpp0079648 RnrL -0.16 0.22 0.39 0.71 0.60 0.38 
FBpp0087152 RnrS -0.19 -0.60 -0.41 0.74 0.32 0.50 
FBpp0085156 rod -0.65 -0.17 0.48 0.46 0.84 0.59 
FBpp0302971 row 0.26 -0.89 -1.16 0.65 0.13 0.06 
FBpp0305404 Rox8 -0.24 0.23 0.47 0.60 0.61 0.31 
FBpp0081356 RpA-70 -0.51 -1.78 -1.27 0.25 0.00 0.01 
FBpp0305226 RPA2 -0.31 -1.86 -1.54 0.46 0.00 0.00 
FBpp0310183 RPA3 -0.28 -1.90 -1.62 0.50 0.00 0.00 
FBpp0075764 RpL10Ab -0.92 -0.15 0.77 0.13 0.80 0.20 
FBpp0072085 RpL12 0.30 0.41 0.11 0.57 0.44 0.83 
FBpp0302626 RpL13 -0.73 0.77 1.50 0.24 0.22 0.03 
FBpp0076359 RpL14 -0.58 -0.60 -0.03 0.33 0.30 0.96 
FBpp0311286 RpL18 -1.39 -0.68 0.71 0.14 0.46 0.44 
FBpp0086103 RpL18A -1.42 0.14 1.56 0.01 0.77 0.01 
FBpp0089141 RpL19 -0.91 -0.59 0.32 0.15 0.34 0.60 
FBpp0311640 RpL21 -0.47 -0.05 0.43 0.29 0.92 0.33 
FBpp0303780 RpL27 -1.09 -1.18 -0.09 0.21 0.18 0.92 
FBpp0311452 RpL27A -0.73 0.33 1.06 0.12 0.46 0.03 
FBpp0307759 RpL3 -2.77 -0.90 1.87 0.01 0.35 0.07 
FBpp0309280 RpL30 -0.04 0.35 0.39 0.96 0.65 0.62 
FBpp0308319 RpL34b -1.03 0.24 1.27 0.23 0.77 0.15 
FBpp0310250 RpL7 -0.41 -0.75 -0.34 0.49 0.22 0.56 
FBpp0072802 RpL8 -0.09 -1.00 -0.91 0.89 0.11 0.15 
FBpp0306232 RpLP0 -0.73 -0.41 0.32 0.20 0.46 0.56 
FBpp0086252 RpLP2 -0.41 0.03 0.44 0.59 0.97 0.57 
FBpp0074662 Rpn1 0.04 0.11 0.07 0.95 0.85 0.90 
FBpp0305644 Rpn10 0.61 0.50 -0.11 0.19 0.27 0.81 
FBpp0078664 Rpn11 0.11 -0.61 -0.72 0.85 0.30 0.22 
FBpp0075068 Rpn12 -0.11 -0.62 -0.51 0.89 0.44 0.53 
FBpp0306599 Rpn2 0.33 0.08 -0.25 0.55 0.88 0.65 
FBpp0307804 Rpn3 0.22 -0.11 -0.33 0.66 0.83 0.52 
FBpp0078278 Rpn5 -0.03 -0.27 -0.25 0.96 0.58 0.62 
FBpp0297513 Rpn6 0.12 -0.21 -0.33 0.81 0.67 0.50 
FBpp0083687 Rpn7 -0.06 -0.71 -0.65 0.91 0.17 0.20 
FBpp0305141 Rpn8 -0.24 -1.90 -1.66 0.65 0.00 0.01 
FBpp0083861 Rpn9 0.03 -0.05 -0.08 0.95 0.91 0.86 
FBpp0310720 RpS10b 0.40 1.81 1.41 0.38 0.00 0.01 
FBpp0087115 RpS11 0.11 2.09 1.97 0.87 0.01 0.01 
FBpp0075612 RpS12 -0.52 1.25 1.77 0.25 0.01 0.00 
FBpp0312104 RpS13 0.97 2.72 1.74 0.15 0.00 0.02 
FBpp0311458 RpS14b -0.73 0.85 1.58 0.18 0.12 0.01 
FBpp0309759 RpS16 -0.29 1.65 1.94 0.53 0.00 0.00 
FBpp0076207 RpS17 -0.49 0.28 0.76 0.44 0.65 0.23 
FBpp0085586 RpS18 -0.35 1.64 2.00 0.54 0.01 0.00 
FBpp0311350 RpS19a -1.11 0.29 1.40 0.09 0.64 0.04 
FBpp0311561 RpS2 0.94 2.62 1.68 0.12 0.00 0.01 
FBpp0083371 RpS20 -0.86 1.20 2.05 0.16 0.06 0.00 
FBpp0308991 RpS23 0.66 2.38 1.72 0.27 0.00 0.01 
FBpp0081846 RpS25 -0.28 1.57 1.85 0.64 0.02 0.01 
FBpp0079606 RpS27A -0.24 0.55 0.79 0.61 0.25 0.11 
FBpp0310057 RpS28b -0.33 1.64 1.97 0.49 0.00 0.00 
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FBpp0306740 RpS29 0.52 0.48 -0.04 0.44 0.47 0.95 
FBpp0312066 RpS3 -0.88 1.03 1.92 0.10 0.06 0.00 
FBpp0300615 RpS3A -2.51 -0.67 1.84 0.00 0.30 0.01 
FBpp0312080 RpS4 -0.24 1.81 2.05 0.62 0.00 0.00 
FBpp0071087 RpS6 -0.86 1.44 2.30 0.08 0.01 0.00 
FBpp0308324 RpS7 0.30 2.19 1.90 0.62 0.00 0.01 
FBpp0311987 RpS8 -0.44 1.44 1.88 0.44 0.02 0.01 
FBpp0088021 Rpt1 -0.54 -0.79 -0.25 0.31 0.15 0.63 
FBpp0311982 Rpt2 0.53 0.43 -0.10 0.27 0.36 0.84 
FBpp0312031 Rpt3 0.74 0.92 0.18 0.13 0.06 0.70 
FBpp0293948 Rpt4 0.37 -0.38 -0.75 0.46 0.45 0.15 
FBpp0083843 Rpt5 0.34 0.15 -0.19 0.50 0.77 0.70 
FBpp0076890 Rpt6 0.85 0.20 -0.65 0.09 0.68 0.19 
FBpp0288680 Rrp1 -0.17 -1.02 -0.85 0.74 0.06 0.11 
FBpp0081601 rump 0.19 -1.00 -1.18 0.77 0.13 0.08 
FBpp0089284 Sar1 0.41 -0.37 -0.78 0.43 0.47 0.14 
FBpp0297362 SC35 0.55 -0.33 -0.88 0.28 0.51 0.09 
FBpp0074285 scu 2.58 -0.28 -2.86 0.00 0.56 0.00 
FBpp0082877 sds22 -1.74 -1.08 0.66 0.07 0.23 0.46 
FBpp0083932 Sec10 -0.12 -0.20 -0.08 0.79 0.65 0.85 
FBpp0311988 Sec13 -0.47 0.20 0.68 0.26 0.62 0.12 
FBpp0309105 Sec16 -0.43 -0.01 0.42 0.48 0.99 0.49 
FBpp0303000 Sec24CD -0.73 -0.42 0.31 0.20 0.45 0.58 
FBpp0087723 Sec31 0.31 -0.03 -0.35 0.47 0.94 0.43 
FBpp0086691 SelD 0.54 -0.17 -0.71 0.30 0.75 0.18 
FBpp0307454 SerRS 0.43 0.79 0.36 0.43 0.15 0.50 
FBpp0089160 sgg -0.26 -1.09 -0.84 0.65 0.07 0.15 
FBpp0296963 Sgt 0.32 0.64 0.32 0.42 0.12 0.42 
FBpp0305484 shep -0.27 -0.66 -0.39 0.63 0.25 0.49 
FBpp0305866 shi 0.44 -0.77 -1.21 0.37 0.14 0.03 
FBpp0070792 Shmt 1.65 1.29 -0.36 0.01 0.02 0.49 
FBpp0073893 shtd -0.49 -0.61 -0.11 0.41 0.31 0.85 
FBpp0303964 simj -0.08 0.00 0.08 0.84 1.00 0.85 
FBpp0081709 sle -0.51 0.13 0.64 0.24 0.76 0.15 
FBpp0306059 slmb 0.70 0.33 -0.37 0.26 0.59 0.54 
FBpp0293061 SmB 0.01 0.36 0.34 0.97 0.42 0.44 
FBpp0083926 SMC1 0.34 -1.18 -1.52 0.53 0.04 0.01 
FBpp0086591 SMC2 -0.18 -1.01 -0.83 0.69 0.04 0.09 
FBpp0075684 SmD1 0.68 -0.29 -0.98 0.16 0.53 0.05 
FBpp0081234 SmD2 0.59 0.10 -0.48 0.28 0.84 0.37 
FBpp0304234 smid -0.43 0.18 0.61 0.57 0.81 0.42 
FBpp0078984 smt3 -0.38 -0.79 -0.41 0.38 0.08 0.34 
FBpp0078331 Snr1 0.03 -0.45 -0.48 0.96 0.44 0.41 
FBpp0079247 Snx6 0.26 0.52 0.26 0.71 0.46 0.71 
FBpp0075958 Sod1 -0.48 0.29 0.76 0.36 0.58 0.16 
FBpp0075122 spd-2 0.46 -0.01 -0.47 0.33 0.99 0.33 
FBpp0297149 SpdS 0.12 0.42 0.30 0.86 0.54 0.66 
FBpp0310470 spel1 1.39 0.34 -1.04 0.05 0.60 0.13 
FBpp0301102 sqd -0.24 -0.15 0.10 0.66 0.79 0.86 
FBpp0079471 Srp54 -0.13 0.22 0.35 0.77 0.63 0.44 
FBpp0076872 Srp54k -0.06 -0.67 -0.61 0.91 0.23 0.27 
FBpp0076244 Srp68 0.04 -0.90 -0.95 0.93 0.09 0.08 
FBpp0083319 Srp72 0.10 -0.36 -0.46 0.86 0.51 0.41 
FBpp0079211 Ssb-c31a -0.37 -0.64 -0.27 0.42 0.18 0.56 
FBpp0072151 Ssrp -0.44 0.64 1.07 0.32 0.16 0.02 
FBpp0308666 sta 1.03 1.85 0.81 0.04 0.00 0.10 
FBpp0078827 stai -0.07 0.34 0.41 0.88 0.48 0.40 
FBpp0077790 Stip1 -0.05 -0.16 -0.11 0.92 0.73 0.80 
FBpp0307636 Strn-Mlck-RV -0.76 -0.30 0.46 0.23 0.62 0.47 
FBpp0312201 Su(H) 0.12 -2.00 -2.12 0.81 0.00 0.00 
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FBpp0079252 Su(var)205 -0.02 -0.60 -0.58 0.96 0.17 0.19 
FBpp0290871 Su(var)3-7 0.08 -0.69 -0.77 0.90 0.29 0.24 
FBpp0078372 Sym -1.07 -1.09 -0.02 0.08 0.07 0.98 
FBpp0304718 tacc -0.32 -1.56 -1.24 0.48 0.00 0.01 
FBpp0073459 Tango4 -1.04 -0.42 0.62 0.07 0.44 0.26 
FBpp0080045 Tap42 0.02 -0.26 -0.29 0.97 0.65 0.62 
FBpp0081820 Tctp -0.05 0.10 0.15 0.91 0.82 0.73 
FBpp0290143 tea -0.85 -1.50 -0.65 0.08 0.01 0.18 
FBpp0110174 tefu -0.20 -0.44 -0.23 0.68 0.39 0.64 
FBpp0087479 TER94 0.01 -0.23 -0.24 0.99 0.60 0.60 
FBpp0081350 tex -0.61 -1.19 -0.58 0.34 0.08 0.36 
FBpp0083355 TFAM -0.39 -1.52 -1.13 0.49 0.02 0.06 
FBpp0084526 TfIIA-L 0.26 1.20 0.94 0.70 0.09 0.18 
FBpp0306851 tho2 0.78 0.50 -0.28 0.16 0.36 0.61 
FBpp0312095 ThrRS 0.30 -0.22 -0.51 0.49 0.62 0.24 
FBpp0082180 timeout -1.14 -0.52 0.62 0.08 0.39 0.32 
FBpp0077346 toc -0.19 -0.69 -0.50 0.71 0.19 0.33 
FBpp0304598 Top2 -0.24 -1.21 -0.97 0.63 0.03 0.06 
FBpp0080787 Top3alpha -0.41 -1.40 -0.99 0.41 0.01 0.06 
FBpp0087193 tou 0.02 -0.03 -0.05 0.96 0.96 0.91 
FBpp0084948 Tpi 0.17 1.01 0.85 0.75 0.07 0.12 
FBpp0310608 TppII -0.86 -0.45 0.42 0.14 0.43 0.46 
FBpp0304887 tral 1.13 0.67 -0.45 0.05 0.22 0.40 
FBpp0079437 Trx-2 0.57 0.29 -0.28 0.32 0.60 0.62 
FBpp0071117 Trxr-1 -0.09 0.17 0.26 0.87 0.75 0.63 
FBpp0312205 Tsf1 -0.40 0.18 0.58 0.40 0.69 0.22 
FBpp0072097 tsr 0.04 0.39 0.35 0.94 0.45 0.50 
FBpp0304417 Tudor-SN 0.05 -0.01 -0.06 0.91 0.99 0.90 
FBpp0083956 twin 0.03 -0.81 -0.84 0.95 0.12 0.11 
FBpp0311386 tws 0.71 0.09 -0.62 0.19 0.87 0.25 
FBpp0076804 Txl 0.55 0.55 0.00 0.22 0.22 1.00 
FBpp0075168 TyrRS 0.02 0.14 0.11 0.96 0.79 0.82 
FBpp0077912 tzn 0.37 0.37 0.00 0.51 0.50 1.00 
FBpp0305600 U2af38 -1.58 -2.33 -0.75 0.04 0.00 0.29 
FBpp0298007 U2af50 0.64 -0.75 -1.38 0.24 0.18 0.02 
FBpp0087583 Uba1 0.29 -0.72 -1.01 0.65 0.27 0.13 
FBpp0076457 Uba2 -0.39 0.18 0.57 0.54 0.77 0.37 
FBpp0311673 Ubc4 -0.16 -0.16 -0.01 0.81 0.80 0.99 
FBpp0304449 UbcE2M 0.75 0.66 -0.08 0.29 0.34 0.91 
FBpp0309477 Ubqn 0.02 0.12 0.10 0.96 0.79 0.83 
FBpp0292511 Uch 0.30 0.23 -0.07 0.59 0.68 0.90 
FBpp0306000 Uch-L5 0.04 -0.30 -0.34 0.93 0.48 0.43 
FBpp0311276 Uev1A -0.09 -0.18 -0.09 0.83 0.67 0.83 
FBpp0290913 UGP 0.11 -0.87 -0.98 0.85 0.17 0.13 
FBpp0081284 unc-45 0.54 0.33 -0.21 0.24 0.46 0.65 
FBpp0304059 Usp14 0.75 -0.10 -0.85 0.16 0.84 0.11 
FBpp0298309 Usp5 0.17 -0.54 -0.72 0.72 0.28 0.16 
FBpp0073474 Usp7 -0.39 0.13 0.52 0.50 0.82 0.37 
FBpp0305353 ValRS 0.11 0.17 0.06 0.83 0.74 0.91 
FBpp0311965 Vha26 0.82 -0.01 -0.83 0.22 0.99 0.21 
FBpp0086468 Vha36-1 0.12 0.14 0.03 0.79 0.75 0.95 
FBpp0086320 Vha44 -1.01 -0.03 0.98 0.07 0.95 0.07 
FBpp0290875 Vha55 -0.73 -0.05 0.67 0.47 0.96 0.50 
FBpp0307597 Vha68-2 0.39 0.28 -0.11 0.40 0.54 0.82 
FBpp0307142 VhaSFD -0.34 0.33 0.67 0.65 0.66 0.38 
FBpp0310907 vib -0.52 -1.98 -1.46 0.37 0.00 0.02 
FBpp0112266 vig2 1.03 0.68 -0.34 0.06 0.19 0.50 
FBpp0309628 Vps4 0.57 0.98 0.41 0.21 0.04 0.36 
FBpp0072691 Vta1 -2.45 -1.05 1.40 0.06 0.39 0.25 
FBpp0084579 wdb -0.32 -0.36 -0.05 0.58 0.52 0.93 
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FBpp0300790 wds -0.01 0.23 0.24 0.99 0.62 0.61 
FBpp0289361 wech -0.04 -0.74 -0.70 0.94 0.19 0.21 
FBpp0306779 woc -0.54 -0.68 -0.13 0.31 0.21 0.80 
FBpp0307569 wrd 0.18 -0.78 -0.97 0.74 0.17 0.10 
FBpp0291513 WRNexo -0.77 -1.01 -0.24 0.10 0.04 0.59 
FBpp0304606 x16 0.54 -0.71 -1.26 0.25 0.14 0.02 
FBpp0071503 Xpd 0.16 0.06 -0.09 0.83 0.93 0.90 
FBpp0071049 Ykt6 0.37 -0.37 -0.73 0.49 0.49 0.18 
FBpp0312020 Yp1 -0.03 -0.05 -0.02 0.95 0.91 0.95 
FBpp0308710 Yp2 -0.04 -0.05 -0.02 0.93 0.90 0.97 
FBpp0311924 Yp3 -0.12 -0.03 0.09 0.78 0.94 0.84 
FBpp0309943 ytr 0.79 -0.13 -0.92 0.15 0.80 0.10 
FBpp0072306 zip 0.30 -1.26 -1.56 0.73 0.17 0.09 
FBpp0085138 Zwilch -0.92 -1.30 -0.38 0.08 0.02 0.45 
 
 
2. RECRUITMENT OF FACTORS TO FREE DNA ENDS  
(see VI.B.1) 
 
a) OEB – BEB – CONTROL   
 
 Flybase 
polypeptide ID  Flybase symbol 
differences p-values 
oeb-
control 
beb-
control 
(oeb-
control)-
(beb-
control) 
oeb-
control 
beb-
control 
(oeb-
control)-
(beb-
control) 
FBpp0304748 - 0.32 0.07 0.25 0.40 0.85 0.51 
FBpp0308925 - 0.99 0.91 0.08 0.03 0.05 0.85 
FBpp0087084 128up 0.31 0.74 -0.43 0.52 0.14 0.38 
FBpp0082987 14-3-3epsilon 0.36 -0.28 0.64 0.38 0.49 0.13 
FBpp0305137 14-3-3zeta 0.58 0.16 0.41 0.17 0.69 0.31 
FBpp0075508 26-29-p 0.43 0.21 0.22 0.48 0.73 0.71 
FBpp0085204 Acf 2.16 2.20 -0.04 0.00 0.00 0.93 
FBpp0311818 Act5C 0.28 0.35 -0.07 0.59 0.50 0.89 
FBpp0100051 Adh 1.33 1.53 -0.20 0.00 0.00 0.59 
FBpp0086845 AGBE -0.87 0.12 -0.99 0.18 0.85 0.13 
FBpp0075313 AGO2 -0.30 -0.41 0.11 0.56 0.43 0.82 
FBpp0312000 Ahcy 0.11 -0.40 0.52 0.88 0.59 0.49 
FBpp0087757 AIMP1 0.71 0.51 0.20 0.14 0.28 0.67 
FBpp0075318 AIMP2 1.67 1.55 0.12 0.03 0.04 0.86 
FBpp0082682 Akt1 0.87 0.66 0.22 0.12 0.23 0.69 
FBpp0089366 AlaRS 0.46 0.01 0.45 0.47 0.98 0.49 
FBpp0308680 Ald 0.12 0.26 -0.14 0.83 0.65 0.81 
FBpp0309805 alien 0.74 0.60 0.14 0.17 0.26 0.78 
FBpp0084610 ALiX -1.77 -1.98 0.21 0.01 0.00 0.71 
FBpp0072694 alphaCOP 0.56 0.46 0.10 0.26 0.35 0.83 
FBpp0076122 alphaTub67C -0.90 -0.65 -0.25 0.05 0.14 0.55 
FBpp0081153 alphaTub84B -0.64 -0.99 0.35 0.12 0.03 0.38 
FBpp0290266 AMPdeam -1.90 0.32 -2.23 0.24 0.84 0.17 
FBpp0311374 Amun 0.04 -0.39 0.43 0.95 0.59 0.55 
FBpp0082065 Aos1 2.55 1.74 0.80 0.00 0.01 0.19 
FBpp0074558 AP-1-2beta 0.50 0.35 0.15 0.20 0.36 0.69 
FBpp0070907 APC7 0.69 0.96 -0.27 0.27 0.13 0.66 
FBpp0311464 apolpp 1.15 1.42 -0.27 0.03 0.01 0.58 
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FBpp0305852 Arf102F 1.02 1.30 -0.28 0.16 0.08 0.69 
FBpp0304364 Arf79F 1.53 1.37 0.16 0.01 0.02 0.76 
FBpp0076271 Argk 0.57 0.47 0.10 0.38 0.46 0.87 
FBpp0073965 ArgRS 2.46 2.81 -0.35 0.00 0.00 0.47 
FBpp0304830 AsnRS 0.12 -0.34 0.46 0.78 0.43 0.30 
FBpp0084071 asp -0.09 0.22 -0.31 0.87 0.70 0.58 
FBpp0308483 AspRS 2.49 2.51 -0.02 0.00 0.00 0.96 
FBpp0306920 atms 0.84 -0.08 0.92 0.18 0.89 0.14 
FBpp0289825 ATPCL 0.18 1.31 -1.13 0.76 0.05 0.08 
FBpp0311086 ATPsynbeta 0.83 0.73 0.10 0.21 0.26 0.88 
FBpp0082555 Atx2 -2.76 -3.54 0.77 0.00 0.00 0.15 
FBpp0079769 aurB 1.42 2.14 -0.72 0.01 0.00 0.17 
FBpp0312191 awd -0.24 -0.89 0.65 0.64 0.10 0.22 
FBpp0300517 B52 0.42 0.66 -0.24 0.44 0.24 0.66 
FBpp0305308 baf 0.11 -0.29 0.40 0.81 0.52 0.38 
FBpp0085442 Bap170 1.75 2.00 -0.25 0.00 0.00 0.59 
FBpp0086115 Bap55 0.31 0.93 -0.62 0.56 0.09 0.25 
FBpp0073572 Bap60 1.65 0.96 0.69 0.00 0.05 0.14 
FBpp0310394 barr 1.88 2.17 -0.29 0.01 0.01 0.65 
FBpp0306433 bel 1.10 0.62 0.48 0.02 0.15 0.26 
FBpp0305067 ben 1.10 0.54 0.56 0.09 0.39 0.37 
FBpp0084021 beta-PheRS 0.07 0.40 -0.33 0.89 0.41 0.49 
FBpp0074348 betaCOP 0.01 0.36 -0.35 0.98 0.56 0.57 
FBpp0085720 betaTub56D -0.15 -0.74 0.59 0.71 0.10 0.18 
FBpp0080362 BicC -1.08 -0.64 -0.44 0.03 0.16 0.32 
FBpp0082428 BigH1 2.46 2.65 -0.19 0.00 0.00 0.76 
FBpp0071794 blw -0.59 0.10 -0.70 0.23 0.83 0.16 
FBpp0311234 bol -1.69 -1.65 -0.04 0.00 0.00 0.93 
FBpp0079417 borr 1.80 2.05 -0.26 0.00 0.00 0.60 
FBpp0305757 brm 0.19 0.33 -0.14 0.68 0.49 0.77 
FBpp0304073 Bruce 0.25 -0.14 0.39 0.57 0.75 0.38 
FBpp0308293 Bub3 -1.03 -1.13 0.10 0.11 0.08 0.86 
FBpp0080450 BuGZ -2.42 -1.81 -0.61 0.00 0.01 0.33 
FBpp0087402 Caf1-105 0.10 0.87 -0.77 0.90 0.27 0.33 
FBpp0071172 Caf1-180 1.27 1.53 -0.26 0.03 0.01 0.60 
FBpp0082511 Caf1-55 0.62 1.17 -0.55 0.18 0.02 0.23 
FBpp0311269 Cam -1.77 -1.51 -0.26 0.02 0.03 0.69 
FBpp0304507 Cand1 0.13 0.30 -0.17 0.78 0.52 0.72 
FBpp0084818 Cap-D2 1.68 2.12 -0.44 0.00 0.00 0.31 
FBpp0288780 Cap-G 1.52 1.59 -0.07 0.01 0.01 0.90 
FBpp0099391 capt 1.11 0.50 0.60 0.02 0.24 0.17 
FBpp0308803 casp 0.04 -0.39 0.43 0.96 0.56 0.52 
FBpp0083684 CCT1 0.93 0.72 0.21 0.05 0.13 0.63 
FBpp0071226 CCT2 0.98 0.56 0.42 0.05 0.23 0.36 
FBpp0291566 CCT3 0.44 0.34 0.09 0.34 0.45 0.83 
FBpp0079992 CCT4 0.84 0.63 0.21 0.13 0.25 0.69 
FBpp0087095 CCT5 0.51 0.20 0.31 0.39 0.73 0.60 
FBpp0073902 CCT6 0.44 0.24 0.20 0.45 0.68 0.73 
FBpp0081401 CCT7 0.48 0.54 -0.06 0.53 0.48 0.94 
FBpp0087764 CCT8 0.96 0.80 0.16 0.04 0.08 0.72 
FBpp0083769 Cdc16 0.14 0.08 0.06 0.77 0.87 0.89 
FBpp0305185 Cdc23 -0.54 0.11 -0.64 0.52 0.90 0.45 
FBpp0305561 Cdc27 0.65 0.45 0.20 0.26 0.42 0.72 
FBpp0072660 Cdc37 0.49 0.38 0.11 0.28 0.40 0.80 
FBpp0076371 Cdc6 0.48 0.29 0.19 0.34 0.55 0.70 
FBpp0079641 Cdk1 0.27 0.49 -0.22 0.53 0.25 0.59 
FBpp0289675 Cdk2 -0.71 0.59 -1.30 0.26 0.35 0.05 
FBpp0305296 CG10077 -0.76 -0.28 -0.49 0.31 0.71 0.51 
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FBpp0306293 CG10237 1.38 2.51 -1.13 0.03 0.00 0.07 
FBpp0293954 CG10565 0.34 0.39 -0.05 0.50 0.44 0.92 
FBpp0311825 CG10576 0.33 -0.08 0.41 0.72 0.93 0.66 
FBpp0292528 CG11089 -0.37 0.37 -0.74 0.71 0.72 0.47 
FBpp0306623 CG11334 -0.11 -1.06 0.94 0.81 0.04 0.06 
FBpp0112044 CG11486 -2.62 -1.97 -0.65 0.00 0.00 0.27 
FBpp0072658 CG12018 0.49 1.16 -0.67 0.50 0.12 0.35 
FBpp0078279 CG1218 0.63 -0.20 0.83 0.35 0.77 0.23 
FBpp0305787 CG13025 0.69 -0.50 1.19 0.20 0.35 0.04 
FBpp0304298 CG1344 0.11 -0.25 0.36 0.90 0.77 0.68 
FBpp0307859 CG1354 1.37 1.27 0.11 0.01 0.02 0.83 
FBpp0085260 CG1416 0.41 0.67 -0.26 0.54 0.32 0.70 
FBpp0077144 CG15440 -3.98 -3.36 -0.62 0.00 0.00 0.41 
FBpp0112211 CG1646 -4.42 -4.74 0.32 0.00 0.00 0.60 
FBpp0312121 CG16772 -3.27 -2.89 -0.39 0.00 0.00 0.48 
FBpp0300672 CG16817 0.22 0.02 0.20 0.68 0.97 0.71 
FBpp0297346 CG17018 -0.70 -0.08 -0.62 0.52 0.94 0.56 
FBpp0310240 CG1703 0.71 0.91 -0.20 0.14 0.07 0.67 
FBpp0271746 CG18190 0.89 0.78 0.10 0.03 0.05 0.78 
FBpp0303935 CG18815 1.42 1.36 0.06 0.01 0.01 0.89 
FBpp0304910 CG2034 -0.45 0.54 -0.99 0.32 0.24 0.04 
FBpp0078327 CG2091 1.26 1.24 0.02 0.01 0.01 0.97 
FBpp0307423 CG2246 2.08 1.46 0.62 0.00 0.03 0.32 
FBpp0311613 CG2852 -0.15 -1.07 0.91 0.77 0.06 0.10 
FBpp0307127 CG2862 -0.16 -0.50 0.34 0.85 0.55 0.68 
FBpp0290146 CG30122 -0.32 0.35 -0.67 0.49 0.46 0.17 
FBpp0291433 CG30382 0.14 -0.51 0.65 0.79 0.33 0.22 
FBpp0307202 CG31549 1.61 0.12 1.48 0.10 0.89 0.12 
FBpp0303949 CG32164 1.02 0.80 0.22 0.03 0.08 0.60 
FBpp0070953 CG3226 1.38 0.93 0.45 0.01 0.06 0.34 
FBpp0078978 CG3430 0.62 0.23 0.39 0.17 0.59 0.38 
FBpp0070273 CG3740 0.58 1.09 -0.51 0.31 0.07 0.36 
FBpp0081650 CG3909 -4.03 -4.70 0.67 0.01 0.00 0.59 
FBpp0303976 CG40045 1.97 1.99 -0.02 0.01 0.01 0.97 
FBpp0288574 CG42232 2.60 2.73 -0.13 0.00 0.00 0.75 
FBpp0079789 CG4751 -0.39 -0.27 -0.12 0.53 0.66 0.85 
FBpp0112210 CG4951 1.76 2.10 -0.34 0.00 0.00 0.45 
FBpp0309480 CG5162 0.42 1.40 -0.98 0.55 0.07 0.18 
FBpp0309317 CG5174 0.56 -0.01 0.57 0.20 0.98 0.19 
FBpp0079637 CG5355 -0.36 -1.05 0.69 0.50 0.07 0.21 
FBpp0084281 CG5886 -0.27 -0.07 -0.20 0.73 0.93 0.80 
FBpp0303937 CG6084 -0.69 -1.13 0.44 0.30 0.10 0.50 
FBpp0079979 CG6180 -0.89 -0.29 -0.60 0.18 0.65 0.35 
FBpp0079809 CG6287 -1.42 -1.42 0.00 0.06 0.06 1.00 
FBpp0080044 CG6523 0.94 -0.31 1.25 0.10 0.56 0.03 
FBpp0307760 CG6693 0.40 0.15 0.25 0.44 0.78 0.62 
FBpp0311284 CG6767 0.65 0.90 -0.25 0.17 0.07 0.59 
FBpp0293610 CG7546 0.40 0.47 -0.07 0.41 0.34 0.89 
FBpp0087347 CG7637 -3.00 -2.14 -0.86 0.00 0.00 0.13 
FBpp0292226 CG7971 -1.06 -0.09 -0.96 0.16 0.90 0.20 
FBpp0303962 CG8003 -0.54 -0.27 -0.27 0.49 0.73 0.73 
FBpp0081371 CG8036 -1.14 -2.13 0.99 0.09 0.00 0.13 
FBpp0074246 CG8142 1.84 1.89 -0.04 0.00 0.00 0.91 
FBpp0081398 CG8223 0.42 -0.26 0.68 0.45 0.63 0.23 
FBpp0087733 CG8243 -2.79 -2.84 0.05 0.00 0.00 0.93 
FBpp0078684 CG8891 1.60 0.90 0.70 0.02 0.16 0.27 
FBpp0311963 CG9135 0.77 -0.24 1.02 0.25 0.71 0.14 
FBpp0072610 CG9184 -2.49 -3.06 0.56 0.03 0.01 0.60 
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FBpp0309269 CG9281 0.70 0.53 0.17 0.18 0.30 0.73 
FBpp0074708 CG9330 -1.23 -0.93 -0.30 0.04 0.10 0.58 
FBpp0308531 Chc 0.47 0.95 -0.48 0.28 0.04 0.28 
FBpp0074766 Chd3 0.72 1.03 -0.30 0.34 0.19 0.69 
FBpp0301152 chic 0.91 0.86 0.05 0.17 0.19 0.93 
FBpp0310070 cib -0.61 -1.14 0.53 0.37 0.11 0.43 
FBpp0311360 CkIIalpha 0.82 1.29 -0.47 0.06 0.01 0.26 
FBpp0305406 CkIIbeta 0.51 0.67 -0.16 0.32 0.20 0.75 
FBpp0304514 cmet -0.05 0.04 -0.09 0.94 0.95 0.89 
FBpp0304029 Cnot4 -2.31 -2.50 0.19 0.00 0.00 0.71 
FBpp0307640 coro 1.03 0.93 0.11 0.05 0.07 0.83 
FBpp0076300 Cp19 -2.92 -3.10 0.19 0.00 0.00 0.79 
FBpp0080484 Cse1 1.25 1.16 0.09 0.02 0.03 0.85 
FBpp0077927 CSN3 2.15 2.04 0.11 0.00 0.01 0.86 
FBpp0290448 CSN4 0.71 0.87 -0.16 0.14 0.08 0.73 
FBpp0083658 CSN6 0.60 0.42 0.18 0.25 0.41 0.72 
FBpp0087821 CSN7 -0.25 0.12 -0.37 0.77 0.89 0.66 
FBpp0086732 Ctf4 0.72 0.86 -0.14 0.10 0.05 0.74 
FBpp0072562 Ctr9 -0.19 0.14 -0.33 0.73 0.79 0.54 
FBpp0310479 ctrip -0.04 0.94 -0.98 0.96 0.26 0.24 
FBpp0087924 Cul1 1.76 1.58 0.18 0.26 0.31 0.91 
FBpp0312102 cup -0.16 0.76 -0.92 0.82 0.27 0.19 
FBpp0074017 Cyp1 -0.53 -1.23 0.70 0.39 0.06 0.27 
FBpp0290739 D1 -0.75 -1.22 0.47 0.25 0.07 0.46 
FBpp0084349 Dak1 1.07 1.06 0.01 0.11 0.12 0.98 
FBpp0112438 Dbp80 0.37 0.50 -0.13 0.47 0.33 0.80 
FBpp0306615 dco -0.23 -0.65 0.42 0.75 0.37 0.56 
FBpp0087722 DCTN2-p50 0.72 0.44 0.28 0.13 0.34 0.54 
FBpp0305164 Dek -0.81 -0.53 -0.29 0.17 0.36 0.62 
FBpp0291138 deltaCOP 1.22 0.95 0.27 0.01 0.04 0.53 
FBpp0082849 Det 0.69 0.42 0.26 0.23 0.45 0.64 
FBpp0099688 Df31 -1.01 -1.46 0.44 0.38 0.21 0.69 
FBpp0308700 dgt5 0.90 0.36 0.55 0.06 0.42 0.22 
FBpp0084783 dgt6 0.53 0.14 0.39 0.22 0.73 0.35 
FBpp0304991 Dhc64C 0.51 0.32 0.20 0.24 0.46 0.65 
FBpp0099973 Dhpr -0.03 0.08 -0.11 0.96 0.88 0.83 
FBpp0307849 Dhx15 0.58 0.61 -0.03 0.25 0.23 0.96 
FBpp0082996 Dlc90F 1.70 1.37 0.33 0.00 0.01 0.49 
FBpp0076830 DnaJ-1 -1.95 -1.48 -0.47 0.00 0.02 0.41 
FBpp0072041 DNAlig1 0.00 -0.76 0.76 1.00 0.39 0.39 
FBpp0073678 DNAlig4 1.02 0.78 0.25 0.13 0.24 0.70 
FBpp0075277 DNApol-delta 0.18 0.42 -0.23 0.68 0.36 0.60 
FBpp0311418 Dp1 0.83 0.75 0.08 0.05 0.07 0.84 
FBpp0311783 dpa 0.35 0.57 -0.21 0.48 0.27 0.67 
FBpp0083673 Dph5 1.18 1.19 -0.01 0.02 0.02 0.98 
FBpp0072744 dre4 1.32 1.34 -0.02 0.01 0.01 0.96 
FBpp0082223 Droj2 0.42 0.28 0.14 0.30 0.49 0.71 
FBpp0307166 Drp1 0.58 1.12 -0.54 0.32 0.07 0.35 
FBpp0309113 Dsor1 0.53 -0.07 0.60 0.18 0.85 0.13 
FBpp0308813 Dsp1 0.49 1.44 -0.95 0.40 0.02 0.11 
FBpp0079746 dUTPase -0.18 -0.77 0.59 0.70 0.12 0.23 
FBpp0304413 E(bx) 0.83 -0.18 1.00 0.38 0.85 0.30 
FBpp0305157 Eb1 0.96 0.38 0.58 0.15 0.55 0.36 
FBpp0311691 eEF1beta 1.06 0.55 0.51 0.03 0.21 0.24 
FBpp0079542 eEF1delta 1.62 1.40 0.21 0.00 0.00 0.57 
FBpp0305182 eEF2 -0.21 -1.05 0.84 0.77 0.17 0.26 
FBpp0072082 eEF5 0.09 -0.85 0.94 0.87 0.16 0.13 
FBpp0307824 eff 0.73 1.25 -0.52 0.24 0.06 0.39 
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FBpp0072908 eIF1 -1.52 -1.39 -0.13 0.08 0.11 0.87 
FBpp0309768 eIF2alpha 0.30 0.45 -0.15 0.51 0.34 0.75 
FBpp0291521 eIF2Bdelta 1.66 1.60 0.06 0.00 0.00 0.88 
FBpp0089217 eIF2Bepsilon 0.56 1.08 -0.52 0.33 0.07 0.36 
FBpp0075700 eIF2beta 0.22 0.22 0.00 0.61 0.62 0.99 
FBpp0307983 eIF2gamma 0.70 0.95 -0.25 0.10 0.03 0.53 
FBpp0312226 eIF3a -0.96 -0.89 -0.07 0.06 0.08 0.87 
FBpp0088565 eIF3d1 -1.15 -1.24 0.09 0.06 0.04 0.87 
FBpp0075104 eIF3e 0.39 -0.67 1.06 0.68 0.49 0.28 
FBpp0078532 eIF3f1 1.29 0.91 0.38 0.02 0.08 0.44 
FBpp0071587 eIF3k 0.18 -0.04 0.22 0.75 0.94 0.70 
FBpp0075754 eIF3l 0.12 0.71 -0.59 0.84 0.25 0.34 
FBpp0303628 eIF4A 0.97 0.70 0.27 0.03 0.11 0.51 
FBpp0306017 eIF4E1 0.72 0.25 0.47 0.32 0.72 0.51 
FBpp0288389 eIF4G1 0.16 0.41 -0.24 0.73 0.40 0.61 
FBpp0089140 eIF5 1.15 1.56 -0.41 0.08 0.02 0.51 
FBpp0301573 eIF5B 0.88 0.59 0.29 0.15 0.32 0.62 
FBpp0083354 EloB -0.26 -0.68 0.42 0.61 0.20 0.41 
FBpp0085725 EloC 0.24 0.06 0.18 0.65 0.91 0.73 
FBpp0079278 emb 0.56 0.13 0.43 0.22 0.77 0.34 
FBpp0305267 endos -0.22 -1.89 1.67 0.77 0.03 0.04 
FBpp0077574 Eno -1.00 -1.48 0.48 0.05 0.01 0.31 
FBpp0304201 eRF1 1.35 1.61 -0.26 0.00 0.00 0.51 
FBpp0311174 eRF3 1.05 1.17 -0.12 0.02 0.01 0.75 
FBpp0079496 Etl1 1.51 0.94 0.56 0.02 0.12 0.34 
FBpp0099726 fabp 0.53 0.53 0.00 0.29 0.29 1.00 
FBpp0308326 faf 0.68 1.11 -0.42 0.18 0.04 0.39 
FBpp0083399 Fancd2 1.70 1.79 -0.08 0.00 0.00 0.86 
FBpp0087756 FANCI 2.14 2.06 0.08 0.00 0.00 0.86 
FBpp0307371 FASN1 0.23 -0.47 0.70 0.63 0.33 0.16 
FBpp0081767 Fdh -0.74 -1.14 0.40 0.18 0.05 0.46 
FBpp0086223 Fen1 0.62 0.05 0.57 0.28 0.93 0.32 
FBpp0073266 feo 0.62 0.76 -0.14 0.44 0.34 0.86 
FBpp0071892 Fib 0.13 0.36 -0.23 0.79 0.47 0.65 
FBpp0074215 Fim -0.05 0.70 -0.76 0.93 0.21 0.18 
FBpp0271718 Fis1 0.42 1.12 -0.70 0.42 0.05 0.19 
FBpp0083551 fit -0.51 -0.60 0.09 0.57 0.50 0.92 
FBpp0082574 FK506-bp1 0.33 0.57 -0.24 0.47 0.23 0.60 
FBpp0085703 FK506-bp2 -0.60 -1.19 0.59 0.37 0.09 0.38 
FBpp0309663 FKBP59 0.13 -0.47 0.60 0.79 0.34 0.23 
FBpp0075581 flr -0.87 -1.77 0.90 0.22 0.02 0.21 
FBpp0300445 Fmr1 0.78 0.21 0.56 0.13 0.66 0.26 
FBpp0304175 fmt 0.57 0.15 0.42 0.21 0.73 0.35 
FBpp0290502 fon -0.42 -0.31 -0.11 0.32 0.46 0.79 
FBpp0088923 for 0.30 -0.33 0.63 0.65 0.62 0.35 
FBpp0070463 fs(1)Ya 1.13 0.32 0.81 0.14 0.66 0.28 
FBpp0294038 Fs(2)Ket 0.87 0.52 0.35 0.05 0.20 0.39 
FBpp0080391 fzy 0.07 -0.31 0.39 0.90 0.60 0.52 
FBpp0290505 gammaCOP -0.64 -0.12 -0.52 0.34 0.86 0.43 
FBpp0304827 gammaTub37C 0.51 0.65 -0.13 0.34 0.23 0.80 
FBpp0304864 Gapdh2 -1.08 -2.10 1.02 0.10 0.01 0.13 
FBpp0311558 Gdi 0.49 0.25 0.24 0.29 0.59 0.60 
FBpp0079819 Ge-1 -0.14 0.50 -0.64 0.80 0.36 0.25 
FBpp0077263 gkt 1.39 0.49 0.90 0.00 0.24 0.04 
FBpp0084240 GlnRS 1.33 1.74 -0.41 0.01 0.00 0.36 
FBpp0080489 glu 1.30 1.87 -0.57 0.02 0.00 0.28 
FBpp0083898 GluProRS 2.23 2.45 -0.21 0.00 0.00 0.64 
FBpp0099923 GlyP -0.01 -0.31 0.30 0.98 0.43 0.45 
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FBpp0306062 GlyRS 0.89 1.12 -0.22 0.05 0.02 0.60 
FBpp0082496 GlyS 0.04 0.30 -0.27 0.97 0.79 0.81 
FBpp0078478 Gnf1 1.35 1.47 -0.11 0.02 0.01 0.83 
FBpp0075793 Grip163 0.59 0.64 -0.05 0.42 0.38 0.94 
FBpp0290523 Grip84 0.04 -0.48 0.52 0.93 0.33 0.29 
FBpp0073672 Grip91 0.26 0.16 0.10 0.54 0.70 0.82 
FBpp0310520 grsm -0.47 -1.60 1.13 0.41 0.01 0.06 
FBpp0099824 GstD1 0.74 -0.10 0.84 0.19 0.85 0.14 
FBpp0085855 GstE6 0.70 0.00 0.69 0.36 1.00 0.36 
FBpp0290108 Gyf -0.51 -0.04 -0.47 0.51 0.96 0.54 
FBpp0310171 hang 0.89 1.71 -0.82 0.15 0.01 0.18 
FBpp0078319 Hat1 1.69 1.41 0.28 0.00 0.01 0.55 
FBpp0311451 Hcf 1.15 0.82 0.34 0.05 0.15 0.54 
FBpp0073173 HDAC1 -0.38 -0.06 -0.32 0.39 0.90 0.46 
FBpp0078756 Hel25E 1.23 0.82 0.41 0.02 0.10 0.38 
FBpp0305905 HIP-R 0.15 -0.79 0.93 0.82 0.25 0.18 
FBpp0091110 His1:CG33864 1.27 0.76 0.51 0.04 0.20 0.38 
FBpp0306426 His2Av 2.24 1.58 0.66 0.06 0.16 0.55 
FBpp0091155 His2B 5.48 5.50 -0.02 0.00 0.00 0.97 
FBpp0306146 His4r 4.15 3.99 0.15 0.00 0.00 0.73 
FBpp0305939 HisRS 0.89 -0.28 1.17 0.09 0.56 0.03 
FBpp0071501 Hmg-2 1.36 1.79 -0.43 0.00 0.00 0.28 
FBpp0307711 HnRNP-K 0.59 0.54 0.04 0.24 0.28 0.93 
FBpp0307465 hoip 0.63 0.61 0.02 0.29 0.30 0.97 
FBpp0297875 Hrb27C -2.60 -3.01 0.41 0.00 0.00 0.51 
FBpp0305265 Hsc70Cb 0.45 -0.27 0.72 0.32 0.54 0.13 
FBpp0312159 Hsp27 -0.26 -0.13 -0.13 0.57 0.78 0.77 
FBpp0073018 ida -1.50 -1.33 -0.16 0.09 0.12 0.84 
FBpp0078152 IleRS 2.28 2.77 -0.48 0.00 0.00 0.26 
FBpp0307848 Incenp 1.69 1.91 -0.22 0.01 0.00 0.69 
FBpp0076091 iPLA2-VIA 0.65 0.31 0.34 0.23 0.55 0.52 
FBpp0081861 Irbp 3.28 0.94 2.34 0.00 0.06 0.00 
FBpp0086956 Iswi 1.50 1.92 -0.43 0.01 0.00 0.36 
FBpp0311371 Jafrac1 -0.61 -0.75 0.14 0.26 0.17 0.79 
FBpp0307568 Karybeta3 0.88 0.76 0.12 0.14 0.20 0.83 
FBpp0086328 Khc 1.11 0.63 0.48 0.18 0.44 0.55 
FBpp0289115 kis -1.26 -0.55 -0.71 0.02 0.25 0.15 
FBpp0303946 Klc 0.90 0.46 0.43 0.08 0.34 0.37 
FBpp0312027 Klp10A 0.95 0.68 0.27 0.04 0.12 0.51 
FBpp0309092 Klp3A 0.78 0.31 0.47 0.09 0.48 0.29 
FBpp0072616 Klp61F 1.02 0.98 0.04 0.05 0.06 0.94 
FBpp0080322 Ku80 3.62 1.03 2.58 0.00 0.05 0.00 
FBpp0080906 La -0.12 -1.06 0.93 0.83 0.08 0.12 
FBpp0312110 Lam -0.72 -0.32 -0.40 0.17 0.53 0.43 
FBpp0081255 lds 0.22 0.91 -0.69 0.66 0.09 0.19 
FBpp0311704 LeuRS 2.63 2.80 -0.17 0.00 0.00 0.79 
FBpp0073551 lic -0.11 -0.06 -0.04 0.87 0.92 0.95 
FBpp0303481 lig -3.30 -3.14 -0.16 0.00 0.00 0.82 
FBpp0088383 lola 1.86 0.75 1.11 0.01 0.23 0.08 
FBpp0078561 lost 0.25 0.62 -0.36 0.61 0.23 0.47 
FBpp0309608 lva -0.92 -0.51 -0.40 0.28 0.54 0.63 
FBpp0292593 LysRS 2.57 2.88 -0.30 0.00 0.00 0.56 
FBpp0076819 mad2 0.74 0.54 0.19 0.18 0.32 0.72 
FBpp0310551 mahe -1.08 -1.01 -0.07 0.05 0.07 0.89 
FBpp0085235 Map205 0.41 0.32 0.09 0.55 0.64 0.90 
FBpp0078631 Marcal1 0.37 0.19 0.19 0.68 0.84 0.84 
FBpp0311207 mars 0.87 0.35 0.52 0.09 0.47 0.29 
FBpp0293580 mask -1.40 -1.36 -0.04 0.03 0.04 0.94 
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FBpp0311400 mats 0.27 0.27 0.00 0.67 0.67 0.99 
FBpp0300535 Mbs -1.02 -0.66 -0.37 0.41 0.59 0.76 
FBpp0081317 Mcm2 1.09 1.21 -0.12 0.01 0.01 0.75 
FBpp0070729 Mcm3 0.85 1.66 -0.81 0.11 0.01 0.13 
FBpp0081756 Mcm5 1.21 0.90 0.31 0.02 0.06 0.49 
FBpp0070913 Mcm6 1.06 1.28 -0.23 0.10 0.05 0.71 
FBpp0076312 Mcm7 1.43 0.81 0.61 0.07 0.28 0.42 
FBpp0293887 MCTS1 -0.03 1.63 -1.66 0.97 0.09 0.09 
FBpp0311560 Mdh1 0.49 0.17 0.32 0.23 0.67 0.42 
FBpp0079565 me31B 0.34 0.40 -0.05 0.39 0.32 0.89 
FBpp0085809 MetRS 1.64 2.28 -0.65 0.00 0.00 0.18 
FBpp0081882 mgr 0.66 0.01 0.65 0.28 0.98 0.29 
FBpp0304462 Mi-2 1.01 0.92 0.09 0.04 0.06 0.83 
FBpp0297606 Mlf -3.87 -2.81 -1.06 0.00 0.00 0.14 
FBpp0301951 mod 0.67 0.42 0.25 0.10 0.29 0.53 
FBpp0083467 mod(mdg4) -1.00 -2.15 1.15 0.40 0.09 0.33 
FBpp0082692 mor 0.98 1.37 -0.39 0.09 0.03 0.48 
FBpp0079802 mre11 2.58 1.69 0.89 0.00 0.00 0.06 
FBpp0086340 mrj -2.80 -1.32 -1.48 0.00 0.03 0.02 
FBpp0084256 msi -1.17 -0.96 -0.21 0.01 0.03 0.58 
FBpp0076408 msk 0.95 0.42 0.53 0.06 0.36 0.26 
FBpp0293342 msps 0.99 1.49 -0.50 0.06 0.01 0.32 
FBpp0304737 Mtor -0.94 -0.65 -0.29 0.11 0.26 0.60 
FBpp0310063 mts -0.21 -0.23 0.02 0.62 0.58 0.95 
FBpp0305424 mub 0.24 0.15 0.09 0.69 0.80 0.88 
FBpp0111603 mute -0.20 -0.84 0.64 0.81 0.33 0.46 
FBpp0311394 Nacalpha 0.64 0.32 0.32 0.33 0.62 0.62 
FBpp0297132 Nap1 0.73 0.70 0.03 0.19 0.21 0.95 
FBpp0306828 NAT1 1.71 1.57 0.14 0.01 0.01 0.78 
FBpp0297182 nbs -0.36 -0.91 0.54 0.62 0.23 0.47 
FBpp0309711 Nedd8 1.04 0.30 0.74 0.12 0.64 0.25 
FBpp0305289 NHP2 -2.24 -2.62 0.38 0.00 0.00 0.47 
FBpp0306756 Nlp -1.27 -1.30 0.02 0.09 0.09 0.97 
FBpp0309175 NO66 1.64 2.07 -0.43 0.01 0.00 0.38 
FBpp0309274 nonA -1.38 -1.24 -0.14 0.11 0.15 0.86 
FBpp0078997 nop5 0.37 1.09 -0.72 0.41 0.03 0.13 
FBpp0290083 Nop60B -2.48 -2.90 0.43 0.01 0.01 0.62 
FBpp0308486 Not1 0.67 -0.08 0.75 0.28 0.90 0.23 
FBpp0112220 Nph -0.10 -0.24 0.13 0.86 0.70 0.83 
FBpp0312079 Nplp2 -0.76 -1.58 0.82 0.27 0.04 0.24 
FBpp0297079 nudC 0.21 -0.34 0.56 0.84 0.75 0.61 
FBpp0079710 Nup107 0.02 0.42 -0.40 0.97 0.51 0.53 
FBpp0074568 Nup205 -0.46 0.33 -0.79 0.50 0.63 0.26 
FBpp0071905 Nup214 -0.96 -1.73 0.77 0.04 0.00 0.09 
FBpp0293235 Nup358 -2.23 -2.21 -0.02 0.00 0.00 0.97 
FBpp0087063 Nup54 -0.02 -0.59 0.57 0.97 0.24 0.25 
FBpp0073659 Nup93-1 0.50 0.20 0.30 0.21 0.61 0.44 
FBpp0306915 Nup98-96 -2.64 -2.08 -0.56 0.00 0.00 0.32 
FBpp0271761 Nurf-38 -0.34 0.59 -0.92 0.57 0.33 0.14 
FBpp0072061 or 0.21 1.39 -1.17 0.71 0.03 0.06 
FBpp0088033 Orc1 1.31 1.13 0.18 0.04 0.06 0.75 
FBpp0082329 Orc2 2.20 2.22 -0.02 0.00 0.00 0.97 
FBpp0086882 Orc3 1.09 1.14 -0.05 0.05 0.04 0.92 
FBpp0072330 Orc4 1.84 2.73 -0.89 0.01 0.00 0.12 
FBpp0080120 Orc5 1.25 1.11 0.14 0.03 0.05 0.79 
FBpp0309148 p115 -0.91 -0.01 -0.90 0.17 0.98 0.17 
FBpp0088069 p47 -0.19 -0.73 0.53 0.79 0.32 0.46 
FBpp0085919 pAbp -0.88 -1.36 0.48 0.05 0.01 0.26 
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FBpp0305933 Paics 0.35 0.68 -0.34 0.42 0.13 0.44 
FBpp0308411 PAN2 -3.16 -2.91 -0.25 0.00 0.00 0.60 
FBpp0112608 Parp -0.24 0.13 -0.37 0.62 0.79 0.45 
FBpp0308299 Patr-1 -1.15 -1.57 0.42 0.04 0.01 0.42 
FBpp0290074 PCB -2.80 -2.74 -0.06 0.00 0.00 0.91 
FBpp0308430 pch2 0.73 0.32 0.41 0.16 0.52 0.42 
FBpp0089395 PCNA 0.17 -0.27 0.44 0.72 0.58 0.37 
FBpp0086647 pea 0.52 -0.01 0.53 0.58 0.99 0.58 
FBpp0079527 Pen 1.24 0.96 0.28 0.01 0.03 0.47 
FBpp0304954 Pfdn2 -1.12 -1.07 -0.05 0.14 0.16 0.94 
FBpp0290701 Pfdn5 1.13 0.46 0.67 0.09 0.47 0.30 
FBpp0303214 Pfdn6 -0.92 -1.14 0.22 0.22 0.14 0.76 
FBpp0293464 Pfk 0.32 0.68 -0.35 0.46 0.13 0.41 
FBpp0303827 Pgd 1.31 0.28 1.03 0.14 0.74 0.24 
FBpp0306279 Pgk -0.90 -1.20 0.30 0.08 0.02 0.53 
FBpp0099920 Pglym78 0.79 0.91 -0.12 0.08 0.05 0.77 
FBpp0082177 pic -0.16 -0.30 0.14 0.76 0.57 0.79 
FBpp0310466 Plap 0.93 0.00 0.93 0.07 0.99 0.07 
FBpp0085618 plu -0.61 -0.25 -0.37 0.36 0.71 0.58 
FBpp0305301 poe 1.40 0.41 0.99 0.05 0.54 0.15 
FBpp0099722 polo 1.05 1.11 -0.05 0.03 0.02 0.90 
FBpp0084115 polybromo 0.38 1.42 -1.04 0.53 0.03 0.11 
FBpp0081704 pont 1.14 1.94 -0.80 0.06 0.00 0.17 
FBpp0082067 Pp1-87B 0.15 0.51 -0.37 0.69 0.18 0.33 
FBpp0293227 Pp2A-29B 1.08 0.56 0.52 0.02 0.17 0.20 
FBpp0301546 Pp2B-14D 1.10 0.32 0.77 0.03 0.49 0.12 
FBpp0312200 Pp4-19C -0.08 -0.64 0.56 0.85 0.16 0.22 
FBpp0089154 PPP4R2r -0.63 -0.22 -0.41 0.36 0.74 0.55 
FBpp0303849 PpV 0.30 -0.30 0.60 0.64 0.63 0.35 
FBpp0099895 primo-1 -0.21 -0.38 0.16 0.70 0.50 0.77 
FBpp0082062 Prosalpha2 0.67 -0.11 0.79 0.36 0.87 0.28 
FBpp0071451 Prosalpha3 0.23 -0.21 0.44 0.69 0.73 0.46 
FBpp0073989 Prosalpha4 -0.12 -0.57 0.45 0.77 0.19 0.30 
FBpp0086067 Prosalpha5 0.79 0.02 0.77 0.10 0.96 0.11 
FBpp0310201 Prosalpha6 0.41 0.17 0.24 0.47 0.76 0.68 
FBpp0089041 Prosalpha7 -0.38 -1.39 1.00 0.59 0.07 0.18 
FBpp0086400 Prosbeta1 0.48 0.22 0.26 0.31 0.64 0.57 
FBpp0075382 Prosbeta2 -0.23 -0.64 0.42 0.75 0.38 0.56 
FBpp0087320 Prosbeta5 -0.09 -0.02 -0.07 0.90 0.98 0.92 
FBpp0075119 Prosbeta6 0.19 -0.39 0.58 0.67 0.38 0.20 
FBpp0078449 Prosbeta7 0.00 -0.61 0.61 1.00 0.22 0.22 
FBpp0085902 Prp19 -3.06 -2.69 -0.37 0.00 0.00 0.58 
FBpp0308280 puf 0.37 -0.30 0.67 0.50 0.59 0.23 
FBpp0082932 Pxt -0.06 0.29 -0.35 0.90 0.55 0.47 
FBpp0083611 PyK 0.36 0.31 0.05 0.48 0.54 0.93 
FBpp0309142 r -2.22 -1.92 -0.29 0.00 0.00 0.47 
FBpp0083440 r-l 0.73 0.80 -0.08 0.24 0.19 0.89 
FBpp0083503 Rab1 0.82 1.87 -1.06 0.25 0.02 0.14 
FBpp0083414 Rab11 1.26 2.39 -1.13 0.04 0.00 0.07 
FBpp0307641 Rab2 0.14 0.83 -0.70 0.83 0.20 0.28 
FBpp0303520 Rab5 2.12 2.61 -0.49 0.00 0.00 0.33 
FBpp0300836 Rab7 1.15 1.51 -0.36 0.09 0.03 0.58 
FBpp0311572 Rack1 -2.98 -2.88 -0.11 0.00 0.00 0.89 
FBpp0290882 rad50 2.19 1.13 1.06 0.00 0.04 0.05 
FBpp0071600 Rae1 -2.68 -2.64 -0.03 0.00 0.00 0.95 
FBpp0309151 Ran 1.05 0.85 0.20 0.04 0.09 0.67 
FBpp0312218 Ranbp9 0.28 0.65 -0.37 0.65 0.30 0.55 
FBpp0306292 RanGAP -0.72 -1.16 0.43 0.14 0.03 0.36 
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FBpp0293634 Rbfox1 -1.27 -0.92 -0.35 0.02 0.08 0.48 
FBpp0076784 Rcc1 2.63 3.14 -0.51 0.00 0.00 0.26 
FBpp0302766 REG 1.32 1.00 0.32 0.02 0.07 0.53 
FBpp0311247 rept 1.12 1.21 -0.09 0.04 0.03 0.86 
FBpp0079609 RfC3 1.19 1.34 -0.15 0.02 0.01 0.75 
FBpp0311114 RfC38 1.76 1.88 -0.12 0.00 0.00 0.80 
FBpp0073120 RfC4 1.00 1.31 -0.31 0.06 0.02 0.53 
FBpp0305319 rhea 0.68 0.93 -0.24 0.25 0.13 0.68 
FBpp0086441 Rif1 0.62 0.17 0.45 0.58 0.88 0.68 
FBpp0310006 rngo 0.64 0.60 0.05 0.49 0.52 0.96 
FBpp0079648 RnrL 1.39 1.29 0.11 0.01 0.02 0.83 
FBpp0087152 RnrS 0.80 1.00 -0.20 0.09 0.04 0.66 
FBpp0302971 row 0.67 0.49 0.17 0.27 0.41 0.77 
FBpp0084067 Rpb10 -0.54 -0.06 -0.48 0.25 0.90 0.31 
FBpp0296955 Rpi 0.09 -0.69 0.78 0.90 0.32 0.27 
FBpp0075764 RpL10Ab -2.71 -1.70 -1.01 0.02 0.11 0.33 
FBpp0302626 RpL13 -2.86 -1.86 -1.00 0.03 0.12 0.39 
FBpp0300655 RpL15 -3.07 -2.68 -0.39 0.00 0.00 0.51 
FBpp0311286 RpL18 -2.16 -2.13 -0.03 0.11 0.11 0.98 
FBpp0089141 RpL19 -2.70 -2.20 -0.50 0.01 0.02 0.55 
FBpp0311640 RpL21 -2.35 -3.02 0.67 0.01 0.00 0.36 
FBpp0072687 RpL23A -4.03 -2.70 -1.33 0.00 0.02 0.21 
FBpp0311573 RpL24 -2.53 -0.70 -1.82 0.07 0.59 0.17 
FBpp0311452 RpL27A -2.78 -2.43 -0.35 0.00 0.00 0.61 
FBpp0309280 RpL30 -0.80 -0.56 -0.24 0.54 0.67 0.85 
FBpp0308319 RpL34b -1.60 -2.06 0.46 0.04 0.01 0.52 
FBpp0311481 RpL36 -2.14 -2.65 0.51 0.07 0.03 0.64 
FBpp0084617 RpL4 -3.29 -2.12 -1.17 0.00 0.02 0.16 
FBpp0311121 RpL5 -1.97 -1.97 0.00 0.03 0.03 1.00 
FBpp0310250 RpL7 -2.42 -1.48 -0.93 0.01 0.07 0.23 
FBpp0072802 RpL8 -2.09 -1.91 -0.17 0.03 0.04 0.84 
FBpp0306232 RpLP0 -0.72 -0.84 0.12 0.29 0.22 0.85 
FBpp0074662 Rpn1 0.89 1.20 -0.31 0.07 0.02 0.50 
FBpp0305644 Rpn10 1.09 0.98 0.11 0.01 0.02 0.78 
FBpp0078664 Rpn11 0.73 1.04 -0.31 0.14 0.05 0.51 
FBpp0075068 Rpn12 0.82 0.94 -0.12 0.08 0.05 0.79 
FBpp0112987 Rpn13 0.64 0.71 -0.07 0.29 0.24 0.91 
FBpp0306599 Rpn2 0.27 0.01 0.26 0.62 0.99 0.63 
FBpp0307804 Rpn3 -0.20 0.11 -0.31 0.73 0.86 0.60 
FBpp0078278 Rpn5 0.56 0.57 0.00 0.40 0.39 1.00 
FBpp0297513 Rpn6 1.64 1.17 0.47 0.00 0.03 0.32 
FBpp0083687 Rpn7 0.60 0.78 -0.18 0.25 0.14 0.72 
FBpp0305141 Rpn8 1.00 0.80 0.20 0.06 0.13 0.69 
FBpp0083861 Rpn9 0.78 0.72 0.06 0.11 0.14 0.90 
FBpp0310720 RpS10b -2.71 -3.23 0.52 0.00 0.00 0.33 
FBpp0087115 RpS11 -3.84 -2.68 -1.16 0.00 0.00 0.15 
FBpp0075612 RpS12 -3.23 -2.86 -0.38 0.00 0.00 0.54 
FBpp0312104 RpS13 -3.16 -2.85 -0.31 0.00 0.00 0.70 
FBpp0311458 RpS14b -3.07 -2.98 -0.09 0.00 0.00 0.87 
FBpp0309759 RpS16 -3.55 -3.40 -0.15 0.00 0.00 0.78 
FBpp0076207 RpS17 -2.58 -2.81 0.23 0.00 0.00 0.76 
FBpp0085586 RpS18 -4.06 -3.82 -0.24 0.00 0.00 0.63 
FBpp0311350 RpS19a -3.00 -2.92 -0.09 0.00 0.00 0.90 
FBpp0311561 RpS2 -2.24 -2.33 0.09 0.00 0.00 0.84 
FBpp0307130 RpS21 -3.82 -3.22 -0.60 0.00 0.00 0.29 
FBpp0081846 RpS25 -2.76 -3.15 0.39 0.00 0.00 0.62 
FBpp0079606 RpS27A 1.88 1.98 -0.10 0.27 0.24 0.95 
FBpp0312066 RpS3 -3.41 -3.31 -0.10 0.00 0.00 0.86 
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FBpp0300615 RpS3A -4.21 -3.58 -0.64 0.00 0.00 0.23 
FBpp0312080 RpS4 -3.81 -3.22 -0.60 0.00 0.00 0.16 
FBpp0071087 RpS6 -3.91 -3.32 -0.59 0.00 0.00 0.28 
FBpp0308324 RpS7 -2.74 -2.94 0.20 0.00 0.00 0.66 
FBpp0311987 RpS8 -3.70 -3.13 -0.57 0.00 0.00 0.27 
FBpp0088021 Rpt1 -0.30 -0.33 0.03 0.65 0.62 0.96 
FBpp0311982 Rpt2 0.93 0.51 0.42 0.07 0.29 0.38 
FBpp0312031 Rpt3 0.21 0.46 -0.25 0.64 0.32 0.59 
FBpp0293948 Rpt4 0.31 0.07 0.24 0.48 0.87 0.59 
FBpp0083843 Rpt5 0.27 0.10 0.18 0.51 0.81 0.66 
FBpp0076890 Rpt6 0.68 -0.11 0.78 0.26 0.85 0.20 
FBpp0288680 Rrp1 3.18 3.62 -0.44 0.00 0.00 0.33 
FBpp0080746 RtcB 1.57 2.68 -1.11 0.28 0.08 0.44 
FBpp0081601 rump -0.47 -0.42 -0.05 0.24 0.29 0.90 
FBpp0089284 Sar1 0.90 1.06 -0.17 0.09 0.05 0.73 
FBpp0297362 SC35 -1.20 -0.81 -0.39 0.03 0.13 0.45 
FBpp0074285 scu -0.30 -0.63 0.33 0.48 0.16 0.44 
FBpp0082877 sds22 0.73 0.35 0.38 0.21 0.54 0.51 
FBpp0083932 Sec10 0.53 0.88 -0.35 0.41 0.18 0.58 
FBpp0311988 Sec13 -0.88 -0.92 0.04 0.05 0.04 0.92 
FBpp0309105 Sec16 -1.72 -1.35 -0.37 0.01 0.03 0.52 
FBpp0308424 Sec23 0.88 0.87 0.01 0.16 0.17 0.99 
FBpp0087723 Sec31 0.37 0.23 0.14 0.39 0.60 0.74 
FBpp0086691 SelD 0.82 0.60 0.22 0.13 0.26 0.66 
FBpp0307454 SerRS 0.42 -0.65 1.07 0.50 0.31 0.11 
FBpp0089160 sgg 0.52 1.64 -1.12 0.47 0.04 0.14 
FBpp0296963 Sgt -0.20 -0.22 0.01 0.69 0.67 0.98 
FBpp0291704 Sh3beta -0.10 -1.30 1.20 0.87 0.07 0.09 
FBpp0305866 shi 1.14 0.67 0.47 0.02 0.12 0.26 
FBpp0073893 shtd -2.14 -1.77 -0.36 0.02 0.04 0.65 
FBpp0081709 sle 0.30 0.81 -0.50 0.68 0.28 0.50 
FBpp0086591 SMC2 2.18 2.62 -0.44 0.00 0.00 0.36 
FBpp0075684 SmD1 0.15 -0.33 0.48 0.73 0.43 0.27 
FBpp0081234 SmD2 0.37 0.66 -0.29 0.46 0.19 0.55 
FBpp0079182 SmE 0.19 0.79 -0.61 0.73 0.17 0.28 
FBpp0288543 smg -0.70 0.12 -0.81 0.34 0.87 0.27 
FBpp0304234 smid 0.37 0.54 -0.18 0.46 0.28 0.72 
FBpp0078984 smt3 0.64 0.57 0.06 0.18 0.22 0.89 
FBpp0078331 Snr1 0.08 -0.29 0.36 0.91 0.68 0.60 
FBpp0079247 Snx6 0.27 0.61 -0.34 0.62 0.28 0.53 
FBpp0075958 Sod1 -0.75 -1.79 1.04 0.15 0.00 0.05 
FBpp0075122 spd-2 0.05 0.03 0.02 0.92 0.95 0.97 
FBpp0297149 SpdS 0.77 0.76 0.02 0.13 0.14 0.97 
FBpp0310470 spel1 1.24 1.85 -0.60 0.05 0.01 0.31 
FBpp0301102 sqd 0.49 0.37 0.12 0.52 0.63 0.87 
FBpp0271779 Srp14 -1.03 -0.72 -0.31 0.08 0.20 0.57 
FBpp0079471 Srp54 0.47 0.78 -0.31 0.35 0.13 0.52 
FBpp0076872 Srp54k -0.81 -0.83 0.01 0.09 0.09 0.97 
FBpp0076244 Srp68 -0.14 -0.11 -0.03 0.73 0.78 0.95 
FBpp0083319 Srp72 0.54 -0.15 0.69 0.39 0.81 0.28 
FBpp0079211 Ssb-c31a 0.48 0.11 0.37 0.41 0.85 0.53 
FBpp0072151 Ssrp 0.92 0.27 0.64 0.11 0.62 0.25 
FBpp0308666 sta -2.00 -2.87 0.86 0.00 0.00 0.16 
FBpp0078827 stai -0.18 -0.90 0.72 0.80 0.20 0.30 
FBpp0077790 Stip1 0.20 -0.36 0.56 0.75 0.58 0.38 
FBpp0290871 Su(var)3-7 1.14 1.10 0.04 0.03 0.03 0.93 
FBpp0078372 Sym -0.32 -0.04 -0.28 0.47 0.92 0.53 
FBpp0304718 tacc 1.06 0.51 0.55 0.02 0.22 0.18 
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FBpp0080045 Tap42 0.48 -0.31 0.79 0.39 0.58 0.17 
FBpp0081820 Tctp -0.29 -0.82 0.53 0.53 0.10 0.26 
FBpp0110174 tefu -0.68 0.22 -0.90 0.50 0.83 0.38 
FBpp0087479 TER94 1.05 0.99 0.07 0.02 0.02 0.86 
FBpp0083355 TFAM 0.94 1.27 -0.34 0.21 0.10 0.64 
FBpp0084526 TfIIA-L 0.58 1.34 -0.75 0.22 0.01 0.12 
FBpp0312095 ThrRS 0.74 1.19 -0.46 0.12 0.02 0.32 
FBpp0082180 timeout 0.02 -0.27 0.29 0.97 0.58 0.55 
FBpp0305273 Tnpo 1.52 1.15 0.37 0.00 0.02 0.37 
FBpp0077346 toc -0.27 0.17 -0.44 0.62 0.75 0.43 
FBpp0304598 Top2 3.85 4.12 -0.27 0.00 0.00 0.50 
FBpp0080787 Top3alpha 0.91 0.52 0.40 0.16 0.41 0.53 
FBpp0087193 tou -0.89 -0.63 -0.26 0.06 0.16 0.54 
FBpp0084948 Tpi -0.93 -1.09 0.15 0.14 0.09 0.80 
FBpp0310608 TppII -0.02 0.05 -0.07 0.96 0.90 0.86 
FBpp0304887 tral -0.54 -0.84 0.30 0.28 0.11 0.54 
FBpp0087398 trsn -0.21 -0.16 -0.05 0.63 0.71 0.91 
FBpp0079437 Trx-2 0.25 -0.74 0.99 0.75 0.35 0.22 
FBpp0071117 Trxr-1 -0.32 -0.73 0.42 0.58 0.22 0.48 
FBpp0310349 Ts 1.50 1.10 0.40 0.04 0.11 0.54 
FBpp0312205 Tsf1 -0.74 -1.38 0.64 0.23 0.04 0.29 
FBpp0072097 tsr -0.75 -1.72 0.97 0.19 0.01 0.10 
FBpp0304417 Tudor-SN 0.91 1.15 -0.24 0.06 0.02 0.60 
FBpp0311386 tws -0.16 0.17 -0.34 0.75 0.74 0.52 
FBpp0076804 Txl 0.61 0.42 0.19 0.54 0.67 0.85 
FBpp0077912 tzn 0.22 0.15 0.07 0.81 0.87 0.94 
FBpp0298007 U2af50 0.07 0.25 -0.18 0.95 0.81 0.86 
FBpp0087583 Uba1 1.47 1.70 -0.22 0.00 0.00 0.60 
FBpp0076457 Uba2 0.95 0.96 -0.01 0.11 0.11 0.99 
FBpp0073354 Uba5 1.07 0.48 0.59 0.08 0.40 0.31 
FBpp0311673 Ubc4 0.27 0.19 0.08 0.78 0.84 0.93 
FBpp0309477 Ubqn -0.40 -0.72 0.32 0.33 0.09 0.44 
FBpp0292511 Uch 0.01 -0.18 0.19 0.99 0.82 0.81 
FBpp0306000 Uch-L5 -1.95 -1.86 -0.09 0.00 0.00 0.84 
FBpp0311276 Uev1A 0.42 0.76 -0.34 0.66 0.43 0.72 
FBpp0290913 UGP 1.60 1.47 0.13 0.05 0.07 0.86 
FBpp0311454 und 0.34 0.80 -0.45 0.56 0.19 0.44 
FBpp0304059 Usp14 0.65 0.85 -0.20 0.16 0.07 0.64 
FBpp0298309 Usp5 0.74 0.65 0.09 0.08 0.12 0.82 
FBpp0073474 Usp7 0.51 0.49 0.02 0.27 0.29 0.97 
FBpp0305353 ValRS 0.71 0.65 0.06 0.07 0.10 0.87 
FBpp0086468 Vha36-1 0.21 -0.01 0.23 0.79 0.99 0.77 
FBpp0086320 Vha44 0.69 0.86 -0.16 0.17 0.10 0.74 
FBpp0290875 Vha55 0.80 -0.02 0.82 0.10 0.97 0.09 
FBpp0307597 Vha68-2 0.71 0.50 0.20 0.13 0.26 0.64 
FBpp0307142 VhaSFD 0.65 0.15 0.50 0.18 0.75 0.29 
FBpp0309628 Vps4 0.68 -0.16 0.84 0.45 0.86 0.35 
FBpp0300790 wds -1.88 -2.15 0.27 0.00 0.00 0.59 
FBpp0289361 wech -0.73 -0.29 -0.43 0.33 0.69 0.55 
FBpp0306779 woc -0.37 -0.43 0.05 0.51 0.45 0.92 
FBpp0307569 wrd 0.41 0.54 -0.13 0.31 0.18 0.73 
FBpp0291513 WRNexo 1.51 2.05 -0.54 0.00 0.00 0.23 
FBpp0304606 x16 -0.84 -0.92 0.08 0.15 0.12 0.89 
FBpp0071049 Ykt6 -0.36 0.68 -1.04 0.66 0.40 0.21 
FBpp0072306 zip 0.88 0.53 0.35 0.09 0.28 0.47 
FBpp0085138 Zwilch 0.34 0.72 -0.38 0.50 0.17 0.46 
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b) OEB – BEB – 15 min – 3 h 
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FBpp0304169 - 0.36 -0.45 0.54 1.36 0.82 0.12 0.10 0.04 0.00 0.03 
FBpp0304748 - 0.31 -0.42 0.06 0.80 0.74 0.13 0.08 0.78 0.00 0.02 
FBpp0308925 - 0.05 0.03 0.45 0.47 0.01 0.86 0.92 0.12 0.11 0.97 
FBpp0312116 - 0.11 -0.01 -1.30 -1.19 0.12 0.82 0.99 0.02 0.03 0.87 
FBpp0087084 128up 0.37 -0.69 -0.64 0.42 1.06 0.34 0.13 0.13 0.32 0.08 
FBpp0082990 14-3-3epsilon 0.02 0.05 -0.47 -0.50 -0.03 0.92 0.84 0.04 0.03 0.93 
FBpp0305137 14-3-3zeta -0.43 0.24 0.06 -0.60 -0.66 0.20 0.55 0.86 0.11 0.20 
FBpp0075508 26-29-p -0.28 0.22 2.41 1.90 -0.50 0.52 0.67 0.00 0.00 0.46 
FBpp0087947 ACC -0.83 0.62 2.89 1.44 -1.45 0.02 0.13 0.00 0.00 0.01 
FBpp0085204 Acf -0.25 0.01 1.31 1.05 -0.26 0.46 0.98 0.00 0.01 0.62 
FBpp0311818 Act5C 0.29 1.20 1.43 0.52 -0.91 0.63 0.10 0.04 0.43 0.34 
FBpp0100051 Adh -0.04 0.10 -0.52 -0.66 -0.14 0.94 0.85 0.33 0.22 0.85 
FBpp0082816 AdSL 0.09 0.74 0.47 -0.18 -0.65 0.84 0.17 0.34 0.71 0.35 
FBpp0312000 Ahcy -0.40 0.53 -1.13 -2.06 -0.93 0.44 0.38 0.05 0.00 0.24 
FBpp0087757 AIMP1 -0.83 -0.48 0.21 -0.15 -0.36 0.21 0.54 0.77 0.84 0.72 
FBpp0075318 AIMP2 -0.49 -0.17 0.15 -0.17 -0.32 0.21 0.71 0.73 0.68 0.59 
FBpp0071969 AIMP3 -0.24 -0.49 0.28 0.53 0.25 0.44 0.18 0.41 0.12 0.59 
FBpp0309214 Akap200 0.04 0.23 0.16 -0.02 -0.19 0.92 0.64 0.71 0.96 0.77 
FBpp0311050 Akt1 0.68 0.35 0.38 0.71 0.33 0.38 0.70 0.65 0.40 0.78 
FBpp0089366 AlaRS -0.45 0.31 0.15 -0.61 -0.76 0.12 0.36 0.63 0.06 0.09 
FBpp0308680 Ald -0.46 0.63 -0.14 -1.22 -1.08 0.05 0.02 0.57 0.00 0.00 
FBpp0309805 alien 1.68 0.00 -0.91 0.77 1.67 0.02 1.00 0.23 0.31 0.12 
FBpp0084610 ALiX 0.07 -0.34 0.56 0.98 0.41 0.73 0.18 0.02 0.00 0.21 
FBpp0071138 alpha-PheRS -0.73 -1.07 0.62 0.95 0.34 0.50 0.41 0.61 0.43 0.84 
FBpp0072694 alphaCOP 0.46 -0.42 -1.13 -0.26 0.87 0.09 0.19 0.00 0.37 0.04 
FBpp0076122 alphaTub67C -0.31 -0.19 -0.31 -0.42 -0.11 0.25 0.54 0.29 0.15 0.78 
FBpp0081153 alphaTub84B -0.24 0.45 -0.26 -0.95 -0.69 0.30 0.11 0.30 0.00 0.06 
FBpp0311374 Amun 0.21 -0.19 -1.07 -0.67 0.40 0.54 0.63 0.01 0.08 0.45 
FBpp0082065 Aos1 -0.70 0.67 0.86 -0.51 -1.37 0.13 0.22 0.09 0.32 0.06 
FBpp0074558 AP-1-2beta -1.07 0.34 0.64 -0.77 -1.41 0.08 0.62 0.33 0.24 0.13 
FBpp0311464 apolpp -0.06 0.39 -0.53 -0.98 -0.45 0.85 0.27 0.11 0.01 0.33 
FBpp0305852 Arf102F 0.44 -0.69 -0.99 0.14 1.14 0.59 0.47 0.27 0.87 0.37 
FBpp0304364 Arf79F -1.83 0.58 1.11 -1.30 -2.40 0.05 0.59 0.27 0.20 0.10 
FBpp0304160 ArfGAP3 0.03 -0.43 -0.75 -0.28 0.46 0.96 0.56 0.28 0.68 0.63 
FBpp0076271 Argk 0.07 -0.08 -1.24 -1.09 0.15 0.82 0.83 0.00 0.00 0.75 
FBpp0073965 ArgRS -0.52 -0.11 0.28 -0.14 -0.41 0.06 0.73 0.34 0.64 0.32 
FBpp0082121 Arp1 0.48 -0.31 -0.29 0.51 0.79 0.04 0.25 0.26 0.05 0.03 
FBpp0081780 Art1 -0.09 -1.02 -1.82 -0.89 0.93 0.85 0.07 0.00 0.08 0.19 
FBpp0305840 Art4 0.32 -0.62 -2.07 -1.13 0.94 0.29 0.09 0.00 0.00 0.05 
FBpp0304830 AsnRS 0.23 -0.38 -1.52 -0.91 0.61 0.54 0.40 0.00 0.04 0.30 
FBpp0084071 asp -0.61 -0.37 1.66 1.41 -0.24 0.09 0.38 0.00 0.00 0.66 
FBpp0308483 AspRS -0.48 -0.11 0.17 -0.21 -0.38 0.10 0.75 0.58 0.51 0.39 
FBpp0309030 ATPCL -0.01 0.75 -0.09 -0.85 -0.76 0.98 0.14 0.84 0.07 0.25 
FBpp0311086 ATPsynbeta 0.40 -0.38 -0.38 0.40 0.78 0.49 0.58 0.55 0.53 0.39 
FBpp0312191 awd -1.92 -0.01 0.87 -1.04 -1.91 0.24 1.00 0.62 0.56 0.45 
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FBpp0307124 Bacc -0.73 0.02 0.42 -0.33 -0.75 0.23 0.98 0.52 0.62 0.43 
FBpp0084466 ball -0.67 0.49 2.30 1.15 -1.15 0.10 0.30 0.00 0.01 0.07 
FBpp0071235 Bap111 -1.34 0.55 0.96 -0.92 -1.88 0.01 0.31 0.06 0.07 0.01 
FBpp0085442 Bap170 -0.20 -0.28 0.53 0.61 0.08 0.57 0.52 0.19 0.14 0.89 
FBpp0086115 Bap55 -0.32 -0.79 -0.09 0.38 0.47 0.32 0.04 0.80 0.28 0.35 
FBpp0073572 Bap60 -1.18 -0.38 0.99 0.20 -0.80 0.28 0.76 0.40 0.87 0.63 
FBpp0310394 barr -0.44 -0.43 -0.27 -0.27 -0.01 0.19 0.27 0.46 0.45 0.99 
FBpp0306433 bel 0.00 -0.33 0.06 0.40 0.34 0.99 0.31 0.83 0.19 0.44 
FBpp0080048 beta'COP 0.47 0.33 -0.43 -0.29 0.13 0.18 0.41 0.26 0.43 0.80 
FBpp0074348 betaCOP 0.36 -0.21 -0.02 0.55 0.58 0.28 0.59 0.95 0.14 0.27 
FBpp0085720 betaTub56D -0.28 0.77 -0.13 -1.19 -1.06 0.31 0.03 0.66 0.00 0.02 
FBpp0086896 bic -0.97 2.30 1.24 -2.03 -3.28 0.31 0.05 0.24 0.06 0.03 
FBpp0080362 BicC 0.17 0.26 1.20 1.10 -0.09 0.62 0.52 0.00 0.01 0.86 
FBpp0082428 BigH1 -3.18 -1.25 1.99 0.05 -1.94 0.04 0.47 0.22 0.98 0.40 
FBpp0071794 blw 0.22 -0.27 0.38 0.87 0.49 0.73 0.72 0.58 0.22 0.62 
FBpp0311234 bol -0.40 0.47 3.19 2.31 -0.88 0.37 0.37 0.00 0.00 0.21 
FBpp0079417 borr -0.86 0.34 2.29 1.09 -1.21 0.22 0.68 0.01 0.17 0.27 
FBpp0305757 brm -0.63 -0.83 0.31 0.51 0.20 0.14 0.10 0.50 0.27 0.76 
FBpp0308293 Bub3 0.47 -0.67 0.56 1.70 1.15 0.12 0.06 0.09 0.00 0.02 
FBpp0310411 bur 0.03 -0.63 -0.64 0.02 0.66 0.95 0.26 0.21 0.97 0.36 
FBpp0087402 Caf1-105 -1.04 -0.41 0.40 -0.22 -0.63 0.02 0.43 0.40 0.64 0.36 
FBpp0071172 Caf1-180 -0.44 -0.28 0.34 0.18 -0.17 0.22 0.51 0.38 0.65 0.76 
FBpp0082511 Caf1-55 0.18 -0.83 -0.21 0.80 1.00 0.75 0.21 0.73 0.19 0.24 
FBpp0311269 Cam -0.88 0.47 1.91 0.56 -1.35 0.06 0.37 0.00 0.25 0.06 
FBpp0301600 CanB2 -0.04 -0.37 -0.51 -0.18 0.33 0.95 0.63 0.48 0.80 0.74 
FBpp0304507 Cand1 -0.15 0.21 0.27 -0.09 -0.35 0.58 0.51 0.36 0.77 0.39 
FBpp0084818 Cap-D2 0.01 -0.23 -0.33 -0.09 0.24 0.97 0.47 0.27 0.76 0.57 
FBpp0288780 Cap-G -0.03 -0.29 -0.28 -0.02 0.26 0.94 0.56 0.54 0.96 0.69 
FBpp0304563 capt 0.32 -0.21 -0.46 0.07 0.53 0.11 0.38 0.04 0.74 0.09 
FBpp0308803 casp 1.52 0.98 0.21 0.75 0.54 0.02 0.17 0.74 0.25 0.55 
FBpp0083684 CCT1 -0.04 0.26 -0.26 -0.57 -0.31 0.86 0.36 0.33 0.04 0.42 
FBpp0071226 CCT2 -0.11 0.08 -0.33 -0.52 -0.19 0.69 0.80 0.27 0.09 0.65 
FBpp0291566 CCT3 -0.17 -0.06 -0.73 -0.84 -0.11 0.52 0.86 0.02 0.01 0.78 
FBpp0079992 CCT4 -0.04 0.27 -0.58 -0.89 -0.31 0.90 0.43 0.08 0.01 0.49 
FBpp0087095 CCT5 -0.12 0.35 -0.50 -0.97 -0.47 0.67 0.28 0.10 0.00 0.27 
FBpp0073902 CCT6 0.17 0.40 -0.18 -0.41 -0.22 0.48 0.18 0.49 0.14 0.55 
FBpp0081401 CCT7 0.13 0.31 -0.49 -0.67 -0.17 0.54 0.24 0.05 0.01 0.60 
FBpp0087764 CCT8 0.05 0.06 -0.45 -0.47 -0.02 0.83 0.81 0.07 0.06 0.96 
FBpp0079641 Cdk1 0.26 -0.14 0.00 0.39 0.40 0.23 0.59 0.99 0.10 0.23 
FBpp0308475 ced-6 -0.15 -0.30 0.61 0.76 0.15 0.79 0.64 0.31 0.21 0.86 
FBpp0305296 CG10077 0.78 -0.99 0.68 2.45 1.77 0.40 0.37 0.50 0.02 0.22 
FBpp0080749 CG10237 0.27 -0.67 0.33 1.27 0.94 0.55 0.21 0.50 0.01 0.18 
FBpp0306810 CG10254 0.25 0.05 -0.16 0.04 0.20 0.60 0.92 0.76 0.94 0.79 
FBpp0309810 CG10341 -0.69 0.71 3.01 1.61 -1.39 0.32 0.39 0.00 0.04 0.20 
FBpp0293954 CG10565 0.22 -0.09 0.44 0.74 0.31 0.42 0.78 0.15 0.02 0.46 
FBpp0311825 CG10576 -0.68 -0.06 -0.10 -0.72 -0.62 0.29 0.93 0.88 0.30 0.53 
FBpp0309343 CG11164 0.32 -1.16 -0.39 1.09 1.48 0.62 0.13 0.58 0.13 0.14 
FBpp0084759 CG11899 0.27 0.04 -2.23 -1.99 0.23 0.62 0.95 0.00 0.00 0.78 
FBpp0072658 CG12018 1.12 -1.29 -1.93 0.49 2.42 0.02 0.02 0.00 0.31 0.00 
FBpp0312072 CG12702 0.25 -0.06 -0.68 -0.36 0.31 0.61 0.92 0.22 0.50 0.68 
FBpp0307859 CG1354 0.59 -0.24 -1.69 -0.86 0.83 0.23 0.67 0.00 0.11 0.27 
FBpp0085260 CG1416 0.32 0.12 -0.91 -0.71 0.20 0.40 0.79 0.04 0.10 0.73 
FBpp0311823 CG14434 0.04 0.35 -0.88 -1.19 -0.31 0.94 0.55 0.11 0.03 0.68 
FBpp0077145 CG15439 0.02 0.38 1.74 1.37 -0.36 0.96 0.40 0.00 0.00 0.54 
FBpp0084691 CG1646 -0.93 0.42 2.33 0.98 -1.35 0.36 0.72 0.04 0.38 0.39 
FBpp0300672 CG16817 -0.15 0.34 -0.18 -0.67 -0.49 0.87 0.76 0.86 0.52 0.74 
FBpp0310240 CG1703 -0.07 -0.19 0.14 0.26 0.13 0.88 0.70 0.77 0.58 0.85 
FBpp0085374 CG17337 -0.83 0.79 -0.18 -1.80 -1.62 0.22 0.32 0.80 0.02 0.13 
FBpp0087367 CG17765 -0.32 0.47 -0.37 -1.16 -0.79 0.60 0.52 0.57 0.09 0.40 
FBpp0271746 CG18190 0.62 -0.07 0.34 1.03 0.69 0.03 0.83 0.26 0.00 0.11 
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FBpp0303935 CG18815 -0.46 -0.51 -0.28 -0.23 0.05 0.40 0.43 0.64 0.70 0.95 
FBpp0306729 CG1943 -0.20 0.31 -1.76 -2.27 -0.51 0.84 0.79 0.11 0.04 0.74 
FBpp0304910 CG2034 0.44 -0.57 -1.60 -0.59 1.01 0.23 0.19 0.00 0.15 0.08 
FBpp0078327 CG2091 0.14 1.22 -0.44 -1.53 -1.09 0.83 0.12 0.53 0.04 0.28 
FBpp0307423 CG2246 0.16 0.70 -0.99 -1.53 -0.54 0.69 0.14 0.03 0.00 0.38 
FBpp0311613 CG2852 -0.51 0.79 1.38 0.08 -1.30 0.47 0.34 0.08 0.92 0.24 
FBpp0307127 CG2862 -1.88 -0.02 0.47 -1.39 -1.86 0.01 0.98 0.52 0.06 0.08 
FBpp0086057 CG30105 -0.76 -0.07 1.05 0.36 -0.69 0.21 0.92 0.12 0.58 0.46 
FBpp0291433 CG30382 0.23 -0.01 -0.36 -0.13 0.24 0.28 0.97 0.12 0.57 0.46 
FBpp0070997 CG3040 0.68 0.78 1.62 1.52 -0.10 0.45 0.47 0.11 0.13 0.94 
FBpp0076007 CG32066 -0.27 -1.04 -0.18 0.60 0.78 0.71 0.22 0.82 0.45 0.48 
FBpp0311522 CG32165 0.35 -0.52 0.13 0.99 0.86 0.64 0.55 0.87 0.22 0.45 
FBpp0070953 CG3226 -0.72 0.00 -0.34 -1.07 -0.73 0.32 1.00 0.66 0.18 0.51 
FBpp0311482 CG33722 -0.49 1.09 -1.21 -2.78 -1.57 0.59 0.32 0.23 0.01 0.27 
FBpp0310197 CG3939 1.67 0.60 -0.89 0.18 1.07 0.06 0.56 0.35 0.85 0.42 
FBpp0303976 CG40045 -0.67 -0.28 -1.69 -2.07 -0.38 0.33 0.72 0.03 0.01 0.71 
FBpp0288574 CG42232 -0.18 0.10 1.30 1.02 -0.29 0.59 0.79 0.00 0.01 0.58 
FBpp0304189 CG4603 -0.40 -0.28 0.00 -0.12 -0.12 0.17 0.41 0.99 0.70 0.79 
FBpp0079789 CG4751 -0.10 -0.59 1.92 2.41 0.49 0.90 0.53 0.04 0.01 0.69 
FBpp0112210 CG4951 -2.27 0.75 3.97 0.95 -3.02 0.04 0.55 0.00 0.42 0.08 
FBpp0309480 CG5162 -0.49 0.03 4.40 3.88 -0.53 0.05 0.91 0.00 0.00 0.16 
FBpp0309317 CG5174 0.01 -0.31 0.49 0.82 0.33 0.95 0.28 0.08 0.01 0.39 
FBpp0311410 CG5515 0.24 0.64 -0.38 -0.78 -0.40 0.53 0.17 0.37 0.08 0.51 
FBpp0085950 CG5721 0.12 -0.30 -0.94 -0.52 0.42 0.76 0.51 0.04 0.23 0.48 
FBpp0084281 CG5886 -0.19 -0.36 0.39 0.56 0.17 0.56 0.36 0.28 0.13 0.74 
FBpp0303937 CG6084 -0.62 0.91 0.01 -1.52 -1.53 0.03 0.01 0.98 0.00 0.00 
FBpp0079979 CG6180 -1.58 2.15 1.27 -2.45 -3.73 0.08 0.05 0.19 0.02 0.01 
FBpp0083213 CG6195 0.50 -0.19 -1.03 -0.33 0.70 0.14 0.63 0.01 0.37 0.19 
FBpp0079809 CG6287 -0.45 0.32 -0.50 -1.27 -0.77 0.21 0.45 0.20 0.00 0.17 
FBpp0080044 CG6523 -0.09 0.09 0.15 -0.02 -0.17 0.86 0.88 0.78 0.97 0.82 
FBpp0311284 CG6767 -0.61 0.56 0.65 -0.51 -1.17 0.23 0.35 0.24 0.35 0.14 
FBpp0309927 CG6907 0.63 -0.34 -1.25 -0.28 0.97 0.12 0.48 0.01 0.53 0.13 
FBpp0304957 CG7519 0.58 -0.27 -1.41 -0.56 0.85 0.29 0.68 0.03 0.35 0.32 
FBpp0302568 CG7946 -0.74 -0.05 0.95 0.27 -0.68 0.20 0.94 0.13 0.66 0.44 
FBpp0303962 CG8003 0.34 -0.43 -0.45 0.33 0.78 0.18 0.15 0.11 0.24 0.05 
FBpp0081371 CG8036 -0.91 0.21 0.25 -0.87 -1.12 0.06 0.69 0.62 0.09 0.12 
FBpp0074246 CG8142 -0.29 0.46 0.96 0.21 -0.75 0.46 0.33 0.03 0.62 0.22 
FBpp0081539 CG8149 0.13 0.11 -2.33 -2.31 0.02 0.79 0.85 0.00 0.00 0.98 
FBpp0076470 CG8209 0.27 0.32 -0.75 -0.80 -0.05 0.64 0.64 0.24 0.21 0.96 
FBpp0081398 CG8223 0.34 -0.02 -0.78 -0.42 0.36 0.52 0.97 0.19 0.47 0.66 
FBpp0087733 CG8243 -0.10 0.01 2.08 1.96 -0.12 0.74 0.97 0.00 0.00 0.81 
FBpp0087116 CG8858 0.52 0.21 -0.45 -0.14 0.31 0.07 0.52 0.16 0.66 0.48 
FBpp0074128 CG9132 0.54 -0.29 -0.36 0.47 0.83 0.02 0.26 0.14 0.05 0.02 
FBpp0311963 CG9135 0.35 0.15 0.59 0.80 0.20 0.45 0.79 0.25 0.12 0.78 
FBpp0072610 CG9184 -0.36 0.47 2.04 1.21 -0.83 0.62 0.59 0.02 0.14 0.46 
FBpp0309269 CG9281 -0.28 0.60 0.07 -0.82 -0.88 0.34 0.09 0.84 0.02 0.06 
FBpp0074708 CG9330 -1.33 0.66 1.20 -0.79 -1.99 0.02 0.30 0.05 0.18 0.02 
FBpp0081343 CG9601 0.65 1.12 1.41 0.95 -0.47 0.44 0.26 0.13 0.30 0.72 
FBpp0088471 chb -0.13 -0.14 0.84 0.84 0.01 0.84 0.86 0.24 0.24 1.00 
FBpp0308531 Chc 0.02 -0.16 -0.52 -0.34 0.18 0.93 0.57 0.06 0.20 0.63 
FBpp0301152 chic -0.18 0.82 -0.03 -1.02 -0.99 0.63 0.07 0.95 0.02 0.09 
FBpp0083939 CHORD 0.27 1.13 -0.87 -1.74 -0.87 0.55 0.04 0.08 0.00 0.21 
FBpp0099657 Chrac-14 -0.55 -0.02 1.17 0.64 -0.53 0.22 0.97 0.02 0.19 0.44 
FBpp0308688 Chrac-16 -0.09 0.13 1.23 1.01 -0.22 0.81 0.75 0.00 0.01 0.69 
FBpp0310070 cib -0.32 0.34 -0.24 -0.91 -0.66 0.25 0.30 0.42 0.01 0.13 
FBpp0311360 CkIIalpha -0.22 -0.58 -0.98 -0.61 0.37 0.61 0.26 0.05 0.20 0.58 
FBpp0305406 CkIIbeta 0.26 -0.26 -0.83 -0.31 0.52 0.74 0.79 0.35 0.73 0.68 
FBpp0301627 cnn -0.04 -0.95 0.43 1.34 0.91 0.95 0.22 0.54 0.07 0.36 
FBpp0304029 Cnot4 -0.93 0.02 2.51 1.55 -0.95 0.12 0.98 0.00 0.02 0.30 
FBpp0086719 Cp1 0.22 0.12 1.58 1.69 0.11 0.60 0.82 0.00 0.00 0.87 
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FBpp0304020 cpb 1.32 -0.79 -0.23 1.88 2.11 0.01 0.13 0.63 0.00 0.00 
FBpp0074329 CrebB -0.10 -0.50 0.15 0.55 0.40 0.82 0.34 0.75 0.25 0.55 
FBpp0080484 Cse1 -0.05 0.25 -0.29 -0.60 -0.31 0.85 0.46 0.36 0.07 0.50 
FBpp0077927 CSN3 -0.04 -0.52 -0.74 -0.26 0.48 0.89 0.13 0.02 0.41 0.28 
FBpp0290448 CSN4 0.27 -0.25 -0.37 0.16 0.53 0.35 0.45 0.24 0.62 0.24 
FBpp0082743 CSN5 0.23 -1.38 -0.50 1.11 1.61 0.78 0.16 0.58 0.22 0.21 
FBpp0087821 CSN7 0.27 0.01 -0.97 -0.70 0.27 0.70 1.00 0.22 0.37 0.81 
FBpp0306584 CtBP -0.45 -0.26 -0.17 -0.36 -0.19 0.34 0.64 0.74 0.48 0.79 
FBpp0086732 Ctf4 0.23 -0.45 0.88 1.57 0.69 0.54 0.32 0.04 0.00 0.25 
FBpp0312102 cup -0.03 -0.06 2.23 2.25 0.03 0.92 0.87 0.00 0.00 0.96 
FBpp0074017 Cyp1 -0.84 1.12 -0.08 -2.05 -1.97 0.06 0.04 0.86 0.00 0.01 
FBpp0290739 D1 -0.89 0.74 1.74 0.11 -1.63 0.27 0.43 0.05 0.89 0.19 
FBpp0084349 Dak1 -1.21 -0.40 0.18 -0.63 -0.81 0.16 0.69 0.85 0.50 0.54 
FBpp0075498 DCTN1-p150 0.14 0.07 0.42 0.49 0.07 0.66 0.86 0.23 0.16 0.88 
FBpp0087722 DCTN2-p50 0.23 -0.10 -0.69 -0.36 0.33 0.50 0.80 0.07 0.34 0.53 
FBpp0071097 dec-1 0.52 0.39 -2.79 -2.67 0.12 0.44 0.62 0.00 0.00 0.91 
FBpp0291138 deltaCOP -0.17 -0.15 -2.17 -2.19 -0.02 0.81 0.86 0.01 0.01 0.98 
FBpp0099688 Df31 -1.95 0.17 0.80 -1.32 -2.12 0.04 0.87 0.42 0.19 0.14 
FBpp0304991 Dhc64C 0.14 -0.49 -0.37 0.27 0.64 0.52 0.07 0.13 0.28 0.07 
FBpp0311766 dhd 0.16 -0.09 0.45 0.70 0.25 0.81 0.91 0.54 0.34 0.81 
FBpp0073299 Dlic -0.30 -0.47 0.11 0.27 0.16 0.50 0.38 0.83 0.58 0.81 
FBpp0076830 DnaJ-1 -0.42 -0.19 2.87 2.65 -0.22 0.26 0.66 0.00 0.00 0.69 
FBpp0072041 DNAlig1 0.09 -0.63 -0.15 0.57 0.72 0.73 0.04 0.59 0.05 0.07 
FBpp0073678 DNAlig4 0.43 1.24 2.75 1.94 -0.81 0.40 0.05 0.00 0.00 0.31 
FBpp0075277 DNApol-delta 0.75 -1.36 -0.65 1.46 2.12 0.09 0.01 0.17 0.00 0.00 
FBpp0311418 Dp1 -0.09 -0.29 0.01 0.21 0.20 0.68 0.25 0.96 0.36 0.54 
FBpp0311783 dpa -0.14 0.36 -0.55 -1.04 -0.49 0.64 0.31 0.10 0.00 0.29 
FBpp0083673 Dph5 0.19 1.01 -1.04 -1.87 -0.82 0.72 0.12 0.08 0.00 0.32 
FBpp0072744 dre4 0.04 0.55 -0.36 -0.86 -0.50 0.89 0.14 0.30 0.02 0.30 
FBpp0082223 Droj2 0.16 0.00 0.74 0.91 0.17 0.43 0.99 0.00 0.00 0.61 
FBpp0307166 Drp1 0.10 -0.37 0.00 0.46 0.47 0.67 0.19 0.99 0.08 0.21 
FBpp0309113 Dsor1 0.94 0.00 -1.30 -0.37 0.93 0.13 1.00 0.06 0.58 0.32 
FBpp0308813 Dsp1 -0.15 -0.24 0.97 1.06 0.09 0.79 0.71 0.12 0.09 0.92 
FBpp0079746 dUTPase -0.08 0.67 -0.74 -1.50 -0.76 0.87 0.28 0.20 0.01 0.35 
FBpp0304413 E(bx) -0.29 0.52 1.66 0.85 -0.82 0.73 0.60 0.08 0.36 0.53 
FBpp0305157 Eb1 0.45 0.13 -0.11 0.21 0.32 0.05 0.63 0.65 0.40 0.36 
FBpp0311273 eEF1alpha1 0.42 0.01 -0.81 -0.40 0.41 0.07 0.97 0.00 0.11 0.24 
FBpp0311691 eEF1beta 0.04 0.05 0.60 0.60 -0.01 0.86 0.87 0.04 0.04 0.99 
FBpp0079542 eEF1delta -0.05 0.16 0.27 0.07 -0.20 0.84 0.56 0.28 0.77 0.57 
FBpp0305182 eEF2 -0.01 0.52 -0.52 -1.05 -0.53 0.97 0.06 0.05 0.00 0.14 
FBpp0072082 eEF5 -0.36 0.76 0.01 -1.10 -1.12 0.48 0.22 0.98 0.06 0.17 
FBpp0072908 eIF1 0.61 0.30 -1.30 -0.99 0.32 0.28 0.65 0.04 0.11 0.71 
FBpp0309768 eIF2alpha 0.29 -0.17 0.38 0.83 0.45 0.18 0.50 0.11 0.00 0.17 
FBpp0291521 eIF2Bdelta -0.07 -0.41 0.05 0.38 0.33 0.81 0.27 0.88 0.26 0.49 
FBpp0075700 eIF2beta -0.29 0.40 1.14 0.46 -0.68 0.81 0.78 0.39 0.73 0.71 
FBpp0307983 eIF2gamma 0.41 -0.04 0.08 0.53 0.45 0.04 0.87 0.71 0.02 0.15 
FBpp0312226 eIF3a 0.45 0.95 0.48 -0.02 -0.50 0.38 0.12 0.39 0.98 0.53 
FBpp0075104 eIF3e -0.93 2.63 2.73 -0.83 -3.56 0.31 0.02 0.01 0.40 0.02 
FBpp0070430 eIF3g1 -1.33 -0.35 1.93 0.95 -0.98 0.13 0.73 0.05 0.32 0.47 
FBpp0071587 eIF3k 0.36 -0.54 -0.59 0.31 0.90 0.22 0.12 0.07 0.32 0.05 
FBpp0075754 eIF3l 0.15 -0.17 -0.38 -0.07 0.32 0.59 0.62 0.22 0.83 0.47 
FBpp0303628 eIF4A 0.23 -0.20 -0.78 -0.36 0.42 0.45 0.59 0.03 0.29 0.37 
FBpp0306959 eIF4B 0.85 0.77 0.14 0.23 0.08 0.11 0.22 0.80 0.69 0.92 
FBpp0288389 eIF4G1 0.28 -0.91 0.53 1.72 1.19 0.28 0.01 0.07 0.00 0.01 
FBpp0310226 eIF4H1 0.61 -0.72 -1.03 0.30 1.34 0.17 0.17 0.04 0.53 0.06 
FBpp0089140 eIF5 0.83 -0.64 -1.50 -0.03 1.47 0.10 0.28 0.01 0.96 0.06 
FBpp0301573 eIF5B 0.72 0.62 -0.76 -0.66 0.10 0.26 0.41 0.28 0.34 0.92 
FBpp0072144 eIF6 -0.08 -0.74 -1.13 -0.48 0.65 0.80 0.07 0.00 0.20 0.21 
FBpp0311547 Eip55E 0.13 1.52 -0.12 -1.50 -1.39 0.81 0.03 0.85 0.02 0.12 
FBpp0083354 EloB -0.01 -0.26 -0.15 0.10 0.25 0.99 0.82 0.89 0.92 0.87 
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FBpp0079278 emb -0.19 -0.35 -0.21 -0.05 0.16 0.57 0.38 0.58 0.90 0.76 
FBpp0303860 EndoGI 0.46 -0.51 -1.17 -0.20 0.97 0.25 0.28 0.01 0.64 0.12 
FBpp0077574 Eno -0.75 -0.04 -0.69 -1.41 -0.72 0.02 0.93 0.05 0.00 0.15 
FBpp0304201 eRF1 -0.43 -0.06 -1.43 -1.80 -0.37 0.59 0.95 0.11 0.05 0.76 
FBpp0311174 eRF3 0.22 0.20 -1.09 -1.06 0.02 0.60 0.70 0.03 0.03 0.97 
FBpp0079496 Etl1 0.46 -0.65 0.13 1.25 1.12 0.52 0.45 0.87 0.12 0.32 
FBpp0099726 fabp 0.36 0.32 -0.73 -0.69 0.04 0.10 0.21 0.00 0.01 0.90 
FBpp0308326 faf -0.05 -0.65 -0.26 0.34 0.60 0.87 0.08 0.44 0.31 0.21 
FBpp0083399 Fancd2 -0.12 0.35 2.26 1.78 -0.48 0.81 0.57 0.00 0.00 0.56 
FBpp0087756 FANCI -0.20 0.25 2.58 2.13 -0.45 0.76 0.75 0.00 0.01 0.66 
FBpp0307371 FASN1 0.60 -0.34 -1.06 -0.12 0.94 0.11 0.44 0.01 0.76 0.11 
FBpp0081767 Fdh -0.40 0.48 -1.56 -2.44 -0.89 0.56 0.55 0.05 0.00 0.41 
FBpp0071892 Fib 0.41 0.17 0.76 1.00 0.24 0.57 0.84 0.34 0.22 0.83 
FBpp0074215 Fim 0.43 0.25 -0.19 -0.02 0.18 0.22 0.53 0.61 0.97 0.74 
FBpp0083551 fit -0.02 0.79 0.28 -0.53 -0.81 0.96 0.13 0.55 0.27 0.23 
FBpp0082574 FK506-bp1 -1.87 0.77 1.14 -1.49 -2.63 0.05 0.47 0.25 0.14 0.07 
FBpp0085703 FK506-bp2 -0.05 0.41 -0.45 -0.92 -0.47 0.83 0.17 0.11 0.00 0.24 
FBpp0309663 FKBP59 0.14 -0.30 -0.80 -0.37 0.44 0.57 0.31 0.01 0.18 0.26 
FBpp0300445 Fmr1 0.10 0.52 1.15 0.73 -0.42 0.87 0.47 0.09 0.27 0.65 
FBpp0304175 fmt -0.40 0.33 0.66 -0.08 -0.73 0.47 0.61 0.28 0.90 0.40 
FBpp0310694 fray 2.12 -2.23 -2.18 2.17 4.35 0.04 0.06 0.05 0.05 0.01 
FBpp0294038 Fs(2)Ket 0.22 -0.16 -0.23 0.15 0.38 0.39 0.59 0.42 0.58 0.34 
FBpp0303129 gammaCOP 0.58 -0.34 -1.62 -0.70 0.92 0.11 0.42 0.00 0.08 0.11 
FBpp0304827 gammaTub37C 0.27 -0.13 0.40 0.80 0.40 0.28 0.66 0.14 0.01 0.30 
FBpp0099914 Gapdh1 -0.30 1.37 -0.57 -2.24 -1.67 0.63 0.08 0.41 0.00 0.10 
FBpp0304864 Gapdh2 -4.04 0.23 1.86 -2.41 -4.27 0.01 0.89 0.23 0.13 0.06 
FBpp0311558 Gdi -1.18 1.13 0.13 -2.18 -2.31 0.11 0.20 0.87 0.01 0.05 
FBpp0307688 Gel -0.59 -0.02 1.85 1.28 -0.57 0.45 0.98 0.04 0.14 0.63 
FBpp0084240 GlnRS -0.44 -0.36 0.11 0.04 -0.08 0.13 0.28 0.71 0.91 0.86 
FBpp0080489 glu 0.00 0.04 0.04 -0.01 -0.04 1.00 0.90 0.91 0.98 0.92 
FBpp0083898 GluProRS -0.48 -0.26 0.30 0.07 -0.23 0.23 0.58 0.49 0.86 0.71 
FBpp0099923 GlyP -0.17 0.04 -1.35 -1.57 -0.21 0.49 0.89 0.00 0.00 0.58 
FBpp0306062 GlyRS -0.20 0.14 -0.75 -1.09 -0.34 0.49 0.69 0.03 0.00 0.46 
FBpp0305474 GlyS 0.51 0.09 -1.60 -1.18 0.42 0.31 0.88 0.01 0.04 0.58 
FBpp0078478 Gnf1 -0.02 0.12 0.67 0.52 -0.15 0.94 0.73 0.05 0.12 0.76 
FBpp0310187 Grip84 -0.46 0.52 0.52 -0.46 -0.98 0.40 0.42 0.38 0.44 0.25 
FBpp0073672 Grip91 -0.84 -0.91 0.54 0.62 0.08 0.14 0.17 0.38 0.31 0.93 
FBpp0300970 Grx1 -0.61 0.86 0.91 -0.55 -1.47 0.28 0.20 0.15 0.37 0.10 
FBpp0290201 Gss2 0.49 0.55 -1.21 -1.27 -0.06 0.36 0.39 0.05 0.04 0.95 
FBpp0099824 GstD1 -1.05 0.35 -0.68 -2.08 -1.40 0.10 0.64 0.32 0.01 0.16 
FBpp0085855 GstE6 0.51 0.20 -1.16 -0.85 0.31 0.03 0.45 0.00 0.00 0.37 
FBpp0305731 GstS1 -0.76 -0.12 -0.47 -1.12 -0.64 0.31 0.89 0.56 0.18 0.57 
FBpp0305263 Gug -0.34 0.23 3.02 2.45 -0.57 0.45 0.66 0.00 0.00 0.41 
FBpp0310171 hang -0.64 -0.01 1.11 0.48 -0.63 0.20 0.99 0.05 0.37 0.41 
FBpp0078319 Hat1 -0.03 0.10 -0.88 -1.01 -0.13 0.96 0.87 0.15 0.10 0.88 
FBpp0311451 Hcf -1.00 -0.80 1.88 1.68 -0.20 0.15 0.33 0.02 0.03 0.85 
FBpp0073173 HDAC1 -0.07 -1.18 -0.18 0.93 1.11 0.89 0.05 0.73 0.09 0.15 
FBpp0078756 Hel25E 0.11 -0.14 -0.38 -0.13 0.25 0.65 0.64 0.17 0.64 0.52 
FBpp0305905 HIP-R 0.01 0.02 -0.71 -0.72 -0.01 0.96 0.94 0.03 0.03 0.98 
FBpp0071028 Hira -0.26 -0.54 1.22 1.50 0.28 0.67 0.47 0.09 0.04 0.77 
FBpp0091111 His2A 0.33 -2.09 0.59 3.02 2.43 0.74 0.09 0.59 0.01 0.13 
FBpp0306426 His2Av 0.02 0.27 3.27 3.03 -0.25 0.96 0.64 0.00 0.00 0.74 
FBpp0091155 His2B -0.10 0.23 2.51 2.18 -0.33 0.78 0.58 0.00 0.00 0.55 
FBpp0091112 His3 -0.03 1.99 2.49 0.48 -2.01 0.98 0.09 0.03 0.65 0.19 
FBpp0306146 His4r -0.09 0.53 2.47 1.85 -0.62 0.83 0.29 0.00 0.00 0.34 
FBpp0307711 HnRNP-K 1.70 -0.52 -0.78 1.44 2.22 0.05 0.59 0.39 0.11 0.09 
FBpp0297875 Hrb27C -0.12 -0.13 3.04 3.06 0.01 0.89 0.90 0.00 0.00 0.99 
FBpp0307982 Hsc70-4 -0.28 0.11 1.89 1.50 -0.38 0.34 0.76 0.00 0.00 0.40 
FBpp0305265 Hsc70Cb -0.44 0.84 -0.25 -1.53 -1.28 0.10 0.01 0.40 0.00 0.00 
FBpp0312157 Hsp26 0.41 0.05 0.49 0.85 0.35 0.10 0.86 0.07 0.00 0.35 
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FBpp0312159 Hsp27 -0.08 0.12 0.89 0.69 -0.20 0.78 0.71 0.01 0.03 0.64 
FBpp0073291 Hsp60A 0.19 -0.61 -0.65 0.14 0.79 0.67 0.26 0.19 0.77 0.26 
FBpp0305095 Hsp83 0.08 -0.09 -0.63 -0.46 0.17 0.73 0.72 0.02 0.07 0.62 
FBpp0305272 Idh -0.68 -0.33 -0.87 -1.22 -0.35 0.23 0.62 0.17 0.06 0.69 
FBpp0078152 IleRS -0.68 -0.38 0.28 -0.02 -0.30 0.03 0.28 0.38 0.95 0.51 
FBpp0307848 Incenp -1.02 0.81 1.47 -0.35 -1.83 0.05 0.18 0.01 0.52 0.02 
FBpp0084842 IntS11 0.11 -0.13 -0.44 -0.19 0.24 0.86 0.86 0.54 0.79 0.81 
FBpp0076091 iPLA2-VIA 0.68 -0.64 -0.12 1.20 1.32 0.19 0.30 0.83 0.04 0.11 
FBpp0081861 Irbp 2.69 2.63 1.39 1.45 0.05 0.00 0.00 0.05 0.04 0.96 
FBpp0086956 Iswi -0.34 0.05 1.62 1.23 -0.38 0.33 0.91 0.00 0.00 0.47 
FBpp0311371 Jafrac1 -0.80 0.41 0.01 -1.20 -1.21 0.02 0.31 0.98 0.00 0.03 
FBpp0307568 Karybeta3 0.20 -0.24 -0.64 -0.20 0.44 0.46 0.46 0.04 0.51 0.30 
FBpp0086328 Khc 0.30 -0.44 -0.87 -0.12 0.75 0.24 0.16 0.00 0.66 0.07 
FBpp0289115 kis -0.53 -0.33 1.98 1.79 -0.19 0.26 0.55 0.00 0.00 0.79 
FBpp0303946 Klc 0.66 0.04 -0.70 -0.07 0.63 0.27 0.96 0.29 0.91 0.50 
FBpp0312027 Klp10A 0.39 -0.05 0.42 0.86 0.44 0.09 0.86 0.10 0.00 0.22 
FBpp0309092 Klp3A -0.31 0.12 1.13 0.69 -0.44 0.30 0.73 0.00 0.04 0.35 
FBpp0072616 Klp61F 0.26 0.06 -0.48 -0.28 0.20 0.45 0.89 0.20 0.45 0.70 
FBpp0078399 kra -0.07 -0.24 -0.18 -0.01 0.17 0.89 0.67 0.73 0.99 0.81 
FBpp0080322 Ku80 2.20 1.92 1.29 1.57 0.28 0.00 0.00 0.01 0.00 0.68 
FBpp0307649 l(1)G0156 0.12 -0.70 0.71 1.53 0.82 0.86 0.39 0.35 0.05 0.44 
FBpp0080906 La 0.21 -0.46 -0.88 -0.20 0.67 0.49 0.21 0.01 0.54 0.16 
FBpp0312110 Lam -0.16 -0.36 1.43 1.63 0.20 0.53 0.24 0.00 0.00 0.62 
FBpp0081255 lds -0.50 0.19 1.97 1.28 -0.68 0.28 0.73 0.00 0.02 0.34 
FBpp0311704 LeuRS -0.76 -0.05 0.51 -0.21 -0.71 0.03 0.90 0.16 0.57 0.17 
FBpp0073551 lic 0.31 -0.10 0.25 0.66 0.41 0.15 0.69 0.29 0.01 0.22 
FBpp0088383 lola -0.68 -0.47 0.74 0.52 -0.22 0.30 0.54 0.31 0.47 0.83 
FBpp0078561 lost 0.27 0.03 -0.06 0.18 0.24 0.28 0.92 0.82 0.51 0.53 
FBpp0311908 Lsd-2 0.40 -0.06 -0.36 0.10 0.46 0.24 0.88 0.33 0.78 0.38 
FBpp0071301 LysRS -0.92 -0.39 0.19 -0.34 -0.53 0.07 0.51 0.73 0.53 0.49 
FBpp0076819 mad2 -0.34 0.69 0.28 -0.75 -1.03 0.66 0.45 0.74 0.38 0.39 
FBpp0085235 Map205 -0.74 0.86 1.34 -0.26 -1.60 0.11 0.12 0.01 0.60 0.03 
FBpp0087613 Map60 -0.69 0.44 1.15 0.02 -1.13 0.14 0.42 0.03 0.97 0.12 
FBpp0289639 Mapmodulin 0.95 0.36 -1.83 -1.24 0.59 0.09 0.58 0.01 0.05 0.49 
FBpp0306961 mask -1.10 -0.99 0.90 0.78 -0.11 0.06 0.15 0.16 0.21 0.90 
FBpp0087350 Mat1 -0.13 0.03 1.53 1.38 -0.15 0.84 0.97 0.03 0.04 0.87 
FBpp0311400 mats 0.36 -0.48 -0.04 0.81 0.84 0.13 0.09 0.89 0.00 0.03 
FBpp0300203 Mccc1 -0.33 0.40 2.29 1.56 -0.73 0.26 0.24 0.00 0.00 0.11 
FBpp0081317 Mcm2 -0.64 0.28 -0.52 -1.44 -0.92 0.24 0.66 0.38 0.02 0.27 
FBpp0081756 Mcm5 -0.04 -0.47 -1.17 -0.75 0.43 0.92 0.28 0.01 0.07 0.45 
FBpp0070913 Mcm6 0.22 -0.59 -1.73 -0.92 0.81 0.43 0.08 0.00 0.01 0.07 
FBpp0076312 Mcm7 1.03 0.44 -1.34 -0.75 0.59 0.14 0.59 0.08 0.32 0.58 
FBpp0293887 MCTS1 0.21 -0.06 -0.89 -0.63 0.26 0.59 0.90 0.04 0.14 0.65 
FBpp0311560 Mdh1 -0.34 0.28 -0.91 -1.53 -0.62 0.31 0.47 0.02 0.00 0.23 
FBpp0079565 me31B 0.65 -0.08 -0.77 -0.04 0.73 0.02 0.81 0.02 0.90 0.09 
FBpp0288779 MEP-1 0.17 -0.54 1.17 1.88 0.71 0.77 0.44 0.08 0.01 0.44 
FBpp0085809 MetRS -0.58 -0.52 0.15 0.09 -0.05 0.06 0.15 0.65 0.77 0.91 
FBpp0304462 Mi-2 -0.29 -0.76 1.27 1.73 0.46 0.48 0.13 0.01 0.00 0.47 
FBpp0297604 Mlf 0.15 -0.42 1.09 1.66 0.57 0.78 0.53 0.09 0.01 0.51 
FBpp0301951 mod -0.38 0.13 -0.02 -0.53 -0.51 0.54 0.86 0.98 0.44 0.59 
FBpp0083472 mod(mdg4) -1.99 0.13 2.16 0.05 -2.11 0.03 0.90 0.03 0.96 0.13 
FBpp0075450 mop 0.38 1.27 1.61 0.72 -0.89 0.54 0.09 0.02 0.29 0.35 
FBpp0291706 mor -1.15 0.12 0.80 -0.46 -1.26 0.10 0.88 0.28 0.53 0.23 
FBpp0079802 mre11 0.19 1.00 1.47 0.66 -0.81 0.53 0.01 0.00 0.06 0.10 
FBpp0305821 msi -0.09 0.29 2.94 2.57 -0.37 0.78 0.43 0.00 0.00 0.44 
FBpp0076408 msk 0.15 0.00 0.11 0.25 0.14 0.61 0.99 0.73 0.43 0.75 
FBpp0293342 msps -0.42 -0.14 0.91 0.63 -0.28 0.13 0.66 0.00 0.04 0.50 
FBpp0303028 Mtap 0.20 0.96 -0.32 -1.08 -0.76 0.77 0.24 0.67 0.16 0.47 
FBpp0304737 Mtor 0.73 0.79 0.84 0.78 -0.06 0.06 0.08 0.05 0.06 0.92 
FBpp0310063 mts -1.52 -1.63 -1.51 -1.39 0.12 0.14 0.18 0.18 0.21 0.94 
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FBpp0082729 mtSSB 1.28 0.60 1.24 1.92 0.68 0.09 0.50 0.13 0.02 0.55 
FBpp0305424 mub 0.36 0.40 1.16 1.12 -0.04 0.35 0.38 0.01 0.01 0.95 
FBpp0311946 mus201 -1.02 -0.19 1.55 0.72 -0.83 0.07 0.77 0.01 0.23 0.32 
FBpp0311394 Nacalpha 0.31 0.08 -0.84 -0.61 0.23 0.24 0.80 0.01 0.04 0.56 
FBpp0297132 Nap1 -0.06 -0.26 -0.67 -0.48 0.19 0.78 0.33 0.01 0.06 0.57 
FBpp0306828 NAT1 -0.30 -0.69 0.95 1.34 0.39 0.37 0.08 0.01 0.00 0.44 
FBpp0297182 nbs 0.49 0.64 1.32 1.17 -0.16 0.11 0.08 0.00 0.00 0.74 
FBpp0311231 ncd -0.02 0.99 1.99 0.98 -1.01 0.99 0.39 0.07 0.36 0.51 
FBpp0309711 Nedd8 -0.49 0.16 1.08 0.43 -0.65 0.51 0.86 0.19 0.59 0.57 
FBpp0080867 nesd -0.15 -0.67 0.34 0.86 0.52 0.81 0.37 0.62 0.22 0.59 
FBpp0306756 Nlp -0.36 0.00 -0.40 -0.77 -0.37 0.17 0.99 0.17 0.01 0.36 
FBpp0076451 Nmt -0.26 0.96 0.75 -0.47 -1.22 0.69 0.23 0.30 0.52 0.24 
FBpp0309175 NO66 -0.75 -0.67 0.80 0.72 -0.08 0.16 0.28 0.17 0.21 0.92 
FBpp0290083 Nop60B 0.39 -0.45 2.17 3.01 0.84 0.47 0.47 0.00 0.00 0.31 
FBpp0112220 Nph -0.60 -0.17 -1.29 -1.72 -0.43 0.07 0.65 0.00 0.00 0.40 
FBpp0289954 Npl4 0.60 -1.09 -1.56 0.13 1.69 0.07 0.01 0.00 0.71 0.00 
FBpp0312079 Nplp2 -0.15 -0.09 -0.66 -0.72 -0.06 0.63 0.80 0.06 0.04 0.90 
FBpp0311095 Nsf2 0.59 -0.79 -1.09 0.29 1.38 0.24 0.19 0.06 0.59 0.08 
FBpp0305904 Ntf-2 0.26 0.31 -0.61 -0.65 -0.04 0.39 0.40 0.08 0.06 0.93 
FBpp0297079 nudC -0.15 -0.33 0.09 0.27 0.18 0.60 0.32 0.77 0.38 0.68 
FBpp0079710 Nup107 -0.05 -0.64 0.27 0.86 0.59 0.93 0.36 0.67 0.19 0.52 
FBpp0083695 Nup133 0.49 -0.46 0.08 1.02 0.95 0.44 0.54 0.91 0.14 0.33 
FBpp0309144 Nup153 0.79 -0.42 -1.17 0.04 1.21 0.04 0.34 0.01 0.93 0.04 
FBpp0297623 Nup188 0.41 -0.94 -0.61 0.75 1.35 0.13 0.00 0.04 0.01 0.00 
FBpp0074568 Nup205 0.29 -0.53 0.22 1.04 0.82 0.50 0.29 0.63 0.03 0.21 
FBpp0071905 Nup214 0.09 -0.90 -0.55 0.44 1.00 0.84 0.10 0.27 0.37 0.16 
FBpp0293235 Nup358 -0.22 0.34 2.50 1.94 -0.56 0.71 0.63 0.00 0.01 0.55 
FBpp0087861 Nup50 0.22 -0.02 -0.25 -0.01 0.24 0.65 0.98 0.64 0.99 0.75 
FBpp0087063 Nup54 2.55 1.24 -0.55 0.75 1.31 0.01 0.23 0.56 0.43 0.34 
FBpp0306915 Nup98-96 -1.38 0.96 1.97 -0.37 -2.34 0.05 0.23 0.01 0.62 0.03 
FBpp0297127 Nurf-38 -0.65 -0.60 -0.19 -0.23 -0.04 0.21 0.31 0.73 0.68 0.96 
FBpp0072061 or -1.29 0.07 1.54 0.18 -1.35 0.08 0.94 0.06 0.82 0.23 
FBpp0088033 Orc1 -0.80 0.07 3.50 2.64 -0.86 0.08 0.90 0.00 0.00 0.21 
FBpp0082329 Orc2 -1.13 0.07 3.56 2.37 -1.19 0.07 0.93 0.00 0.00 0.21 
FBpp0086882 Orc3 -0.33 0.95 2.32 1.04 -1.28 0.63 0.25 0.00 0.17 0.23 
FBpp0072330 Orc4 -0.11 0.14 2.15 1.90 -0.25 0.71 0.70 0.00 0.00 0.59 
FBpp0080120 Orc5 -0.04 0.07 2.66 2.54 -0.11 0.93 0.89 0.00 0.00 0.88 
FBpp0307031 osa 0.18 -0.12 -0.99 -0.68 0.30 0.84 0.91 0.32 0.49 0.83 
FBpp0088069 p47 -0.39 -0.06 0.16 -0.17 -0.33 0.57 0.94 0.83 0.82 0.75 
FBpp0085919 pAbp 0.13 -0.53 0.68 1.33 0.65 0.58 0.06 0.01 0.00 0.07 
FBpp0073976 Paf-AHalpha -0.22 0.93 -0.17 -1.32 -1.15 0.73 0.22 0.80 0.06 0.24 
FBpp0305933 Paics 0.22 0.53 -0.74 -1.05 -0.31 0.50 0.17 0.05 0.01 0.53 
FBpp0112608 Parp -1.61 -0.25 1.61 0.25 -1.36 0.01 0.72 0.02 0.69 0.14 
FBpp0082124 Past1 0.15 -0.25 -0.58 -0.18 0.40 0.67 0.53 0.13 0.63 0.45 
FBpp0290074 PCB -0.53 -0.63 2.15 2.25 0.10 0.30 0.30 0.00 0.00 0.90 
FBpp0308430 pch2 0.21 -0.09 -0.97 -0.67 0.30 0.72 0.90 0.15 0.31 0.74 
FBpp0089395 PCNA -1.15 1.07 1.10 -1.12 -2.22 0.03 0.08 0.06 0.05 0.01 
FBpp0297204 pds5 -0.33 -0.33 0.21 0.21 0.00 0.72 0.76 0.83 0.83 1.00 
FBpp0079527 Pen -0.04 0.00 0.20 0.16 -0.03 0.89 0.99 0.51 0.59 0.94 
FBpp0304954 Pfdn2 -1.04 -0.73 0.76 0.45 -0.31 0.15 0.39 0.34 0.56 0.78 
FBpp0303214 Pfdn6 -0.76 -0.48 -0.31 -0.60 -0.29 0.32 0.60 0.71 0.48 0.81 
FBpp0293464 Pfk -0.40 1.04 0.71 -0.73 -1.44 0.45 0.11 0.23 0.22 0.09 
FBpp0303827 Pgd -1.34 0.02 1.41 0.05 -1.35 0.04 0.98 0.05 0.94 0.17 
FBpp0306279 Pgk -0.30 0.65 -0.45 -1.40 -0.95 0.24 0.04 0.11 0.00 0.02 
FBpp0099920 Pglym78 0.23 0.05 -0.99 -0.81 0.18 0.50 0.90 0.01 0.03 0.73 
FBpp0072932 PHGPx -0.97 0.14 0.55 -0.57 -1.11 0.13 0.85 0.43 0.41 0.26 
FBpp0301844 PI31 -0.63 0.61 3.12 1.87 -1.25 0.19 0.29 0.00 0.00 0.10 
FBpp0088847 Pih1D1 0.16 1.28 2.25 1.13 -1.12 0.77 0.06 0.00 0.07 0.20 
FBpp0310466 Plap 0.43 -0.36 -0.20 0.59 0.79 0.08 0.22 0.44 0.04 0.04 
FBpp0305301 poe 0.26 -1.17 -0.43 0.99 1.43 0.58 0.04 0.39 0.06 0.05 
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FBpp0307818 Pol32 -0.03 0.34 -0.01 -0.38 -0.37 0.95 0.49 0.98 0.41 0.57 
FBpp0099722 polo -0.34 -0.21 0.33 0.20 -0.13 0.38 0.65 0.43 0.63 0.82 
FBpp0292357 poly 0.20 -0.86 -0.86 0.19 1.05 0.76 0.27 0.23 0.79 0.30 
FBpp0084115 polybromo -0.20 0.00 0.47 0.27 -0.20 0.55 0.99 0.21 0.46 0.71 
FBpp0081704 pont -0.13 -0.22 -0.05 0.04 0.09 0.52 0.36 0.83 0.86 0.78 
FBpp0082067 Pp1-87B -0.39 0.16 1.81 1.26 -0.55 0.36 0.74 0.00 0.01 0.40 
FBpp0293227 Pp2A-29B -0.15 -0.07 -0.01 -0.09 -0.08 0.62 0.85 0.97 0.78 0.86 
FBpp0304082 PpD3 -0.61 -1.69 -1.93 -0.85 1.08 0.58 0.21 0.12 0.49 0.53 
FBpp0071451 Prosalpha3 0.16 0.77 0.30 -0.30 -0.61 0.88 0.55 0.80 0.80 0.72 
FBpp0073989 Prosalpha4 -0.12 -0.97 -1.04 -0.19 0.85 0.77 0.06 0.03 0.68 0.20 
FBpp0086067 Prosalpha5 -0.17 -0.73 -1.48 -0.92 0.55 0.75 0.27 0.02 0.13 0.52 
FBpp0310201 Prosalpha6 -0.03 0.24 -0.02 -0.30 -0.27 0.88 0.30 0.92 0.18 0.38 
FBpp0089041 Prosalpha7 -0.21 -0.07 -0.60 -0.74 -0.14 0.64 0.89 0.24 0.15 0.85 
FBpp0086400 Prosbeta1 -0.90 0.43 0.47 -0.86 -1.33 0.06 0.44 0.36 0.10 0.07 
FBpp0075382 Prosbeta2 -1.64 0.60 0.87 -1.38 -2.25 0.05 0.54 0.34 0.13 0.09 
FBpp0087320 Prosbeta5 -0.65 0.29 0.56 -0.38 -0.94 0.08 0.51 0.17 0.34 0.11 
FBpp0075119 Prosbeta6 -0.32 -0.24 -0.02 -0.09 -0.07 0.30 0.50 0.96 0.78 0.87 
FBpp0078449 Prosbeta7 -0.26 0.37 0.13 -0.50 -0.62 0.30 0.21 0.64 0.07 0.11 
FBpp0085902 Prp19 -0.74 0.11 1.62 0.76 -0.86 0.08 0.82 0.00 0.10 0.19 
FBpp0100080 Prx5 0.18 0.48 -0.69 -0.99 -0.30 0.52 0.16 0.03 0.00 0.50 
FBpp0077277 Ptpa 0.35 0.26 0.88 0.97 0.09 0.63 0.76 0.27 0.22 0.93 
FBpp0305823 pum -0.29 -0.59 1.85 2.15 0.30 0.48 0.23 0.00 0.00 0.63 
FBpp0082932 Pxt -0.19 0.50 2.24 1.55 -0.69 0.47 0.13 0.00 0.00 0.11 
FBpp0083611 PyK -0.17 0.30 0.73 0.26 -0.47 0.63 0.46 0.06 0.50 0.38 
FBpp0309142 r 0.27 0.68 0.28 -0.13 -0.41 0.39 0.08 0.41 0.72 0.40 
FBpp0083440 r-l 0.09 0.06 -0.42 -0.38 0.03 0.81 0.90 0.32 0.36 0.96 
FBpp0083503 Rab1 0.39 -0.87 -0.74 0.53 1.27 0.41 0.13 0.16 0.31 0.09 
FBpp0083414 Rab11 0.31 -0.04 -0.01 0.34 0.34 0.36 0.93 0.99 0.36 0.51 
FBpp0307641 Rab2 -0.29 -1.46 -1.36 -0.19 1.17 0.64 0.06 0.05 0.77 0.23 
FBpp0303520 Rab5 -0.68 0.44 1.13 0.01 -1.12 0.32 0.58 0.13 0.99 0.29 
FBpp0311572 Rack1 -0.63 0.02 -0.48 -1.13 -0.65 0.37 0.98 0.53 0.15 0.55 
FBpp0293866 rad50 0.09 0.98 1.70 0.80 -0.90 0.82 0.04 0.00 0.06 0.14 
FBpp0071600 Rae1 -0.92 0.43 1.95 0.60 -1.35 0.12 0.53 0.00 0.34 0.14 
FBpp0309151 Ran 0.14 0.48 -0.47 -0.81 -0.35 0.51 0.06 0.05 0.00 0.29 
FBpp0307011 RanBP3 -2.13 2.10 1.03 -3.21 -4.23 0.01 0.03 0.23 0.00 0.00 
FBpp0312218 Ranbp9 0.42 -0.41 -0.63 0.19 0.82 0.13 0.21 0.04 0.52 0.06 
FBpp0306292 RanGAP 0.12 -1.35 -0.77 0.70 1.47 0.82 0.03 0.18 0.22 0.08 
FBpp0076784 Rcc1 -0.34 0.15 1.91 1.42 -0.49 0.26 0.66 0.00 0.00 0.29 
FBpp0302766 REG -0.14 0.32 0.03 -0.42 -0.45 0.60 0.30 0.91 0.14 0.26 
FBpp0311247 rept -0.04 -0.46 -0.48 -0.06 0.42 0.85 0.08 0.05 0.80 0.22 
FBpp0079609 RfC3 -0.12 0.27 0.62 0.22 -0.39 0.71 0.47 0.08 0.52 0.43 
FBpp0311114 RfC38 0.12 -0.06 0.63 0.81 0.18 0.66 0.85 0.04 0.01 0.67 
FBpp0073120 RfC4 -0.85 0.42 1.28 0.01 -1.27 0.09 0.47 0.02 0.99 0.10 
FBpp0305320 rhea 0.15 -0.51 -0.21 0.44 0.65 0.60 0.13 0.49 0.16 0.14 
FBpp0304185 RhoGDI -0.10 0.29 -0.60 -0.99 -0.39 0.87 0.70 0.38 0.15 0.69 
FBpp0312064 rin -0.44 0.07 -0.60 -1.12 -0.51 0.39 0.91 0.29 0.06 0.52 
FBpp0310006 rngo 0.04 0.41 1.23 0.85 -0.37 0.97 0.71 0.23 0.40 0.79 
FBpp0079648 RnrL -0.67 0.26 0.05 -0.88 -0.93 0.09 0.57 0.91 0.04 0.13 
FBpp0087152 RnrS 0.46 -0.13 -1.17 -0.58 0.59 0.16 0.73 0.00 0.11 0.24 
FBpp0302971 row 0.43 0.37 0.70 0.77 0.07 0.53 0.65 0.36 0.31 0.95 
FBpp0305404 Rox8 -0.68 0.66 2.86 1.53 -1.33 0.09 0.16 0.00 0.00 0.03 
FBpp0081356 RpA-70 -0.24 1.05 4.27 2.97 -1.29 0.73 0.22 0.00 0.00 0.24 
FBpp0305226 RPA2 0.48 1.53 4.09 3.04 -1.05 0.15 0.00 0.00 0.00 0.05 
FBpp0310183 RPA3 0.50 1.41 3.93 3.02 -0.91 0.17 0.00 0.00 0.00 0.11 
FBpp0302626 RpL13 0.10 -0.45 -0.50 0.05 0.55 0.90 0.64 0.57 0.95 0.66 
FBpp0311452 RpL27A -0.35 0.51 0.58 -0.28 -0.86 0.72 0.65 0.59 0.79 0.56 
FBpp0306837 RpL40 -1.43 0.54 3.02 1.04 -1.97 0.09 0.58 0.00 0.25 0.13 
FBpp0306232 RpLP0 -1.21 0.18 0.58 -0.82 -1.39 0.04 0.79 0.36 0.20 0.12 
FBpp0074662 Rpn1 0.16 0.15 -0.67 -0.65 0.02 0.61 0.70 0.06 0.07 0.97 
FBpp0305644 Rpn10 -0.24 0.90 0.45 -0.69 -1.14 0.45 0.02 0.19 0.05 0.02 
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FBpp0078664 Rpn11 0.48 -0.02 -0.06 0.43 0.49 0.02 0.95 0.77 0.05 0.11 
FBpp0075068 Rpn12 0.26 -0.48 -1.02 -0.28 0.74 0.41 0.21 0.01 0.43 0.14 
FBpp0112987 Rpn13 0.26 0.41 0.07 -0.08 -0.15 0.62 0.51 0.91 0.89 0.86 
FBpp0306599 Rpn2 0.09 -0.07 -0.47 -0.31 0.16 0.66 0.79 0.05 0.18 0.62 
FBpp0307804 Rpn3 0.04 -0.52 -0.31 0.25 0.57 0.84 0.06 0.20 0.30 0.11 
FBpp0078278 Rpn5 -0.34 -0.14 0.39 0.19 -0.20 0.64 0.87 0.63 0.81 0.86 
FBpp0297513 Rpn6 -0.06 -0.10 0.23 0.26 0.03 0.85 0.81 0.54 0.48 0.95 
FBpp0083687 Rpn7 -0.03 0.31 0.16 -0.19 -0.35 0.90 0.34 0.59 0.54 0.41 
FBpp0305141 Rpn8 0.29 0.61 -0.64 -0.96 -0.32 0.61 0.37 0.32 0.14 0.72 
FBpp0083861 Rpn9 0.63 0.23 -0.32 0.08 0.40 0.03 0.48 0.30 0.79 0.36 
FBpp0087115 RpS11 0.35 -0.93 -1.01 0.27 1.28 0.64 0.29 0.21 0.74 0.27 
FBpp0311350 RpS19a 0.09 -0.02 0.51 0.62 0.11 0.92 0.98 0.61 0.53 0.94 
FBpp0311561 RpS2 0.24 0.73 -0.08 -0.57 -0.49 0.51 0.10 0.85 0.16 0.39 
FBpp0071087 RpS6 -0.71 -1.26 -0.43 0.11 0.54 0.32 0.14 0.58 0.89 0.62 
FBpp0311987 RpS8 0.12 -0.27 -0.50 -0.11 0.39 0.73 0.50 0.19 0.76 0.46 
FBpp0088021 Rpt1 0.18 -0.04 -0.42 -0.20 0.23 0.36 0.86 0.06 0.37 0.47 
FBpp0311982 Rpt2 0.15 0.33 -0.60 -0.79 -0.19 0.61 0.33 0.07 0.02 0.67 
FBpp0293948 Rpt4 0.10 0.17 -0.36 -0.44 -0.08 0.74 0.61 0.26 0.17 0.86 
FBpp0083843 Rpt5 -0.06 -0.14 -0.95 -0.86 0.08 0.86 0.73 0.02 0.03 0.88 
FBpp0076890 Rpt6 0.31 0.95 -0.43 -1.07 -0.65 0.44 0.05 0.33 0.02 0.29 
FBpp0288680 Rrp1 -0.20 0.23 1.29 0.86 -0.43 0.55 0.55 0.00 0.02 0.40 
FBpp0311555 Rrp40 0.28 -0.48 -1.26 -0.49 0.76 0.73 0.62 0.18 0.59 0.55 
FBpp0081601 rump 0.11 -1.04 1.00 2.16 1.16 0.88 0.25 0.23 0.01 0.32 
FBpp0089284 Sar1 -0.95 0.85 1.95 0.15 -1.80 0.12 0.23 0.01 0.82 0.06 
FBpp0074285 scu 0.15 -0.01 1.44 1.60 0.16 0.78 0.98 0.02 0.01 0.84 
FBpp0082877 sds22 0.62 0.52 -0.24 -0.14 0.10 0.12 0.26 0.57 0.73 0.87 
FBpp0309105 Sec16 0.30 -0.08 0.86 1.25 0.38 0.72 0.94 0.36 0.19 0.77 
FBpp0303000 Sec24CD 0.57 -0.74 -1.14 0.17 1.31 0.20 0.16 0.02 0.72 0.06 
FBpp0311417 Sec31 0.34 -1.08 -0.62 0.80 1.42 0.46 0.06 0.22 0.12 0.05 
FBpp0086691 SelD -2.51 -0.96 -1.13 -2.68 -1.56 0.01 0.33 0.22 0.01 0.23 
FBpp0307454 SerRS 0.53 0.37 -0.31 -0.15 0.16 0.46 0.66 0.69 0.85 0.89 
FBpp0296963 Sgt 0.21 -0.30 -0.47 0.05 0.52 0.50 0.42 0.19 0.89 0.30 
FBpp0081351 Sgt1 0.25 -0.18 -0.61 -0.19 0.42 0.53 0.70 0.15 0.65 0.48 
FBpp0309359 shi 0.16 -0.09 0.22 0.47 0.25 0.62 0.81 0.53 0.19 0.62 
FBpp0311477 Shmt -1.08 0.49 0.56 -1.01 -1.56 0.08 0.49 0.40 0.13 0.10 
FBpp0306437 skap 0.48 0.63 0.30 0.16 -0.14 0.57 0.53 0.74 0.86 0.91 
FBpp0311474 SkpA -0.27 -1.52 -0.60 0.66 1.25 0.70 0.07 0.44 0.39 0.25 
FBpp0081710 sle -0.26 0.56 0.93 0.12 -0.82 0.60 0.34 0.09 0.83 0.29 
FBpp0293061 SmB 0.92 -1.05 -1.45 0.52 1.97 0.15 0.17 0.04 0.45 0.05 
FBpp0086591 SMC2 0.07 -0.20 0.04 0.31 0.27 0.84 0.62 0.92 0.42 0.61 
FBpp0074065 SMC3 0.12 0.04 -0.21 -0.13 0.08 0.81 0.95 0.70 0.82 0.92 
FBpp0305647 SMC5 0.30 -0.12 0.67 1.09 0.42 0.49 0.82 0.17 0.03 0.53 
FBpp0081234 SmD2 -0.17 0.02 0.37 0.18 -0.19 0.73 0.97 0.50 0.74 0.81 
FBpp0078984 smt3 -1.52 -0.41 1.64 0.52 -1.11 0.12 0.72 0.13 0.62 0.45 
FBpp0078331 Snr1 -0.86 -0.02 1.47 0.63 -0.84 0.09 0.98 0.01 0.25 0.28 
FBpp0082111 Snx3 0.59 -1.33 -1.35 0.56 1.91 0.27 0.04 0.03 0.33 0.03 
FBpp0075958 Sod1 -0.27 0.65 -0.71 -1.63 -0.92 0.73 0.48 0.40 0.06 0.44 
FBpp0072164 spag 0.59 1.00 0.45 0.04 -0.41 0.13 0.03 0.28 0.92 0.49 
FBpp0297149 SpdS 0.13 0.67 -0.76 -1.30 -0.54 0.69 0.09 0.04 0.00 0.28 
FBpp0307742 spg -0.95 0.51 1.16 -0.31 -1.47 0.07 0.39 0.04 0.58 0.07 
FBpp0301102 sqd -0.05 1.27 -0.05 -1.37 -1.32 0.87 0.00 0.89 0.00 0.01 
FBpp0076244 Srp68 -0.42 0.13 0.98 0.44 -0.55 0.44 0.84 0.10 0.46 0.51 
FBpp0083319 Srp72 0.56 -0.45 0.34 1.35 1.01 0.11 0.27 0.37 0.00 0.07 
FBpp0072151 Ssrp -0.24 0.05 -0.96 -1.25 -0.30 0.55 0.91 0.04 0.01 0.64 
FBpp0078827 stai -1.65 0.15 0.23 -1.58 -1.80 0.03 0.86 0.77 0.05 0.11 
FBpp0077790 Stip1 -0.24 0.48 0.56 -0.16 -0.72 0.35 0.13 0.06 0.57 0.08 
FBpp0079252 Su(var)205 -0.05 -0.45 0.36 0.75 0.40 0.88 0.24 0.31 0.04 0.42 
FBpp0082204 Su(var)3-7 -0.40 0.35 0.87 0.11 -0.76 0.49 0.61 0.18 0.86 0.40 
FBpp0309283 Swip-1 0.47 -0.42 0.92 1.81 0.89 0.49 0.60 0.23 0.02 0.40 
FBpp0304719 tacc -0.74 0.52 1.02 -0.25 -1.27 0.19 0.43 0.11 0.68 0.15 
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FBpp0311865 Taf4 -1.55 -0.51 1.26 0.22 -1.04 0.07 0.60 0.17 0.80 0.42 
FBpp0085690 TBCB 0.94 1.17 -0.04 -0.26 -0.22 0.18 0.17 0.96 0.74 0.84 
FBpp0081820 Tctp -0.06 0.05 -1.06 -1.16 -0.10 0.87 0.90 0.01 0.00 0.84 
FBpp0110174 tefu -0.31 -0.67 0.70 1.06 0.36 0.49 0.21 0.16 0.04 0.60 
FBpp0087479 TER94 0.29 0.39 -0.40 -0.50 -0.10 0.27 0.21 0.17 0.09 0.80 
FBpp0083355 TFAM -0.46 0.06 1.26 0.75 -0.51 0.45 0.94 0.06 0.26 0.58 
FBpp0081216 TfIIFalpha -0.45 -0.43 1.24 1.22 -0.02 0.46 0.55 0.07 0.07 0.98 
FBpp0306851 tho2 -0.55 0.26 0.59 -0.22 -0.81 0.19 0.60 0.20 0.63 0.22 
FBpp0312095 ThrRS 0.19 0.18 -0.87 -0.85 0.01 0.48 0.58 0.01 0.01 0.97 
FBpp0304598 Top2 -0.23 0.32 1.55 1.00 -0.55 0.53 0.46 0.00 0.02 0.34 
FBpp0080787 Top3alpha -0.17 1.15 3.13 1.81 -1.32 0.79 0.14 0.00 0.02 0.19 
FBpp0111979 tou 0.38 -0.08 1.80 2.26 0.46 0.33 0.87 0.00 0.00 0.45 
FBpp0084948 Tpi -0.89 0.07 -0.29 -1.25 -0.96 0.01 0.85 0.41 0.00 0.06 
FBpp0304887 tral -0.44 -0.87 -1.73 -1.29 0.43 0.38 0.15 0.00 0.03 0.58 
FBpp0079437 Trx-2 -0.96 0.41 0.27 -1.10 -1.37 0.07 0.49 0.62 0.05 0.09 
FBpp0312205 Tsf1 -0.87 0.78 0.74 -0.91 -1.65 0.07 0.17 0.16 0.09 0.03 
FBpp0075088 TSG101 0.38 0.18 -0.77 -0.56 0.21 0.44 0.76 0.16 0.30 0.79 
FBpp0072097 tsr -0.48 -0.18 -0.80 -1.09 -0.30 0.24 0.70 0.08 0.02 0.63 
FBpp0309672 tud -0.62 -0.76 0.65 0.79 0.14 0.10 0.09 0.12 0.06 0.81 
FBpp0304417 Tudor-SN 0.75 -0.08 -0.93 -0.10 0.82 0.07 0.87 0.04 0.81 0.19 
FBpp0311386 tws 0.29 -0.55 -1.38 -0.54 0.84 0.32 0.11 0.00 0.09 0.07 
FBpp0076804 Txl 0.13 0.07 -0.41 -0.35 0.06 0.55 0.79 0.09 0.15 0.85 
FBpp0075168 TyrRS -0.45 0.06 -0.51 -1.02 -0.50 0.33 0.92 0.31 0.05 0.48 
FBpp0077912 tzn 0.15 -0.21 0.78 1.13 0.35 0.62 0.56 0.03 0.00 0.45 
FBpp0087583 Uba1 -0.01 0.27 -0.81 -1.10 -0.28 0.97 0.31 0.00 0.00 0.42 
FBpp0076457 Uba2 0.22 0.35 -1.29 -1.43 -0.14 0.50 0.35 0.00 0.00 0.78 
FBpp0073354 Uba5 0.57 -0.05 -1.06 -0.44 0.62 0.08 0.89 0.00 0.20 0.20 
FBpp0311673 Ubc4 -0.25 -0.23 -0.89 -0.91 -0.02 0.66 0.73 0.16 0.15 0.98 
FBpp0304449 UbcE2M -0.50 0.12 -0.26 -0.88 -0.62 0.43 0.87 0.70 0.21 0.52 
FBpp0083740 Ublcp1 -0.40 0.29 -1.31 -2.01 -0.70 0.55 0.71 0.09 0.01 0.51 
FBpp0292511 Uch -1.02 0.25 -0.43 -1.69 -1.26 0.05 0.68 0.43 0.00 0.11 
FBpp0306000 Uch-L5 0.16 0.89 0.01 -0.71 -0.72 0.57 0.01 0.97 0.03 0.11 
FBpp0311276 Uev1A 1.42 0.06 -2.60 -1.24 1.37 0.02 0.93 0.00 0.05 0.12 
FBpp0075952 Ufd1-like 0.26 -0.62 -0.89 -0.01 0.88 0.64 0.36 0.16 0.99 0.32 
FBpp0309077 Ufm1 -1.16 -0.05 -0.23 -1.34 -1.11 0.20 0.96 0.81 0.18 0.42 
FBpp0290912 UGP -0.48 0.38 0.20 -0.66 -0.86 0.42 0.59 0.76 0.31 0.36 
FBpp0311454 und 0.29 0.90 -1.57 -2.18 -0.61 0.65 0.23 0.03 0.00 0.53 
FBpp0311664 Unr 0.47 1.90 -0.31 -1.74 -1.43 0.49 0.03 0.69 0.03 0.19 
FBpp0304059 Usp14 -0.18 0.10 -0.51 -0.78 -0.27 0.74 0.87 0.38 0.18 0.73 
FBpp0298309 Usp5 -0.03 0.25 -0.14 -0.43 -0.29 0.91 0.48 0.66 0.20 0.54 
FBpp0309600 Usp7 0.76 -0.21 -0.67 0.30 0.97 0.02 0.56 0.06 0.38 0.05 
FBpp0305353 ValRS 0.50 -0.42 -1.46 -0.55 0.92 0.30 0.46 0.01 0.30 0.22 
FBpp0311933 Vha13 -0.11 -1.73 -1.43 0.20 1.62 0.89 0.09 0.13 0.83 0.22 
FBpp0311965 Vha26 0.14 0.07 -0.63 -0.55 0.08 0.61 0.84 0.05 0.08 0.86 
FBpp0086468 Vha36-1 0.43 0.02 -0.80 -0.38 0.41 0.33 0.97 0.11 0.44 0.55 
FBpp0288471 Vha44 0.24 0.01 -1.63 -1.40 0.23 0.48 0.98 0.00 0.00 0.67 
FBpp0290875 Vha55 -0.51 0.78 -0.29 -1.58 -1.28 0.09 0.03 0.36 0.00 0.01 
FBpp0307597 Vha68-2 0.48 -0.12 -1.42 -0.82 0.59 0.36 0.85 0.02 0.16 0.47 
FBpp0307142 VhaSFD -0.68 -1.29 -0.95 -0.33 0.62 0.25 0.07 0.15 0.60 0.50 
FBpp0075794 viaf -0.59 -0.26 0.63 0.30 -0.33 0.33 0.71 0.35 0.65 0.73 
FBpp0310907 vib 0.37 -1.39 -1.78 -0.01 1.76 0.42 0.02 0.00 0.98 0.02 
FBpp0112266 vig2 0.05 -1.52 -1.67 -0.10 1.57 0.93 0.03 0.01 0.86 0.08 
FBpp0075690 vih 0.00 -0.40 -0.69 -0.28 0.40 1.00 0.31 0.07 0.44 0.44 
FBpp0309623 Vinc -0.21 -0.85 -1.58 -0.94 0.64 0.61 0.08 0.00 0.04 0.31 
FBpp0309628 Vps4 0.38 -0.59 -1.58 -0.60 0.98 0.58 0.47 0.05 0.43 0.37 
FBpp0084579 wdb 0.34 0.18 0.50 0.66 0.16 0.54 0.79 0.42 0.28 0.85 
FBpp0300790 wds -1.00 -0.28 2.11 1.39 -0.72 0.14 0.72 0.01 0.06 0.49 
FBpp0307569 wrd 0.04 -0.75 -0.15 0.64 0.79 0.93 0.13 0.74 0.16 0.22 
FBpp0308997 WRNexo -1.05 0.28 2.08 0.75 -1.33 0.26 0.80 0.05 0.46 0.35 
FBpp0071049 Ykt6 0.59 -0.72 0.64 1.95 1.32 0.04 0.03 0.04 0.00 0.00 
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FBpp0312020 Yp1 -0.40 0.48 0.57 -0.32 -0.89 0.52 0.52 0.41 0.64 0.37 
FBpp0308710 Yp2 -0.91 0.55 0.33 -1.13 -1.46 0.03 0.23 0.43 0.01 0.02 
FBpp0311924 Yp3 -0.18 0.59 -0.01 -0.79 -0.77 0.42 0.04 0.95 0.00 0.04 
FBpp0075111 zetaCOP -1.08 -0.79 0.04 -0.25 -0.29 0.21 0.43 0.97 0.78 0.82 
FBpp0072305 zip 0.34 0.40 0.02 -0.03 -0.05 0.39 0.41 0.96 0.94 0.93 
 
3. IDENTIFICATION OF ACF1 INTERACTORS BY CO-IMMUNOPRECIPITATION  
(see VI.C.1) 
a) 3F1 – 8E3 – control 
 
  differences p-values 
Flybase 
polypeptide 
ID 
Flybase symbol 3F1-con 8E3-con 3F1-8E3 3F1-con 8E3-con 3F1-8E3 
FBpp0308925 - 6.08 -1.38 7.46 0.00 0.00 0.00 
FBpp0082990 14-3-3epsilon -0.75 -0.47 -0.28 0.03 0.17 0.40 
FBpp0085204 Acf 2.68 3.01 -0.32 0.00 0.00 0.30 
FBpp0311818 Act5C -0.98 -1.33 0.35 0.01 0.00 0.28 
FBpp0309215 Akap200 -1.93 0.91 -2.84 0.00 0.12 0.00 
FBpp0072694 alphaCOP 0.09 -0.28 0.36 0.79 0.39 0.26 
FBpp0076122 alphaTub67C -0.71 -0.18 -0.54 0.28 0.79 0.41 
FBpp0081153 alphaTub84B -0.11 -0.44 0.33 0.77 0.26 0.40 
FBpp0086107 APC10 -1.76 -0.43 -1.33 0.00 0.45 0.03 
FBpp0301606 APC4 -1.31 0.57 -1.88 0.01 0.21 0.00 
FBpp0070907 APC7 -1.25 0.66 -1.91 0.22 0.52 0.07 
FBpp0311464 apolpp -1.52 -1.15 -0.37 0.00 0.00 0.28 
FBpp0082121 Arp1 -1.96 -0.56 -1.41 0.00 0.38 0.03 
FBpp0084071 asp 0.13 -0.97 1.10 0.78 0.05 0.03 
FBpp0306920 atms 3.74 -1.11 4.86 0.00 0.00 0.00 
FBpp0311086 ATPsynbeta 0.22 -0.27 0.49 0.81 0.77 0.59 
FBpp0078353 Atu 4.23 -1.03 5.26 0.00 0.01 0.00 
FBpp0082555 Atx2 -1.00 -0.84 -0.16 0.03 0.07 0.71 
FBpp0300517 B52-RO -1.79 -0.21 -1.57 0.00 0.49 0.00 
FBpp0305308 baf 1.11 0.65 0.46 0.33 0.57 0.68 
FBpp0306433 bel -0.47 -0.85 0.37 0.38 0.12 0.49 
FBpp0080048 beta'COP 0.58 -0.11 0.69 0.19 0.81 0.12 
FBpp0074348 betaCOP -0.19 -0.27 0.08 0.53 0.37 0.79 
FBpp0085720 betaTub56D -0.29 0.02 -0.32 0.48 0.96 0.45 
FBpp0304072 Bruce -0.75 2.98 -3.73 0.08 0.00 0.00 
FBpp0083988 BRWD3 -0.32 -0.66 0.34 0.60 0.29 0.58 
FBpp0308293 Bub3 -1.56 1.40 -2.96 0.01 0.01 0.00 
FBpp0085368 BubR1 -1.47 1.40 -2.87 0.00 0.00 0.00 
FBpp0291059 Caf1-55 -1.84 -1.32 -0.52 0.00 0.01 0.30 
FBpp0311269 Cam 0.26 -1.07 1.33 0.69 0.12 0.05 
FBpp0304507 Cand1 -1.19 -0.90 -0.30 0.03 0.09 0.56 
FBpp0083684 CCT1 -0.54 -0.73 0.19 0.30 0.17 0.72 
FBpp0071226 CCT2 -1.56 -1.47 -0.09 0.01 0.01 0.88 
FBpp0291566 CCT3 -1.09 -0.85 -0.24 0.07 0.15 0.67 
FBpp0079992 CCT4 -0.89 -0.83 -0.06 0.11 0.13 0.92 
FBpp0087095 CCT5 -0.14 0.06 -0.21 0.79 0.91 0.70 
FBpp0073902 CCT6 -1.79 -1.58 -0.21 0.00 0.01 0.71 
FBpp0081401 CCT7 -0.25 -0.04 -0.21 0.80 0.97 0.83 
FBpp0087764 CCT8 -0.85 -0.50 -0.35 0.10 0.32 0.49 
FBpp0083769 Cdc16 -0.04 2.37 -2.41 0.92 0.00 0.00 
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FBpp0305185 Cdc23 -1.28 1.91 -3.19 0.01 0.00 0.00 
FBpp0305561 Cdc27 -0.30 2.43 -2.73 0.48 0.00 0.00 
FBpp0076371 Cdc6 0.27 -2.19 2.46 0.55 0.00 0.00 
FBpp0289675 Cdk2 1.65 0.66 0.99 0.01 0.23 0.08 
FBpp0305296 CG10077 -0.36 0.50 -0.86 0.40 0.25 0.05 
FBpp0271702 CG10336 -2.34 1.87 -4.21 0.00 0.00 0.00 
FBpp0087300 CG12391 0.13 2.22 -2.09 0.82 0.00 0.00 
FBpp0099493 CG13175 3.67 -1.28 4.95 0.00 0.01 0.00 
FBpp0302006 CG13185 -1.61 2.09 -3.69 0.00 0.00 0.00 
FBpp0079879 CG14945 -2.74 -2.57 -0.17 0.00 0.00 0.66 
FBpp0087535 CG1513 0.29 2.42 -2.13 0.71 0.00 0.01 
FBpp0087421 CG18011 -0.74 -0.46 -0.27 0.12 0.33 0.56 
FBpp0304657 CG2061 -3.70 -3.95 0.25 0.00 0.00 0.57 
FBpp0078327 CG2091 3.69 -0.32 4.02 0.00 0.37 0.00 
FBpp0291763 CG2246 0.96 -1.01 1.96 0.11 0.09 0.00 
FBpp0290146 CG30122 -0.91 4.68 -5.59 0.03 0.00 0.00 
FBpp0083880 CG31142 1.81 -2.05 3.86 0.00 0.00 0.00 
FBpp0083372 CG31223 -1.45 -2.17 0.72 0.07 0.01 0.35 
FBpp0309501 CG3436 1.83 -0.08 1.91 0.00 0.82 0.00 
FBpp0077333 CG3542 2.29 -1.13 3.42 0.00 0.01 0.00 
FBpp0307919 CG3679 0.22 0.32 -0.10 0.63 0.48 0.82 
FBpp0081650 CG3909 3.82 -0.89 4.71 0.00 0.03 0.00 
FBpp0309405 CG4119 2.18 -0.58 2.76 0.00 0.19 0.00 
FBpp0288574 CG42232 0.17 1.84 -1.67 0.67 0.00 0.00 
FBpp0079789 CG4751 -1.75 2.10 -3.85 0.00 0.00 0.00 
FBpp0084626 CG4849 2.07 -0.19 2.26 0.00 0.50 0.00 
FBpp0309317 CG5174-RP -1.56 -1.23 -0.33 0.05 0.13 0.67 
FBpp0074386 CG6617 -0.11 2.37 -2.49 0.76 0.00 0.00 
FBpp0311284 CG6767 0.65 -1.49 2.14 0.14 0.00 0.00 
FBpp0271876 CG7504 -0.36 -0.39 0.03 0.69 0.67 0.98 
FBpp0074246 CG8142 0.50 0.02 0.48 0.10 0.96 0.11 
FBpp0072518 CG9205 -1.55 0.10 -1.65 0.01 0.86 0.01 
FBpp0088471 chb -1.48 -2.06 0.58 0.02 0.00 0.34 
FBpp0308531 Chc -0.39 -0.24 -0.15 0.41 0.61 0.75 
FBpp0099657 Chrac-14 2.54 2.76 -0.22 0.00 0.00 0.56 
FBpp0308688 Chrac-16 3.09 3.49 -0.40 0.00 0.00 0.34 
FBpp0311360 CkIIalpha 0.81 0.76 0.05 0.09 0.11 0.92 
FBpp0305406 CkIIbeta 0.50 0.19 0.31 0.23 0.64 0.45 
FBpp0312156 Claspin -0.36 0.38 -0.74 0.37 0.33 0.07 
FBpp0304513 cmet -1.79 -1.89 0.10 0.00 0.00 0.85 
FBpp0311194 coil -1.94 -1.47 -0.47 0.00 0.01 0.40 
FBpp0307637 coro -2.02 -1.71 -0.31 0.00 0.01 0.63 
FBpp0297908 ctp -1.12 1.16 -2.28 0.15 0.13 0.01 
FBpp0072562 Ctr9 2.27 -1.40 3.66 0.00 0.00 0.00 
FBpp0312102 cup -1.30 -0.14 -1.16 0.00 0.58 0.00 
FBpp0294012 CycE 0.60 -1.36 1.96 0.19 0.01 0.00 
FBpp0075498 DCTN1-p150 -1.53 -1.00 -0.52 0.00 0.02 0.22 
FBpp0087722 DCTN2-p50 -2.20 -0.88 -1.32 0.00 0.10 0.02 
FBpp0301952 dec-01 -3.28 -2.22 -1.06 0.00 0.02 0.22 
FBpp0070355 deltaCOP -0.53 -0.52 -0.01 0.14 0.15 0.97 
FBpp0304991 Dhc64C -2.39 -2.08 -0.31 0.00 0.00 0.42 
FBpp0073299 Dlic -2.02 -1.53 -0.50 0.00 0.00 0.18 
FBpp0072744 dre4 0.83 -0.31 1.14 0.05 0.44 0.01 
FBpp0082223 Droj2 0.14 -0.34 0.49 0.59 0.21 0.08 
FBpp0304412 E(bx) -2.47 -1.59 -0.89 0.00 0.04 0.25 
FBpp0072781 ecd 2.42 -1.41 3.83 0.00 0.00 0.00 
FBpp0311273 eEF1alpha1 2.36 -1.75 4.11 0.00 0.00 0.00 
FBpp0311691 eEF1beta 6.67 -0.94 7.61 0.00 0.02 0.00 
FBpp0079542 eEF1delta 5.68 -1.16 6.84 0.00 0.00 0.00 
FBpp0305182 eEF2 -0.27 -0.29 0.02 0.62 0.59 0.97 
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FBpp0309768 eIF2alpha 1.73 1.73 0.00 0.00 0.00 1.00 
FBpp0075700 eIF2beta 0.66 0.34 0.32 0.03 0.24 0.27 
FBpp0307983 eIF2gamma 0.68 0.34 0.34 0.01 0.20 0.20 
FBpp0312226 eIF3a 0.92 0.40 0.51 0.01 0.23 0.13 
FBpp0086098 eIF3b 1.04 0.72 0.32 0.01 0.04 0.36 
FBpp0309235 eIF3c 0.90 0.51 0.39 0.00 0.06 0.15 
FBpp0088565 eIF3d1 1.23 0.72 0.51 0.00 0.06 0.17 
FBpp0075104 eIF3e 0.23 0.12 0.11 0.39 0.64 0.69 
FBpp0078532 eIF3f1 0.51 0.18 0.33 0.05 0.47 0.20 
FBpp0070430 eIF3g1 -0.39 -0.06 -0.33 0.20 0.83 0.28 
FBpp0089133 eIF3h 0.35 0.26 0.10 0.27 0.42 0.77 
FBpp0078689 eIF3i 0.68 0.81 -0.13 0.05 0.02 0.70 
FBpp0308512 eIF3j -0.39 -0.28 -0.12 0.40 0.55 0.80 
FBpp0071587 eIF3k 0.76 0.59 0.17 0.06 0.14 0.66 
FBpp0075754 eIF3l 0.44 0.38 0.05 0.07 0.11 0.82 
FBpp0308985 eIF3m 0.66 0.26 0.40 0.06 0.44 0.24 
FBpp0303628 eIF4A -1.07 -1.34 0.27 0.00 0.00 0.40 
FBpp0306017 eIF4E1 -0.88 0.10 -0.98 0.00 0.71 0.00 
FBpp0288389 eIF4G1 -1.77 -1.42 -0.35 0.00 0.00 0.22 
FBpp0072144 eIF6 -0.43 -0.16 -0.27 0.20 0.64 0.42 
FBpp0079496 Etl1 4.16 -1.37 5.52 0.00 0.00 0.00 
FBpp0310097 Fcp1 -1.86 4.13 -5.99 0.00 0.00 0.00 
FBpp0071892 Fib -1.09 -1.14 0.05 0.04 0.03 0.93 
FBpp0082574 FK506-bp1 -0.23 -0.61 0.38 0.62 0.20 0.42 
FBpp0307052 Fmr1 -2.95 -2.72 -0.24 0.00 0.00 0.65 
FBpp0304176 fmt -1.52 -0.65 -0.87 0.05 0.38 0.24 
FBpp0307786 fon -1.46 -1.33 -0.12 0.01 0.02 0.83 
FBpp0070463 fs(1)Ya -2.30 0.92 -3.23 0.01 0.26 0.00 
FBpp0294038 Fs(2)Ket 1.04 1.55 -0.50 0.00 0.00 0.12 
FBpp0080391 fzy -1.56 1.54 -3.11 0.00 0.00 0.00 
FBpp0290505 gammaCOP 0.11 -0.30 0.42 0.71 0.33 0.18 
FBpp0304827 gammaTub37C -1.49 -0.66 -0.83 0.00 0.09 0.04 
FBpp0304864 Gapdh2 -0.17 -0.98 0.82 0.86 0.31 0.40 
FBpp0079819 Ge-1 -0.42 -0.73 0.30 0.32 0.09 0.47 
FBpp0099923 GlyP -0.16 0.42 -0.58 0.83 0.58 0.45 
FBpp0305474 GlyS 0.33 0.14 0.18 0.45 0.74 0.67 
FBpp0078478 Gnf1 0.43 -0.23 0.67 0.16 0.43 0.03 
FBpp0080649 Grip71 -1.45 -0.63 -0.82 0.03 0.33 0.21 
FBpp0073672 Grip91 -3.03 -2.46 -0.56 0.00 0.00 0.40 
FBpp0072593 hfp -3.76 -2.83 -0.93 0.00 0.00 0.23 
FBpp0091111 His2A 2.59 1.78 0.81 0.00 0.00 0.15 
FBpp0091155 His2B 0.00 -1.04 1.03 1.00 0.08 0.08 
FBpp0091112 His3 2.59 1.52 1.06 0.00 0.00 0.01 
FBpp0306146 His4r 0.96 0.07 0.90 0.04 0.88 0.06 
FBpp0307465 hoip -1.21 -1.33 0.12 0.00 0.00 0.74 
FBpp0083702 HP1c -0.53 1.08 -1.61 0.36 0.07 0.01 
FBpp0084672 Hrb98DE -4.34 -3.63 -0.71 0.00 0.00 0.36 
FBpp0307982 Hsc70-4 0.01 -0.05 0.06 0.98 0.82 0.81 
FBpp0312157 Hsp26 -1.22 -1.46 0.24 0.03 0.01 0.65 
FBpp0312159 Hsp27 -1.54 -1.66 0.12 0.00 0.00 0.78 
FBpp0305095 Hsp83 -0.05 -0.53 0.48 0.89 0.19 0.23 
FBpp0289644 hyx 3.47 -1.15 4.63 0.00 0.00 0.00 
FBpp0073018 ida -0.22 2.30 -2.51 0.63 0.00 0.00 
FBpp0293679 Imp -1.82 -1.46 -0.36 0.00 0.02 0.53 
FBpp0086956 Iswi 3.23 3.81 -0.58 0.00 0.00 0.11 
FBpp0311371 Jafrac1 -1.47 -1.65 0.18 0.00 0.00 0.63 
FBpp0074650 Kap-alpha1 3.58 0.33 3.24 0.00 0.58 0.00 
FBpp0307568 Karybeta3 5.37 1.25 4.12 0.00 0.00 0.00 
FBpp0300573 kis -1.31 2.46 -3.77 0.00 0.00 0.00 
FBpp0312027 Klp10A 2.28 -1.40 3.68 0.00 0.01 0.00 
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FBpp0075282 l(3)72Ab 1.48 -1.09 2.57 0.01 0.05 0.00 
FBpp0081255 lds 1.11 -1.21 2.32 0.00 0.00 0.00 
FBpp0078561 lost -0.99 -0.92 -0.06 0.11 0.14 0.92 
FBpp0309608 lva -0.40 -1.01 0.61 0.47 0.08 0.27 
FBpp0087680 Mad1 -1.61 -1.98 0.36 0.02 0.01 0.59 
FBpp0076819 mad2 -1.58 0.78 -2.37 0.02 0.23 0.00 
FBpp0293270 mahj -2.91 -2.53 -0.38 0.00 0.00 0.39 
FBpp0306414 Map205 1.23 -0.79 2.02 0.00 0.03 0.00 
FBpp0087613 Map60 0.94 0.13 0.81 0.09 0.80 0.14 
FBpp0083244 mdlc 4.80 -1.25 6.05 0.00 0.00 0.00 
FBpp0079565 me31B -1.80 -0.07 -1.74 0.00 0.84 0.00 
FBpp0070749 Mlc-c -0.07 -1.26 1.19 0.90 0.03 0.04 
FBpp0301951 mod 2.97 0.19 2.78 0.00 0.71 0.00 
FBpp0072065 mr -1.04 1.65 -2.68 0.04 0.00 0.00 
FBpp0079802 mre11 -1.17 -0.78 -0.39 0.07 0.22 0.54 
FBpp0072830 msn 2.94 -2.49 5.43 0.00 0.00 0.00 
FBpp0293343 msps -1.88 -1.81 -0.07 0.00 0.00 0.82 
FBpp0310063 mts -2.01 -1.52 -0.49 0.00 0.02 0.43 
FBpp0290680 mu2 -0.64 -0.74 0.10 0.29 0.22 0.87 
FBpp0086999 muskelin -1.72 1.05 -2.76 0.00 0.01 0.00 
FBpp0297132 Nap1 2.24 1.30 0.94 0.00 0.01 0.04 
FBpp0306828 NAT1 -0.92 -1.06 0.14 0.21 0.15 0.84 
FBpp0309175 NO66 -1.30 -1.08 -0.22 0.00 0.02 0.60 
FBpp0305169 nocte -0.39 -0.63 0.25 0.27 0.08 0.48 
FBpp0309274 nonA -2.62 -1.69 -0.93 0.00 0.02 0.17 
FBpp0083625 Nop56 -1.63 -1.74 0.11 0.12 0.10 0.91 
FBpp0305035 Nopp140 -4.33 -3.91 -0.42 0.00 0.00 0.43 
FBpp0079710 Nup107 -1.34 -2.47 1.12 0.01 0.00 0.03 
FBpp0083695 Nup133 0.43 -1.41 1.83 0.29 0.00 0.00 
FBpp0074568 Nup205 -2.25 -2.10 -0.15 0.00 0.00 0.78 
FBpp0293235 Nup358 -0.34 0.12 -0.46 0.38 0.74 0.23 
FBpp0082998 Nup43 0.63 -1.71 2.34 0.38 0.02 0.00 
FBpp0087938 Nup44A 0.65 -1.32 1.97 0.22 0.02 0.00 
FBpp0085954 Nup75 -0.54 -1.26 0.72 0.31 0.02 0.18 
FBpp0085919 pAbp -0.78 0.02 -0.81 0.03 0.94 0.02 
FBpp0078405 Pcmt -2.32 -2.53 0.21 0.00 0.00 0.70 
FBpp0089395 PCNA -0.15 -1.52 1.37 0.86 0.09 0.12 
FBpp0079527 Pen 0.70 1.33 -0.63 0.03 0.00 0.04 
FBpp0293516 Pep -0.38 0.81 -1.19 0.49 0.16 0.04 
FBpp0303214 Pfdn6 1.72 0.27 1.46 0.01 0.64 0.02 
FBpp0305727 Phf7 2.40 -1.32 3.73 0.00 0.01 0.00 
FBpp0082177 pic 1.12 -0.16 1.29 0.01 0.66 0.00 
FBpp0305301 poe -0.80 -1.23 0.43 0.09 0.01 0.36 
FBpp0099722 polo 0.82 -0.02 0.84 0.08 0.96 0.07 
FBpp0081704 pont 2.96 0.31 2.65 0.00 0.36 0.00 
FBpp0082067 Pp1-87B -0.85 -1.11 0.26 0.05 0.01 0.54 
FBpp0308836 Pp2A-29B -1.46 -1.06 -0.40 0.00 0.03 0.39 
FBpp0312200 Pp4-19C -1.46 -0.08 -1.38 0.02 0.89 0.03 
FBpp0089154 PPP4R2r -0.47 2.72 -3.19 0.13 0.00 0.00 
FBpp0085902 Prp19 -0.32 1.59 -1.91 0.65 0.03 0.01 
FBpp0087124 Prp8 2.09 -0.44 2.53 0.00 0.13 0.00 
FBpp0308280 puf -0.33 2.64 -2.96 0.42 0.00 0.00 
FBpp0082932 Pxt -1.78 -1.79 0.01 0.00 0.00 0.98 
FBpp0083610 PyK -0.82 -0.91 0.09 0.15 0.11 0.86 
FBpp0304178 pzg -0.06 -0.45 0.40 0.90 0.35 0.41 
FBpp0309142 r -0.29 -0.46 0.17 0.28 0.10 0.53 
FBpp0311572 Rack1 1.02 1.06 -0.04 0.00 0.00 0.90 
FBpp0293866 rad50 0.79 0.37 0.42 0.02 0.26 0.21 
FBpp0305773 RAF2 -2.57 -1.32 -1.25 0.00 0.01 0.01 
FBpp0309151 Ran 2.48 1.49 0.99 0.00 0.00 0.03 
- Appendix - 
 
 194 
FBpp0312218 Ranbp9 4.53 -1.23 5.76 0.00 0.00 0.00 
FBpp0297357 RanBPM -0.35 2.17 -2.52 0.35 0.00 0.00 
FBpp0306292 RanGAP -1.19 -0.50 -0.70 0.00 0.17 0.06 
FBpp0302766 REG -1.29 0.46 -1.75 0.01 0.28 0.00 
FBpp0311247 rept 0.93 -0.25 1.18 0.01 0.48 0.00 
FBpp0079609 RfC3 0.85 0.43 0.42 0.01 0.13 0.14 
FBpp0311114 RfC38 0.92 0.41 0.51 0.00 0.11 0.05 
FBpp0073120 RfC4 0.49 0.18 0.32 0.09 0.53 0.26 
FBpp0085564 rig 1.32 1.47 -0.15 0.01 0.00 0.75 
FBpp0312064 rin -1.07 -0.51 -0.56 0.14 0.48 0.44 
FBpp0291753 Rm62 -1.99 -0.80 -1.19 0.01 0.23 0.08 
FBpp0085156 rod -1.07 -0.86 -0.21 0.11 0.20 0.75 
FBpp0302971 row -1.06 4.35 -5.41 0.02 0.00 0.00 
FBpp0081356 RpA-70 1.23 0.94 0.28 0.01 0.04 0.52 
FBpp0305226 RPA2 3.40 3.20 0.21 0.00 0.00 0.70 
FBpp0310183 RPA3 -0.53 -1.38 0.85 0.40 0.04 0.19 
FBpp0306039 RpL10 1.56 1.47 0.10 0.02 0.03 0.88 
FBpp0075764 RpL10Ab 0.74 0.95 -0.22 0.32 0.20 0.77 
FBpp0309436 RpL11 0.25 0.31 -0.06 0.56 0.47 0.89 
FBpp0072085 RpL12 0.74 0.74 0.00 0.16 0.16 1.00 
FBpp0302626 RpL13 1.17 1.23 -0.06 0.07 0.06 0.92 
FBpp0076359 RpL14 0.87 0.99 -0.12 0.16 0.11 0.84 
FBpp0300655 RpL15 0.53 0.25 0.29 0.42 0.71 0.67 
FBpp0311459 RpL17 -0.57 -0.02 -0.55 0.48 0.98 0.50 
FBpp0311286 RpL18 1.53 0.93 0.61 0.04 0.19 0.39 
FBpp0086103 RpL18A 0.82 0.74 0.07 0.14 0.18 0.89 
FBpp0089141 RpL19 -0.63 -0.36 -0.27 0.28 0.54 0.64 
FBpp0311640 RpL21 0.75 0.66 0.09 0.26 0.31 0.89 
FBpp0070143 RpL22 0.53 0.64 -0.11 0.40 0.31 0.86 
FBpp0071808 RpL23 1.14 1.06 0.08 0.08 0.10 0.89 
FBpp0072687 RpL23A -0.26 0.29 -0.55 0.69 0.66 0.40 
FBpp0311573 RpL24 1.03 1.26 -0.23 0.10 0.05 0.71 
FBpp0305858 RpL26 1.72 1.66 0.06 0.01 0.01 0.92 
FBpp0303780 RpL27 0.80 0.77 0.03 0.24 0.25 0.96 
FBpp0311452 RpL27A 1.19 1.39 -0.20 0.10 0.06 0.78 
FBpp0297522 RpL28 0.05 -0.13 0.19 0.92 0.81 0.74 
FBpp0307759 RpL3 0.55 0.52 0.02 0.32 0.34 0.97 
FBpp0309280 RpL30 1.77 1.76 0.01 0.01 0.01 0.99 
FBpp0087610 RpL31 -0.49 -0.42 -0.07 0.41 0.47 0.91 
FBpp0308319 RpL34b 0.44 1.63 -1.19 0.57 0.04 0.13 
FBpp0078416 RpL35A -0.90 -0.58 -0.32 0.17 0.37 0.62 
FBpp0084617 RpL4 0.56 0.86 -0.30 0.30 0.12 0.58 
FBpp0306837 RpL40 -0.82 -0.43 -0.39 0.02 0.21 0.26 
FBpp0311121 RpL5 0.08 0.58 -0.50 0.89 0.31 0.38 
FBpp0085166 RpL6 -0.31 0.29 -0.60 0.70 0.72 0.46 
FBpp0310250 RpL7 0.98 1.13 -0.15 0.09 0.05 0.79 
FBpp0311460 RpL7A 0.81 1.11 -0.30 0.20 0.09 0.63 
FBpp0072802 RpL8 0.36 0.58 -0.22 0.53 0.31 0.70 
FBpp0309201 RpL9 0.84 1.05 -0.21 0.21 0.12 0.75 
FBpp0306232 RpLP0 -0.29 0.21 -0.50 0.59 0.70 0.36 
FBpp0304265 RpLP1 0.26 0.50 -0.24 0.56 0.26 0.58 
FBpp0086252 RpLP2 0.01 0.27 -0.26 0.97 0.56 0.58 
FBpp0074662 Rpn1 1.34 -0.07 1.41 0.05 0.91 0.04 
FBpp0078664 Rpn11 0.19 -0.64 0.83 0.82 0.45 0.32 
FBpp0075068 Rpn12 -1.43 -1.94 0.51 0.01 0.00 0.28 
FBpp0306599 Rpn2 0.09 0.35 -0.26 0.88 0.57 0.68 
FBpp0078278 Rpn5 1.22 1.23 -0.01 0.01 0.01 0.99 
FBpp0310720 RpS10b 0.74 0.91 -0.18 0.06 0.02 0.65 
FBpp0087115 RpS11 0.63 0.41 0.22 0.12 0.30 0.57 
FBpp0075612 RpS12 0.58 0.48 0.10 0.07 0.12 0.74 
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FBpp0312104 RpS13 0.42 0.35 0.06 0.60 0.66 0.94 
FBpp0311458 RpS14b 0.98 0.52 0.46 0.00 0.10 0.14 
FBpp0086270 RpS15 0.64 0.62 0.02 0.05 0.06 0.95 
FBpp0290052 RpS15Aa 0.87 1.27 -0.39 0.05 0.01 0.35 
FBpp0309759 RpS16 0.32 0.34 -0.02 0.34 0.31 0.96 
FBpp0076207 RpS17 0.35 0.79 -0.45 0.64 0.29 0.55 
FBpp0085586 RpS18 -0.32 -0.36 0.04 0.31 0.25 0.90 
FBpp0311350 RpS19a 0.58 0.52 0.06 0.12 0.16 0.88 
FBpp0311561 RpS2 1.18 1.06 0.12 0.01 0.02 0.78 
FBpp0083371 RpS20 0.44 0.87 -0.43 0.43 0.12 0.44 
FBpp0271801 RpS21 1.07 0.92 0.15 0.00 0.00 0.61 
FBpp0308991 RpS23 1.29 1.01 0.28 0.00 0.01 0.42 
FBpp0071846 RpS24 1.89 1.94 -0.05 0.00 0.00 0.89 
FBpp0081846 RpS25 1.05 1.25 -0.20 0.00 0.00 0.54 
FBpp0312181 RpS26 0.73 0.38 0.34 0.02 0.19 0.23 
FBpp0293236 RpS27 1.10 0.90 0.20 0.01 0.02 0.59 
FBpp0310057 RpS28b 0.76 0.70 0.06 0.01 0.02 0.81 
FBpp0306740 RpS29 2.88 2.36 0.51 0.00 0.00 0.27 
FBpp0312066 RpS3 1.04 0.86 0.17 0.00 0.00 0.54 
FBpp0300615 RpS3A -0.87 -0.98 0.11 0.02 0.01 0.75 
FBpp0312080 RpS4 -0.17 0.05 -0.23 0.53 0.85 0.42 
FBpp0311353 RpS5a 1.43 0.63 0.80 0.09 0.44 0.33 
FBpp0082465 RpS5b 0.12 -0.47 0.58 0.83 0.39 0.28 
FBpp0071087 RpS6 1.14 1.04 0.11 0.00 0.00 0.72 
FBpp0308324 RpS7 0.35 0.59 -0.23 0.27 0.07 0.46 
FBpp0311987 RpS8 0.52 0.60 -0.07 0.08 0.05 0.80 
FBpp0309532 RpS9 0.82 0.75 0.06 0.00 0.01 0.80 
FBpp0088021 Rpt1 0.52 0.02 0.49 0.24 0.96 0.26 
FBpp0293948 Rpt4 -0.99 0.39 -1.39 0.31 0.68 0.16 
FBpp0081601 rump -1.20 -0.16 -1.03 0.00 0.62 0.00 
FBpp0311988 Sec13 -0.09 -1.66 1.57 0.88 0.01 0.02 
FBpp0311417 Sec31 -0.68 -0.07 -0.62 0.15 0.89 0.19 
FBpp0082521 Set -0.39 -0.15 -0.23 0.66 0.86 0.79 
FBpp0293269 SF2 -1.73 -1.36 -0.37 0.01 0.05 0.57 
FBpp0291704 Sh3beta -3.05 -0.41 -2.65 0.00 0.53 0.00 
FBpp0073893 shtd -0.52 1.89 -2.41 0.17 0.00 0.00 
FBpp0311474 SkpA -1.87 -1.80 -0.07 0.00 0.00 0.89 
FBpp0081710 sle 2.18 -0.37 2.55 0.00 0.45 0.00 
FBpp0081234 SmD2 -2.60 -1.79 -0.81 0.00 0.00 0.07 
FBpp0087094 SmD3 1.00 -0.26 1.25 0.05 0.60 0.02 
FBpp0079182 SmE -0.80 -2.42 1.62 0.30 0.00 0.04 
FBpp0302954 Smn 0.21 -0.52 0.72 0.79 0.51 0.36 
FBpp0078984 smt3 -2.64 -1.45 -1.20 0.00 0.03 0.07 
FBpp0075122 spd-2 -1.87 -1.33 -0.54 0.01 0.04 0.38 
FBpp0072151 Ssrp 1.42 0.26 1.16 0.00 0.43 0.00 
FBpp0308666 sta 1.04 0.86 0.17 0.00 0.01 0.59 
FBpp0079252 Su(var)205 1.17 0.42 0.74 0.03 0.42 0.16 
FBpp0309241 sub 1.58 0.08 1.50 0.00 0.83 0.00 
FBpp0311329 Svil-RW -0.84 -2.13 1.29 0.09 0.00 0.01 
FBpp0309319 sw-RO -2.29 -1.50 -0.79 0.00 0.05 0.29 
FBpp0081154 Tailor 2.10 -0.74 2.84 0.00 0.04 0.00 
FBpp0310395 TER94 -3.28 -2.72 -0.57 0.00 0.00 0.50 
FBpp0082180 timeout -2.16 4.46 -6.61 0.00 0.00 0.00 
FBpp0305284 tou -1.01 2.16 -3.17 0.02 0.00 0.00 
FBpp0310608 TppII 0.50 0.09 0.41 0.15 0.79 0.24 
FBpp0304887 tral -0.99 0.55 -1.54 0.00 0.04 0.00 
FBpp0309477 Ubqn -1.38 3.73 -5.11 0.00 0.00 0.00 
FBpp0290875 Vha55 0.09 -0.57 0.66 0.87 0.31 0.24 
FBpp0112266 vig2 0.83 0.50 0.34 0.10 0.31 0.49 
FBpp0072691 Vta1 3.72 0.21 3.51 0.00 0.64 0.00 
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FBpp0308553 wde -1.28 0.31 -1.59 0.02 0.54 0.00 
FBpp0306779 woc -1.24 4.22 -5.46 0.00 0.00 0.00 
FBpp0312020 Yp1 -1.38 -0.99 -0.39 0.01 0.04 0.39 
FBpp0308710 Yp2 -1.55 -1.33 -0.23 0.00 0.00 0.58 
FBpp0311924 Yp3 -1.83 -1.46 -0.38 0.00 0.00 0.35 
FBpp0075759 yps -0.50 0.96 -1.46 0.21 0.02 0.00 
FBpp0070425 Zw10 -2.19 -1.99 -0.20 0.00 0.00 0.75 
FBpp0085138 Zwilch -0.95 -1.83 0.88 0.25 0.03 0.29 
 
 
b) 8E3 – control  
 
Flybase 
polypeptide 
ID 
Flybase 
symbol 
difference 
8E3-con 
p-value 
8E3-con 
Flybase 
polypeptide 
ID 
Flybase 
symbol 
difference 
8E3-con 
p-value 
8E3-con 
FBpp0085065 - -0.74 0.25 FBpp0310551 mahe 0.67 0.42 
FBpp0300412 - -0.78 0.17 FBpp0085235 Map205 -0.49 0.53 
FBpp0304748 - -1.15 0.03 FBpp0289639 Mapmodulin 0.01 0.98 
FBpp0308925 - -0.86 0.08 FBpp0293580 mask -0.39 0.52 
FBpp0082987 14-3-3epsilon -0.81 0.09 FBpp0311400 mats -0.74 0.12 
FBpp0305137 14-3-3zeta -0.13 0.79 FBpp0300535 Mbs 0.01 0.99 
FBpp0075508 26-29-p -0.42 0.58 FBpp0081317 Mcm2 -0.07 0.88 
FBpp0085204 Acf 8.08 0.00 FBpp0081756 Mcm5 -0.61 0.20 
FBpp0071448 Act57B -1.44 0.02 FBpp0070913 Mcm6 -0.18 0.71 
FBpp0311818 Act5C -1.35 0.01 FBpp0290646 MCPH1 0.81 0.39 
FBpp0100051 Adh -1.47 0.01 FBpp0311560 Mdh1 -1.48 0.02 
FBpp0086845 AGBE -1.46 0.02 FBpp0079565 me31B 0.09 0.82 
FBpp0312000 Ahcy -1.60 0.03 FBpp0085809 MetRS -0.23 0.70 
FBpp0087757 AIMP1 0.78 0.23 FBpp0081882 mgr -1.18 0.27 
FBpp0075318 AIMP2 0.49 0.34 FBpp0297606 Mlf 1.71 0.02 
FBpp0309215 Akap200 3.03 0.00 FBpp0301951 mod 3.12 0.00 
FBpp0308680 Ald -1.20 0.04 FBpp0082692 mor 1.45 0.06 
FBpp0084610 ALiX 0.95 0.60 FBpp0072065 mr 2.38 0.00 
FBpp0305102 alpha-Spec 0.30 0.71 FBpp0076408 msk -0.79 0.18 
FBpp0076122 alphaTub67C -0.91 0.06 FBpp0293342 msps -0.86 0.17 
FBpp0081153 alphaTub84B -0.46 0.29 FBpp0304737 Mtor 0.54 0.41 
FBpp0290266 AMPdeam 3.62 0.00 FBpp0310063 mts 0.07 0.89 
FBpp0307770 AnxB9 -2.48 0.08 FBpp0305424 mub 0.22 0.70 
FBpp0082065 Aos1 -0.87 0.10 FBpp0111603 mute -1.05 0.03 
FBpp0301606 APC4 2.53 0.00 FBpp0311394 Nacalpha -0.19 0.67 
FBpp0070907 APC7 0.17 0.72 FBpp0297132 Nap1 0.39 0.36 
FBpp0311464 apolpp -0.44 0.47 FBpp0306828 NAT1 -0.06 0.89 
FBpp0305852 Arf102F 0.07 0.88 FBpp0311231 ncd 0.99 0.06 
FBpp0304364 Arf79F -0.52 0.37 FBpp0309711 Nedd8 -1.62 0.02 
FBpp0076271 Argk -2.38 0.01 FBpp0305289 NHP2 1.33 0.02 
FBpp0073965 ArgRS 0.01 0.98 FBpp0309274 nonA 0.17 0.81 
FBpp0079751 Art8 -1.13 0.29 FBpp0078997 nop5 -0.26 0.63 
FBpp0304830 AsnRS -0.97 0.05 FBpp0083625 Nop56 0.86 0.25 
FBpp0084071 asp -0.16 0.71 FBpp0290083 Nop60B 1.52 0.22 
FBpp0304013 AspRS-m 0.88 0.08 FBpp0305034 Nopp140 1.05 0.06 
FBpp0308483 AspRS -0.38 0.46 FBpp0308486 Not1 0.19 0.80 
FBpp0289825 ATPCL -1.41 0.02 FBpp0112220 Nph -1.84 0.09 
FBpp0311086 ATPsynbeta 1.07 0.03 FBpp0312079 Nplp2 0.23 0.85 
FBpp0082555 Atx2 -0.88 0.15 FBpp0297079 nudC -1.29 0.04 
FBpp0312191 awd -0.22 0.70 FBpp0310208 Nup160 0.01 0.98 
FBpp0300517 B52 1.84 0.00 FBpp0074568 Nup205 0.31 0.65 
FBpp0307124 Bacc 0.77 0.17 FBpp0293235 Nup358 -0.24 0.69 
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FBpp0305308 baf 1.61 0.07 FBpp0073659 Nup93-1 -0.17 0.79 
FBpp0086115 Bap55 -0.49 0.28 FBpp0306915 Nup98-96 0.80 0.59 
FBpp0306433 bel -0.23 0.65 FBpp0271761 Nurf-38 -0.80 0.09 
FBpp0305067 ben -0.76 0.14 FBpp0072061 or -1.39 0.08 
FBpp0080048 beta'COP 0.92 0.16 FBpp0082329 Orc2 1.10 0.15 
FBpp0074348 betaCOP 0.31 0.61 FBpp0086882 Orc3 2.08 0.02 
FBpp0085720 betaTub56D -0.96 0.03 FBpp0072330 Orc4 1.08 0.04 
FBpp0082428 BigH1 1.43 0.00 FBpp0080120 Orc5 2.15 0.03 
FBpp0071794 blw -0.42 0.61 FBpp0300672 p23 -0.49 0.41 
FBpp0304073 Bruce 3.65 0.00 FBpp0085919 pAbp -0.51 0.32 
FBpp0308293 Bub3 1.93 0.01 FBpp0073976 Paf-AHalpha 2.63 0.18 
FBpp0085368 BubR1 2.34 0.00 FBpp0305933 Paics 0.02 0.98 
FBpp0309346 cactin 1.19 0.25 FBpp0308411 PAN2 0.08 0.86 
FBpp0071172 Caf1-180 0.88 0.11 FBpp0112608 Parp 2.09 0.01 
FBpp0082511 Caf1-55 0.20 0.69 FBpp0078405 Pcmt -1.52 0.02 
FBpp0311269 Cam -0.73 0.22 FBpp0089395 PCNA -0.27 0.64 
FBpp0304507 Cand1 -0.75 0.13 FBpp0086647 pea -1.27 0.01 
FBpp0084818 Cap-D2 0.81 0.14 FBpp0079527 Pen -0.13 0.79 
FBpp0099391 capt -1.16 0.04 FBpp0293516 Pep 0.88 0.31 
FBpp0083684 CCT1 -0.43 0.29 FBpp0304954 Pfdn2 0.02 0.98 
FBpp0071226 CCT2 -0.82 0.08 FBpp0293464 Pfk -1.19 0.12 
FBpp0291566 CCT3 -0.44 0.26 FBpp0303827 Pgd -0.09 0.93 
FBpp0079992 CCT4 -0.41 0.34 FBpp0087762 Pgi -0.58 0.42 
FBpp0087095 CCT5 -0.31 0.54 FBpp0306279 Pgk -2.10 0.02 
FBpp0073902 CCT6 -1.39 0.15 FBpp0099920 Pglym78 -1.80 0.02 
FBpp0081401 CCT7 -1.10 0.10 FBpp0075247 Pgm 0.63 0.64 
FBpp0087764 CCT8 -0.90 0.10 FBpp0301844 PI31 0.23 0.86 
FBpp0083769 Cdc16 2.30 0.01 FBpp0082177 pic -0.34 0.42 
FBpp0305185 Cdc23 2.58 0.00 FBpp0076285 pix 0.95 0.40 
FBpp0305561 Cdc27 2.67 0.00 FBpp0310466 Plap -0.74 0.19 
FBpp0076371 Cdc6 0.17 0.87 FBpp0305301 poe 0.48 0.29 
FBpp0079641 Cdk1 -0.34 0.40 FBpp0099722 polo -0.01 0.99 
FBpp0308475 ced-6 0.28 0.55 FBpp0081704 pont -1.16 0.26 
FBpp0306293 CG10237 -1.06 0.09 FBpp0082067 Pp1-87B -0.11 0.81 
FBpp0075686 CG10418 0.33 0.55 FBpp0301546 Pp2B-14D -0.83 0.11 
FBpp0311825 CG10576 -1.30 0.05 FBpp0312200 Pp4-19C 3.09 0.00 
FBpp0292528 CG11089 -0.75 0.40 FBpp0089154 PPP4R2r 3.30 0.00 
FBpp0112044 CG11486 -0.63 0.37 FBpp0303849 PpV 1.01 0.06 
FBpp0084759 CG11899 0.06 0.95 FBpp0082062 Prosalpha2 -0.14 0.77 
FBpp0072658 CG12018 -0.84 0.51 FBpp0086067 Prosalpha5 0.16 0.70 
FBpp0078279 CG1218 0.54 0.55 FBpp0310201 Prosalpha6 0.19 0.69 
FBpp0083036 CG12321 0.18 0.80 FBpp0086400 Prosbeta1 -0.31 0.42 
FBpp0302006 CG13185 1.70 0.34 FBpp0075382 Prosbeta2 -0.47 0.26 
FBpp0070154 CG13364 -0.65 0.18 FBpp0087320 Prosbeta5 0.81 0.30 
FBpp0307859 CG1354 -1.17 0.03 FBpp0075119 Prosbeta6 -0.38 0.39 
FBpp0085260 CG1416 -0.94 0.10 FBpp0078449 Prosbeta7 2.00 0.15 
FBpp0308525 CG1440 -0.31 0.82 FBpp0085902 Prp19 1.39 0.02 
FBpp0079879 CG14945 -1.45 0.01 FBpp0087124 Prp8 2.34 0.06 
FBpp0087535 CG1513 5.97 0.00 FBpp0308280 puf 4.88 0.00 
FBpp0112211 CG1646 1.31 0.36 FBpp0082932 Pxt -0.99 0.11 
FBpp0297346 CG17018 -0.14 0.84 FBpp0083611 PyK -0.80 0.09 
FBpp0085374 CG17337 -1.52 0.02 FBpp0297295 qua -0.42 0.76 
FBpp0311847 CG18067 0.89 0.20 FBpp0309142 r -0.01 0.98 
FBpp0271746 CG18190 -0.62 0.21 FBpp0083414 Rab11 -1.57 0.02 
FBpp0072674 CG2021 0.54 0.27 FBpp0303520 Rab5 -0.46 0.32 
FBpp0304657 CG2061 -1.27 0.03 FBpp0311572 Rack1 0.70 0.32 
FBpp0311613 CG2852 -0.87 0.10 FBpp0071600 Rae1 -0.84 0.15 
FBpp0307127 CG2862 1.41 0.01 FBpp0309151 Ran -1.00 0.06 
FBpp0290146 CG30122 3.77 0.00 FBpp0312218 Ranbp9 -0.50 0.41 
FBpp0291433 CG30382 -0.81 0.14 FBpp0297357 RanBPM 2.57 0.00 
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FBpp0307202 CG31549 0.04 0.98 FBpp0306292 RanGAP 0.34 0.44 
FBpp0110163 CG3689 -0.63 0.13 FBpp0311247 rept -0.41 0.42 
FBpp0081650 CG3909 0.36 0.46 FBpp0079609 RfC3 1.43 0.01 
FBpp0288574 CG42232 5.05 0.00 FBpp0311114 RfC38 0.36 0.58 
FBpp0310306 CG4747 -0.52 0.40 FBpp0073120 RfC4 1.01 0.07 
FBpp0079789 CG4751 3.58 0.00 FBpp0305319 rhea 0.00 1.00 
FBpp0077868 CG4858 0.26 0.86 FBpp0304185 RhoGDI -0.80 0.08 
FBpp0112210 CG4951 -0.69 0.22 FBpp0086441 Rif1 -0.79 0.42 
FBpp0309317 CG5174 -0.26 0.62 FBpp0312064 rin -0.23 0.61 
FBpp0084312 CG5913 3.18 0.03 FBpp0291753 Rm62 1.38 0.13 
FBpp0303937 CG6084 -1.71 0.01 FBpp0310006 rngo -0.32 0.68 
FBpp0083213 CG6195 -0.38 0.50 FBpp0079648 RnrL -0.52 0.34 
FBpp0079809 CG6287 -1.98 0.01 FBpp0087152 RnrS -0.81 0.13 
FBpp0080044 CG6523 -1.38 0.03 FBpp0085156 rod 1.35 0.17 
FBpp0307760 CG6693 1.45 0.05 FBpp0302971 row 5.35 0.00 
FBpp0309927 CG6907 0.73 0.26 FBpp0305404 Rox8 -0.74 0.15 
FBpp0088545 CG7730 1.12 0.13 FBpp0081356 RpA-70 0.42 0.42 
FBpp0303962 CG8003 -1.27 0.09 FBpp0305226 RPA2 0.53 0.38 
FBpp0081371 CG8036 -1.28 0.02 FBpp0310183 RPA3 0.57 0.31 
FBpp0081398 CG8223 -0.75 0.23 FBpp0084067 Rpb10 2.47 0.17 
FBpp0087733 CG8243 2.65 0.03 FBpp0296955 Rpi -1.22 0.07 
FBpp0087116 CG8858 0.60 0.56 FBpp0306039 RpL10 0.67 0.66 
FBpp0311963 CG9135 -0.96 0.07 FBpp0075764 RpL10Ab 1.47 0.18 
FBpp0072560 CG9149 -1.20 0.06 FBpp0309436 RpL11 1.15 0.29 
FBpp0072518 CG9205 4.29 0.00 FBpp0072085 RpL12 0.69 0.36 
FBpp0309269 CG9281 -0.44 0.32 FBpp0302626 RpL13 0.34 0.67 
FBpp0074708 CG9330 0.54 0.66 FBpp0078354 RpL13A 1.12 0.15 
FBpp0071449 CG9344 0.60 0.26 FBpp0076359 RpL14 0.43 0.51 
FBpp0305785 CG9674 0.31 0.77 FBpp0300655 RpL15 1.52 0.09 
FBpp0088471 chb 1.70 0.03 FBpp0311459 RpL17 1.32 0.32 
FBpp0308531 Chc -0.10 0.81 FBpp0311286 RpL18 0.38 0.72 
FBpp0301152 chic -1.40 0.04 FBpp0086103 RpL18A 0.41 0.71 
FBpp0083939 CHORD -0.70 0.59 FBpp0311640 RpL21 1.10 0.24 
FBpp0099657 Chrac-14 7.30 0.00 FBpp0071808 RpL23 -0.08 0.90 
FBpp0308688 Chrac-16 6.18 0.00 FBpp0072687 RpL23A 1.79 0.12 
FBpp0310070 cib -1.77 0.02 FBpp0311573 RpL24 1.22 0.26 
FBpp0311360 CkIIalpha 1.17 0.02 FBpp0303780 RpL27 1.98 0.12 
FBpp0305406 CkIIbeta 0.51 0.29 FBpp0311452 RpL27A 1.72 0.14 
FBpp0304514 cmet 0.03 0.96 FBpp0297522 RpL28 0.86 0.40 
FBpp0292516 CNBP -0.55 0.23 FBpp0309280 RpL30 2.61 0.07 
FBpp0307640 coro -1.15 0.08 FBpp0113047 RpL32 1.94 0.15 
FBpp0304020 cpb 0.70 0.68 FBpp0308319 RpL34b 1.42 0.15 
FBpp0080484 Cse1 -0.99 0.08 FBpp0311481 RpL36 1.06 0.16 
FBpp0083658 CSN6 0.23 0.72 FBpp0291726 RpL37A -0.37 0.61 
FBpp0087821 CSN7 -0.45 0.48 FBpp0084617 RpL4 0.93 0.27 
FBpp0086732 Ctf4 -1.09 0.07 FBpp0311121 RpL5 1.52 0.11 
FBpp0072562 Ctr9 -0.34 0.47 FBpp0310250 RpL7 1.54 0.16 
FBpp0312102 cup -1.60 0.10 FBpp0311460 RpL7A 2.07 0.15 
FBpp0074017 Cyp1 -1.29 0.02 FBpp0072802 RpL8 1.77 0.11 
FBpp0086373 CysRS 1.26 0.15 FBpp0306232 RpLP0 0.58 0.46 
FBpp0290739 D1 3.17 0.00 FBpp0304265 RpLP1 0.96 0.26 
FBpp0112438 Dbp80 -0.38 0.51 FBpp0086252 RpLP2 0.51 0.39 
FBpp0306615 dco 0.05 0.96 FBpp0074662 Rpn1 -0.89 0.19 
FBpp0305164 Dek -0.03 0.95 FBpp0305644 Rpn10 -0.48 0.27 
FBpp0291138 deltaCOP 0.33 0.60 FBpp0078664 Rpn11 -0.55 0.21 
FBpp0099688 Df31 -1.55 0.02 FBpp0075068 Rpn12 0.06 0.89 
FBpp0084783 dgt6 -0.97 0.40 FBpp0306599 Rpn2 0.64 0.34 
FBpp0099973 Dhpr -0.80 0.25 FBpp0307804 Rpn3 0.40 0.44 
FBpp0307849 Dhx15 -0.02 0.96 FBpp0078278 Rpn5 -0.01 0.99 
FBpp0082996 Dlc90F 2.40 0.03 FBpp0297513 Rpn6 0.27 0.63 
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FBpp0076830 DnaJ-1 0.12 0.78 FBpp0083687 Rpn7 -0.39 0.36 
FBpp0075277 DNApol-delta 0.24 0.59 FBpp0305141 Rpn8 -0.33 0.49 
FBpp0311418 Dp1 0.47 0.27 FBpp0083861 Rpn9 0.55 0.34 
FBpp0311783 dpa -0.55 0.21 FBpp0310720 RpS10b -0.05 0.92 
FBpp0072744 dre4 1.77 0.01 FBpp0087115 RpS11 1.29 0.06 
FBpp0086817 drk 0.01 0.99 FBpp0075612 RpS12 0.86 0.38 
FBpp0082223 Droj2 -0.51 0.26 FBpp0312104 RpS13 1.67 0.02 
FBpp0307166 Drp1 -0.47 0.54 FBpp0311458 RpS14b 0.78 0.20 
FBpp0079746 dUTPase -2.06 0.00 FBpp0086270 RpS15 0.89 0.63 
FBpp0311273 eEF1alpha1 -1.22 0.02 FBpp0309759 RpS16 0.19 0.73 
FBpp0311691 eEF1beta -0.65 0.14 FBpp0076207 RpS17 -0.20 0.68 
FBpp0079542 eEF1delta -0.80 0.14 FBpp0085586 RpS18 -0.62 0.53 
FBpp0305182 eEF2 -1.14 0.02 FBpp0311350 RpS19a 0.58 0.34 
FBpp0072082 eEF5 -1.42 0.06 FBpp0311561 RpS2 1.44 0.12 
FBpp0307824 eff 1.22 0.40 FBpp0308991 RpS23 0.89 0.23 
FBpp0310418 eIF1A -1.56 0.04 FBpp0071846 RpS24 1.10 0.17 
FBpp0309768 eIF2alpha -0.37 0.37 FBpp0081846 RpS25 0.07 0.92 
FBpp0075700 eIF2beta 0.64 0.27 FBpp0079606 RpS27A 0.48 0.31 
FBpp0307983 eIF2gamma -0.22 0.62 FBpp0310057 RpS28b 1.04 0.48 
FBpp0088565 eIF3d1 1.80 0.00 FBpp0306740 RpS29 0.68 0.39 
FBpp0075104 eIF3e 0.49 0.31 FBpp0312066 RpS3 0.67 0.28 
FBpp0078532 eIF3f1 -0.68 0.22 FBpp0311976 RpS30 0.74 0.42 
FBpp0078689 eIF3i -0.67 0.53 FBpp0300615 RpS3A 1.18 0.08 
FBpp0071587 eIF3k -0.19 0.68 FBpp0312080 RpS4 1.10 0.07 
FBpp0075754 eIF3l -0.93 0.08 FBpp0311353 RpS5a 1.59 0.06 
FBpp0303628 eIF4A -0.87 0.07 FBpp0071087 RpS6 0.55 0.58 
FBpp0288389 eIF4G1 -1.23 0.06 FBpp0308324 RpS7 0.24 0.73 
FBpp0301573 eIF5B 1.20 0.30 FBpp0311987 RpS8 1.46 0.06 
FBpp0311547 Eip55E -1.10 0.15 FBpp0309532 RpS9 1.18 0.33 
FBpp0088654 elg1 0.47 0.59 FBpp0311982 Rpt2 0.20 0.67 
FBpp0083354 EloB -0.46 0.25 FBpp0312031 Rpt3 -0.23 0.59 
FBpp0085725 EloC -0.54 0.31 FBpp0293948 Rpt4 -0.62 0.23 
FBpp0307426 Elp1 0.43 0.73 FBpp0083843 Rpt5 -0.61 0.26 
FBpp0305267 endos -1.22 0.03 FBpp0288680 Rrp1 1.76 0.04 
FBpp0077574 Eno -1.80 0.01 FBpp0081601 rump 0.27 0.73 
FBpp0304201 eRF1 0.06 0.89 FBpp0081088 Sas-4 0.59 0.64 
FBpp0079496 Etl1 0.36 0.47 FBpp0297362 SC35 0.43 0.33 
FBpp0099726 fabp -1.44 0.04 FBpp0306437 ScsbetaA 0.61 0.37 
FBpp0307371 FASN1 1.37 0.38 FBpp0074285 scu -0.54 0.45 
FBpp0310097 Fcp1 5.87 0.00 FBpp0082877 sds22 -0.74 0.13 
FBpp0081767 Fdh -1.15 0.06 FBpp0083932 Sec10 0.27 0.55 
FBpp0071892 Fib -0.45 0.32 FBpp0087723 Sec31 0.48 0.28 
FBpp0271718 Fis1 -0.03 0.96 FBpp0307454 SerRS -1.31 0.01 
FBpp0083551 fit -1.29 0.06 FBpp0089160 sgg -0.12 0.87 
FBpp0085703 Fkbp12 -0.93 0.12 FBpp0296963 Sgt -1.18 0.04 
FBpp0082574 Fkbp39 1.57 0.01 FBpp0291704 Sh3beta 2.11 0.01 
FBpp0309663 Fkbp59 -1.35 0.02 FBpp0305866 shi -0.64 0.29 
FBpp0311112 flfl 2.39 0.00 FBpp0070792 Shmt -0.14 0.89 
FBpp0075581 flr -1.66 0.01 FBpp0073893 shtd 2.06 0.00 
FBpp0300445 Fmr1 0.31 0.70 FBpp0311474 SkpA 1.19 0.25 
FBpp0304175 fmt 1.66 0.01 FBpp0081709 sle 1.48 0.00 
FBpp0290502 fon -1.46 0.02 FBpp0293061 SmB 1.44 0.35 
FBpp0070463 fs(1)Ya 0.40 0.47 FBpp0086591 SMC2 0.55 0.19 
FBpp0294038 Fs(2)Ket 0.62 0.16 FBpp0075684 SmD1 0.08 0.88 
FBpp0080391 fzy 3.69 0.00 FBpp0081234 SmD2 0.15 0.71 
FBpp0290505 gammaCOP -0.05 0.91 FBpp0079182 SmE -0.40 0.44 
FBpp0304827 gammaTub37 0.68 0.21 FBpp0078984 smt3 -1.50 0.03 
FBpp0099914 Gapdh1 -0.87 0.13 FBpp0078331 Snr1 0.30 0.65 
FBpp0304864 Gapdh2 -1.22 0.02 FBpp0075958 Sod1 -1.34 0.02 
FBpp0311558 Gdi -0.92 0.12 FBpp0075122 spd-2 0.29 0.63 
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FBpp0079819 Ge-1 -0.28 0.51 FBpp0297149 SpdS -0.84 0.10 
FBpp0077263 gkt -0.16 0.80 FBpp0301102 sqd -0.54 0.23 
FBpp0084240 GlnRS -0.01 0.99 FBpp0079471 Srp54 0.20 0.80 
FBpp0088858 glo 1.09 0.08 FBpp0076872 Srp54k 0.24 0.54 
FBpp0080489 glu 0.25 0.60 FBpp0076244 Srp68 0.31 0.44 
FBpp0083898 GluProRS 0.03 0.94 FBpp0079211 Ssb-c31a -0.03 0.96 
FBpp0099923 GlyP -0.64 0.18 FBpp0072151 Ssrp 2.87 0.00 
FBpp0082496 GlyS 0.60 0.21 FBpp0308666 sta -0.42 0.29 
FBpp0078478 Gnf1 0.73 0.23 FBpp0077790 Stip1 -1.20 0.07 
FBpp0075793 Grip163 0.26 0.73 FBpp0300967 Stlk 3.99 0.01 
FBpp0080649 Grip71 1.72 0.00 FBpp0307636 Strn-Mlck-RV 1.77 0.14 
FBpp0290523 Grip84 2.86 0.00 FBpp0079252 Su(var)205 0.83 0.10 
FBpp0073672 Grip91 2.78 0.00 FBpp0290871 Su(var)3-7 2.78 0.03 
FBpp0310520 grsm 0.31 0.57 FBpp0311334 SvilB -1.42 0.05 
FBpp0085855 GstE6 -0.49 0.65 FBpp0303744 swm 1.01 0.38 
FBpp0099646 GstS1 -0.59 0.32 FBpp0078372 Sym 0.59 0.60 
FBpp0302680 gw -1.73 0.06 FBpp0072050 Taldo -0.75 0.35 
FBpp0290108 Gyf -1.43 0.02 FBpp0081820 Tctp -1.38 0.03 
FBpp0078319 Hat1 -0.48 0.40 FBpp0087479 TER94 -0.75 0.14 
FBpp0073173 HDAC1 -0.23 0.63 FBpp0083355 TFAM 1.79 0.14 
FBpp0078756 Hel25E -1.02 0.13 FBpp0312095 ThrRS -0.99 0.08 
FBpp0078162 Hem 1.02 0.40 FBpp0082180 timeout 6.22 0.00 
FBpp0072593 hfp 0.28 0.52 FBpp0077346 toc -0.93 0.17 
FBpp0305905 HIP-R -0.81 0.18 FBpp0087193 tou 4.79 0.00 
FBpp0091111 His2A 2.24 0.05 FBpp0084948 Tpi -1.13 0.07 
FBpp0306426 His2Av 1.54 0.09 FBpp0310608 TppII 1.87 0.02 
FBpp0091155 His2B 0.35 0.38 FBpp0304887 tral 0.35 0.42 
FBpp0306146 His4r 1.46 0.01 FBpp0079437 Trx-2 -0.19 0.78 
FBpp0305939 HisRS -1.06 0.04 FBpp0071117 Trxr-1 -1.90 0.03 
FBpp0307711 HnRNP-K -0.05 0.91 FBpp0310349 Ts -0.23 0.64 
FBpp0307465 hoip -0.40 0.35 FBpp0312205 Tsf1 -1.11 0.03 
FBpp0301605 HP1b 3.52 0.00 FBpp0072097 tsr -1.11 0.04 
FBpp0083702 HP1c 4.40 0.00 FBpp0304417 Tudor-SN -0.98 0.15 
FBpp0297875 Hrb27C -0.91 0.07 FBpp0083956 twin 0.10 0.90 
FBpp0306562 Hrb87F -0.14 0.78 FBpp0311386 tws -0.21 0.67 
FBpp0084672 Hrb98DE -0.01 0.98 FBpp0076804 Txl -0.05 0.91 
FBpp0311376 Hsc70-3 -1.24 0.01 FBpp0075168 TyrRS -0.56 0.24 
FBpp0307982 Hsc70-4 -0.92 0.04 FBpp0305600 U2af38 -1.30 0.09 
FBpp0308990 Hsc70-5 -1.82 0.05 FBpp0298007 U2af50 -0.36 0.58 
FBpp0305265 Hsc70Cb -1.48 0.02 FBpp0087583 Uba1 -1.06 0.08 
FBpp0312157 Hsp26 -1.25 0.04 FBpp0076457 Uba2 -0.60 0.39 
FBpp0312159 Hsp27 -0.76 0.16 FBpp0309477 Ubqn 4.89 0.00 
FBpp0305095 Hsp83 -1.51 0.02 FBpp0292511 Uch -1.15 0.08 
FBpp0073018 ida 2.64 0.00 FBpp0311276 Uev1A -0.79 0.15 
FBpp0078152 IleRS 0.27 0.65 FBpp0290913 UGP -0.25 0.62 
FBpp0081861 Irbp -0.09 0.85 FBpp0311454 und 0.56 0.28 
FBpp0086956 Iswi 7.25 0.00 FBpp0087607 Updo -0.05 0.96 
FBpp0311371 Jafrac1 -1.65 0.01 FBpp0304059 Usp14 -0.64 0.15 
FBpp0307568 Karybeta3 -0.90 0.08 FBpp0298309 Usp5 0.08 0.94 
FBpp0289115 kis 4.57 0.00 FBpp0073474 Usp7 0.72 0.20 
FBpp0312027 Klp10A -0.11 0.81 FBpp0311933 Vha13 -0.19 0.82 
FBpp0309092 Klp3A 1.32 0.10 FBpp0086468 Vha36-1 -0.90 0.23 
FBpp0072616 Klp61F 2.20 0.03 FBpp0290875 Vha55 -0.82 0.07 
FBpp0078399 kra -0.38 0.59 FBpp0307597 Vha68-2 -1.66 0.01 
FBpp0080322 Ku80 1.00 0.21 FBpp0112266 vig2 -0.77 0.23 
FBpp0080906 La -0.01 0.98 FBpp0077625 Vps29 7.81 0.00 
FBpp0312110 Lam -0.85 0.06 FBpp0072691 Vta1 3.35 0.01 
FBpp0081255 lds -0.90 0.40 FBpp0300790 wds -0.09 0.87 
FBpp0311704 LeuRS -0.45 0.53 FBpp0289361 wech -0.39 0.39 
FBpp0073551 lic -0.63 0.18 FBpp0112025 wmd 1.37 0.40 
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FBpp0303481 lig -0.37 0.39 FBpp0306779 woc 5.41 0.00 
FBpp0088383 lola 1.23 0.61 FBpp0304606 x16 0.16 0.73 
FBpp0078561 lost 0.19 0.66 FBpp0303324 yem 0.32 0.78 
FBpp0310328 LSm7 1.82 0.05 FBpp0312020 Yp1 -0.66 0.18 
FBpp0309608 lva 0.86 0.45 FBpp0308710 Yp2 -1.09 0.03 
FBpp0292593 LysRS 0.14 0.78 FBpp0311924 Yp3 -0.84 0.11 
FBpp0087680 Mad1 -0.42 0.57 FBpp0075111 zetaCOP -0.08 0.95 
FBpp0076819 mad2 2.87 0.00 FBpp0085138 Zwilch -0.63 0.57 
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C. CHIP-SEQ PROFILES OF gH2A.V ON BAF-COUPLED FLYFOSMIDS  
(see VI.B.3) 
 
 
FIGURE 100: gH2A.V PROFILES FROM CHIP-SEQ ON A MIX OF CIRCULAR CONTROL FLYFOSMID AND 
EITHER CIRCULAR OR LIEARIZED TARGET FLYFOSMID PREINCUBATED WITH 0.1 µM OR 1 µM BAF, OR NO 
BAF (-) AS A CONTROL. UNCUT: BOTH FLYFOSMID ARE CIRCULAR; CUT: THE CONTROL FLYFOSMID IS 
CIRCULAR, THE TARGET FLYFOSMID IS LINEARIZED. SIGNALS WERE EITHER NORMALIZED TO THE READS ON 
THE TARGET FLYFOSMID OR TO THE CONTROL FLYFOSMID
  
  
 
 
 
